<SEC-DOCUMENT>0001159036-24-000024.txt : 20240315
<SEC-HEADER>0001159036-24-000024.hdr.sgml : 20240315
<ACCEPTANCE-DATETIME>20240315160604
ACCESSION NUMBER:		0001159036-24-000024
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		27
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240315
DATE AS OF CHANGE:		20240315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		24754726

	BUSINESS ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>halo-20240313.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:halo="http://www.halozyme.com/20240313" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20240313</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-2">0001159036</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-3">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-4">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20240313.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i869f1d465dff42fea57e8581b65450da_1"></div><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SCHEDULE 14A </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY STATEMENT PURSUANT TO SECTION 14(a) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:4.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Materials Pursuant to &#167;240.14a-12</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">Halozyme Therapeutics, Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Name of Registrant as Specified in Its Charter)</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Filing Fee (Check all boxes that apply):</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20240313_g1.jpg" alt="halologobwa09.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;15, 2024</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the 2024 Annual Meeting of Stockholders of Halozyme Therapeutics, Inc., which will be held on April&#160;25, 2024, at 12:00 p.m. Pacific Time. The meeting will be online only, so there is no physical meeting location.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notice of Annual Meeting of Stockholders and a Proxy Statement, which describes the formal business to be conducted at the meeting, follow this letter. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important that you use this opportunity to take part in the affairs of Halozyme Therapeutics, Inc. by voting on the business to come before this meeting. Whether or not you plan to attend the Annual Meeting online, we hope you vote as soon as possible to assure your representation. You can vote your shares over the Internet, by telephone or if you requested printed proxy material by mail, by using a traditional proxy card. Instructions on each of these voting methods are outlined in the enclosed proxy statement. Regardless of the number of shares you own, your careful consideration of, and vote on, the matters before our stockholders is important. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of Halozyme&#8217;s Annual Report on Form 10-K accompanies these proxy materials for your information. At the Annual Meeting, we will review Halozyme&#8217;s activities over the past year and our plans for the future. The Board of Directors and management look forward to seeing you at the Annual Meeting. </span></div><div style="margin-top:12.6pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely yours, </span></div><div style="padding-left:306pt;text-indent:-45pt"><img src="halo-20240313_g2.jpg" alt="htsignaturea10.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:188px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ELEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ORLEY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, M.B. Ch.B., M.R.C.P. </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">President and Chief Executive Officer</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:92.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_13">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_16">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_22">SOLICITATION AND VOTING</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_22">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_25">PROPOSAL NO. 1 - ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_25">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_28">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_28">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_31">PROPOSAL NO. 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_31">(SAY-ON-PAY)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_31">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_34">PROPOSAL NO. 3 - APPROVAL OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING EXCULPATION OF OFFICERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_34">23</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_37">PROPOSAL NO. 4 - RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_37">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_40">REPORT OF THE AUDIT COMMITTEE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_40">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_43">EXECUTIVE COMPENSATION AND RELATED INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_43">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_67">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_67">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_70">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_70">AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_70">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_73">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_73">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_76">TRANSACTION OF OTHER BUSINESS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_76">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_79">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i869f1d465dff42fea57e8581b65450da_79">60</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_13"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20240313_g1.jpg" alt="Image3.jpg" style="height:74px;margin-bottom:5pt;vertical-align:text-bottom;width:184px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12390 El Camino Real </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">San Diego, California 92130 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To Be Held on April&#160;25, 2024 </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO THE STOCKHOLDERS OF HALOZYME THERAPEUTICS, INC.: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the Annual Meeting of the Stockholders of Halozyme Therapeutics, Inc., a Delaware corporation, will be held on April&#160;25, 2024, at 12:00 p.m. Pacific Time. The meeting will be online only, so there is no physical meeting location. The Annual Meeting is being held for the following purposes: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect two Class II directors to hold office for a three-year term and until their respective successors are elected and qualified; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, by a non-binding advisory vote, the compensation of our Named Executive Officers;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve an amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding exculpation of officers; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be able to attend the Annual Meeting, submit questions and vote during the live webcast by visiting </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and entering the 16 digit control number included in your Notice of Internet Availability, on your proxy card, or voting instruction form, or in the instructions you received by email. Please refer to the additional logistical details and recommendations in the accompanying proxy statement. Only stockholders of record at the close of business on February&#160;26, 2024 are entitled to notice of, and to vote at, this Annual Meeting and any adjournment or postponement thereof. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR each of the nominees to the Board of Directors named in the accompanying Proxy Statement and FOR Proposals 2, 3 and 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20240313_g3.jpg" alt="Mark's signature.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:278px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;15, 2024</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Annual Meeting of Stockholder To Be Held on April&#160;25, 2024 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Proxy Statement and the 2023 Annual Report to Stockholders and the means to vote by Internet are available at www.proxyvote.com. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IMPORTANT: You are cordially invited to attend the virtual meeting online. Whether or not you expect to attend the virtual meeting online, please vote as soon as possible by using the Internet or telephone or for those receiving paper copies of these proxy materials by completing, signing, dating and mailing your proxy card in the accompanying postage-paid envelope. Even if you have voted by proxy, you may still vote in person if you attend the virtual meeting online. </span></td></tr></table></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying proxy is solicited on behalf of the Board of Directors of Halozyme Therapeutics, Inc., a Delaware corporation (&#8220;Halozyme&#8221; or the &#8220;Company&#8221;), for use at Halozyme&#8217;s Annual Meeting of Stockholders to be held online on April&#160;25, 2024 at 12:00 p.m. Pacific Time and at any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. This Proxy Statement, notice, the notice of internet availability of the proxy materials, and the proxy card are first being made available and/or mailed to stockholders on or about March&#160;15, 2024. </span></div><div id="i869f1d465dff42fea57e8581b65450da_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL MEETING AGENDA AND BOARD OF DIRECTORS VOTE RECOMMENDATIONS</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders are being asked to vote on each of the following items at the Annual Meeting:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The election of two Class II director nominees named in this Proxy Statement to the Board of Directors, each to serve a three-year term and until their respective successors are elected and qualified;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of a non-binding advisory resolution approving the compensation of our Named Executive Officers; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of an amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding exculpation of officers; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR the nominees to the Board of Directors named in this Proxy Statement and FOR Proposals 2, 3 and 4.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOLICITATION AND VOTING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only stockholders of record as of the close of business on February&#160;26, 2024, the record date for the Annual Meeting, will be entitled to vote at the meeting and any adjournment or postponement thereof. As of that date, we had 127,054,240 shares of common stock outstanding, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting. Each stockholder of record as of that date is entitled to one vote for each share of common stock held by him or her. Our Bylaws provide that a majority of all of the shares of the stock entitled to vote, whether present in person or represented by proxy, shall constitute a quorum for the transaction of business at the meeting. When a quorum is present at the meeting, all matters other than the election of directors and the proposed amendment to our certificate of incorporation to reflect Delaware law provisions regarding the exculpation of officers, will be determined by a majority in voting power of the shares present in person or represented by proxy and entitled to vote on the matter. The election of directors will be determined by a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter. The proposed amendment to our certificate of incorporation to reflect Delaware law provisions regarding the exculpation of officers will be determined by a majority in voting power of the shares outstanding on the record date. Votes for and against, abstentions and &#8220;broker non-votes&#8221; will each be counted as present for purposes of determining the presence of a quorum.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted by rules adopted by the Securities and Exchange Commission (&#8220;SEC&#8221;), we are furnishing our proxy statement, 2023 Annual Report to Stockholders and proxy card over the internet to most of our stockholders. This means that most of our stockholders will initially receive only a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy materials over the Internet. If you would like to receive a paper copy of the proxy materials, the Notice of Internet Availability of Proxy Materials contains instructions on how you can request copies of these documents at no cost to you.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting of Proxies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All valid proxies received before the meeting will be exercised. All shares represented by a proxy will be voted, and where a proxy specifies a stockholder&#8217;s choice with respect to any matter to be acted upon, the shares will be voted in accordance with that specification. If no choice is indicated on the proxy provided by a stockholder of record, the shares will be voted for the nominees and for proposals 2, 3 and 4. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may vote by attending the Annual Meeting online, by using the Internet or telephone to submit a proxy or by completing and returning a proxy by mail, if you requested printed proxy material by mail. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Internet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by Internet, go to </span><span style="background-color:#ffffff;color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Internet voting is available 24 hours a day, although your vote by Internet must be received by 11:59 p.m. Eastern Time on April 24, 2024. You will need the control number found either on the Notice of Internet Availability of Proxy Materials or on the proxy card if you are receiving a printed copy of these materials. If you vote by Internet, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the voting instruction form or notice provided to you by your broker, bank or other holder of record for Internet voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by telephone, call </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1-800-690-6903</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and follow the instructions. Telephone voting is available 24 hours a day, although your vote by telephone must be received by 11:59 p.m. Eastern Time on April 24, 2024. You will need the control number found on your Notice of Internet Availability of Proxy Materials, voting instruction form or on the proxy card if you are receiving a printed copy of these materials. If you vote by telephone, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the Notice of Internet Availability of Proxy Materials or voting instruction card provided to you by your broker, bank or other holder of record for telephone voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Mail.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If you requested printed proxy materials by mail, by completing, signing and returning the proxy card in the prepaid and addressed envelope enclosed with proxy materials delivered by mail, you are authorizing the individuals named on the proxy card to vote your shares at the Annual Meeting in the manner you indicate. You are encouraged to sign and return the proxy card even if you plan to attend the Annual Meeting so that your shares will be voted if you are unable to attend the Annual Meeting. If you receive more than one proxy card, it is an indication that your shares are held in multiple accounts. Please complete, sign and return all proxy cards to ensure that all your shares are voted. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Online During Annual Meeting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are entitled to participate in the Annual Meeting if you were a shareholder as of the close of business on February&#160;26, 2024, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. To be admitted to the Annual Meeting at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, you must enter the control number found on your Notice of Internet Availability of Proxy Materials, proxy card, or voting instruction form you previously received. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. The meeting&#8217;s virtual attendance format will provide you the ability to participate and ask questions in writing during the meeting. Whether or not you plan to participate in the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the methods described in the proxy materials for the Annual Meeting. If your shares are registered directly in your name with our transfer agent, EQ by Equiniti, you are considered the stockholder of record and you have the right to vote in person at the Annual Meeting. If your shares are held in the name of your broker or other nominee, you are considered the beneficial owner of shares held in &#8220;street name.&#8221; Beneficial owners whose stock is held in the name of a bank, broker or other nominee generally will receive instructions for voting from their banks, brokers or other nominees, rather than directly from us. You can vote your shares held through a bank, broker or other nominee by following the voting instructions sent to you by that institution. Shares for which you are the beneficial owner but not the stockholder of record may also be voted electronically during the Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revocability of Proxies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A stockholder giving a proxy has the power to revoke it at any time before it is exercised by delivering to the Secretary of Halozyme a written instrument revoking the proxy or by executing a duly executed proxy with a later date, or by attending the Annual Meeting online and voting in person.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker Non-Votes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A broker non-vote occurs when a broker submits a proxy card with respect to shares held in street name on behalf of a beneficial owner but is prohibited from voting on a particular matter because the broker has not received voting instructions from the beneficial owner and therefore does not have discretion to vote the beneficial owner&#8217;s shares with respect to that matter. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote such shares on routine matters, but not on non-routine matters. Routine matters include the ratification of our independent registered public accounting firm. Non-routine matters include the election of directors, the advisory vote on executive compensation matters and the proposed amendment to our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding officer exculpation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solicitation of Proxies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We will bear the entire cost of soliciting proxies for the upcoming meeting. In addition to soliciting stockholders by mail through our employees, we will request banks, brokers and other custodians, nominees and fiduciaries to solicit customers for whom they hold our stock and will reimburse them for their reasonable, out-of-pocket costs. We may use the services of our officers, directors and others to solicit proxies, personally or by telephone, without additional compensation.</span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a classified Board of Directors that currently consists of three Class I directors, two Class II directors and three Class III directors. Our directors are elected for a term of three years, with one class of directors up for election every year. At the 2024 Annual Meeting of Stockholders, we will be electing two Class II directors, while the Class III directors will be elected at the 2025 Annual Meeting of Stockholders and the Class I directors will be elected at the 2026 Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class II nominees recommended by the Board of Directors for election at the 2024 Annual Meeting are: Barbara Duncan and Mahesh Krishnan, M.D. Ms. Duncan is a current member of our Board of Directors and Dr. Krishnan is a new director nominee who, if elected, will join the Board of Directors following the 2024 Annual Meeting of Stockholders. Dr. Bizzari is not standing for re-election and his term will expire as of the meeting date. Based on Dr. Bizzari not standing for re-election, a vacancy is created with his Board seat. Dr. Krishnan was recommended to the chair of the Nominating and Corporate Governance Committee by Dr. Torley as a possible replacement candidate. He subsequently met with members of the Nominating and Corporate Governance Committee and then met with the other members of the Board of Directors. Based upon the Board&#8217;s assessment of his extensive industry experience as further described in this proxy statement, the Board recommended his nomination for election at the Annual Meeting. If elected, Ms. Duncan and Dr. Krishnan will serve as directors until our Annual Meeting in 2027 or until their successors are elected and qualified. If any nominee declines to serve or becomes unavailable for any reason, or if a vacancy occurs before the election (although we know of no reason to anticipate that this will occur), the proxies may be voted for such substitute nominees as our Board of Directors may designate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Majority Voting Standard</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that in any election of one or more directors at a meeting at which a quorum is present, other than in a contested election, each director shall be elected by the vote of a majority of the votes cast by the stockholders with respect to the director. If a director does not receive in an election, other than a contested election, a majority of the votes, the director must tender his or her resignation to the Board of Directors. Within 90 days after the date of the certification of the election results, the Nominating and Corporate Governance Committee of the Board of Directors (or other committee that may be designated by the Board of Directors) will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will promptly act on such committee&#8217;s recommendation and publicly disclose within four business days on a Current Report on Form 8-K filed with the SEC its decision and the rationale behind such decision.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a quorum is present at the meeting, election of each of the two nominees for Class II directors requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter. Abstentions and broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends a vote &#8220;FOR&#8221; each of the nominees named above.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Candidate Expertise Selection Criteria</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee, with input from the Board of Directors, has determined that the following areas of expertise are of particular importance in providing appropriate oversight of the Company&#8217;s business and operations. Accordingly, the Nominating and Corporate Governance Committee seeks candidates for the Board of Directors from diverse professional backgrounds in order to ensure that the Board of Directors is comprised of individuals possessing extensive expertise in one or more of the following areas:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Skill</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Rationale</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicine and Science</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a Company directly and indirectly involved in the development, approval and commercialization of drugs, expertise in medicine and science is a key to the ongoing assessment of potential new technologies we may acquire.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Business Leadership and Operations<br/></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in, and knowledge of, the pharmaceutical business contributes to deep understanding of business strategy, operations, key performance indicators and the competitive environment.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complementary Business/Industry Segment Experience</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diverse experience gained from adjacent and complementary industries contributes to identification and evaluation of new opportunities and ideas.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business experience adds to our understanding of diverse business environments, economic conditions and cultural perspectives that informs our global business initiatives and strategy.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human Capital Management</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of our strategy requires the development and retention of highly skilled and diverse set of leaders and team members.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance and Capital Markets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience overseeing financial transactions provides knowledge and skills necessary to evaluate and oversee the Company&#8217;s design and implementation of financial and capital allocation strategies.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M&amp;A</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in the identification, negotiation and execution of M&amp;A transactions provides knowledge to oversee the Company&#8217;s potential M&amp;A activities.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Management</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in risk management contributes to the identification, prioritization, assessment and mitigation of significant risk facing the company.</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its review of each director&#8217;s and director nominee&#8217;s professional experience and background, the Nominating and Corporate Governance Committee has determined that our current board members and director nominee possess expertise in the following areas noted below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Medicine and Science</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pharma Business Leadership and Operations</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Complementary Business/Industry Segment Experience</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">International Business</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Human Capital Management</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance and Capital Markets</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">M&amp;A</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey W. Henderson</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mahesh Krishnan, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie L. Matsui</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew L. Posard</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon responses received from each of our directors with respect to diversity, the Company&#8217;s Board of Directors is currently comprised of individuals from the following diverse backgrounds:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.187%"><tr><td style="width:1.0%"/><td style="width:62.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.003%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Diversity Matrix (As of March&#160;15, 2024)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Number of Directors</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Female</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Male</span></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part I: Gender Identity</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Directors</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part II: Demographic Background</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">African American or Black</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alaskan Native or Native American</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Asian</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hispanic or Latinx</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Native Hawaiian or Pacific Islander</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">White</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Two or More Races or Ethnicities</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To see our Board Diversity Matrix as of March 24, 2023, please see our proxy statement filed with the SEC on March 24, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Nominated for Election at the 2024 Annual Meeting</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Barbara Duncan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (age 59)<br/>Director Since: 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Audit Committee and Compensation Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Pharma Business Leadership and Operations, International Business, Finance and Capital Markets, M&amp;A</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Atea Pharmaceuticals, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fusion Pharmaceuticals, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ovid Therapeutics, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Aevi Genomics Medicine, Inc., Adaptimmune Therapeutics, plc, Immunomedics, Inc., Innoviva, Inc., Jounce Therapeutics, Inc., ObsEva S.A.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan brings over 16 years of pharmaceutical and biotechnology industry experience to the Board of Directors. She retired from Intercept Pharmaceuticals, Inc., a biopharmaceutical company, where she served as Chief Financial Officer and Treasurer from May 2009 to June 2016. From 2001 to 2009, Ms. Duncan held various senior leadership roles of increasing responsibility at DOV Pharmaceutical, Inc., a biotechnology company, including Chief Financial Officer and ultimately serving as Chief Executive Officer prior to DOV&#8217;s sale in 2010 to Euthymics Bioscience, Inc. Prior to joining DOV, Ms.&#160;Duncan served as Vice President of Corporate Finance&#8201;-&#8201;Global Healthcare at Lehman Brothers Inc. from 1998 to 2001, and as Director of Corporate Finance at SBC Warburg Dillon Read Inc. from 1994 to 1998. She also worked for PepsiCo, Inc. from 1989 to 1992 in its international audit division, and was a certified public accountant in the audit division of Deloitte &amp; Touche LLP from 1986 to 1989. Ms. Duncan received her BBA from Louisiana State University and her MBA from the Wharton School of the University of Pennsylvania.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, Ms. Duncan helped lead the operational and strategic plans of this biopharmaceutical company, including managing the buildout of international operations and preparing financial teams for commercial product launch. At DOV Pharmaceutical, Ms. Duncan developed and lead in the execution of strategic plans, restructured several of the company&#8217;s partnerships and led negotiations on licensing transactions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan&#8217;s gained extensive financing experience serving as Chief Financial Officer for two public biopharmaceutical companies. Through the successful execution of both private and public financings, Ms. Duncan&#8217;s leadership supported operations and strategic plans. Ms. Duncan managed all phases of Intercept&#8217;s initial public offering and following on offerings. Further, while serving as Chief Financial Officer at both Intercept and DOV Pharmaceutical, Ms. Duncan managed the investor relations function and research analyst and investment banking relationships. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan gained extensive M&amp;A experience in her role as Vice President at Lehman Brothers with an emphasis in the healthcare space. While at Lehman, Ms. Duncan reviewed potential merger opportunities, reviewed valuation work product and authored advisory presentations to assist clients in formulating strategic corporate structuring strategies. While serving as Chief Executive Officer of DOV Pharmaceutical, she led the execution of the company&#8217;s sale to Euthymics.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: As further described in Ms. Duncan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Ms. Duncan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) finance and capital markets, (iii) international business and (iv) M&amp;A. Ms. Duncan&#8217;s extensive industry and financial experience, including her experience as chief financial officer at public biopharmaceutical companies, combined with her business acumen and experience serving on other public biopharmaceutical boards, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Duncan should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Mahesh Krishnan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 53)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Candidate</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: N/A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Medicine and Science, Pharma Business Leadership &amp; Operations, Complimentary Business/Industry Segment Experience, International Business, Finance &amp; Capital Markets, M&amp;A</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Chinook Therapeutics, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mahesh Krishnan, M.D., brings more than 20 years of health care practitioner and biotechnology and health service industry experience to the Board of Directors. Since 2009, Dr. Krishnan has served in various roles at DaVita, Inc., a provider of kidney dialysis services, including service as the co-lead of DaVita Venture Group, the external innovation arm of DaVita, Inc., where he is responsible for strategic partnerships in technology and research and development at DaVita, as well as medical policy in Washington, D.C. Since May 2019, Dr. Krishnan has also served as DaVita&#8217;s Group Vice President of Research and Development and prior to that role, Dr. Krishnan served as DaVita&#8217;s first international Chief Medical Officer from 2015 to May 2019. From 2004 to 2009, Dr. Krishnan served in various roles at Amgen Inc., a multinational biopharmaceutical company, including serving as the Global Development Leader for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and as Executive Director, Medical Policy for all of Amgen&#8217;s domestic products. From 2000 to 2004, Dr. Krishnan was a practicing nephrologist at Virginia Nephrology Group. He earned his M.D. from Jefferson Medical College at Thomas Jefferson University and his B.S. in pre-medicine from The Pennsylvania State University. He also holds an M.P.H. from Johns Hopkins University and an M.B.A. in health care management from the Johns Hopkins Carey School of Business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science; and Complementary Business/Industry Segment Expertise</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishnan served as a practicing nephrologist at Virginia Nephrology Group where he managed daily operations. While at Amgen, he oversaw clinical trial execution for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and served as the executive director for medical policy and as the executive director for medical affairs. He also served as Vice President, Clinical Research and Publishing, Vice President Clinical Innovation and Public Policy and as Founding International Chief Medical Officer for DaVita during which time he was involved in a wide variety of operational and commercial functions for a premier nephrology health services company. As a Chief Medical Officer for DaVita he gained extensive experience in multi-site and international medical services delivery.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishan gained extensive experience in pharma business leadership and operations in his role as executive director, medical affairs at Amgen. While at Amgen, he developed and executed on the medical affairs and marketing plan for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and negotiated multiple label iterations with the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;). As global development leader for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> he also oversaw multiple aspects of the FDA regulatory advisory committee meetings and successfully implemented a large molecule manufacturing change clinical program. At DaVita, Dr. Krishnan served as the international chief medical officer and oversaw clinical, operational and safety performance for DaVita&#8217;s clinical healthcare operations in eleven countries. Dr. Krishnan has also authored two books on pharmaceutical sales training.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishnan currently serves as group vice president of DaVita Venture Group. In this capacity, he oversees corporate development and mergers and acquisitions. He has executed multiple industry partnerships including through the use of joint ventures, corporate spinouts and the founding of health care services, pharma, medical device and diagnostic companies. He has also overseen fundraising, venture capital investments in industry related companies and worked closely with corporate investor relations for capital market presentations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Dr. Krishnan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Dr. Krishnan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) complimentary business and industry experience, (iv) international business, (v) finance and capital markets, and (vi) M&amp;A. Dr. Krishnan&#8217;s extensive industry, financial and M&amp;A experience, including his experience in senior management positions in the biopharmaceutical industry, combined with his experience as a healthcare professional and his business acumen, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Dr. Krishnan should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Continuing in Office Until the 2025 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Jeffrey W. Henderson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(age 59)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2015</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Chair</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Audit Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, Complementary Business/Industry Segment Experience, International Business, Human Capital Management, Finance and Capital Markets, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Becton Dickinson and Company, a medical technology company</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fibrogen, Inc., a biotechnology company</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Qualcomm, Inc., a wireless communications and semiconductor company</span></div><div style="text-indent:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson brings nearly 30 years of financial, commercial and pharmaceutical industry expertise to the Board of Directors. He has served as President of JWH Consulting LLC, an investment and business advisory firm, since January 2018. From 2015 to 2019, he served as a Healthcare Advisory Director to Berkshire Partners LLC. Mr. Henderson previously served as the Chief Financial Officer of Cardinal Health, Inc., a multinational health care services company, from May 2005 to November 2014, and in an executive capacity until his retirement from Cardinal in August 2015. From 1998 to 2005, Mr. Henderson held various senior management positions at Eli Lilly and Company, a multinational pharmaceutical company, including President and General Manager, Eli Lilly Canada, Inc. and Controller and Treasurer of Eli Lilly, Inc. He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson gained deep experience in a broad range of business and operational topics during his nearly 10-year tenure as Chief Financial Officer for Cardinal Health, a $100 billion health care products and services company. During a portion of this tenure he was also responsible for commercial operations in China and Canada. These experiences built on prior expertise, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specifically gained in pharmaceuticals, when he served as general manager of Eli Lilly Canada and Controller/Treasurer of Eli Lilly Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Experience</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a member of the board of directors of Becton Dickinson, a leading global medical technology company, and during his time as an executive at Cardinal Health, Mr. Henderson has gained a deep exposure to, and experience in, key aspects of the medical device business and market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his almost 15 years experience as Chief Financial Officer at Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson gained extensive experience in finance and capital markets. During his tenure at Cardinal Health, the company acquired more than 30 companies, spun-off or sold multi-billion-dollar businesses and expanded into new geographic locations and market segments. During his time with the PE firm of Berkshire Partners, he was involved in the identification, evaluation and execution of multiple acquisition opportunities in the healthcare sector.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his positions as a Chief Financial Officer for Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson played a key role in risk identification and risk mitigation. Further, Mr. Henderson has been operationally accountable for commercial operations in both China (Cardinal Health) and Canada (Eli Lilly and Cardinal Health). These unique experiences in both staff and line roles enable a broad perspective on identifying potential risks and risk management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson has substantial experience leading organizations with multi-thousands of employees, including related aspects of organizational and compensation/incentive design.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  As further described in Mr. Henderson&#8217;s biography, the Nominating and Corporate Governance Committee believes Mr. Henderson has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) pharma business leadership and operations, (ii) complementary business and industry segment experience, (iii) international business, (iv) human capital management, (v) finance and capital markets, (vi) M&amp;A and (vii) risk management. Mr. Henderson&#8217;s extensive experience serving in executive leadership positions, including as Chief Financial Officer, with large publicly-traded healthcare and pharmaceutical corporations, combined with his business acumen and judgment, including his qualifications as an audit committee financial expert, provide our Board with valuable financial, strategic and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Mr. Henderson should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Connie L. Matsui</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 70)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2006</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Compensation Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management, Risk Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Artelo Biosciences, Inc., a biopharmaceutical company </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sutro Biopharma, Inc., a biopharmaceutical company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Matsui brings 30 years of pharmaceutical and biotech industry expertise to the Board of Directors. She retired from Biogen Idec Inc., a biotechnology company, in January 2009 as the Executive Vice President, Knowledge and Innovation Networks. She served as an Executive Committee member at both Biogen Idec and IDEC Pharmaceuticals, a predecessor of Biogen Idec. Among the many major roles she played after joining IDEC Pharmaceuticals in November 1992 was Senior Vice President, overseeing investor relations, corporate communications, human resources, project management and strategic planning. Prior to entering the biotechnology industry, Ms. Matsui worked for Wells Fargo Bank in general management, marketing and human resources. She received her BA and MBA from Stanford University.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Matsui gained deep experience in a broad range of business and operational topics during her tenure at IDEC Pharmaceuticals and then Biogen Idec, overseeing human resources, alliance management, investor relations, corporate communications, project management and strategic planning. In addition, she served as Collaboration Chair for the late stage development and commercialization of rituximab (tradenames: Rituxan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, MabThera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in partnership with Roche and Genentech, a position requiring strong alliance management and business expertise. She also served as project team leader for the late stage development and commercialization of Zevalin, the first FDA-approved radioimmunoconguate for the treatment of cancer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her Collaboration Chair position for rituximab, Ms. Matsui served as the IDEC member of the collaboration oversight team with counterparts from Roche, Genentech and Zenyaku Kogyo, responsible for progress on all aspects of late stage development, manufacturing, regulatory approval and global commercialization. In addition, as IDEC&#8217;s Project Leader for Zevalin, she worked with leadership at global partner Schering AG based in Germany and radioisotope supplier Nordion, which had nuclear facilities in Canada and Belgium. At Biogen Idec, she was directly responsible for staff teams based in the U.S. and Europe.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Matsui also led Human Resources at IDEC Pharmaceuticals and Biogen Idec, where key experiences included the growth of IDEC from a 100-employee R&amp;D entity to a 1,000-employee fully integrated biotech company and, ultimately, to 4,000 employees worldwide following the merger of equals between IDEC and Biogen. Prior to this position, Ms. Matsui also held various operating positions, including a senior Human Resources position in the banking industry, where experiences were gained in the area of human capital management and integration of merged and acquired entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Co-Integration lead for the Biogen IDEC merger of equals, Ms. Matsui was engaged in assessing merger feasibility and strategic acceleration potential and had a leading role in communication and implementation of merger plans. This experience included the divestiture of IDEC&#8217;s large scale manufacturing plant and successful integration by Genentech and, later on, assimilation of a small-molecule company in San Diego. Ms. Matsui has also guided multiple nonprofit mergers to optimization and facilitated the rapid assimilation of acquired banks and savings &amp; loans while at Wells Fargo.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her more than 30 years in the biotech industry, initially as an executive officer and then while serving on the board of directors for biotechnology and pharmaceutical companies, Ms. Matsui has provided guidance to companies in a highly regulated industry in managing and mitigating risks in the following areas: corporate restructuring, financing transactions, data communication, employee retention and ESG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Ms. Matsui&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Matsui has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business, (iii) human capital management, (iv) risk management and (v) M&amp;A. Ms. Matsui&#8217;s operational experience, including her extensive knowledge of the biotechnology industry, her service in other public company management teams and her prior business experience, combined with her business acumen and judgment, provide our Board with valuable management and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Ms. Matsui should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 61)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2014</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">President and Chief Executive Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Medicine and Science, Pharma Business Leadership and Operations, Human Capital Management, Finance and Capital Markets, Risk Management </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Quest Diagnostics Incorporated, a diagnostic information services company</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr Torley brings over 30 years of drug development, drug commercialization and general management expertise in pharmaceutical and biotechnology to the Board of Directors. She has served as Chief Executive Officer (&#8220;CEO&#8221;) of Halozyme since 2014, successfully leading the company through a critical strategic transition in 2019. Dr Torley previously served as Chief Commercial Officer at Onyx Pharmaceuticals from 2011-2013, leading the successful US launch for Kyprolis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Carfilzomib), until the acquisition of Onyx by Amgen in 2013. From 2002-2011 Dr Torley held several senior commercial positions at Amgen including Vice President and General Manager US Bone Health and Vice President and General Manager US Nephrology. In these positions she led the successful launches of Prolia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(denosumab) and Sensipar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (cinacalcet) and significantly grew Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Epoetin alfa) and Aranesp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(darbepoetin alfa) revenue. From 1997-2002 she held a range of senior sales and marketing leadership positions at Bristol Myers Squib. She began her industry career at Sandoz, which merged with Ciba-Geigy to become Novartis in 1996, where she held a range of positions of increasing responsibility in Clinical Development, culminating in the position of Vice President of Medical Affairs, responsible for overseeing the design and conduct of a broad portfolio of clinical studies across nephrology, rheumatology, oncology and CNS indications. She received her M.B.Ch.B. degree (US equivalent to MD) from the University of Glasgow, Scotland and her M.R.C.P from the Royal College of Physicians, Glasgow, Scotland. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley is a trained physician who while in clinical practice specialized in Internal Medicine and Rheumatology. She served in leadership positions at Sandoz/Novartis from1990 to 1997, most recently as Vice President, Medical Affairs where she oversaw the design and conduct of Phase 1 through 4 clinical studies across multiple disease areas. While at Sandoz/Novartis she led clinical development programs for new products being evaluated in organ transplantation and rheumatoid arthritis and wrote and submitted New Drug Application filings. She has led and played key strategic positions in multiple successful FDA Advisory Committee meetings including for Neoral</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cyclosporin) in Rheumatoid Arthritis, Neoral (cyclosporin) in Organ Transplantation, Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Epoetin alfa) in anemia in chronic renal failure and HyQvia (immune Globulin infusion 10% with Recombinant Human Hyaluronidase) in Primary Immune Deficiency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley gained deep experience in a broad range of business and operational topics in her commercial positions. In particular, as General Manager of Bone Health and Nephrology at Amgen and as Chief Commercial Officer at Onyx, she was responsible for hiring and leading sales and marketing organizations, including hiring and training a more than 650-person team for a new drug launch, working on policy topics related to her products and leading three successful new product launches. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley has substantial experience leading large organizations, ranging from 120 to approximately 700 people. Her human capital management experiences include hiring and successfully onboarding large new sales teams into an established culture and effective reorganizations as dictated by changes in strategy. She has a strong focus on and understanding of the important role organizational culture, diverse teams, talent development and accountability play in driving results and success. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance and Capital Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As CEO of Halozyme, Dr. Torley has gained experience in Finance and Capital Markets including direct experience with raising over $1.5 billion through follow-on offerings and through three convertible debt offerings, and executing two share repurchase programs resulting in approximately $1.3 billion in capital returned to stockholders to date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her position as CEO of Halozyme, Dr. Torley plays a key role in risk identification and mitigation. In addition, in her previous positions with other organizations as Chief Commercial Officer and General Manager in which she was accountable for commercial launches, a key accountability was risk identification and mitigation. This wide range of experiences enable a broad perspective on identifying potential risks and executing appropriate mitigations strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in her biography, the Nominating and Corporate Governance Committee believes Dr. Torley has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) human capital management, (iv) finance and capital markets and (v) risk management. Dr. Torley&#8217;s extensive commercial and operational experience, including successful launches of products, and her deep knowledge of the biotechnology industry and the competitive environment, her service as our Chief Executive Officer, combined with her business acumen and judgment, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide our Board with valuable commercial and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Dr. Torley should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Directors Continuing in Office Until the 2026 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Bernadette Connaughton</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 65)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2018</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Compensation Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Editas Medicine, Inc., a clinical stage biotechnology company</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zealand Pharma A/S, a biotechnology company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Syneos Health Inc., a biopharmaceutical services company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. From 2004 to October, 2017, she served in senior management position at Bristol-Myers Squibb Pharmaceutical Company, most recently served as president, China, Latin America, Central and Eastern Europe and Middle East. In this position, she developed the multi-year strategy for the successful commercialization of a number of oncology, virology and immunology products, including Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to serving in that role, Ms. Connaughton served as Bristol-Myers Squibb&#8217;s president, European Markets, Canada and Australia; president, Intercontinental; and president, Japan, Pacific Rim, Australia and Canada; senior vice president, Cardiovascular and Metabolic Business Unit, U.S.; and senior vice president, Primary Care Marketing, U.S. Ms. Connaughton also served on the European Federation of Pharmaceutical Industry Association, Patient Access and European Markets Committees from 2014 to 2016. She received her Bachelor of Arts from Johns Hopkins University and her Master of Business Administration from The Wharton School, University of Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Connaughton&#8217;s extensive experience in business and operations was developed during her 30-year career at Bristol-Myers Squibb where she built a consistent track record of achieving sales growth, improving profitability and transforming operational models in U.S. and international markets. She built expertise and demonstrated success across a wide range of therapeutic areas, including cardiovascular, metabolic diseases, virology and oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through her positions leading large global business regions for Bristol Myers Squibb, Ms. Connaughton brings deep experience in international markets. Specific achievements include developing and leading execution of the multi-year strategy for the successful commercialization of Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. She most recently served as President Intercontinental Region, which included China, Latin America, Central and Eastern Europe and Middle East. Other positions included President, European Markets, Canada and Australia; President, Intercontinental Region; and President, Japan, Pacific Rim, Australia and Canada.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of her senior management positions, Ms. Connaughton led diverse, cross-functional teams, building the capabilities to successfully develop and commercialize pharmaceutical products. She has broad experience selecting and developing talent and building high performance teams with the skills, motivation and culture to achieve sustainable results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in Ms. Connaughton&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Connaughton has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business and (iii) human capital management. Ms. Connaughton&#8217;s extensive operations and commercialization experience in the pharmaceutical industry including the development of successful commercialization strategies for a number of oncology products and her consistent track record of achieving sales growth provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Ms. Connaughton should serve as one of our directors.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Moni Miyashita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 68)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Nominating and Corporate Governance Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Complementary Business/Industry Segment Expertise, International Business, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Miyashita brings over 25 years of global experience leading business transformations and building new businesses through strategy, new business models, and mergers &amp; acquisitions. Since May 2019, she has served as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence computation. Prior to Valo Health, from August 2015 to May 2019, she was a Partner at Innosight Consulting, where she provided growth strategy consulting services for businesses in the biotech, healthcare and technology industries. From 2011 to 2015, she was a Senior Advisor at McKinsey where she advised senior executive leadership teams on executing strategic M&amp;A. Prior to McKinsey, she served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. She received her BS degree in marketing from the University of Colorado and her MBA from the University of Denver.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Ms. Miyashita joined Valo Health as Chief Strategy Officer where she develops and drives complex business models, building a disruptive technology platform, and applying it to drug discovery, clinical development, and strategic partnerships across a regulated pharmaceutical ecosystem. While serving as Partner at Innosight Consulting, she advised and supported CEOs and their executive leadership teams on disruptive growth strategies in the biotech and healthcare industries. While serving as Senior Advisor at McKinsey, Ms. Miyashita provided global advisory services on M&amp;A to executive and senior leadership teams across the pharmaceutical, biotech, and healthcare industries.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During her tenure as Vice President at IBM, Ms. Miyashita was a key architect in developing and executing M&amp;A globally, anchored on strategy, with successful deal flow, transaction execution and post-merger integration. This strategy and effort resulted in over 40 quarters of double-digit earnings per share growth and creating the highest revenue and market capitalization in IBM&#8217;s history. Prior to this position, Ms. Miyashita had executive positions in IBM Asia. While serving as Senior Advisor at McKinsey, Ms. Miyashita helped build McKinsey&#8217;s M&amp;A practice and provided global advisory services to executive and senior leadership teams in the Americas, Europe, and Asia on transforming and growing their businesses through M&amp;A.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Miyashita has extensive human capital management experience having led human capital integration efforts in over 100 acquisitions during her tenure as Vice President at IBM. In her prior roles at McKinsey and Innosight, she advised chief executive officers and executive leadership teams on human capital management matters as they transitioned their companies when executing transformational M&amp;A transactions or when transforming their core business. In her current role at Valo Health, she influences the human capital management needed to build a novel platform to accelerate drug discovery and development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During her tenure as Vice President at IBM, Ms. Miyashita was involved in over 100 acquisitions or transactions and multiple business carve outs for divestiture from IBM to other companies which included developing cross functional processes and approaches to manage risk. Under her leadership, cross functional teams prepared for and passed multiple business audits to ensure risk was identified, mitigated and managed for executing all acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Ms. Miyashita&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Miyashita has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) complementary business and industry experience, (ii) international business, (iii) human capital management, (iv) M&amp;A and (v) risk management. Ms. Miyashita&#8217;s extensive experience in developing and executing complex corporate transactions and her experience providing strategy execution advice to senior leadership teams provide our Board with valuable strategic and operational expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Miyashita should serve as one of our directors.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Matthew L. Posard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 56)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2013</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Nominating and Corporate Governance Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Medicine and Science, Complementary Business/Industry Segment Expertise, International Business, Human Capital Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DermTech, Inc. (Chairman), a precision dermatology company</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc., (Chairman) a development stage life sciences company </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Talis Biomedical, a developer of diagnostic tests for infectious diseases</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard brings over 30 years of general management and commercialization experience in the biotechnology and diagnostics industry to the Board of Directors. He is Founding Principal of Explore DNA, a life sciences executive consulting firm, a position he has held since March 2016. Since 2017, he has provided advisory services to CEOs for several emerging life sciences companies. From February 2017 to April 2018, Mr. Posard served as President and Chief Commercial Officer of GenePeeks, Inc., a genetic research company. From March 2015 to April 2016, he served as Chief Commercial Officer of Trovagene, Inc., a molecular diagnostic biotechnology company. From February 2006 to February 2015, he held various commercial and general management positions at Illumina, Inc., a genomics company focusing on DNA sequencing, including senior executive positions overseeing Global Sales, Marketing, and General Manager of Clinical and Consumer Genomics as well as New and Emerging Markets. Mr. Posard holds a BA degree in Management Science from the University of San Diego.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has deep expertise introducing novel and transformative products to medical and research markets while scaling organizations efficiently. He is a Founding Principal of Explore DNA and provides advisory services to executive officers of several emerging life sciences companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard adds to his biotech expertise with deep knowledge in the diagnostics area, having served in senior positions at Illumina, Biosite, Inc. and Gen-Probe, Inc. At Illumina he was part of the executive management team that led the company to its first $1 billion in revenue. At Biosite he was instrumental in the successful introduction of the company&#8217;s BNP congestive heart failure biomarker and its BNP co-marketing collaboration with Beckman Coulter. At Gen-Probe, Mr. Posard helped the company attain leading market positions in DNA probe-based infectious disease diagnostics and blood banking.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has extensive international business experience, having served as the Vice President of Global Sales for Illumina where he led an international commercial sales team. He also served as Senior Vice President and General Manager of Illumina&#8217;s Translational and Consumer Genomics and New and Emerging Markets business units and was responsible for over $100 million of sales growth in his first year in this position. This experience provided substantial exposure to commercial markets around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his senior commercial marketing positions with various companies, Mr. Posard has managed and led a number of large and diverse marketing teams. A seasoned executive in the genomics and life science space, Mr. Posard has extensive background in effectively scaling organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has served on the board of directors and in senior leadership positions at a variety of startup and emerging companies and has extensive experience in the area of mergers and acquisitions in the biotech and diagnostics space. In his position as advisor to senior executives of life science companies, he has provided guidance and effective consultation in the execution of strategic acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in his biography, the Nominating and Corporate Governance Committee believes Mr. Posard has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) medicine and science, (ii) complementary business and industry segment expertise, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) international business, (iv) human capital management and (v) M&amp;A. Mr. Posard&#8217;s general management, sales and marketing experience including the successful launch of products and management of sales operations provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Mr. Posard should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors (or &#8220;Board&#8221;) has determined that, other than Dr.&#160;Torley, each of Jeffrey W. Henderson, Bernadette Connaughton, Barbara Duncan, Mahesh Krishnan, M.D., Connie L. Matsui, Moni Miyashita, and Matthew L. Posard is an independent director within the meaning set forth under applicable rules of the NASDAQ Stock Market. Dr. Torley does not meet the requirements for director independence because she serves as the President and Chief Executive Officer of Halozyme</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has separated the Chief Executive Officer and Board Chair positions to: (i)&#160;provide a stronger corporate governance structure; (ii)&#160;improve overall Board effectiveness; and (iii)&#160;enhance communication between management and the Board. Mr. Henderson began serving as the non-employee Chair of the Board of Directors in May 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Tenure</span></div><div style="margin-top:4.5pt;text-align:center"><img src="halo-20240313_g4.jpg" alt="Board Tenure.jpg" style="height:412px;margin-bottom:5pt;vertical-align:text-bottom;width:616px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Sessions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent directors generally meet in executive session without management present each time the Board holds its regularly scheduled meetings. The Chair of the Board of Directors, acts as the presiding director for such executive sessions of independent directors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Meetings and Committees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors held ten meetings during the fiscal year ended December&#160;31, 2023. The Board of Directors has three standing committees: (i)&#160;Audit Committee; (ii)&#160;Compensation Committee; and (iii)&#160;Nominating and Corporate Governance Committee. During the last fiscal year, each director attended at least 75% of the total number of meetings of the Board for the period in which they served as a director and the committees of the Board on which such director served during that period. Our standing committees are currently comprised of the following directors:</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:5.873%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.933%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation <br/>&#160;Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating / Corporate <br/>Governance Committee</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.D. Ch.B., M.R.C.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Audit Committee are Jeffrey W. Henderson (Chair), Barbara Duncan and Matthew L. Posard. All members of the Audit Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market and Rule 10A-3 of the Exchange Act, and each of them is able to read and fundamentally understand financial statements. Mr. Henderson and Ms. Duncan are &#8220;audit committee financial experts,&#8221; as defined in the rules of the SEC. The Audit Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Audit Committee is to oversee our accounting and financial reporting processes and the functions of the Audit Committee include retaining our independent registered public accounting firm, reviewing its independence, reviewing and approving the planned scope of its annual audit, reviewing and approving any fee arrangements with our independent registered public accounting firm, overseeing its audit work, reviewing and pre-approving any non-audit services that may be performed by the independent registered public accounting firm, reviewing the adequacy of our accounting and financial controls, reviewing our critical accounting policies and reviewing, approving any related party transactions, overseeing the Company&#8217;s cybersecurity strategy, reviewing the Company&#8217;s cybersecurity risks and receiving periodic updates from management regarding cybersecurity. The Audit Committee held five meetings during the fiscal year ended December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information regarding the Audit Committee is set forth in the Report of the Audit Committee contained in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Compensation Committee are Bernadette Connaughton (Chair), Barbara Duncan and Connie Matsui. All members of the Compensation Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market, and qualify as non-employee directors as defined in Rule 16b-3 under the Securities Exchange Act. The Compensation Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Compensation Committee is to discharge the Board&#8217;s responsibilities relating to compensation and benefits of our executive officers. More specifically, the Compensation Committee reviews and approves the salary and annual cash incentive earned by the Chief Executive Officer and other executive officers; approves equity awards to executive officers; approves employment and severance agreements of executive officers; and reviews the compensation of non-employee directors for service on the Board of Directors and its committees. The Compensation Committee held five meetings during the fiscal year ended December&#160;31, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Nominating and Corporate Governance Committee are Matthew L. Posard (Chair), Jean-Pierre Bizzari, M.D, and Moni Miyashita. All members of the Nominating and Corporate Governance Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market. The Nominating and Corporate Governance Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary responsibilities of the Nominating and Corporate Governance Committee are to (i)&#160;identify individuals qualified to become Board members; (ii)&#160;select, or recommend to the Board, director nominees for each election of directors; (iii)&#160;develop and recommend to the Board criteria for selecting qualified director candidates; (iv)&#160;consider committee member qualifications, appointment and removal; (v)&#160;recommend applicable corporate governance principles, codes of conduct and compliance mechanisms, and (vi)&#160;provide oversight in the evaluation of the Board and each committee. The Nominating and Corporate Governance Committee held four meetings during the fiscal year ended December&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Board membership, the Nominating and Corporate Governance Committee&#8217;s goal is to assemble a Board of Directors that brings a variety of perspectives and skills derived from high quality business and professional experience. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no stated minimum criteria for director nominees. The Nominating and Corporate Governance Committee also believes it is appropriate for at least one key member of management to participate as a member of the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Halozyme Board of Directors believes that our Board should have diversity of knowledge base, professional experience and skills, and actively seeks director candidates who bring diversity of age, gender, nationality, race, ethnicity and sexual orientation. When considering whether to recommend any candidate for inclusion in the Board&#8217;s slate of recommended director nominees, including candidates recommended by our stockholders, the Nominating and Corporate Governance Committee will review the candidate&#8217;s integrity, business acumen, age, experience, commitment, diligence, conflicts of interest, existing time commitments and the ability to act in the interests of all stockholders. Once a potential qualified candidate is identified, multiple members of the Nominating and Corporate Governance Committee will interview that candidate. The committee may also ask the candidate to meet with non-committee members of the Board and/or members of management and, if the committee believes a candidate would be a valuable addition to the Board, it will recommend that candidate to the full Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of its charter and our Corporate Governance Guidelines, the Nominating and Corporate Governance Committee will consider qualified director candidates suggested by our stockholders. Stockholders may recommend individuals for the Nominating and Corporate Governance Committee to consider as potential director candidates by submitting the candidate&#8217;s name, contact information and biographical information in writing to the &#8220;Halozyme Nominating and Corporate Governance Committee&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The biographical information and background materials of any such candidate will be forwarded to the Nominating and Corporate Governance Committee for its review and consideration. The committee&#8217;s review process for candidates identified by our stockholders is essentially identical to the review process for candidates identified by the committee. In addition to the process discussed above regarding the consideration of the Nominating and Corporate Governance Committee of candidates suggested by our stockholders, our Bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to our Board at our Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program is reviewed quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Our Board is responsible for reviewing and assessing business enterprise risk and other major risks facing the Company, and evaluating management&#8217;s approach to addressing such risks. In connection with these reviews, our Board members rely on information from external sources as well as on their individual experiences identifying and managing business enterprise risk for other entities both within and outside of our industry. In addition, the committees of our Board consider and address risk as they perform their respective committee responsibilities. For example, financial risks and cyber security risks are overseen by our Audit Committee and our Compensation Committee periodically reviews our compensation programs to ensure they do not encourage excessive risk-taking. All committees report to the full Board as appropriate, including when a matter rises to the level of a material or enterprise risk.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management team is responsible for day-to-day risk management and regularly reports on risks to our full Board or a relevant committee. Our legal, finance and regulatory areas serve as the primary monitoring and evaluation function for company-wide policies and procedures, and manage the day-to-day oversight of the risk management strategy for our business. This oversight includes identifying, evaluating, and addressing potential risks that may exist at the enterprise, strategic, financial, operational, compliance and reporting levels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the division of risk management responsibilities described above is an effective approach for identifying and addressing the risks facing our Company, and that the leadership structure of our Board is effective in implementing this approach.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESG and Corporate Responsibility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme continues to build a sustainable, environmentally conscious business while fulfilling our mission of bringing disruptive solutions that can significantly improve patient experiences and outcomes for emerging and established therapies. We are driven by our mission and dedicated to our sustainability efforts across our entire ecosystem internally and externally. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the discussion under the heading &#8220;Human Capital Management&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our human capital priorities and programs. We also recognize that certain stakeholders (such as customers, employees and non-governmental organizations) as well as some stockholders may be interested in more detailed information about our ESG programs and sustainability efforts. We encourage you to review the information available on our website at www.halozyme.com under the section titled &#8220;Responsibility&#8221; where our 2023 Environmental, Social &amp; Governance Report can be accessed. Information on our website is not part of this Proxy Statement.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program, which includes information technology and cybersecurity risk, is reviewed quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Additionally, Halozyme&#8217;s CEO is briefed quarterly and the Audit Committee is briefed annually or as determined by CIO and CEO, on our cybersecurity program. Our cybersecurity strategy is based on four fundamental areas: policy, procedure, people and technology. Halozyme maintains policies and procedures that describe our employees&#8217; responsibilities for accessing computerized systems, handling data and information, and reporting cybersecurity events in a timely manner. The Board of Directors receives educational updates from outside experts on key emergent topics. All employees and contractors are required to complete formal training on these policies. Halozyme has a well-defined and proven Business Continuity Plan (BCP). The IT Disaster Recovery Plan and the IT Incident Response Plan, which are standalone components of Halozyme&#8217;s BCP, provide the framework and guidance to manage risk. Please see the discussion under the heading &#8220;Cybersecurity&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our cybersecurity risk management, strategy and governance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communications with Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders may communicate with any and all directors by transmitting correspondence by mail addressed as follows: &#8220;Halozyme Board of Directors&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The Corporate Secretary will transmit as soon as practicable such communications to the identified director addressee(s), unless there are safety or security concerns that mitigate against further transmission of the communication as determined by the Corporate Secretary. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance at Annual Meetings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate Governance Guidelines state that all directors shall make every effort to attend the Company&#8217;s Annual Meeting of Stockholders. All nine of our then-serving directors attended our Annual Meeting of Stockholders in 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct and Ethics and Corporate Governance Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Code of Conduct and Ethics that applies to all of our employees, officers and directors. The Board has also adopted Corporate Governance Guidelines. Copies of these documents are available on our website at: www.halozyme.com. Amendments to or waivers of our Code of Conduct and Ethics granted to any of our directors or executive officers will be published promptly within four business days on our website, www.halozyme.com.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the information on our website is not incorporated by reference in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the directors who served on the Compensation Committee during 2023 has ever been an officer or employee of ours or had a relationship in 2023 requiring disclosure under applicable SEC regulations. None of our executive officers currently serves, or served during 2023, on the compensation committee or board of directors of any other entity that has an executive officer serving as a member of our Board of Directors or Compensation Committee.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVISORY (NON-BINDING) VOTE </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON EXECUTIVE COMPENSATION (SAY-ON-PAY)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is a non-binding vote on the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure, set forth in this Proxy Statement. Please read the Executive Compensation and Related Information section of this Proxy Statement for a detailed discussion about our executive compensation programs, including information about the fiscal year 2023 compensation of our Named Executive Officers. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is not a vote on our general compensation policies, the compensation of our Board of Directors, or our compensation policies as they relate to risk management. The Dodd-Frank Wall Street Reform and Consumer Protection Act requires that we hold the advisory vote on executive compensation at least once every three years. Upon the recommendation of our stockholders at our 2023 Annual Meeting of Stockholders, our Board of Directors determined that we will hold the advisory vote on executive compensation annually until the next required non-binding stockholder advisory vote on the frequency of future non-binding stockholder advisory votes on the compensation of our Named Executive Officers which will occur no later than our 2030 Annual Meeting of Stockholders. Accordingly, as required by Section 14A of the Securities Exchange Act of 1934, as amended, we are asking our stockholders to cast an advisory vote to approve the executive compensation as described in this Proxy Statement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have many compensation practices that ensure consistent leadership, decision-making and actions without taking inappropriate or unnecessary risks. These compensation practices are discussed in detail in the Compensation Discussion and Analysis section of this Proxy Statement and have the following objectives:</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Properly align the interests of our stockholders with those of our executive leadership team;</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reward actions and achievements that are consistent with the short- and long-term goals of Halozyme&#8217;s business strategy; and</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Remain competitive to attract, retain and motivate employees with relevant experience and skills needed to achieve our business goals. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vote solicited by this Proposal No. 2 is advisory, and therefore is not binding on the Company, our Board of Directors or our Compensation Committee, nor will its outcome require the Company, our Board of Directors or our Compensation Committee to take any action. Moreover, the outcome of the vote will not be construed as overruling any decision by the Company, the Board of Directors or the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because this non-binding, advisory resolution primarily relates to the compensation of our Named Executive Officers that has already been paid or contractually committed, there is generally no opportunity for us to revisit these past decisions. However, our Board of Directors, including our Compensation Committee, values the opinions of our stockholders and, to the extent there is any significant vote against the Named Executive Officer compensation as disclosed in this Proxy Statement, we will consider our stockholders&#8217; concerns and evaluate what actions, if any, may be appropriate to address those concerns.&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders will be asked at the Annual Meeting to approve the following resolution pursuant to this Proposal No. 2: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED, that the stockholders of Halozyme Therapeutics, Inc. approve, on an advisory basis, the compensation of the Company&#8217;s Named Executive&#160;Officers,&#160;disclosed pursuant to&#160;Item 402 of Regulation S-K in the Company&#8217;s Definitive Proxy Statement for the 2024 Annual Meeting of Stockholders</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of this resolution requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors believes that the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis and the tabular disclosures and accompanying narrative disclosures under the heading &#8220;Executive Compensation and Related Information&#8221; is appropriate for the reasons stated above. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Therefore, the Board of Directors unanimously recommends a vote &#8220;FOR&#8221; approval of the compensation for our Named Executive Officers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_34"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 3</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING EXCULPATION OF OFFICERS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Article VII of our Amended and Restated Certificate of Incorporation (Certificate) currently provides for the Company to limit the monetary liability of directors in certain circumstances pursuant to and consistent with the Delaware General Corporation Law (&#8220;DGCL&#8221;). The State of Delaware recently amended Section 102(b)(7) of the DGCL to allow Delaware corporations to extend similar protections to officers. Previously, exculpation was only available for directors. Specifically, the amendments to the DGCL allow Delaware corporations to exculpate their officers for personal liability for breaches of the duty of care in certain circumstances. For both directors and officers, the liability limitation does not apply to breaches of the duty of loyalty, acts or omissions not in good faith or acts or omissions that involve intentional misconduct or a knowing violation of law, or any transaction in which the director or officer derived an improper personal benefit. In addition, for officers, amended Section 102(b)(7) only permits exculpation for direct claims brought by stockholders, as opposed to claims brought by or on behalf of the Company (e.g., derivative claims).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adopting an officer exculpation provision that aligns with the protections afforded under the DGCL could prevent protracted or otherwise meritless litigation that distracts from our primary objective of creating stockholder value over the long term. The nature of the role of directors and officers often requires them to make decisions on crucial matters. Frequently, directors and officers must make decisions in response to time-sensitive opportunities and challenges, which can create substantial risk of investigations, claims, actions, suits or proceedings seeking to impose liability on the basis of hindsight, especially in the current litigious environment and regardless of merit. The Board believes that limiting concern about personal liability will empower officers to best exercise their business judgment in furtherance of stockholder interests without the distraction of potentially being subject to claims following actions taken in good faith.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Board believes it is important to provide protection to officers to the extent permitted by the DGCL to attract and retain key executive talent. This protection has long been afforded to directors, and Delaware law now permits expansion to certain officers. Several other public companies have updated their governing documents to align with amended Section 102(b)(7) of the DGCL, and we expect this practice to continue. Therefore, our ability to attract and retain highly qualified officer candidates may be adversely impacted if we do not implement the expanded protections now offered under Delaware law. For these reasons, the Board unanimously approved the amendment to our Certificate described in this proposal, subject to approval by stockholders.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Text of Proposed Certificate of Incorporation Amendment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate currently provides for the exculpation of directors and does not include a provision allowing for the exculpation of officers. If approved by our stockholders, Article SEVENTH of our Certificate would be amended and restated so that it would state in its entirety as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;SEVENTH:  A director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability (i) for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involved intentional misconduct or a knowing violation of law, (iii) with respect to directors, under Section 174 of the Delaware General Corporation Law as the same exists or hereafter may be amended, or (iv) for any transaction from which the director or officer derived an improper personal benefit, or (v) with respect to officers, in any action by or in the right of the Corporation. For purposes of this Article SEVENTH, &#8220;officer&#8221; shall have the meaning provided in Section 102(b)(7) of the Delaware General Corporation Law as the same exists or hereafter may be amended.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Delaware General Corporation Law is hereafter amended to authorize the further elimination or limitation of the liability of a director or officer, then, in addition to the limitation on personal liability provided herein, the liability of a director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended.</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any repeal or modification of the foregoing provisions of this Article SEVENTH by the stockholders of the Corporation shall be prospective only and shall not adversely affect any limitation on personal liability or any other right or protection of a director or officer of the Corporation existing at the time of such repeal or modification.&#8221;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing and Effect of the Proposed Certificate of Incorporation Amendment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If the proposed amendment to our Certificate is approved by our stockholders, it will become effective immediately upon the filing of an Amended and Restated Certificate of Incorporation (the &#8220;Amended and Restated Certificate&#8221;) with the Secretary of State of the State of Delaware, which we expect to file promptly after the Annual Meeting. Other than replacement of the existing Article SEVENTH by the proposed Article SEVENTH, the remaining provision of our Certificate will be unchanged after effectiveness of the Amended and Restated Certificate. If the proposed Article SEVENTH is not approved by our stockholders, our Certificate will remain unchanged.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of this amendment requires the affirmative vote of a majority of the outstanding common stock as of the record date for the Annual Meeting. Abstentions and broker non-votes will be treated as votes &#8220;against&#8221; the proposal. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial owners of shares are urged to give their broker, bank, or other nominee instructions to vote their shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the reasons stated above, the Board has determined that the proposed amendment to the Certificate is advisable and in the best interests of our stockholders. Therefore, the Board of Directors unanimously recommends a vote &#8220;FOR&#8221; approval of the proposed amendment to our Amended and Restated Certificate of Incorporation.</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_37"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 4</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATIFICATION OF SELECTION OF </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors of Halozyme has selected Ernst &amp; Young LLP as the independent registered public accounting firm to audit the consolidated financial statements of Halozyme for the fiscal year ending December 31, 2024. Ernst &amp; Young LLP has acted in such capacity since its appointment on June 28, 2006. A representative of Ernst &amp; Young LLP is expected to be present at the Annual Meeting of Stockholders, with the opportunity to make a statement if the representative desires to do so, and is expected to be available to respond to appropriate questions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm is not required by our Bylaws or otherwise. However, the Board of Directors is submitting the selection of Ernst &amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may appoint a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter shall ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors Recommendation </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors unanimously recommends a vote &#8220;FOR&#8221; the ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. </span></div><div style="margin-top:12.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL ACCOUNTING FEES AND SERVICES </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the aggregate fees billed to Halozyme for the fiscal years ended December&#160;31, 2023 and 2022 by Ernst &amp; Young LLP:</span></div><div style="margin-top:5pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:73.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Related Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Audit Fees consist of fees billed for professional services rendered for the audit of the Company&#8217;s consolidated annual financial statements, including the audit of internal control over financial reporting and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">All Other Fees consist of fees for products and services other than the services reported above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee&#8217;s policy is to pre-approve all audit and permissible non-audit services provided by our independent registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services. The independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval policy. The Chair of the Audit Committee is also authorized, pursuant to delegated authority, to pre-approve additional services on a case-by-case basis, provided that such approvals are communicated to the full Audit Committee at its next meeting. All of the services of Ernst &amp; Young LLP for 2023 and 2022 described above were pre-approved by the Audit Committee.</span></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_40"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF THE AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee oversees the Company&#8217;s financial reporting process on behalf of the Board of Directors and is comprised solely of independent directors as defined by the Nasdaq listing standards and Rule 10A-3 of the Securities Exchange Act of 1934. The Audit Committee is governed by a charter which describes in greater detail the full responsibilities of the Audit Committee. The Company&#8217;s management has the primary responsibility for the consolidated financial statements, for maintaining effective internal control over financial reporting, and for assessing the effectiveness of internal control over financial reporting. In fulfilling its oversight responsibilities, the Audit Committee reviews the consolidated financial statements, internal control over financial reporting, audit matters and reports from management. In connection with these reviews, the Audit Committee meets with management and the independent registered public accounting firm (Ernst &amp; Young LLP) at least once each quarter. These meetings include, whenever appropriate, executive sessions in which the Audit Committee meets separately with the independent registered public accounting firm, internal auditors, management personnel and legal counsel. The meetings of the Audit Committee are designed to facilitate and encourage communication among the Audit Committee, the Company, the Company&#8217;s internal audit function and the independent registered public accounting firm. The Audit Committee is directly and solely responsible for the appointment, compensation, retention, and oversight of the independent registered public accounting firm. The Audit Committee regularly considers the independence, qualifications, audit and non-audit fees and services, and performance of the independent registered public accounting firm.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has reviewed and discussed with the independent registered public accounting firm, which is responsible for expressing an opinion on the conformity of the audited consolidated financial statements with U.S. generally accepted accounting principles, its judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (PCAOB) and the Securities and Exchange Commission, and other applicable regulations. In addition, the Audit Committee reviewed and discussed with Ernst &amp; Young LLP matters related to its independence, including a review of non-audit services and the written disclosures and the letter from Ernst &amp; Young LLP to the Audit Committee required by the PCAOB regarding its communications with the Audit Committee concerning Ernst &amp; Young LLP&#8217;s independence. The Audit Committee concluded that Ernst &amp; Young LLP is independent from the Company and its management.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee discussed with the Company&#8217;s independent registered public accounting firm the overall scope and plans for their respective audits. The Audit Committee has met the independent registered public accounting firm, with and without management present, to discuss the results of their examinations; their evaluations of the Company&#8217;s internal control, including internal control over financial reporting; the critical audit matters addressed during the audit and the overall quality of the Company&#8217;s financial reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also reviewed and discussed with management and the independent registered public accounting firm the Company&#8217;s audited consolidated financial statements and related schedule, the results of management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting and the independent registered public accounting firm&#8217;s audit of internal control over financial reporting for the year ended December&#160;31, 2023. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors, and the Board of Directors has approved, that the audited consolidated financial statements and management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting be included in the Annual Report on Form 10-K for the year ended December&#160;31, 2023 filed by the Company with the Securities and Exchange Commission. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Jeffrey W. Henderson (Chair)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Matthew L. Posard</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Barbara Duncan</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_43"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION AND RELATED INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee oversees the compensation program for the Company&#8217;s executive officers. In this role, the Compensation Committee reviews and approves all compensation decisions relating to our executive officers listed in the table below (referred to in this proxy statement as our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;).</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs for 2023 are:</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.567%"><tr><td style="width:1.0%"/><td style="width:36.691%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:60.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Legal Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation Highlights</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program ties a substantial portion of each executive&#8217;s overall compensation to the achievement of key strategic, financial and operational goals and aligns the interests of executive officers with stockholders by annually awarding long-term equity-based incentives, in the form of time-vesting restricted stock units (&#8220;RSUs&#8221;), performance-vesting stock units (&#8220;PSUs&#8221;) and stock options. Consistent with this approach, the compensation of our NEOs for 2023 featured:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenue and Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> growth performance goals were established for the threshold, base and maximum targets under our 2023 annual cash incentive program. Actual revenue attainment was $829.3 million, a 26% increase over prior year which was 97.5% to target and Adjusted EBITDA was $426.2 million a 19% increase over prior year, which was 87.2% to target. Actual cash payouts under the 2023 annual cash incentive program ranged from 106.7% to 128% of target, with the cash payouts driven by a corporate performance factor under the program of 106.7%. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a compensation package more heavily weighted toward long-term equity-based incentive compensation than salary and shorter-term annual cash incentives in order to emphasize the focus on our long-term performance and stockholder value,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term equity-based incentives that were heavily weighted toward performance &#8211; in addition to the value of all awards being dependent on our stock price, the awards granted in 2023 included PSUs which are subject to performance-based vesting conditions and stock options which have value only if our stock price increases after the date of grant of the awards,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stock ownership and stock retention guidelines, encouraging executives to maintain a meaningful ownership position in the Company, focus on our long-term performance and discourage unreasonable risk-taking,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a recoupment (or &#8220;claw back&#8221;) policy covering certain compensation elements in the event of an accounting restatement due to material noncompliance with any financial reporting requirements,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a practice of not including tax gross-ups in ongoing compensation arrangements,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no &#8220;single trigger&#8221; provisions in executive and employee change-in-control agreements and arrangements (i.e., payout or vesting is not triggered automatically upon a change-in-control), and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no material perquisites.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Engagement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board and the Compensation Committee value the input of our stockholders regarding the Company&#8217;s governance practices and the design and effectiveness of our executive compensation program. Halozyme conducts regular outreach to our stockholders to build relationships and solicit feedback on these topics.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our stockholders are provided with an opportunity to cast an advisory vote on our executive compensation program every year through the &#8220;say-on-pay&#8221; proposal. At our 2023 annual meeting of stockholders, our stockholders approved, on a non-binding, advisory basis, the compensation paid to our NEOs described in our 2023 proxy statement. Approximately 95.9% of the votes cast on the matter were voted in favor of this &#8220;say-on-pay&#8221; proposal. The Compensation Committee considered the voting results and </span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> We use &#8220;EBITDA&#8221; to refer to the Company&#8217;s earnings excluding interest, taxes, depreciation and amortization, and &#8220;Adjusted EBITDA&#8221; means the Company&#8217;s EBITDA excluding one time items such as changes in contingent liabilities and impairment charges, and transaction costs for business combinations.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">high level of stockholder support when establishing our executive compensation programs for fiscal 2024 and, given the high level of stockholder support on our last &#8220;say-on-pay&#8221; proposal, established executive compensation programs for fiscal 2024 that are similar to those that were in place for fiscal 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When making future compensation decisions for our executive officers, the Compensation Committee will continue to consider the opinions that stockholders express through our stockholder engagement program and through our annual &#8220;say-on-pay&#8221; advisory votes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Business Highlights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme&#8217;s strong financial and operating performance in 2023 was supported by internal corporate developments and significant growth and advancements with our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> collaboration partners. The key developments and achievements in 2023 include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reported record total revenues of $829.3 million, which increased 26% from $660.1 million in 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased revenues from royalties 24% year-over-year to $447.9 million driven primarily by continued strong sales from partnered products utilizing our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology including the subcutaneous formulations of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (daratumumab) and Roche&#8217;s Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (pertuzumab/trastuzumab/hyaluronidase-zzxf).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Continued our commitment to returning value to shareholders and repurchased 4.2 million shares of common stock for $150 million at an average price per share of $36.01 and announced an acceleration of the remaining $250 million under the current approved $750 million share repurchase plan authorized in 2021. The Company executed the $250 million share repurchase by entering into an accelerated share repurchase transaction with a financial institution.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Strengthened our balance sheet and redeemed all of the outstanding 1.25% convertible senior notes due 2024 in exchange for $13.5 million in cash and 288,886 shares of common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced positive results of a clinical study with our proprietary high-volume auto-injector demonstrating subcutaneous (&#8220;SC&#8221;) administration of 10 mL of a representative biologic product co-formulated with our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology in approximately 30 seconds.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Entered into a global collaboration and non-exclusive license agreement with Acumen Pharmaceuticals that provides Acumen access to ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a single target. Acumen intends to explore the potential use of ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for ACU193, a clinical stage monoclonal antibody candidate to target Amyloid-&#946; Oligomers for the treatment of early Alzheimer&#8217;s disease.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Regulatory Submissions/Approvals</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx announced that the FDA had accepted for priority review a supplemental Biologics License Application (&#8220;sBLA&#8221;) for VYVGART Hytrulo for the treatment of CIDP. The application has been granted a Prescription Drug User Fee Act action date of June 21, 2024.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda submitted a New Drug Application in Japan seeking approval for TAK-771, subcutaneous 10% human immunoglobulin with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for treatment of primary immunodeficiency.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda announced that the FDA approved a sBLA to expand the use of HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to treat primary immunodeficiency in children.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx received FDA approval for VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo injection with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for SC use for the treatment of generalized myasthenia gravis (&#8220;gMG&#8221;) in adult patients who are anti-acetylcholine receptor (&#8220;AChR&#8221;) antibody positive. VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo was made available to patients, resulting in $33.0 million in milestone payments and the right to receive royalties on net product sales.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced the approval of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by the Medicines and Healthcare products Regulatory Agency in Great Britain, resulting in an $8.0 million milestone payment to Halozyme and the right to receive royalties on net product sales.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Chugai Pharmaceuticals, a member of the Roche Group, obtained regulatory approval for Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the Ministry of Health, Labour and Welfare in Japan. Halozyme is entitled to receive royalties for Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sales in Japan under its agreement with Roche.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx received European Commission (&#8220;EC&#8221;) approval for SC injectable VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as an add-on to standard therapy for the treatment of gMG in adult patients who are AChR antibody positive. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Zai Lab Limited (argenx&#8217;s commercial partner in China) announced the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough Therapy Designation for efgartigimod alfa injection (SC injection) (efgartigimod SC) for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (&#8220;CIDP&#8221;). The Breakthrough Therapy Designation for efgartigimod SC was supported by data from both global and Chinese patients enrolled in the ADHERE study.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche received EC marketing authorization for Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC for all approved indications of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> IV for multiple cancer types.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda received FDA approval for HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of CIDP as maintenance therapy to prevent the relapse of neuromuscular disability and impairment in adults.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda received EC approval for HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of CIDP as maintenance therapy in patients of all ages after stabilization with intravenous immunoglobulin therapy.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx received regulatory approval in Japan for VYVDURA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (efgartigimod alfa and hyaluronidase-qvfc) co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adult patients with gMG including options for self-administration, resulting in a $5.0 million milestone payment.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche filed Ocrelizumab SC with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with regulatory authorities in the U.S., European Union (&#8220;EU&#8221;) and Great Britain.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx submitted a sBLA to the FDA for VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo for CIDP with priority review voucher and if approved, argenx is expected to launch mid-2024.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Janssen announced submission of a sBLA to the FDA seeking approval of a new indication for DARZALEX FASPRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with bortezomib, lenalidomide and dexamethasone for induction and consolidation treatment and with lenalidomide for maintenance treatment of adult patients who are newly diagnosed with multiple myeloma and are eligible for autologous stem cell transplant.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Positive ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Clinical Data Announcements</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda announced positive results from a pivotal Phase 3 trial evaluating HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for maintenance treatment of CIDP and confirmed regulatory applications were under review in the U.S. and EU.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx reported positive data from the ADHERE study evaluating VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in adults with CIDP. The study met its primary endpoint resulting in a 61% reduction in risk of relapse compared to placebo.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced that the Phase III OCARINA II trial evaluating OCREVUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ocrelizumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a twice a year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with relapsing forms of multiple sclerosis (&#8220;MS&#8221;) or primary progressive MS.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Bristol Myers Squibb reported positive topline results from the Phase 3 CheckMate-67T trial evaluating a SC formulation of Opdivo (nivolumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in patients with advanced or metastatic clear cell renal cell carcinoma who have received prior systemic therapy. The study met its co-primary pharmacokinetics (&#8220;PK&#8221;) endpoints and a key secondary endpoint.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Clinical Trial Advancements</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">BMS initiated a Phase 3 trial to demonstrate the drug exposure levels of nivolumab and relatlimab fixed-dose combination with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is not inferior to IV administration in participants with previously untreated metastatic or unresectable melanoma (RELATIVITY-127).</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda initiated a Phase 2/3 study to evaluate PK, safety, and tolerability of subcutaneous administration of TAK-881 in adult and pediatric participants with Primary Immunodeficiency Diseases.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ViiV initiated a Phase 2b study to evaluate the efficacy, safety, PK and tolerability of VH3810109 (N6LS) administered subcutaneously with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with cabotegravir.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ViiV achieved a development milestone, which resulting in a $5 million milestone payment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Device Product Regulatory Approvals</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">Teva announced FDA approval of the generic version of Forteo, featuring our multi-dose auto-injector pen platform for the treatment of osteoporosis among certain women and men.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 CEO Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, the total target annual cash compensation for our CEO, Dr. Helen I. Torley, was $1,748,000 ($920,000 in base salary plus $828,000 in target annual cash incentive opportunity). Dr. Torley&#8217;s base salary was increased for 2023 by 5.5% as a result of the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2022 and its review of base salary paid to other peer group CEOs. (Our executive compensation peer group is discussed below under the heading &#8220;Competitive Peer Group.&#8221;) Dr. Torley&#8217;s target annual cash incentive opportunity for 2023 (assuming achievement of the corporate goals at 100%) was 90% of her base salary, which was a 10% increase (as a percentage of base salary) over her target annual cash incentive opportunity for 2022. The Compensation Committee believes this target annual cash incentive was appropriate based on her level of experience, the Compensation Committee&#8217;s review of annual cash incentive targets for other peer group CEOs, and the Compensation Committee&#8217;s belief that significant portions of total annual cash compensation should be tied to achievement of specified goals. As discussed in more detail below in this CD&amp;A, the annual cash incentive she earned for 2023 was $883,476 which represents approximately 107% of her target annual cash incentive opportunity. As CEO, Dr. Torley is the only NEO whose annual cash incentive is determined solely based on the performance of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley also received a long-term equity incentive (LTI) award during 2023 that had a grant date fair value approximately $10,000,000, comprising the most significant element of her 2023 compensation opportunity. This award was granted based on the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2022, its review of LTI compensation paid to other peer group CEOs and the desire to link a significant portion of her compensation opportunity to Halozyme&#8217;s long-term performance. The Compensation Committee approved a mix of 28.75% PSUs (at target), 38% stock options and 33.25% RSUs for Dr. Torley, and a mix of 25% PSUs (at target), 40% stock options and 35% RSUs for each of the other NEOs, to emphasize Halozyme&#8217;s long-term stock price performance and to promote retention, with particular emphasis on performance (through the larger weight given to PSUs) in the mix for Dr. Torley. The stock options vest 25% on the one-year anniversary of the date of grant with the remaining 75% vesting monthly over the following three years, while RSUs vest in 25% annual installments over a four-year period following the grant date, subject to continued employment. PSUs granted to the NEOs in 2023 vest based on our relative total shareholder return measured against an applicable subset of companies in the NASDAQ Biotechnology Index over a three-year performance period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Halozyme&#8217;s Executive Compensation Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal elements of our executive compensation program are base salary, an annual cash incentive opportunity and an annual Long Term Incentive (&#8220;LTI&#8221;) award opportunity. The LTI awards for 2023 consisted of stock options, RSUs and PSUs.</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.986%"><tr><td style="width:1.0%"/><td style="width:2.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do Not Do</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay annual bonus based on the achievement of Company financial and strategic goals, and in the case of NEOs other than the CEO, individual performance, and contribution in achieving those goals</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No guaranteed annual bonus payouts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Grant PSUs as significant portion of annual LTI awards for all executive officers </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No severance payments or benefits for executives who voluntarily terminate their employment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cap the annual bonus plan payout</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No buyback of stock awards or repricing of stock options without shareholder approval</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prohibit executive officer hedging and pledging of Company stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No executive single-trigger change in control benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain an executive officer recoupment (&#8220;claw back&#8221;) policy</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No material perquisites </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain robust stock ownership and retention guidelines for all executive officers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No supplemental executive benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conduct an annual comprehensive compensation program risk assessment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No excise tax gross-ups</span></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Detailed Discussion and Analysis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This CD&amp;A describes the material elements of 2023 compensation for our NEOs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee makes all decisions relative to the compensation of all executive officers (including the CEO). Except as otherwise noted in this CD&amp;A, the Compensation Committee&#8217;s executive compensation determinations are subjective and the result of the Compensation Committee&#8217;s business judgment. Additional details regarding the role and responsibilities of the Compensation Committee are provided below.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Total Rewards Philosophy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee periodically reviews its total rewards philosophy for executive officers to confirm our programs continue to meet the objectives of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supporting Halozyme&#8217;s short- and long-term business strategy,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anchoring to market-based principles and being tailored to Halozyme&#8217;s culture, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">aligning the interests of the executive officers with the long-term interests of Halozyme stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material elements of 2023 compensation for our NEOs consisted of three primary elements, each has a specific purpose as described below:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.126%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Element</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purpose</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Provides a fixed amount of cash compensation for services rendered based on individual performance, job scope, experience and competitive market for talent</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Cash Incentive</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Motivates and rewards fiscal year contribution to company performance against pre-established financial and operational goals and objectives </span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Incentives (&#8220;LTI&#8221;)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Align compensation with the creation of stockholder value (in the case of stock options) and changes in stock price (in the case of RSUs)  and  relative total shareholder return performance (in the case of PSUs)</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Increases executive stock ownership and aligns with stockholder interests.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Serves as a key retention device</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our NEOs are eligible to receive severance payments and benefits in connection with a qualifying termination of employment under our executive Change-in-Control Agreements and our severance policy for covered terminations unrelated to a change in control, each as described in more detail below. We also provide our NEOs with the same package of benefits that are provided to substantially all our full-time employees, including Company matching contributions to a 401(k) plan, health insurance, group term life insurance, and disability income insurance. From time to time, we may also provide relocation assistance in connection with the recruitment of an officer or employee with needed skills and experience. No material perquisites or supplemental executive benefits were provided to our NEOs in 2023. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As shown below, the majority of our NEOs&#8217; target total direct compensation for 2023 (base salary, target annual cash incentive, and LTI awards, taken into account at their fair value on the grant date) was variable (target annual cash incentive and LTI awards), with the single largest component (LTI awards) based on Halozyme&#8217;s stock price performance. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20240313_g5.jpg" alt="CEO CDA Chart.jpg" style="height:304px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:6pt;text-align:center"><img src="halo-20240313_g6.jpg" alt="NEOs CDA Charts.jpg" style="height:304px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee determines base salaries for NEOs each year based upon the following factors (with no specific weight applied to each factor):</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and complexity of the NEO&#8217;s responsibilities, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a review of external market practices (a more detailed description of the methodology used to assess external market practices is provided below),</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the NEO&#8217;s experience, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal pay equity, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the CEO&#8217;s evaluation of the NEO&#8217;s performance and contribution to the short- and long-term success of Halozyme (in the case of the CEO, the evaluation is done in executive session by the Compensation Committee with input from the other independent members of the Board of Directors). </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reflected in the table below, 2023 annual base salary levels were increased by 5.5% for the CEO, 12.5% for Ms. LaBrosse (to bring her salary closer to the peer median for her position and to recognize her growth in the role since being promoted at the start of 2022), and 4.0% and 3.5%, respectively, for Mr. Snyder and Dr. LaBarre. The base salary increases for our NEOs were approved by the </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee after taking into account the base salaries paid to peer group executives holding similar positions and other factors described above.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.322%"><tr><td style="width:1.0%"/><td style="width:60.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022  Base Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023  Base Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,832</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">525,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">520,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">538,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Cash Incentive</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEOs participate each year in the Employee Bonus Plan (&#8220;EBP&#8221;). The actual cash incentive paid to each NEO with respect to 2023 was determined based on each NEO&#8217;s target annual cash incentive opportunity and based on the performance of Halozyme as measured by the level of achievement of six metrics, of which two are tied to financial performance and have a combined 70% weighting and four are tied to operational performance and have a combined 30% weighting (&#8220;Corporate Performance&#8221;). As CEO, Dr. Torley is responsible for overall corporate performance, and accordingly, her EBP incentive opportunity is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance adjustment. For the other NEOs, the Compensation Committee may modify final payouts based on individual performance during the year relative to the level of achievement of personal goals (&#8220;Individual Performance Factor&#8221;), and the NEO must achieve at least 60% of his/her individual performance objectives in order to be eligible for a cash incentive payment. In all events, an NEO&#8217;s total payout cannot exceed two times the target cash annual incentive opportunity for the NEO. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee sets each NEO&#8217;s target annual cash incentive opportunity as a percentage of the NEO&#8217;s base salary taking into account the same factors as are considered in NEO base salary determinations. As shown below, the 2023 target annual cash incentive opportunities for the NEOs (as a percentage of base salary) were increased over their 2022 target opportunities. These increases were approved by the Compensation Committee and set each NEO&#8217;s target opportunity at approximately the median for peer group executives holding similar positions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.980%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Executive Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2022 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2023 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2023 Target Bonus ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">80%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">828,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">273,094</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">273,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">269,100</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate goals were established by the Compensation Committee (with input from the full Board of Directors) to tie the compensation of our NEOs to the Company&#8217;s achievement of annual operating objectives that were viewed as long-term drivers of sustainable value creation. EBP funding ranges between 0% and 200% for each of the six metrics. The Board of Directors approved the threshold, target, and maximum goals/level of performance for each metric (except that for the organizational effectiveness category, the target level of performance had to be attained in order for there to be any payout based on that measure). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 EBP focused on achievement of key financial and strategic objectives that resulted in (i) revenue growth, (ii) increased Adjusted EBITDA and (iii) certain other operational goals as identified in the table below. The Compensation Committee is responsible for certifying actual performance relative to these goals following completion of the fiscal year. After reviewing the Company&#8217;s performance results in 2023, the Compensation Committee determined the corporate performance factor under the 2023 EBP was achieved at 106.7% of the targeted level for the NEOs (see table below). We used Adjusted EBITDA as one of the financial measures under the 2023 EBP in place of non-GAAP operating income (which had been used under the 2022 EBP) because EBITDA is a common metric used to evaluate earnings and widely understood by investors. Adjusted EBITDA also excludes one-time items such as changes in contingent liabilities and impairment charges, and transaction costs for business combinations that we feel are not reflective of our core operating performance. </span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.867%"><tr><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate Goal</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Threshold</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Result</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBP Funding</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$815.0M</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$830.0M</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$860.0M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$829.3M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$415M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$430M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$455M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$426.2M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add a particular new device agreement</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Submission of new patent applications</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Organizational Effectiveness:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Demonstrate increased efficiency in manufacturing and release of our products</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release a specific number of lots of ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> by December 15, 2023</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release a  specific number of lots of ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> by October 30, 2023</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved prior to October 30, 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Organizational Effectiveness &amp; Health:<br/>Continue to build our high performing culture by building upon the strengths and skills of employees:<br/>Increased team participation in facilitated learning courses and LinkedIn Learning courses above 2022 baseline<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% increase</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15% increase</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40% increase</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increased participation by &gt;40%</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CORPORATE PERFORMANCE FACTOR</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Individual Performance Factor.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes the actual payout to each NEO (other than for Dr. Torley whose payout, as noted above, is based entirely on the attainment of objective, pre-established corporate performance goals) should also reflect the executive&#8217;s:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance relative to individual goals and objectives established for the year,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contribution toward achieving the Corporate Performance results, and </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demonstration of living Halozyme&#8217;s Leadership Attributes and Corporate Values during the year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Ms. LaBrosse&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded her an individual performance factor of 100%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ms. LaBrosse successfully led multiple financial transactions supporting execution of the corporate strategy and strengthened the company&#8217;s balance sheet. These activities included settlement of our 2024 convertible notes, continued execution of our share buy-back program, implementation of a FX hedging strategy and multiple actions to optimize taxes. Under Ms. LaBrosse leadership we further strengthened our Cybersecurity readiness and successfully completed full IT integration of Antares Pharma, Inc.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Mr. Snyder&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded him an individual performance factor of 120%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Mr. Snyder played a key role in successful accomplishment of the corporate goals including support of the submission of multiple co-formulation patent applications achieving 200% attainment of this goal. In addition, Mr. Snyder led a detailed review of our patent portfolio and patents, taking actions to further add to our portfolio. He also played a key role in the successful negotiation of the ENHANZE Collaboration and Licensing Agreement with Acumen, expanding the number of collaboration partners. During the year, Mr. Snyder also led negotiation of multiple supplier and other contracts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Dr. LaBarre&#8217;s accomplishments and other factors, the Compensation Committee supported the CEOs recommendation and awarded him an individual performance factor of 100%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Dr. LaBarre played a key role in successful accomplishment of the corporate goals including helping identify the innovations that supported the submission of multiple co-formulation patent applications, achieving 200% attainment of this goal. In addition, he led the successful execution of the Phase 1 clinical study of the High Volume Auto-Injector Prototype, demonstrating feasibility and patient acceptance of rapid large volume drug delivery by autoinjector.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates the 2023 cash incentive calculation for each NEO based on the following formula (also reflected in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column of the Summary Compensation Table). </span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20240313_g7.jpg" alt="slide1b05.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.065%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized Base Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Target<br/>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized<br/>Target Amount<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Performance Factor</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual Performance Factor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Final Payout<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,094</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">As noted above, Dr. Torley&#8217;s payout is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance factor.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LTI Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All grants of LTI compensation are made under our stockholder-approved equity incentive plan. The Compensation Committee utilized three vehicles to deliver LTI awards to NEOs during 2023:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are strongly aligned with stockholder interests because they deliver value to the NEO only if the value of our stock at the time of exercise exceeds the stock price on the day of grant. As a result, the Compensation Committee believes stock options encourage executives to focus on the decisions and behaviors required to support long-term sustainable increases in our stock price. To ease the transition to retirement for long-serving employees, the Compensation Committee provided in 2023 that employees who retire from Halozyme at age 60 or older with at least seven years of service to Halozyme will have three years from the date of their termination of service to exercise their Halozyme options that are vested at the time of their separation (subject to the applicable maximum option term and subject to earlier termination in connection with certain change in control events).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Time-vesting RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide a counterbalance to the more uncertain value associated with stock options and PSUs while still maintaining alignment with the interests of our long-term stockholders, as the value of RSUs fluctuates (up or down) with changes in our stock price. As a result, the Compensation Committee believes time-vesting RSUs encourage executives to make decisions consistent with the long-term interests of our stockholders and help support retention.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and time-vesting RSUs granted to our NEOs in 2023 generally vest over a four-year period subject to continued employment.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> help link our equity incentive program to achievement of specific performance goals established by the Compensation Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes that the grant of PSUs furthers our executive compensation philosophy to tie achievement of company performance with executive compensation, aligns the interests of executive officers with our stockholders and encourages long-term performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs granted to the NEOs in 2023 are eligible to cliff vest after a three-year period provided they are earned based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index (excluding companies that had not been listed or traded on a national securities exchange for at least three consecutive years as of October 31, 2022, those that had gross revenue of less than $100 million dollars for the period of four consecutive calendar quarters ending with the last fiscal quarter for which there were publicly disclosed financial results as of October 31, 2022, and those that cease to be publicly-traded during the applicable performance period other than due to insolvency). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One-third of the target PSUs are earned based on three discrete performance periods each beginning on the grant date of the awards, with one performance period ending December 31, 2023, one performance period ending December 31, 2024, and one performance period ending December 31, 2025. For purposes of these awards, TSR for Halozyme and the applicable subset of component companies is based on a 20-trading day average trading price beginning on the PSU grant date and a 20-trading day average trading price ending on the last day of the applicable performance period. Dividend equivalents, if any, will be accrued as additional stock units and delivered with earned shares at vesting. The potential vesting percentages for the 2023 PSUs are as follows (with the percentage determined by linear interpolation for performance between the 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentiles):</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.785%"><tr><td style="width:1.0%"/><td style="width:28.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Maximum</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile or Higher</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">150%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Target</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">100%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Threshold</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below Threshold</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&lt; 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">0%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs eligible to vest based on performance become vested on the third anniversary of the grant date of the awards following certification of performance results and assuming continued employment. The three-year cliff vesting schedule serves as additional retention and incentive for stock price performance to support long-term alignment with our stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Annual LTI Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, the Compensation Committee awarded annual LTI compensation for the NEOs based on the grant date value the Committee determined appropriate considering their assessment of annual equity award grants to peer group executives holding similar positions, and taking into account their assessment of the executive&#8217;s experience, expected contribution to the long-term success of the Company, and skill-set relative to industry peers at biopharmaceutical companies (with no specific weight applied to each factor). The Compensation Committee also determined that the award value for each NEO would be allocated 25% PSUs (at target), 40% stock options and 35% RSUs (or 28.75%, 38% and 33.25%, respectively, for Dr. Torley). A greater weight was placed on PSUs in the equity award mix for Dr. Torley to increase the performance-based portion of her overall LTI award. Accordingly, the Compensation Committee awarded the following LTI values to our NEOs in 2023:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.801%"><tr><td style="width:1.0%"/><td style="width:42.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,875,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,000</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400,000</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each NEO, the LTI value allocated to an award was converted into a number of shares based on (i) in the case of RSUs, the closing price of our stock on the grant date, and (ii) in the case of options and PSUs. the per share fair value of the award on the grant date awards as determined under applicable accounting rules, and rounding up to a whole share. The grant date fair value of the options was determined using the Black-Scholes option valuation methodology. The grant date fair value of the PSUs was determined using a Monte Carlo simulation. Differences between the LTI values approved by the Compensation Committee, as shown above, and the actual grant date fair values of the awards as included in the executive compensation tables following the CD&amp;A are due to the rounding of fractional share interests in accordance with the methodology approved by the Compensation Committee.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PSU Award Vesting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2023 that correspond to a performance period ended December 31, 2023, 70.45% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14.7% and this placed us at the 35.2nd percentile against the comparison group of companies for that period). These PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We awarded PSUs in 2021 to Dr. Torley and Dr. LaBarre and awarded PSUs in 2022 to each of the NEOs that are similar to the PSUs awarded in 2023. The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2021 that correspond to a performance period ended December 31, 2023, 150% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was -14.2% and this placed us at the 77.5th percentile against the comparison group of companies for that period). The PSUs vested on the third anniversary of the grant date of the awards. The Compensation Committee has also determined that, as to the one-third of the PSUs awarded in 2022 that correspond to a performance period ended December 31, 2023, 131.58% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 11.7% and this placed us at the 65.8th percentile against the comparison group of companies for that period). These PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Annual LTI Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, the 2023 annual LTI award mix for Dr. Torley was 28.75% PSUs (at target), 38% stock options and 33.25% RSUs, and the 2023 annual LTI award mix for our other NEOs was 25% PSUs (at target), 40% stock options and 35% RSUs. The Company granted its 2024 annual LTI awards in February 2024, with a mix for all NEOs, including Dr. Torley, that was 50% PSUs (at target), 15% stock options and 35% RSUs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two types of PSUs were awarded in 2024. Half of the target PSU value is earned based on our relative TSR performance against a subset of the Nasdaq Biotech Index, consistent with the design of our 2023 PSUs. One-third of these PSUs are eligible to be earned based on our relative TSR performance over three measurement periods, each beginning on the date of grant and ending at the end of 2024, 2025, and 2026, with 0%-150% of the one-third portion of the award allocated to each performance period eligible to be earned based on actual performance for that period. Earned shares, if any, cliff vest on the third anniversary of grant. The other half of the target PSU value is earned based on new target nominations by partners and new collaborations in 2024 related to ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Auto-Injectors, aligned with our strategic goals. These PSUs are earned from 0%-200% of the target number of shares. Earned shares, if any, cliff vest on the third anniversary of grant.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Peer Group</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee annually selects a group of peer companies against which Halozyme benchmarks the competitiveness of executive pay levels and program design (referred to in this CD&amp;A as our &#8220;peer group&#8221; or &#8220;peer companies&#8221;). The peer group companies are identified based upon the Compensation Committee&#8217;s assessment of each company&#8217;s similarity with Halozyme with respect to science/business model, revenue, and market capitalization. The peer group is reviewed annually by the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023 compensation decisions, the Compensation Committee utilized proxy data from the following companies, listed below. The Compensation Committee&#8217;s objective in selecting this peer group was to include a group of similar-sized public companies in the life sciences sector, with an emphasis on pharmaceutical and biotechnology companies with commercialized products. Targeted companies generally had revenues and market capitalization between 0.25x to 4.0x Halozyme&#8217;s size at the time of the analysis with Halozyme near the median on both measures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.537%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="background-color:#00497f;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Peer Group</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acadia Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Agios Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alkermes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alnylam Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amicus Therapeutics</span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BioMarin Pharmaceutical</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Blueprint Medicines</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exelixis</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ionis Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ironwood Pharmaceuticals</span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals<br/>Neurocrine Biosciences<br/>Sarepta Therapeutics<br/>Ultragenyx Pharmaceuticals<br/>United Therapeutics<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/><br/></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following changes to the peer group were made for 2023: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Alkermes, BioMarin Pharmaceutical and United Therapeutics were added to the group based on the Compensation Committee&#8217;s assessment of the criteria noted above.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acceleron Pharmaceuticals, FibroGen, Heron Therapeutics, and Nektar Therapeutics were removed from the group based on the Compensation Committee&#8217;s assessment of the criteria noted above and, in the case of Acceleron Pharmaceuticals, because it was no longer publicly-traded.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Compensation Consultant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee retains F.W. Cook &amp; Co., Inc. (&#8220;FW Cook&#8221;) as its independent compensation consultant to provide advice and counsel on matters related to our executive and non-employee director compensation program and FW Cook provides no other services to Halozyme. In 2023, FW Cook provided recommendations regarding the composition and selection of Halozyme&#8217;s peer group companies to be used with respect to 2023 and 2024 executive compensation decisions, performed a review of compensation levels and practices for similar executive positions at the peer group companies, advised regarding the compensation mix and levels for the NEOs, advised on the design and implementation of our annual LTI awards, reported on executive compensation trends and developments, and advised on the compensation arrangements for our non-employee directors. FW Cook reports directly to the Compensation Committee and regularly attends meetings of the Compensation Committee, as requested. The Compensation Committee assessed the independence of FW Cook pursuant to applicable rules and regulations of the SEC and NASDAQ and concluded that the engagement of FW Cook did not raise any conflicts of interest during fiscal 2023 and currently does not raise any conflicts of interest.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Risk Assessment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee, with assistance from its independent compensation consultant and with input from members of management, annually reviews our compensation programs, policies and practices to determine whether they encourage risk-taking that could have a material adverse effect on the Company. As part of this review, the Company evaluates the primary components of its compensations plans to identify whether those components properly balance compensation opportunities and risk. Our Compensation Committee considers various factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pay philosophy provides an effective balance in cash and equity award mix, short- and long-term performance periods, financial and non-financial performance, formulas and discretion.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s compensation programs include an appropriate mix of short- and long-term goals and incentives.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Compensation Committee has the discretion to make positive and negative adjustments to payouts under the Company&#8217;s compensation plans.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Policies are in place to manage or mitigate risk, such as stock ownership guidelines, vesting periods on equity awards, insider-trading prohibitions that also restrict hedging and pledging, recoupment policy and provisions, and independent Compensation Committee oversight.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s design and oversight principles also apply to its broad-based employee compensation plans.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this review, the Compensation Committee, based in part on the input from its compensation consultants, concluded that the risks arising from the Company&#8217;s compensation policies and practices, for both our executive officers and our other employees, are not reasonably likely to have a material adverse effect on Halozyme.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Compensation Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership and Retention Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock ownership guidelines for our executive officers which stipulate that the CEO is required to own shares of Halozyme common stock with value equal to no less than six times the CEO&#8217;s current base salary and that all other executive officers are required to own shares of Halozyme common stock with value equal to no less than two times the officer&#8217;s current base salary. Certain other officers designated by the Compensation Committee are expected to own shares of Halozyme common stock with value no less than one times the officer&#8217;s current base salary. Each executive officer is expected to comply with the guidelines within five years of appointment as an executive officer, and has three years to comply with any incremental ownership required as a result of a promotion or other increase in applicable ownership multiple. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership includes fully-owned shares (including shares held in trust and by immediate family members), vested but deferred shares, shares held in retirement accounts, and unvested stock units that are subject to time-based vesting only. Stock units subject to unsatisfied performance-based vesting conditions and unexercised stock options are not counted when evaluating compliance. Each executive officer is required to: (i) hold at least 50% of all net shares (after shares withheld or sold to pay tax obligations) of RSUs and PSUs that vest; and (ii) hold at least 50% of the underlying net gain (i.e., not including shares sold to pay the exercise price or to satisfy tax obligations) in shares of the Company&#8217;s common stock as a result of stock option exercises, until the executive officer comes into compliance with the stock ownership guidelines. The Compensation Committee annually reviews progress executive officers are making toward achieving compliance with these guidelines and has determined that all of our NEOs have achieved their specific ownership levels as of February 1, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Deductibility of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Section 162(m) of the Internal Revenue Code generally disallows a tax deduction to public companies for compensation in excess of $1 million paid to a company&#8217;s chief executive officer and certain current and former executive officers. As a result, we expect that compensation paid per year to our NEOs and certain former executive officers in excess of $1 million generally will not be deductible, </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to limited exceptions. The Compensation Committee generally seeks to preserve tax deductions for executive compensation where available but may make compensation decisions based on other factors when it believes doing so is in the best interest of the Company and its stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with our executive officers. We believe that the occurrence or potential occurrence of a change in control transaction creates uncertainty regarding the continued employment of our executive officers. This uncertainty results from the fact that many change in control transactions are common in our industry and often result in significant organizational changes, particularly at the senior executive level. We provide additional severance protections under the Change in Control Agreements to help ensure that executives can objectively evaluate change in control transactions that may be in the best interest of stockholders despite the potential negative consequences such transactions may have on them personally and to encourage executives to remain employed with the Company during an important time when their prospects for continued employment following the transaction are often uncertain. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Change in Control Severance Policy</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has approved a Company-wide severance policy, outside of a change in control context, that is also applicable to our executive officers. We believe that such severance protections are only appropriate in the event an executive is involuntarily terminated without cause and that these severance benefits are appropriate in light of severance protections available to executives at our peer group companies, and are an important component of each executive&#8217;s overall compensation as they help us to attract and retain our key executives who could have other job alternatives that may appear to them to be more attractive absent these protections. The Compensation Committee amended the severance policy in December 2023 to better align the severance benefit level for our CEO with peer group practices. Despite the establishment of the severance policy, however, the Board of Directors or Compensation Committee retains the right to amend, alter or terminate the severance policy at any time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Recoupment (&#8220;Clawback Policy&#8221;)</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC and NASDAQ requirements, the Board has adopted an executive compensation recovery policy regarding the adjustment or recovery of certain incentive awards or payments made to current or former executive officers in the event that we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws. In general, the policy provides that, unless an exception applies, we will seek to recover compensation that is awarded to an executive officer based on the Company&#8217;s attainment of a financial metric during the three-year period prior to the fiscal year in which the restatement occurs, to the extent such compensation exceeds the amount that would have been awarded based on the restated financial results.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Pledging Restrictions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Insider Trading Policy prohibits the pledging of Company securities as collateral and entering into transactions to hedge the value of Company securities owned by executives subject to the policy. Under the policy all directors and employees (including officers), or their designees, are prohibited from purchasing financial instruments (including prepaid variable forward contracts, equity swaps, collars and exchange funds) or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Halozyme&#8217;s equity securities that are either (i) granted to the employee or director by Halozyme as part of the compensation of the employee or director or (ii) held, directly or indirectly, by the employee or director.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Report</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Compensation Committee of the Board of Directors of Halozyme Therapeutics, Inc., have reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management. Based on such review and discussion, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COMPENSATION COMMITTEE</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton (Chair)</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie Matsui</span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_46"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Summary Compensation Table </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal years ended December&#160;31, 2023, 2022 and 2021 by each individual who acted as our principal executive officer, our principal financial officer, and our other most highly compensated executive officers during the fiscal year ended December&#160;31, 2023. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 SUMMARY COMPENSATION TABLE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and Principal Position</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock <br/>Awards<br/>($)(1)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)(2)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Equity <br/>Incentive Plan <br/>Compensation<br/>($)(4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Other <br/>Compensation<br/>($)(5)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200,011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,800,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">883,476</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,364</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,820,858</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,950,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,300,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,289</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">830,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,060,081</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,740,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807,619</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,372</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,800,055</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,001</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,391</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,784</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,849,419</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President,<br/>Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467,836</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,030</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,012</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,997</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,228</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,683,103</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,620,053</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349,549</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,612,927</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,701</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,740,202</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,042</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,005</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287,130</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,564</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,243,941</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,041</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,037</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,123,280</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050,040</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,010</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,217</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,333</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279,600</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock awards granted to the NEOs in fiscal years 2023, 2022 and 2021, in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 filed with the SEC on February&#160;20, 2024. Stock awards granted to executive officers consist of RSUs and PSUs. A portion of the amounts reported in this column for each NEO for 2022 and 2021 reflect the grant-date fair value of PSUs granted to the executives during that fiscal year. In accordance with applicable SEC rules, these amounts were determined based on the probable outcome (determined as of the date of grant of the awards) of the performance-based conditions applicable to the awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these purposes, the grant date fair value for the PSU awards granted to each of the NEOs was determined based on a Monte Carlo simulation pricing model (which probability weights multiple potential outcomes) as of such grant date. The significant assumptions used in the Monte Carlo simulation pricing model were as follows:</span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.245%"><tr><td style="width:1.0%"/><td style="width:43.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.96%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the aggregate grant-date fair value of these performance-based awards granted in fiscal 2023 and 2022 included in the &#8220;Stock Awards&#8221; column for those years and the aggregate grant-date fair value of these awards assuming that the highest level of performance conditions was achieved. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.573%"><tr><td style="width:1.0%"/><td style="width:19.434%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2023)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2022)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Name</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Maximum Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Maximum Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,875,010</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4,312,515</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,062,529</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,093,794</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,125,043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">675,049</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,012,574</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">600,011</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">900,016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">600,008</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">900,012</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock options granted to the NEOs in fiscal years 2023, 2022 and 2021, in accordance with FASB ASC Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 filed with the SEC on February&#160;20, 2024. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts reported in the Summary Compensation Table for stock awards and option awards may not represent the amounts that the NEOs will actually realize from the awards. Whether, and to what extent, an NEO realizes value will depend on stock price fluctuations and the NEO&#8217;s continued employment. To see the exact share amounts and the value of awards made to the NEOs in fiscal 2023, see the 2023 Grants of Plan-Based Awards table below. Additional information on all outstanding awards is reflected in the Outstanding Equity Awards at December&#160;31, 2023 table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Performance-based bonuses are generally paid pursuant to our annual incentive plans and reported as Non-Equity Incentive Plan Compensation. The performance-based bonuses represent amounts earned during each respective fiscal year based on applicable performance levels for such fiscal year, regardless of whether part or all of such amounts were paid in a subsequent fiscal year. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The table below lists the amounts set forth in this column which consist of other compensation including (i) Company contributions to Halozyme Therapeutics, Inc. 401(k) plan, and (ii) Company payments for group term insurance premiums.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"/><td style="width:25.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.487%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">401(k) Plan Company Matching Contributions ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Payout of Accrued Paid Time Off ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Other Compensation ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">13,800</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">3,564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">17,364</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">11,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">534</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">11,784</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">15,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">2,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">17,322</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">15,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">3,564</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">18,564</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Ms. LaBrosse was appointed as Chief Financial Officer on February 2, 2022.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_49"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Grants of Plan-Based Awards </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain summary information with respect to plan-based awards granted during the fiscal year ended December&#160;31, 2023 to our NEOs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:7.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.187%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.791%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.219%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under <br/>Non-Equity Incentive Plan Awards(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under<br/>Equity Incentive Plan Awards (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Stock Awards: Number of Shares or Units(#) (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Option Awards: Number of Securities Underlying Options(#) (4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Exercise or Base Price of Option Awards<br/>($/Sh)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Grant Date Fair Value of Stock and Option Awards($) (5)</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helen I. <br/>Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">828,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,656,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,325,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,875,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,800,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,050,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,307&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750,028&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,200,001&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">945,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">675,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,080,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">538,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,053&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">840,031&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,046&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,091&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For a description of the elements of the annual incentive plan applicable to our NEOs, refer to &#8220;Compensation Discussion and Analysis - Elements of Executive Compensation for 2023&#8221; in this proxy statement. The actual amount of cash paid to each NEO pursuant to the incentive plan established for 2023 is set forth in the Summary Compensation Table under the heading, &#8220;Non-Equity Incentive Plan Compensation.&#8221; </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The PSU awards to our NEOs were granted on February 16, 2023 and vest based on our relative TSR measured against the applicable subset of component companies in the NASDAQ Biotechnology Index over a three-year performance period, subject to the NEO&#8217;s continued employment through the third anniversary of the grant date.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The RSU awards to our NEOs were granted on February 16, 2023 and vest one-fourth on each anniversary of the date of grant.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The option awards to our NEOs were granted on February 16, 2023 and vest one-fourth on the first anniversary of the date of grant and then 1/48 of the shares monthly over the three-year period thereafter.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts represent the grant date fair value of stock awards granted to our NEOs in fiscal year 2023 in accordance with the FASB ASC Topic 718. For information on the assumptions used in the accounting fair value computations, see footnotes (1) through (3) to the Summary Compensation Table above.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_52"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at December&#160;31, 2023 </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the value of all unexercised options and unvested stock awards previously awarded to our NEOs as of December&#160;31, 2023: </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.572%"><tr><td style="width:1.0%"/><td style="width:7.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.300%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.035%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OUTSTANDING EQUITY AWARDS AT </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Exercisable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Unexercisable (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Exercise <br/>Price<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Expiration <br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Shares <br/>or Units of Stock <br/>That Have Not Vested (#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market Value <br/>of Shares <br/>or Units of Stock <br/>That Have Not Vested <br/>($)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Number of Unearned Shares, <br/>Units or Other Rights <br/>That Have Not Vested (#)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Market or Payout Value of <br/>Unearned Shares, Units or <br/>Other Rights That Have Not Vested <br/>($) (3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/6/2015</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/6/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,156,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">967,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,329,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">809,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,494,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">839,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/1/2015</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/1/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">787,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">843,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/2/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/2/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">677,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:29.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each option grant vests at the rate of one-fourth of the underlying shares on the first anniversary of the date of grant and one-forty-eighth of the shares each month thereafter. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each RSU grant vests at the rate of one-fourth of the total number of stock units subject to the award on each of the first four anniversaries of the grant date. Reflects the number of outstanding and unvested RSUs subject to the award. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These values are computed by multiplying the closing trading price of our common stock on NASDAQ on December&#160;31, 2023, the last trading date in fiscal year 2023, of $36.96 by the number of shares or stock units, as applicable, set forth in this table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2021 PSU awards corresponding to the performance periods ending in 2021, 2022 and 2023. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 PSU awards corresponding to the performance periods ending in 2022 and 2023. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 PSU awards corresponding to the performance period ending in 2024. Reflects the maximum number of stock units (131.58% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2023, the performance level would have exceeded the target level.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2023 PSU awards corresponding to the performance period ending in 2023. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance period.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2023 PSU awards corresponding to the performance periods ending in 2024 and 2025. Reflects the maximum number of stock units (70.45% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2023, the performance level would have exceeded the target level.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="height:29.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_55"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Exercises and Stock Awards Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the exercise of stock options and vesting of stock awards by our NEOs during the fiscal year ended December&#160;31, 2023: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:19.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.505%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPTION EXERCISES AND STOCK AWARDS VESTED DURING FISCAL YEAR 2023</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Exercise<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Exercise<br/>($)(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Vesting<br/>(#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Vesting<br/>($)(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,694,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on exercise is based on the difference between the closing trading price of Halozyme common stock on the date of exercise and the exercise price of each option.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts in this column represent the number of RSU or PSU shares that vested. The actual number of shares issued was the number of shares vested reduced by the number of shares withheld to satisfy applicable tax withholding obligations.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on vesting is based on the closing trading price of Halozyme common stock NASDAQ on the vest date. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_58"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments Upon Termination or Change in Control </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section describes the benefits that may be provided to our NEOs upon certain terminations of their employment with the Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Termination Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our severance policy, if an executive officer&#8217;s employment is terminated by the Company without cause, the executive officer is entitled to receive cash severance equal to one times the executive officer&#8217;s then-current annual base salary (in the case of the CEO, one and one-half times the sum of (a) the CEO&#8217;s then-current base salary plus (b) the CEO&#8217;s target annual cash incentive amount), plus a pro-rated portion of the executive&#8217;s target annual cash incentive for the year of termination. Cash payments under the severance policy will normally be made in a lump sum payment, and will be conditioned upon the receipt of a release of claims from the executive officer. In addition to cash severance payments, the Company will also pay certain costs for the executive to continue healthcare coverage over the applicable severance period, and the executive&#8217;s vested options will remain exercisable for one year following the termination date (or, if earlier, until the expiration date of the option).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSU awards granted to our NEOs since 2021 provide that if the executive&#8217;s employment is terminated by the Company without cause or by the executive for good reason and the executive provides a release of claims, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and PSUs subject to a performance period that has not yet been completed will remain outstanding and eligible to vest based on performance during that period, subject to pro-ration to reflect the executive&#8217;s employment during the performance period. If the executive&#8217;s employment terminates due to the executive&#8217;s death or disability, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and the target number of PSUs for the next performance period scheduled to be completed after the termination date will vest pro-rata based on the executive&#8217;s employment during that performance period. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs assuming the NEO was terminated by us without cause (prior to a change in control of the Company) on December&#160;31, 2023 and executed a release of claims in a form satisfactory to the Company: </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023 Potential Payments Upon Termination Without Cause Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:17.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.643%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Severance <br/>Payment ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards ($) (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,600,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the market value of unvested PSUs that would have accelerated if the NEO was terminated without cause (or resigned for good reason) as described above on December&#160;31, 2023. Values were derived using the closing trading price of our common stock on NASDAQ on December&#160;31, 2023, the last trading date in fiscal year 2023, of $36.96. The number of accelerated PSUs for the 2023 performance period was determined based on our relative TSR through December&#160;31, 2023. We did not include any amount for the PSUs allocated to the 2023-2024, or the 2023-2025 performance periods because the number of PSUs that will vest with respect to those periods is not known as it will depend on our future performance (the maximum value of those PSUs at December&#160;31, 2023 was $850,081 for Dr. Torley, $212,040 for Ms. LaBrosse, $203,613 for Mr. Snyder, and $220,764 for Mr. LaBarre. These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs assuming the NEO&#8217;s employment terminated due to death or disability (prior to a change in control of the Company) on December&#160;31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023 Potential Payments Upon Termination Due to Death/Disability Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.502%"><tr><td style="width:1.0%"/><td style="width:28.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.820%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards ($) (1)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,041,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the spread value of unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated due to death or disability on December&#160;31, 2023. Please see the note to the 2023 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs for the 2023 performance period was determined based on our relative TSR through December&#160;31, 2023, and the number of accelerated PSUs for the 2023-2024 and the 2023-2025 performance periods represents the target number of PSUs allocated to each such period (pro-rated for the executive&#8217;s period of employment). These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with each of our executive officers. The Change in Control Agreements provide for cash severance, continued healthcare coverage and accelerated vesting of equity awards if the executive is terminated without cause, resigns for good reason, or is terminated due to death or disability (as such terms are defined in the Change in Control Agreements), in each case on or within 12 months following a change in control transaction. The cash severance, to be made in a lump sum payment, will equal: a multiple (two times for the CEO and one-and-one-half times for the other executive officers) of the sum of (i) the executive&#8217;s then-current annual base salary; and (ii) the amount of the executive&#8217;s target annual cash incentive opportunity (based on the target percentage of annual base salary) in respect of the year the termination of employment occurs. The Company will also make a cash lump sum payment intended to provide the executive officer sufficient amounts to pay expected heath care premiums under the Company&#8217;s group health plans for 18 months after termination of employment (24 months in the case of the CEO). In addition, the Change in Control Agreement provides that the executive&#8217;s outstanding and unvested equity awards granted by the Company will be fully vested upon the executive&#8217;s termination (with equity awards that are subject to performance-based vesting to accelerate based on the greater of (x) the target performance level for the applicable portion of the award and (y) the actual performance level achieved for the applicable portion of the award through the executive&#8217;s termination date). However, the PSU awards granted to the NEOs in 2021, 2022 and 2023 provide that if a change in control occurs any performance period then in progress will terminate and the number of PSUs to be credited under the award will be determined based on performance through the change in control. Such credited PSUs will remain subject to time-based vesting through the third anniversary of the grant date, subject to accelerated vesting if the credited PSUs are not assumed by the acquiring company or if within two years after the change in control the executive&#8217;s employment is terminated by the Company without cause, by the executive for good reason, or due to the executive&#8217;s death or disability. An executive officer will not be entitled to severance benefits under our severance policy described above if the executive is entitled to severance benefits under the executive&#8217;s Change in Control Agreement. The Change in Control Agreements also provide that if an executive officer&#8217;s severance benefits would be subject to the parachute payment taxes of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended, and a reduction in benefits to avoid such taxes would put the executive in a better after-tax position, then the executive&#8217;s benefits will be reduced to the extent necessary to avoid such taxes.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming a change in control took place on December&#160;31, 2023 and each of the NEOs was terminated without cause, resigned for good reason or was terminated due to death or disability in each case on December&#160;31, 2023, the NEOs would have received the following benefits as a result of such terminations:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023 Potential Payments Upon Change in Control Termination</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:22.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity <br/>Awards ($) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Cash Severance ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,861,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,447,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,130,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the value of the unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated in the circumstances described above on December&#160;31, 2023 in connection with a change in control. Please see the note to the 2023 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs was determined based on our relative TSR through December&#160;31, 2023. These amounts were calculated solely for purposes of this disclosure and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">CEO Pay Ratio </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, Dr. Torley&#8217;s total compensation was $11,820,858, as shown in the Summary Compensation Table above. The total compensation for our median employee (excluding the CEO) in 2023 was $201,360. Therefore, Dr. Torley&#8217;s total compensation for 2023 was 59 times that of the median employee&#8217;s total compensation in 2023. The Company believes the pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records, as well as the methodology described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation elements that were considered in the identification of the median employee were annualized base pay, target cash bonus opportunity and target long-term incentive award grant date fair value for 2023 for all employees, excluding the CEO, as of December 31, 2023. The total number of our employees as of December 31, 2023 (excluding the CEO) was 382. We used this population to determine the median employee. The total compensation for the median employee was calculated according to the requirements of the Summary Compensation Table.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_61"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the relationship between our CEO&#8217;s, and our other Named Executive Officers&#8217;, total compensation paid and our financial performance for the years shown in the table (in this discussion, our CEO is also referred to as our principal executive officer or &#8220;PEO&#8221;, and our Named Executive Officers other than our CEO are referred to as our &#8220;Non-PEO NEOs&#8221;): </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-5" escape="true"><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.582%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Pay-Versus-Performance Table</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Millions) ($) (5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue (Millions) ($) (6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">11,820,858</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">3,608,264</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">3,568,762</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">160,639</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-10">208.46</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-11">118.87</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-12">281.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-13">829.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">9,696,978</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">22,817,187</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">2,415,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">3,154,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-18">320.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-19">113.65</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-20">202.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-21">660.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">7,453,294</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">5,992,078</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">2,398,657</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">591,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-26">226.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-27">126.45</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-28">402.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-29">443.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">6,518,876</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">24,374,731</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">1,812,287</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">4,356,681</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-34">240.89</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-35">126.42</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-36">129.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-37">268.0</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-42" continuedAt="f-42-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-38"><ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-39"><ix:nonNumeric contextRef="c-4" name="ecd:PeoName" id="f-40"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-41">Helen I Torley</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> was our CEO for each of the four years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:continuation id="f-42-1">See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2023, 2022 and 2021. The 2020 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar year 2021. The average compensation for the Non-PEO NEOs for 2023 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in calendar year 2023, 2022 and 2021, respectively.</ix:continuation> </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-44" continuedAt="f-44-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-43" continuedAt="f-43-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-44-1" continuedAt="f-44-2"><ix:continuation id="f-43-1" continuedAt="f-43-2"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div></ix:continuation></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-44-2"><ix:continuation id="f-43-2" continuedAt="f-43-3"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2023.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"/><td style="width:83.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.663%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">11,820,858</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">10,000,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">6,462,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">8,088,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-50">3,803,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-52">3,608,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-43-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2023 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"/><td style="width:82.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-53">3,568,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">2,700,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">1,755,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-56">1,806,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-58">657,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">160,639</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-62" continuedAt="f-62-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-61" continuedAt="f-61-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span></ix:nonNumeric></ix:nonNumeric></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-62-1"><ix:continuation id="f-61-1"><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img src="halo-20240313_g8.jpg" alt="CAP vs TSR.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-63" continuedAt="f-63-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our net income for each of those years.</span></ix:nonNumeric></div><ix:continuation id="f-63-1"><div style="text-align:center"><img src="halo-20240313_g9.jpg" alt="CAP vs Net Income.jpg" style="height:369px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(6)</span><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-64" continuedAt="f-64-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2023 executive compensation program because it is used in </span></ix:nonNumeric></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-64-1"><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">determining each of our NEO&#8217;s annual 2023 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our revenue for each of those years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img src="halo-20240313_g10.jpg" alt="CAP vs Revenue.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-65" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2023 with Halozyme performance.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-17" name="ecd:MeasureName" id="f-66">Revenue</ix:nonNumeric> (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-18" name="ecd:MeasureName" id="f-67">Adjusted EBITDA</ix:nonNumeric> (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Price (including <ix:nonNumeric contextRef="c-19" name="ecd:MeasureName" id="f-68">relative TSR</ix:nonNumeric>, as used in our PSUs awarded in 2021, 2022 and 2023 and as described in the Compensation Discussion and Analysis above)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial performance measures listed above, we view our <ix:nonNumeric contextRef="c-20" name="ecd:MeasureName" id="f-69">stock price</ix:nonNumeric>, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div></ix:nonNumeric><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_64"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Directors </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal year ended December&#160;31, 2023 by each individual who served as a non-employee director at any time during the fiscal year: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.853%"><tr><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.743%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.967%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 DIRECTOR COMPENSATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees Earned <br/>or Paid in Cash<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options<br/>($)(1)(3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards<br/>($)(1)(3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,462</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,479</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,017</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,580</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,563</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,145</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,017</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555,017</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,017</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,017</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,808</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,002</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,825</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Represents the grant date fair value of restricted stock unit awards granted in fiscal year 2023 in accordance with FASB ASC Topic 718.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Ms. Duncan was elected to the Board on February 3, 2023 and Mr. Daly resigned from the Board effective December 31, 2023.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The aggregate numbers of shares subject to unvested outstanding stock options, unvested restricted stock unit awards and vested stock units deferred under the Equity Deferral Plan (discussed below), held by the non-employee directors as of December&#160;31, 2023 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.286%"><tr><td style="width:1.0%"/><td style="width:38.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Number of Option Awards Outstanding (#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate&#160;Number&#160;<br/>of&#160;Unvested Stock Awards <br/>Outstanding <br/>(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Number of Vested Deferred Stock Awards Outstanding (#)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr></table></div><div style="padding-left:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation program for our non-employee directors is as follows: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Annual award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Immediately following each Annual Meeting, each non-employee director then in office automatically receives (i) an annual restricted stock unit grant having a value of approximately $250,000 (with the number of shares of Company common stock subject to the award equal to $250,000 divided by the closing trading price of the Company&#8217;s common stock on NASDAQ on the date of grant, with any fraction rounded up to the nearest whole share) and (ii) an annual stock option grant with a value of approximately $150,000 (with the number of shares of Company common stock subject to the award equal to $150,000 divided by the per-share value of Company stock options determined based on the valuation method and assumptions then generally used by the Company in valuing its options for financial statement purposes). Subject to acceleration in the event of a change of control of the Company, these annual awards will vest in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting following the date of the annual grants. All awards granted after our 2021 annual meeting are granted under our 2021 Stock Plan. Vested options granted to our non-employee directors (including the initial option grants described below) generally remain exercisable for three years following the termination of the director&#8217;s service (subject to earlier termination at the end of the term of the option or in connection with a change in control).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(2) Initial award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - each non-employee director receives an initial restricted stock unit grant and stock option grant upon joining the Board (with the number of shares of Company common stock subject to each award determined in the same manner as for the annual award grants described above); provided that, the grant date value of each award for a director first elected or appointed between Annual Meetings shall be prorated based on the number of full quarters the individual is scheduled to serve as a non-employee director from the date of election or appointment until the next Annual Meeting of the Stockholders such that the recipient will receive a grant of restricted stock units valued at $187,500 and a stock option grant valued at $112,500 for a period of service exceeding three quarters, a grant of restricted stock units valued at $125,000 and a stock option grant valued at $75,000 for a period of service exceeding two-quarters (but no more than three quarters), a grant of restricted stock units valued at $62,500 and a stock option grant valued at $37,500 for a period of service exceeding one quarter (but no more than two quarters), and no award for a period of service of one quarter or less. Subject to acceleration in the event of a change of control of the Company, these initial grants will vest upon the date of the next Annual Meeting following the date of grant. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-employee directors also receive an annual retainer of $50,000 for service on the Board (provided that our Chair of the Board of Directors receives an annual retainer of $125,000), as well as an additional annual retainer for service on any committee of the Board. Non-employee directors who serve on the Audit Committee receive an annual retainer of $15,000, provided that the Chair of that committee receives an annual retainer of $30,000. Non-employee directors who serve on the Compensation Committee receive an annual retainer of $10,000, provided that the Chair of that committee receives an annual retainer of $20,000. Non-employee directors who serve on the Nominating and Corporate Governance Committee receive an annual retainer of $5,000, provided that the Chair of that committee receives an annual retainer of $10,000. Employee directors (including our CEO) do not receive any compensation for service on the Board of Directors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain stock ownership guidelines for our non-employee directors which stipulate that each non-employee director is expected to own shares of Halozyme common stock with value equal to no less than five times the non-employee director&#8217;s base annual retainer for service on the Board of Directors. Each non-employee director is expected to comply with the guidelines within five years of election or appointment to the Board of Directors. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership is the same as under our executive stock ownership guidelines, as described in the CD&amp;A above. The same retention requirements apply to a non-employee director whose level of stock ownership does not satisfy the applicable guideline level of ownership as under our executive stock ownership guidelines, as described in the CD&amp;A above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains the Halozyme Nonqualified Deferred Compensation Plan (the &#8220;Cash Deferral Plan&#8221;) and the Halozyme Therapeutics, Inc. Directors Deferred Equity Compensation Plan (the &#8220;Equity Deferral Plan&#8221;). Under the Cash Deferral Plan, a non-employee director may elect to defer payment of all or a portion of the director&#8217;s annual cash compensation, deferrals are credited with earnings or losses based on investment fund elections made by the director, and the deferred amounts (as adjusted for such earnings or losses) will be paid to the director (in a lump sum or annual installments over up to five years, as elected by the director) when the director no longer serves on the Board of Directors or an earlier distribution date elected by the director in accordance with the plan. Under the Equity Deferral Plan, a non-employee director may elect (1) to convert all or a portion of the director&#8217;s annual cash compensation into Company restricted stock units awarded under our 2021 Stock Plan and/or (2) to defer the payment of the director&#8217;s annual restricted stock unit award from the Company. If a non-employee director elects to convert all or a portion of the director&#8217;s cash retainers into restricted stock units, the director will be credited with additional restricted stock units on the date the retainers would have otherwise been paid to the director equal to (1) the amount being deferred to the Equity Deferral Plan that would have otherwise been paid to the director </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on that date, divided by (2) the average closing price for a share of Company common stock over the period of ten consecutive trading days ending with the last trading day prior to the crediting date. Deferred restricted stock units will be credited with dividend equivalents to preserve the value of the awards if/when the Company were to ever pay a dividend. A non-employee director&#8217;s deferred restricted stock units will be paid in Company common stock (in a lump sum or annual installments over up to five years as elected by the director) when the director no longer serves on the Board of Directors or, if earlier, upon a change in control of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i869f1d465dff42fea57e8581b65450da_67"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our Code of Conduct and Ethics, our executive officers, directors, and principal stockholders, including their immediate family members and affiliates, are prohibited from entering into transactions which create, or would appear to create, a conflict of interest with us. Our Audit Committee is responsible for reviewing and approving related party transactions. Our Audit Committee shall approve only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our Audit Committee determines in the good faith exercise of its discretion. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_70"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of February&#160;26, 2024, certain information with respect to the beneficial ownership of our common stock by (i) each stockholder known by Halozyme to be the beneficial owner of more than 5% of our common stock, (ii) each director and director-nominee of Halozyme, (iii) each executive officer named in the Summary Compensation Table above, and (iv) all directors and current executive officers of Halozyme as a group:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:35.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.076%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficial Owner(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares <br/>Beneficially <br/>Owned(2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlackRock, Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 Hudson Yards, New York, NY 10001</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vanguard Group Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,259,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 Vanguard Blvd., Malvern, PA 19355</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artisan Partners Limited Partnership</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,689,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 East Wisconsin Avenue, Suite 800, Milwaukee, WI 53202</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahesh Krishnan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors and current executive officers as a group (12 persons)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7%</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Less than 1%.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and to the information contained in the footnotes to this table. Unless otherwise noted, the address for each beneficial owner is: c/o Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Under the rules of the SEC, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or warrants and vesting of stock awards.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Calculated on the basis of 127,054,420 shares of common stock outstanding as of February&#160;26, 2024, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after February&#160;26, 2024 are deemed to be outstanding for the purpose of calculating that stockholder&#8217;s percentage beneficial ownership. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by BlackRock, Inc. with the SEC on January&#160;23, 2024. BlackRock, Inc. beneficially owned 18,629,818 shares, with sole voting power over 18,441,079 shares and sole dispositive power over </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,629,818 shares and shared voting and dispositive power over 0 shares, which shares are reported by BlackRock, Inc. as a parent holding company of its subsidiaries. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by The Vanguard Group with the SEC on February&#160;13, 2024. The Vanguard Group beneficially owned 13,259,514 shares, with sole voting power over 0 shares, shared voting power over 238,774 shares, sole dispositive power over 12,881,335 shares and shared dispositive power over 378,179 shares, which shares are reported by The Vanguard Group as in its own capacity and on behalf of its subsidiaries.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by Artisan Partners Limited Partnership (and affiliated companies pursuant to a joint filing agreement) with the SEC on February&#160;12, 2024. Artisan beneficially owned 6,689,058 shares, with shared voting power over 5,896,607 shares and shared dispositive power over 6,689,058 shares and sole voting and dispositive power over 0 shares.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 1,723,296 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 150,727 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 280,833 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 62,793 shares subject to options that may be exercised within 60 days after February&#160;26, 2024.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corrected Section 16(a) Reports  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based solely on Halozyme&#8217;s review of the Section 16(a) reports that have been filed by or on behalf of its officers, directors and persons who own more than 10% of a registered class of Halozyme&#8217;s equity securities, and on written representations from the reporting persons, we believe that all such persons complied on a timely basis with all Section 16(a) filing requirements during the fiscal year ended December 31, 2023, except that one Form 4 was subsequently amended to correct a clerical error and report an exercise of 2,984 options to purchase common stock for Dr. LaBarre.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_73"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder proposals, including nominations for candidates for membership on our Board of Directors, may be included in our proxy materials for an Annual Meeting so long as they are provided to us on a timely basis and satisfy the other conditions set forth in applicable SEC rules. For a stockholder proposal to be included in our proxy materials for the 2025 Annual Meeting, the proposal must be received at our principal executive offices, addressed to the Secretary, not later than November&#160;15, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder business that is not intended for inclusion in our proxy materials may be brought before the 2025 Annual Meeting so long as we receive notice of the proposal as specified by our Bylaws, addressed to the Secretary at our principal executive offices, not later than November&#160;15, 2024, in accordance with the specific procedural requirements in our Bylaws. If the Secretary fails to receive notice of the proposal within such timeframe, any such proposal will be considered untimely. Failure to comply with our Bylaw procedures and deadlines may preclude presentation of the proposal at our 2025 Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to satisfying the requirements of our Bylaws, including the earlier notice deadlines set forth above and therein,to comply with universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must also provide notice that sets forth the information required by Rule 14a-19 of the Securities Exchange Act of 1934, as amended, no later than February 24, 2025.</span></div><div id="i869f1d465dff42fea57e8581b65450da_76"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSACTION OF OTHER BUSINESS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the date of this Proxy Statement, the Board of Directors knows of no other business that will be conducted at the 2024 Annual Meeting other than as described in this Proxy Statement. If any other matter or matters are properly brought before the meeting, or any adjournment or postponement of the meeting, it is the intention of the persons named in the accompanying form of proxy to vote the proxy on such matters in accordance with their best judgment.</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_79"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may satisfy SEC&#8217;s rules regarding delivery of proxy statements and annual reports by delivering a Notice of Internet Availability of Proxy Materials to an address shared by two or more stockholders. This process is known as &#8220;householding.&#8221; This delivery method can result in meaningful cost savings for us. In order to take advantage of this opportunity, we have delivered only one Notice of Internet Availability of Proxy Materials to multiple stockholders who share an address, unless contrary instructions were received prior to the mailing date. Accordingly, for many stockholders who hold their shares through a bank, brokerage firm or other holder of record (i.e., in &#8220;street name&#8221;) and share a single address, only one Notice of Internet Availability of Proxy Materials is being delivered to that address unless contrary instructions from any stockholder at that address were received. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We undertake to deliver promptly upon written or oral request a separate copy of Notice of the Internet Availability of Proxy Materials, proxy statement and/or annual report, as requested, to a stockholder at a shared address to which a single copy of these documents was delivered. If you hold stock as a record stockholder and prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact our Secretary at 12390 El Camino Real, San Diego, California 92130, or by telephone at (858) 794-8889. If your stock is held by a brokerage firm or bank and you prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact your brokerage or bank. The voting instruction sent to a street-name stockholder should provide information on how to request (1) householding of future company materials or (2) separate materials if only one set of documents is being sent to a household. If it does not, a stockholder who would like to make one of these requests should contact us as indicated above.</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20240313_g3.jpg" alt="Mark's signature.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:278px"/></div><div style="margin-top:5.25pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;15, 2024</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i869f1d465dff42fea57e8581b65450da_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="halo-20240313_g11.jpg" alt="Proxy Card 1.jpg" style="height:883px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20240313_g12.jpg" alt="Proxy Card 2.jpg" style="height:881px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>halo-20240313.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:caf3ce17-2d69-4b0f-bc7b-ffbdca88ed59,g:1fddac71-8382-46dc-99fd-bcac29db39f9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20240313" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20240313">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20240313_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20240313_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20240313_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="halo_EquityAwardsOptionsAndStockVestedMember" abstract="true" name="EquityAwardsOptionsAndStockVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" abstract="true" name="EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockOutstandingUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockReportedValueMember" abstract="true" name="EquityAwardsOptionsAndStockReportedValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>halo-20240313_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:caf3ce17-2d69-4b0f-bc7b-ffbdca88ed59,g:1fddac71-8382-46dc-99fd-bcac29db39f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_d2828206-2415-40d4-a5b5-408927b4c629" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_d2828206-2415-40d4-a5b5-408927b4c629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_30a6c332-6f2c-4bb0-903e-30da779c2749" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_30a6c332-6f2c-4bb0-903e-30da779c2749" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_4a093c8c-9705-40e0-b5c5-79cc49c2914b" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_4a093c8c-9705-40e0-b5c5-79cc49c2914b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember_9d311ff6-9abb-43c7-8146-c7c31b35ba95" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember_9d311ff6-9abb-43c7-8146-c7c31b35ba95" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_1e41d342-f4e6-462f-8dd4-f8f1e5f72440" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_1e41d342-f4e6-462f-8dd4-f8f1e5f72440" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_db1aad82-3561-4a3e-b052-52f9ad6c2731" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_db1aad82-3561-4a3e-b052-52f9ad6c2731" xlink:type="arc" order="6"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>halo-20240313_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:caf3ce17-2d69-4b0f-bc7b-ffbdca88ed59,g:1fddac71-8382-46dc-99fd-bcac29db39f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_halo_EquityAwardsOptionsAndStockVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockReportedValueMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Reported Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Outstanding, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>halo-20240313_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:caf3ce17-2d69-4b0f-bc7b-ffbdca88ed59,g:1fddac71-8382-46dc-99fd-bcac29db39f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20240313.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>halo-20240313_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X2!417AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,38Z,#,Z
M,#,@,#DZ,S(Z,#0   :0 P "    %   $$:0!  "    %   $#*2D0 "
M S P  "2D@ "     S P  "D(  "    (0  $%KJ'  '   'A@  "*P
M'.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                ,C Q-CHP,SHP
M,R P.3HS,3HR-  R,#$V.C S.C S(# Y.C,Q.C(T #%!,$(U-#1$,3DX,30S
M,T-!0C0R,D0Q1C@Q-S=$1#4X       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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M>2O^% %F&"*WB$4,:QQKT51@#\*DH ** "B@ HH ** "B@ HH ** "B@ HH
M*J:CJ-II5C->WTRPV\2[F=C_ )R?:@#Q+Q1\6-4U*5[?1BUC:9P)!_K7]\_P
M_AS[UY_<7=S=3-+<W$LLC'+/(Y8G\30!UG@/QI>^']9MX)KEWTV9PDL3L2J9
M_B'IC]:^BQR,T <SXS\1_P!A:8(X&'VRXR(_]D=VKQUV9W+NQ9F.22<DF@#J
M/"'A2379_M-R"EA&W)Z&0^@_J:]<M[>*V@2&"-8XT&U548 % $M% !10 44
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MRZ1:W,BC"SK,J@^Y&>?TK-U3PMKVJ&#4+R6.:]\U?W$;!8X8^2<9ZG./_KT
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MX'T'^R-'$\RXNKK#OZJO8?Y]:ZG% "T4 %% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% %>2TCDO8;IMV^%'11GCYL9/U^7]37/:G9_V]XHM;-QFS
MT]1//Z-(?NJ?P&?H: .H I: "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
M ** "B@ HH 0U7M+1+7SBO+32&1V/<G_  &!^% %FB@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** /__9_^$S_FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR
M95-Z3E1C>FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U
M,3@R9C%B(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\B/CQX;7 Z0W)E871O<E1O;VP^36EC<F]S;V9T(%!H;W1O($=A;&QE<GD@
M,38N-"XS-3 U+CDQ,CPO>&UP.D-R96%T;W)4;V]L/CQX;7 Z0W)E871E1&%T
M93XR,#$V+3 S+3 S5# Y.C,Q.C(T/"]X;7 Z0W)E871E1&%T93X\+W)D9CI$
M97-C<FEP=&EO;CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF
M868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.G!R
M969I># ](DU326UA9VEN9U8Q(CX\<')E9FEX,#I0:7!E;&EN959E<G-I;VX^
M,#$N,# \+W!R969I># Z4&EP96QI;F5697)S:6]N/CQP<F5F:7@P.D-A;65R
M84UO9&5L240^/"]P<F5F:7@P.D-A;65R84UO9&5L240^/'!R969I># Z4W1R
M96%M5'EP93XS/"]P<F5F:7@P.E-T<F5A;51Y<&4^/'!R969I># Z5VAI=&5"
M86QA;F-E,#XR+C0Y-S4V,CPO<')E9FEX,#I7:&ET94)A;&%N8V4P/CQP<F5F
M:7@P.E=H:71E0F%L86YC93$^,2XP,# P,# \+W!R969I># Z5VAI=&5"86QA
M;F-E,3X\<')E9FEX,#I7:&ET94)A;&%N8V4R/C$N,#4Q-C$V/"]P<F5F:7@P
M.E=H:71E0F%L86YC93(^/'!R969I># Z17AP;W-U<F5#;VUP96YS871I;VX^
M,"XP,# P,# \+W!R969I># Z17AP;W-U<F5#;VUP96YS871I;VX^/'!R969I
M># Z0V]N=')A<W0^,"XP,# P,# \+W!R969I># Z0V]N=')A<W0^/'!R969I
M># Z0G)I9VAT;F5S<SXP+C P,# P,#PO<')E9FEX,#I"<FEG:'1N97-S/CPO
M<F1F.D1E<V-R:7!T:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T83X-"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @/#]X<&%C:V5T
M(&5N9#TG=R<_/O_; $,  0$! 0$! 0$! 0$! 0$! @$! 0$! @$! 0(" @("
M @(" @,#! ,# P,# @(#! ,#! 0$! 0" P4%! 0%! 0$!/_; $,! 0$! 0$!
M @$! @0# @,$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$!/_  !$( +0!L ,!(@ "$0$#$0'_Q  ?   !!0$! 0$!
M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"N2%&3Z\#UH#RL1\N03QQBA@6=."5/;KBO./B5\3_!'P@\(:SXZ^(OB
M?0_!OA'P]:?VAK7B/Q'J\>CZ5IL2MC=--(0.7\M.OSF0 9)H ]%P^_<6R,<?
M+C'XTCW$*@YECC?J5=@I/YU_)%^VA_P<K:9I-SJ?@S]B[P'#XCN;6::S/QA^
M)-K-;Z#-@D>=I7A])(KJ3(*F*6_DAP1^\M)17\\GQG_X*;_MX?'N[N9_B'^T
MS\4I[6Z^6;1/"OB*7X?>&%'_ #S-AIOV:U/_ &VCH _T\C?VA956XMF)ZD7*
M<?K4X8N#R'0]",;?TK_)>T[XP_%;3-176-.^)'CRPUFWF\^'4[/Q=J,%]!)_
MST\V.7K7[5_\$]/^"Z?[1_[._C+0O"?[17C+Q)\=?@;J6HP:=J\OBV^DUGXB
M^"K>:0K-?V.KR9NKGR=Q/V6\DF\WR1''):_ZR@#^[3XE?#WPK\5/ _B;X>>-
M-+@UCPUXKTF71M6LKE<F2&8-_JY.JR1_ZR.12)(I(T<$$ U_)-^U7_P3#_:#
M^ /B#5-3\&>&==^*OPODN9)=&\1^%;#^U->TVW_Y8PZKI\?[U)(>OG01_9<<
M_NO]57]>'@SQAX;\?^%_#WC3P=JUCKWA;Q5HMMXB\/Z]ITWGV.K6=Y#%<6MQ
M#)W22*2-@?0UU9C\Q"LBI*.F" P_6@#^ #1?@W\5?$6K'P_X<^%WQ"UC7UE\
MM]*TGP=J%[>"3WBCB_6OWO\ ^"<W_!+SQ#X'\3Z#^T!^T=IMOI^KZ!*FJ^!/
MAM*8[^73KD*WDZIJF/W,<L7$L-M%^\BE\MY#&T8B'] HM+57\U+2WC=^"XB5
MZ_(G_@I_^WL/V=O"S?![X7:C&WQF\;Z3(T]_:MM?P#ILWF1&^4C_ )?)=LPM
M1_ 8C(>D:R@&?^W[_P %0?#_ .SZNI?";X+2:=XI^,FS[)JNIR$7OAWX=@Y_
MUP'$]YZ6H_=Q]93P(I?Y<_''C_Q=\1O%&J^,_'6OZQXH\5ZW<_:-3UK5KG[=
M=W0'0*!P(@./)_Y8US=Y>7E_=3W=[/<W5W<RR7=U=7,WGSRR3?ZZ6::HP1$G
M[T;B> V: (V/\/!S^8KJ/!7@?Q;\1?$VC^#/!'A_5/$WBG7KG[%I&CZ5;27E
MY<OU),/T]?\ 5>376_!KX-^._CUX^T7X;?#;1+G6_%6N3?NTV^38Z9;_ /+2
M^NI?^6=M%TEE'_HVO[!_V,?V%/AC^R5X-BATZWA\1?$O6;6)O%WQ U"V07]T
MW[MI+.QQ@V]F)%R(1]\@&3S#@@ ^!OV/?^".OA3PM%IGC;]J7[/XQ\3>5'=6
M_P -[*XQX2T:3;]V^N$_X_)0?)!BC\NV!5AMN1AJ_<;P]X:T7PEI6GZ!X9T7
M2M T/3+9;33]*T:QBTW3[&-?^6<5O$ B(/05T;(I(QP5.1Z$TT+]X,FW=W#9
M!H L8!QD9^HI:0=!]*6@!,#T'Y4N,=!C\*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ H-&:KW-Q%:6\MQ,RQQQ1M(Q;@# S0!\W_ +4'[37PJ_9$^#GBOXV_&+Q#
M%HOA/PM;?);V\/VG6/$-]/N^R:;I\.<RW,\GR@  *,R2-'%')(/\[W_@H3_P
M4M^./_!0+X@3ZOXPO)O"OPJT749)?AS\(=&O9?[#\-1C/E75XW_+[?&//FW4
MO&2?*BAC_=5[M_P64_X*%:K^V[^T9?\ A_P;K=Q)\ ?A+JEUX9^&NEV<C?V=
MXGN89C#J'B*7_GK+=2<0_P#/.U@BP!)+-YGWM_P2M_X(*WGQHT3P[^T!^V+;
M:OX:^'6IK%J_@KX.0/-I?B;QM:YS'=:O= B6QLIE_P!3%#_I4T4WF^=:_N_,
M /YQ_AG\%/B_\9M8DT#X2_##Q_\ $O6X(O.DTOP-X1U#Q5>P1_\ /6:.VBD\
MN+WKU_XH?L+_ +8?P7\.OXN^*7[.'Q@\$^%;>'[1=^(]7\%7T>AZ6O\ T^70
MC\JV'O+BO].?X4_!CX6?!#POI_@KX3> /"_P]\):9%LL]!\*Z1%I%A%]T&3R
MXT^>0A1F1_WDA!)SUKNM8T33=:L;W3]2TNRU&TU"UELKRUO8(I[6YCFC:)XY
M8SPZ2!FR".>AXXH _P C%@ZL48$,#@JP^84?/E<C!QD&OTP_X*Y_LP^'_P!E
M#]NGXM?#?P7I\.D^!-4FM/'O@K2+:#9;Z79ZQ:Q7<ME"N>(K:Y^U6T([0Q1"
MOS0R6!P,=LT ?WM?\&Y7[05_\5?V*M3^&FNWMQ>ZK\!O'UQX3TQ[F?[3.VBZ
MG'%JVG!I>F8I9]4@6(<QQ6<0K^A%7^1B!@[<FOY"O^#5F[NO+_;8L))G:S@?
MX?7$%N?^6,LW_":"8_B(XO\ OW7]>BE6$B#C:O/.1SS0!XG^T-\:?#/[/OP?
M\=?%?Q4R_P!F^$]&:]AL1+Y,^KWDG[FQL8?26YN9(85_VIA7\,'Q3^)GBSXP
M?$7Q9\1_&U_+J/B?QCK,FK:I<%BT.Z3B".$_\LXX8O)BBB_Y910Q1U^T'_!:
MK]I0^*_&WA?]G+PWJ,;Z/X"5?%?Q#AM[C=Y^K7D?_$MLY>./L]K))-@'&-07
MH8Z_",L) '5<$<'C% !Q@Q\F3KUQ78?#KX=^,?BKXR\/?#OP+HEUXA\7^)]5
MCTO2-)M4Q+(TW_HN*&+SIIIO]3#%#++7&E?^6A)5_P Z_;G_ ()C?&+]AO\
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MRE_X+.?M$7O[.G_!/WXVZ[HMX]AXJ\;Z;;_"SPM<V\IM[F"XUZ;['=2PR_\
M+.6*Q.H31'_GK#'7ZL$F..1A^%?S5?\ !SNNIC]CGX.FW _LIOVA;/[>?XOM
M \.^(_L__D/[7G\* /QX_P""!W_!/?1?VJOC5K_Q^^*FDP:K\)O@-J-G/IFC
M:A";BQ\9>*)_WUI:W$6,26^G1QK=S1-@2236*'S8GFBK^]I4$0ACC0+L79A!
M@<+7XD?\&_O@W1?#O_!,OX/^(-%CBAU3QUXH\5>(_$VS[US>6_B34M(B:3T/
MV72K$?\  :_;U1@G(X7H: )1GO0?RHS4-Q((X)W) V1,YR<8PM '^>Y_P<->
M,+?Q+_P4B\<:%;.&D\!?#SPYX7NCU_>36/\ ;W_HO5HJ_#9B5*@#H=P]Z^UO
M^"CGQ-D^+?[=O[4_CKSUN+;4?C+KFD:;=K+YR3V&F7,VCZ?(/^W:SAXKXI1&
ME>),DEV" =<=J /[8?\ @V!^'TVB?L^?M$?$^XMS$/'7Q6L?"EI*ZG-Q#H.E
MQ3^8O^QYNOS1#WMY*_;;]MG]K7PA^R/\(=9\87MQ8W_CC68)-*^'GA2:8FXU
M[4C%\LLB#D6UKNCEFD] $!\R2)6XC_@F)^S=+^RK^PM\!?A'J-L]CXN@\)MX
MK\;B>W\FXMM9UZ>76-0M9N#S:R7GV0>UJE2ZM^P!\)?B1\1=1^+'[0FL^+?C
M=XADNY#H>D>+;_\ LWX?^#K3SI?LMCI^C6?EKY443*LGVMYO..9)/WDDAH _
MD5TWPM\9OVB/B#KNI^'_  SXU^)_C?Q1K-QKVNW6B:+=:S=//>232R7-YY<6
M(OWOF_\ 3*OO3X=_\$>?VQ_&]NE]XETKP1\,;2Y*R[/&?BP2WGEMZ6NGQW"E
MQ_SRE,6*_:S]I7]OG]FK]AS1T^&OP^\,^']=\<:=:[;#X5?#^VM=!T?PZOE_
MN?[4N(HS%9J8U4B)(I)L-&?)\O\ >#\0KO\ :Q_;4_X* ?&+PQ\(M.\<ZEX2
MTSQKK7V*#PCX \SP]X9TFQ;]Y=W5]-%+]IO+>VMH9995N9),F/\ =#F@#Z@T
M_P#X(5?$>ZL)99?V@/ R7\/[L6UIX5O-0LF?_EK'),)X_+'TCKP[XD?\$9OV
ML_!L5U?>$9O OQ/M+9I)+>RT+6I- \07$>,_ZJ\CCB7Z)=2'VK^GWX+?"+PK
M\$OAOX1^'?@ZTDMM(\+Z3'IT32R;[N_F_P!9=7MUTS<74TDTTI[R3L>]>Q8=
M0<@8/8T ?Y]/BGPEX]^%_BN\\/\ B[0/$7@;Q=X=NHY9=,U>RET/6M/D_P!=
M#*/,_P"_L,U?M+_P37_X*6?$+3_B)X1^ /QU\3WGC'PGXOOU\.>"?&&LS_;_
M !%X=U";]U8VMU=?ZVYMYY1Y69P98I9H\R&*OTP_X*D?LV>"_C!^S3XZ\=76
MDVEMX_\ A-H,WC3PYK\448O7M=/C:ZU2QFDQE[>:V6X;RC@>=#$_4<_R4?#:
M/4!X_P# B:-]H.K2>,-/&F_8^+@7'VN'R?)_Z:^;0!_H.*P958'(9=P/K7YX
M_P#!5H_\8"_'S_N5_P#U,O#E?H1:9^R6N>OV=,_]\BOSW_X*M_\ )@OQ\_[E
M?_U,O#E 'SK_ ,$.3_QBE\0O^SAM7_\ 4;\(U^S5?R]_\$U?^"A'P'_9/^!G
MBOX=?%*S\?76OZQ\6=0\96C^$_#=KJUE]CFT;0K.+SII+J/]YYFGR_\ D.OT
M._X?5_L??] KXS?^$3I__P LJ /UVK^7S]K;_E,Q\*_^RR_"?_T;X;K]#?\
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M /@ES^Q1X]T:YTZ/X0P>"+]X/*M?$?@+6K[0M5TX_P#/2*$RR6LA_P"NT,E
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MTYO.L))._E2GS;6;J?)O)L?/BONKJ@ ZM\H[4 E2JC)4YYQTH _B _X)\?\
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MQ_X+?_%$_"[_ ()K_M WMM(%U3QC8Z;\.=-B,OD/<?VSJEG97@7'I9-J$O\
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MU\.O%'AOX4Z/J]O,)X=2_LW6OMFH2Q8XDC^VZAJ$44HXEBABD&17]'O[<_\
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MK_!/XJ^'OC?\*/ 'Q:\*N/[$\=^&;?7H+;S?-FTR>4;;RQF_Z;6EQ'-:R_\
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M_CVN8C)Q>#RO]=*89H_,DBB_JTIA&[Y& 93ZB@#\$/!__!=3P)-HB?\ "=_
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MXGPU^SM^S]X,O8]2\'_ SX.^$M2BD\Z+4?#7PPT70KV.2/\ Y:>=;VT;?RH
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M/MY+.WU[4KN41B:.%^0D5K#9VP'I:COT^NZ** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>halo-20240313_g10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g10.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,W,0  DI(  @    ,W,0  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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MS7Q/8-XT\7ZI:1,6AT;3V$>T9!G;G']/^ U<MM7_ +9^"EU*YS+!:-;R_50
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MNBD!SAE//'RGO0%F=/1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MPABC88V< 9.".IYP<57\'^";G2+;4O[>FAN;B^C6W+PL3B(+MQD@?Y KM**
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD-R7'1B3(<]#ZYKZ J,/B%63TM8SPF+6)3TM8****Z3M"BBB@ HHHH ****
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MP?Q%3]6G:VG]==B5@JJ5KI_T]=M_ZN2Z7/;WFCVUE<3H]P]DAFB\S$F"@!)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$8*T58****HH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M",)CC[H]J8O@C0HO$-MK%O916\MNFU(88D2+.2=Y4+]X9X.>PJW_ ,)3X?\
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M%T>'/^?74O\ OTG_ ,77AU%']E8;S^\/[:Q?=?<>X_\ "Z/#G_/KJ7_?I/\
MXNC_ (71X<_Y]=2_[])_\77AU%']E8;S^\/[:Q?=?<>X_P#"Z/#G_/KJ7_?I
M/_BZT-#^)^B:_K5OIEE;WR3W!8(TL:!1A2W)#$]!Z5\_5U7PS_Y*-I7^])_Z
M+:L:V68>%*4E>Z3ZF^'S?%5*T(2M9M+;S/HFBBBOF#[ **** "BBB@ HHHH
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M_P!%I7HM?%8[_>9^I^@Y;_NE/T"BBBN,[PHHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?,GB[_D==:_Z_YO\ T,UCUL>+O^1UUK_K
M_F_]#-8]?>TOX<?1'YI6_BR]6%%%%:&04444 %%%% 'MWP5_Y$^\_P"O]O\
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MO;B[MY3<"..WBCV'<55E)..OO^=8SQ.+Y9I7UVTVLKOIUT0KL[&-]\:OC&X
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M^?\ !_Y!_9.-_D_%?YGEE?37@_\ Y$G1?^O&'_T 5YQ_PI&X_P"@TG_@-_\
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M (#?_9T?\*1N/^@TG_@-_P#9U]+_ &EA/Y_P?^1\C_9.-_D_%?YGEE%>I_\
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M/^?N/_O@U^2_4,Q[/_P)?YGU_+(Q/[7U'_G_ +G_ +^M_C1_:^H_\_\ <_\
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M^'_"N6<'"3C):G7"<:D5*+NF+!!';6Z0P+LC085<YP*DJ+?<?\\8_P#OX?\
M"C?<?\\8_P#OX?\ "H225D62T5%ON/\ GC'_ -_#_A1ON/\ GC'_ -_#_A3
MEHJ+?<?\\8_^_A_PHWW'_/&/_OX?\* ):*BW7'_/*/\ [^'_  HW3_\ /./_
M +^'_P")H EHIB&4M\Z(!ZAR?Z4^@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YE
M\8?\CMK7_7]-_P"AFL:O>-3^$FAZIJMU?SWFH++<RM*ZI(FT%CDXRG2JO_"E
M?#__ #_:E_W\C_\ B*^JIYIAXP2;>W8^,JY/BI5)226K[GB-%>W?\*5\/_\
M/]J7_?R/_P"(H_X4KX?_ .?[4O\ OY'_ /$5?]JX;N_N,_[%Q?9?>>(T5[=_
MPI7P_P#\_P!J7_?R/_XBC_A2OA__ )_M2_[^1_\ Q%']JX;N_N#^Q<7V7WGB
M-%>W?\*5\/\ _/\ :E_W\C_^(H_X4KX?_P"?[4O^_D?_ ,11_:N&[O[@_L7%
M]E]XGP5_Y%*]_P"OYO\ T6E>C5B>%O"UGX2TZ6ST^:>6.64RDSD$@X [ <<"
MMNOF\54C5K2G'9GUF#I2HX>-.>Z"BBBN8ZPHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !5/5M,@UG2YK"[,BQ3 !C&VUA@@@@]CD"KE%--Q=T*45)-/9G%Z!\/HK
M6&2?Q#=W&HZA+#);-))<LZQQ-E<*2 <[3U]2<5<TWP!IFGZO!J4MWJ&H3VPQ
M!]MN/,$/^Z,#I7445O+$UI-^]N<T<'0BDE'8Y<?#_1_^$?GTAWNWAENS>"1I
M1YD<A&,J<>GJ#U-,'P[TDZ5J%G-<W]Q)J.S[1>3S!YV"L& W$8QE1VKJZ*/K
M-;^9]Q_5*'\JVL8$O@S2I_$ECK<@E-U91"-%W#8VT$*S#&21GU'05;T?0+71
M)]0EM'F=M0NFNI?,8$!F.2%P!Q]<UJ45#K5)+E;T+C0IQES*.NX4445D;!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!6U"&.>QD6>YDMHAAI)(Y?+(4<GYNJC Y((..X
MKDK1[NYETVQENKU-/O;VXD@8SNLSP*F4!?._!.6Y.<8'M76:EIMKJUB]G?HT
MD#D%E61DS@Y'*D'J*JOX=T^6W6&474@202H\E[,TB-C&5<ON7@]B*!F58/')
MH%T-7U"ZCM=-O9HO.%PZ/*BL0H9U^9CR!P<D@=>]33HM0U"ZT_2]8NKZ IIS
MW#".X:.0L9-J;V4@DJF,Y/)Y.:Z"7PYI<VGVUDT$B06K^9"(YY$*OS\VY6!)
MR2<DYR2:2?PWIMS%$DZ7+F(,$D-Y-YF&^\I?=N(/H3B@+B>%[R>_\+V%S=MO
MF>(;WQ]_'&[\<9_&M:F0PQVUO'! BQQ1J$1%& J@8 %/H$%%%% !1110 444
M4 %%%% !1110 4444 %%%% !7.^+(F-KNL[N[34Y@(K&&"X9 9,YW%0<, .6
MW9 "]N<]%6=>Z%8W]^M[.+A;E8O*$D%W+"=F<X^1AW_IZ4#.:U*YNWM-;U47
MES'<Z;>I!;QQ3,L6U1&2#&#AMQ=LYR>0!TK3UN%QK5D-/O+LZA-<QR&(7#>7
M';J0)"T8.W:1GDC)9@ >F+\OAS2Y[P7,UN[R90MF=]LA3[I==VUR/5@3P*67
MP_82ZE+?D7,=S-M\QH;R:,/M&%RJL!Q].Y]: N4H//A\?2PM>7$T,EAYHBD?
MY$/F8^50 .G?KZDUT%9HT"P&K?VE_I/VOIO^V38QG.W;NV[<_P .,>U:5 !1
M110(**** "BBB@ HHHH **** "BBB@ HHHH **** .+U*>YTRZU&YT:]N[D6
M-C/)>M/.9$$Q :,*I^56'S$A0 !C/45=TV.:S\00V,5]=R0W6EF9VFF,I617
M4!UWYQD.>!\O XK2L_#>F6!86T=P$;=NA>[E>-MV=V49BISD]13[3P]IME'*
MEO#)^]A$#,\\CL(QG"*S,2HY/ (H'<R=,MC/>:G'::C>_P!DK$L)GDNF=C,I
M/F%'8D@;< D8YSC!&1;\,>:\=[-'-/+ILL^;$W$K2.4"@,VYB6*E@2,GIST(
MJ5/"NE1Z=)8".Y-I)'Y30/>S,@3(. "_R].V..*O6.FP:<C+;-<,&QQ/<R38
MQZ;V./PH M4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@"GJD<$FG
MR&[NI;2WC^>62.4Q':.2"XY ^A!]ZY:R-[=7&DV-Y<WL=G=O=W$:F=TF,2E?
M*5W!#]'SC.>!GI75:EI=IJ]H+:_C:2(.K@+*R'<#D'*D'@\U7?P_8201QR"Z
M?RI#)'*UY,94)&#B3=N ([ XH&8UE<I-X12YUN^O!%9SS1;H9VC>YVR,B99,
M,S$ # /S'KFH-1MM6B\'V\MVVI2:A#9-NDMKH1K ^,[Y ""Y [ /G!P.>=^?
MPYI<]K9V[0/'%9'-N(9Y(C&<8SE6!)Z\GGD^M)-X;TVX55G6Z?$9B)-[-F1,
MD[7._+CD\-GKB@+E^SE$]C!*DHF62-6$H7;O!&<X[9ZXJ:D1%CC5(U"(H 55
M& !Z"EH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>halo-20240313_g11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,P.0  DI(  @    ,P.0  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
M                                               R,#(T.C S.C U
M(#$T.C0U.C4T #(P,C0Z,#,Z,#4@,30Z-#4Z-30   !' &4 = !A ', 90!W
M "  60!E ', 90!G &$ =    /_A!")H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G
M+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W
M-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT
M<R\Q+C$O(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F
M-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T
M93XR,#(T+3 S+3 U5#$T.C0U.C4T+C Y,SPO>&UP.D-R96%T941A=&4^/"]R
M9&8Z1&5S8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U
M:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC
M<F5A=&]R/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y'971A<V5W(%EE
M<V5G870\+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R
M9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0])W<G/S[_
MVP!#  <%!08%! <&!08(!P<("A$+"@D)"A4/$ P1&!4:&1@5&!<;'B<A&QTE
M'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_VP!# 0<(" H)"A0+"Q0J'!@<*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BK_P  1" 7&!'@# 2(  A$! Q$!_\0 'P   04! 0$! 0$           $"
M P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A
M!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9
MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H
MZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+
M_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1
MH;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W
M^/GZ_]H # ,!  (1 Q$ /P#Z1HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BN0^*WB>]\&_"_6==TH)]LMHT6$N,A6>18]V
M.^-^<'CBOE#_ (7Y\3/^AG?_ , [?_XW0!]O45\7P_&;XJ3Z:E\GBN(1/="U
M"NEHK[R,Y*%<A<?QXV]LUUQUSXW 9_X3;0__  /T_P#PH ^HJ*^(F^/?Q-5B
MI\4/D''%I;D?GLI!\??B8#G_ (2=_P#P#M__ (W0!]O45@^!M:N?$?@'1-8O
M@@N;VRBFFV#"[RHR0.PSVK>H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"U?*MS8HKC?AI\0/^%B:%=:C_9G]G?9[@P>7]H\W=\H.<[5QUZ8K2\<^*?\
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M>_%_QU;W'A?PJFD1L52>2WRT:D')D=PJKG!] 3QUI4=5&.Z_(=3K)Z/\S?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3^"VF:=>_P!L>,+E_$FMR$.\MT2T2-[*?O8]6]. *]-HI      P!T HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW@?_ *$[0/\ P60__$T?\*V\#_\ 0G:!_P""R'_XFLWX@W%SI'P5U>?3GO\
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MKY/&!UK&?XEZP)I-5%K8C0XM>&B-;;'-T6W[#*'W;<;C]S;TYW=J47=I=_\
M-+\6T.3Y;WZ?Y7_)7/4**\?L_B5XPO[W3DB31(HM2UF\TJ/?:RLT7D[BLAQ*
M-W"D%>.>XSQU'A_Q]/>_""3QCJMI'YUO;SRS06V0KF)F'RYR0#M[DXSWI<RY
M'/HM?U&M9<J]/S7Z/[CN**\DU'XG>)-#TN=]3M]*GN;CP^^M6)MXI%2(KC]U
M("Y+\,/F!7// KMK'4_$*_#YM6NK>UU'5WLS<PVEG$T*,Q3<L7S.Q)SQG(SZ
M"JE[J;?3_-K\TR8R4FDNO_ ?ZHZ6BO&+#XRZNVA7YO;:R_MB*6U@BM);.XLW
M@>9PA,L;ELHK9^97^;'1:ZO7?$GB?PYI=K;ZC+HTFJWU]]GLWMK:>03IM+9$
M&X$/QR#*% YW?PTI/E5_ZZ?YK]!IINW]?UH=Y17C&D_%KQ1K\/AV.QM-*M+C
M4[*^FN6GADD5'MVQ\JK(.#CH2>O7CGICXPU37/@%/XKLFBT[4I=*DN5*H76-
ME!SM!(]#C)...N,$D^6+EV_X/^3''WIJ'7_AO\ST&BO"I?%?C'1M7N;V#4[>
M\^P>#[?49X;I)3#*=S$[4\WY7(P"Y)Z=.<#:OOBUK;Z[+;:)HKW<=E;6<\]K
M%IUS<RW!G4,P22,;(@JG.7!W$$#%5;WN7S_5K]"%--7\K_@G_P"W(];HKAO'
MVI7O]N>%=#M[N?3[36;R2.[N(',<FQ(BXC5QRA8CJ,'@X(KS[QIXFO=&TGQG
MI7ASQ!>7=A!IEK?V5XE^\TMLSS[&19]Q<@@9&6)'/:HO_E_7]=/2]K5I>GXN
MWYGO5%>3^ =1N;WXE7%I8S:S8VEAIRC4--UO46NI9)F(*2Q[I),)@GE6 .<8
MJKXGN-2N_BEXELH8/$FHQ6VD02VT&D:NUHEO(V_YROGQ@YP.@;ITIR:BD_7\
M+_Y$Q?-?Y?C;_,]BHKQ>;XI:QIGPZT6YTV\L]5U(:*^H79EM)9'E$9"L2 R"
M-<YRY).1PAK3C^)VN3:CK%RMO81Z3I&B6^JRQ>2[SRF2(OY8?>%7D?>VG@=/
M1R:BWY7_  O_ ),(OF2\_P#@?YH]5HKSFZ\:>*=!\!R^)-;M]'NX[B"W>R2S
M\V,I),RJ$D#%@57<#O!!//RBLW6/B;XA\/WMYH%];Z;=:TMS906]W##(EMBY
M) +QERWRE3P&YXZ4[/FY>M[?/L',G'FZ;_+N>L45X;;^/_$'AO6/$5K?7/V^
M^N?$4.GV[^1/<06RF'>S) C%\8&?+5LY/7C->E>&/%%]J/@NXU?Q!8-I<]HT
MPE^T02VZ.L><2A)!O5&&#@@D<CG%3S+EYNED_O2?ZH:=Y<O6]OQ:_1_U8ZBB
MO!-=^*7B+4_"WB:S=DM'31(M3L;^QBEM'"O(%XW.6(YX?"$\_**W[OXFZ]X9
MDN=(U6#3]0OA:V4EE<0*\<>;A_+Q*"S$[3SN!&X=A36KMUV^>NGX,3DDK]/^
M&_S1ZY17EFH?$CQ!H;:M!J<&G7#Z!?VBZC<V\,B1O:3CEU4N2CKGG)88%9__
M  MW7KHV(L[.U1=7N+Q].E33KF\S:P$*I,<+;F9V_B&%4<X-+F7]>B?Y/\'V
M'>V_];_U\UW/8Z*RO#&JW>M^%]/U+4=.FTR[N(0\UG.K*\+]P0P!Z^HZ5JU3
M5G8$[JZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#A?BUK%]I?A>QAT@WGVV_U.WMT2Q?;,Z[
M][JAR.2J,.HZUYYJ_P 0;Y_!NK2QZS-H][XDUB>"Q:_NA&=.MX5"N5._"G*$
M?*?O/Q7KGB^30].M+77?$%O-.=+F\RT$"22/YK*4&U$^\2"1R"!UXZUQ>C6^
MC2^#-(\0Z)X%:YN]4C:&WM9[IY$@B9WD+R2,&$8)^8L%)R0,GBLFO=E_6]K+
M[X_<V#TDOZVO?\UZM6)/A5X@OO%6L37\U_<3VMKHMA 8VE9E-PZ&21R,X+8*
M@GK61XJUC5KV?Q#K=KK5_9OI&KVVEZ79VUPT<4CEH_,,B#B0MO(P<X XK'MK
M+PGH_A>T\2Z#X"OUBC26[NF_M^YC@B\F39A6W$2LQ'RJ5 8#M6YXFO/"D?BB
M\U7_ (1)[ORC;+JMX;YX3!)<@(A6$$JTH5AEOE(!X.:VD[U$U]WG=/\ S7SZ
MF25H--_TE;_)E[0]#N/$WCV[U72O$'B!/#]G)(C.VK3-'>W!^\(TW;1%&<C@
M<G@<"N9;4_%EY\/;RYN-9O+>339#H%C+#=.'O+IIQ";EV!RV 1M![[CUQ6YX
M6D\,>&O'%G;>&_#EU!I]Q=S:1;Z@VKSRJ9D0LX6!V8! 5*[\@Y!XQS77^)-,
M\.^$? -Q=MI?FV>C.^J16WVAQNG#%P2Q)))=N^1STXJ+14$_LV7_  ?P;MZK
MLF7[SDTOBO\ TOO2OZ/O8\AO=9\<Q-JEIK6J:@]\UQINE1VFE7+*ZGF24H=P
M'FM&N2V1]_&<5[1X#L5M=#>8)XBB:>0DQ>(;LSW"8XX^=@%/7 -<=-X9D\0:
M3J.I^(? =M:2%_[3B">))P9YB@0LSHBF/$8QC!'L.:['X</;3_#W2;JQT^33
M8+J'STM9+M[EHPQ)_P!8_P S9SGGUK2-U%I[Z?BO\TR=&TUM_E_P&CFO&^CR
M:I\3O#NGVVNZY8B_2>6[BLM4F@011)@856 !+NO/?%<FGB?5YO$USHMO<:X+
M2Z\206=KJ#7),2P6J S(&W[]S>6Q;Y<')R:[SQ+K(L_':GP_X:;7=?L]-9YG
M-X8%M[9GR%'#!G9DX 7/R]13["P\#*VDV=PMMIVI/YMU;Z;=7Y2Y22X!\WY"
M^XL=S#OCMBLHW23C_3YKK\K?>5/6Z?\ 2M_FU\K'&^ ;^YU5[CQ)K/\ PF&T
M275_%<27Y&F-"'8QJ(_,YPN.-H&16#X.\8ZOI=K<^)]3OM92WT[3'FU.WU>_
MWI<SS8:V$$9=MB8/WOE].QKT/1O#/PNL6N--T>_LV:ZA>PDM1KTLI*$'=&$,
MIVG"GH 1@^]%MIG@/7=3N=;EBTJ73]%2""'4(M9\R!EC7*B6-6V#86P-^3SF
MJLKV6UK>FZ;_ !7SUZ:CN]7O>_XII?G_ %MYY9>,=8D^&-Y9W'B"]U/4;CQ+
M#:F\TJ=Y9?+<)-(D!C); 7>H"GM52TOO%-QX_GTB\7QW/X>AB>[L[>UO'CU#
M8Y55,I>16V[D? 8Y&:]@M-*^'OVB;Q!83:7BRN_M,US#?_N8)Q'Y>6 ?8I"<
M8('KC/-27G@GP9XUO5\1,IU"2>-8UO++5)E21%)P!Y4@4@$FG&R:?W_^ I?F
MKKU8:VM?^N9M_@[,X_Q+K%[H5YK$.G7^I+%HGA<%([BZ=Y'N;AR(V<Y.Z0;>
MO)Y.#2V/A>YN_B1:Z/-XG\3>7:Z)%=WRIK,X#3LP5>-V ,(Y([YJ7XCS:-I7
MC&"Z'A&#6;ZSTQK^XFFU1[5(X87&S<F&64Y)V[AU%=CHVI>%Y]5BU))[:SUS
M7K."1K6>Z N'C"DHHC+<8W'[HI0?VEY_^W6_&_W$R7V7Y?\ ME_P_P#2CC;O
M4+G2O%GC_P 21:GJD]MX?M$$%C)?2M;F<PEV_=YVXY3C'')J7^S-2TW2)9;+
MX@RC7[W21OM-3O0T9N)L".2-6.(ANW* JX)(]*Z'1O#W@#3-5U;1M+FM)=0U
M)"-0L)=4>XEE7&#NC>1B.#UP.,>@K$\%^&O#VL0>)M"O?"4-C%:W<=M.PU.:
M[:8JH=<2L%=-FY< '@]*25U;R7^3M\W^6FA;T=_/_)K\$_O\R[\*IKAVUFVO
MY];CO;.6.&ZT_5KP7?D2;-VZ.7)+*P(.,X&.E>AUS)\"Z7:^%[O0]#5M.AO'
M#3S"2225^1DEV?<6VC ))QQP1Q72JH50HZ 8%6W<44UH>?>.+6;5/B/X2TJV
MU75+%9OM$]TEC?20+)%&HP&"D Y=EY/;([UP<OC#7KGQ[J6F?VI=Q6FN:U%%
MIACG<>5%;3;;@+@_*&"<XZYYKU^;P3H-QXNC\336LS:M$-J3F\FVJ,8P(]^S
M' XV]1GK2P>"/#MM<Z;<0Z8@FTJ2:2S<R.3$TI)D/)^;))ZY]JB*:<7VO^=U
M^2_$)KF32\OR?ZLXOPBMUXB.C>*;WQ=>65[J=W--#IAN#]GFME+ 0K"2!N"[
M6+X+<&O4JYW1_ 7AK0=8DU32M,6"\<, YFD<1ACE@BLQ5 3UV@5L:=IUMI5F
M+6R5UB#,X#R-(<LQ8_,Q)ZD]ZKHE_7]?J/6[?]?U^A:HHHH&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% &+<>#]!NO%UMXHN-.1]9M83##=%VRJ<\;<[3]X\D9YJ'5O
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MV^J26OBC2H='C%D]^LHO1.(XD8!A+A $;YAP"X.#ACBH3X*U ZT9_P"V;?\
MLYM074C:"Q._SP@7_6>9C9N ;;MSVW5'9^!;VYAO;?Q?JMKK,-ZR/-);6LUG
M<,Z,&C_>+<':JXX50HSSU)R1O;7^M%^M_P %YB][K_6K_2QK^$?$W_"5Z+)J
M L9;$+=36XAF/S_NW*Y88&TG&<=NE0:YXVTOPYXFL-+UNZL]/M[RUFG6\O+M
M84#1M& GS8!)#D]?X>A[)X8\)/X4M);;3M0>:.XU"6[F-X99V*.20BEY3AAD
M9<YW8)(R<U?GT/SO&%EKOVC;]ELIK3R-F=WF/&V[=GC'EXQCG/M5:<R[=?\
MP'_/^K%:Z^NGW_Y?U<QM/^).B76BIJ-Q(RQS7-S%;K9QR7AFCAD*&4")"=F
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNK^2QMM9T^:\B5FDMX[I&D0*<,2H.0 00?0BDERJ*[?HK?\ !ZBMN^_ZN_\
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MK\0C>+3[._XGC5[KEY?1VP_X2*X;2+._TV1K\010B&1F8/ VY, *0APPW L
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /++CX=^)+G6))I)]/\D3
M7S(PNI%#+<1R*I\A8PBL"R@MEBV"<@D@]9X?\,7&CZ^UZYMQ =(M+$)%G(>(
MR%CC &WYQCOUX%8TWQ26W\-ZU?3:3C4=+U7^RUT];G)GD9U6,A]O 8,#T..>
MM6YO'6I7-]JT7A_0(]1@T0^7?R27WDL90H9HX5\M@Y /\109XS4Q:2NNR^ZW
M^4OQ0FDY/O=_??\ SC^#,1/AA?I?7H/V:6-I+V:WNI=3O&;?.K@#[-GRD(\S
M!<;L@?=!.:?;?#.^@U]+B;[/<VSW%K<R2/J=Y'Y3PQHNT6Z$1R<QY5V(QGE6
MQ5S6/B3?6VDZ%K&AZ-9:CI>N3P6]K+-J3P2K)+G&]! X !&"0Q/M5F7QKX@;
MQM_PBUGX?TR2_CTU+^>275Y$B7<Y38I%NQ;IG)"]>E5%<LM-]ONU_#<F5I*[
MZZ_^!.WXLS6\!Z]_8-SI21Z'B%@]G=GS!/<$70N-LC;/W:\8(&_)^;C&*MQ>
M"M7M-/L9X%TV74;+6;K4Q;2RN(91,9, R!"595D&&V'D8QWK?\2^([GPOX#O
MM?OK"*6YL;8S26D-R2A8?PB0H#CWVCZ5B1^/-;75ETJ[\-VIU"ZTM]1L8[34
MVE27;C]V[-"AC)R,'# TM(KE[?\ #_I^!6EK/9_\-^OXF>GPUU$:5JL+S6#3
MW^E75J@!8)#+-,\NU?ER(QO SUXZ5)/X"UJ'47U"T72+V0S7&+2_9_):.:&*
M,EL(<D&(_+C#!B-PS5KPQ\4;?Q?K&FZ?H>G-*\EJUQJA>?:=,8':(G&WYG+
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MU_S?_!/1**\XU'XL2VNBZ/K=IX>:?2=42 QRR7R1S222,!Y44(#&1UY)SM&
M<$UZ.#D XQ[&JLU?R=OF@4D]O4****104444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ10>7$B*#&&V.1LR&*Y7/%:?BRVL[OPEJ46I74=G;F!F:YE8*L!'*R9/ VD
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M-LX[#5KB]U3S;]73>(IA+Y)9@<E=S(=HS@\X!S6KX!\-W&C^)M0N_P#A&O[
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M'P[+XKN&LI<ZO=(UO*=LGS+;-R.1M&TS=1UW=\<>:0?#C5+'2/LB>&H99Y;
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M]<291G*E,F0;6P 3Z2FWS)^7X[_DBM59KI_P+?FSUJ&)(((X8EVQQJ%49S@
M8%/KF/ &B3:!X9-I-!=VRM.\D=O=R0,\2$\#$"+&@[[$R!GJ:Z>K>XH[;!11
M12*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .(_X61;VZRK)I
MVH:A)&;N1S9V\:".*WF\MB=\O./8Y;&0H/RU-_PLG39M:N-+T^QOKR>&(/OC
M6/;N,7FJI4N'4%?XRH3/&[-6H? 6EP-=%)[LFYANX7RZ\"YD\Q\?+U!Z>W7-
M1-\.]-DU6UO)[[4)X[788K6:1&C1D38&5BF]>,_*K!"23MY-1[SC;K;\=?TM
M\_('?F;6UW]VEOUOY&5I?Q52;P_:7FHZ%J(G.E0ZE=_9Q"8X8Y-P!!:7)!*'
M &3@C('.-W4?&]AIUU<6GV2\N;N*XAMH[>!$W7$DB%U5"S ?=!)+%0,55L_A
MOI-II-SIS7=_<07&FIIA,DB!DA0N4VE4'S#?C)S]T9R<D@^'=F8Y7EUC5I;^
M2XBN5U!Y(O.BEC0HK*!'L^Z2""I!STJZCO)\NW_!_P B5S)_+\;?Y_@9L_Q'
MN%UJ[MVTNZLK.&#3Y5FN;8;PUQ,8RCQF567I@''!5B<C:&NM\3])CL9+V73]
M42T-M)=6DYA3;>QIC<8@'SGD$!PI(Y&:FF^'6G7$PDFU+5)"T-M%-YLZR&<P
M3>;&SLREMVXL#@@88C' Q%_PK+2C:O:2W^I2VBV\EM:6[RILLHW(+"/"9/0#
M+EB!P,"CI]_]??\ AOJ-WMIY#;WXFZ;I]NYO=+U*"[6[2T%G+Y".S.A=#O,H
MC *@D9<'/&,\5U>G7T>IZ9;7T,<T<=Q&LBI/&4=01G#*>0:P]3\$VFHSW<Z:
MEJ%G-=RQ2NUN\97*)L *.C(ZD=G5N<$8(%:.B:#!X?L;6QT^><65K!Y,=NVP
MKG.=^0N<^P(7T%*.SO\ UH+73^NO^1J4444R@HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH \+U/Q/J]AJ&M?#Y=5OAK%_K\*6
M%P;ES,EE-B1F1\Y 0*Z\=,BNBL%NO%5_XQN-0UO5+!M$NGL[&.VOI(%MU2)6
M$KJI"R%B<_.&&.U=Q<>#]!NO%UMXHN-.1]9M83##=%VRJ<\;<[3]X\D9YJ'5
MO OA[6[V6[U"QD,LZA+CR+J6%;E1T$JQLJR#V<&HY7R6ZVM?MLD_N7WR8?:O
MTO?\V_S^Y(\SU:_OM<\!>!/$5S?ZK9ZAK&H65M>"SU.YMXY8V+!L1HX5=V <
M@ \]:MZLMS'\9GT**+Q/JNFV^A12QV>G:Y)"R/YK#S'=[F,N<<9+,>E>G:AX
M<TG5+6QMKVR5H=/GCN+6-&:-8I(_N$!2.!Z'CVJEJ?@?0]6UTZU<QWL6HF 6
MYN+/4KFU9HP20I\J101DDUH[<UUMS-_)QLOQU)2?*EULE\T[O\-#'^(-Q<Z1
M\%=7GTY[_3[B#3RT;273/<0GCK*'8EAZ[C]37):2U_)XTT_199?$NAV>LZ),
M"-0U5KEYY@%/F0N)I?**@D_>7.1Q7J-WX<TR_P##4N@7\<UUITT1BD2>ZED=
MU/8R%BY^N[-5-*\$Z'H^I1ZA:0W4MW#$889KR_GNFA0]53S7;8#@9QCI4VO)
MM[/_ ":_5 T^5)=/\U_DSA?AS+XKUWQ7-!XEU"58/".[3V$-RV-2G/(FE ZX
MCV\'/S$FL3XB^--4\(?&^#46U&[70;+38FO+-97,1\QI4#^6#@G<%YQFO9--
MT+3M(N]0NM/M_)FU*?[1=-O9O,DVA<X)(' ' P*S=<\!>&O$EQ=SZWI@NI+R
MWCMIR9I%WQH^]1A6&,-SD8/O2ES/EUVW^:=_Q>@TE:2[[>2NK?A^)XQX6\;Z
M_H/PC\7WOB'6+F?5FO4M[22YN2WD23Q(5 +'Y57>3QP-IJS;>,-1C^"?BO3$
M\3/J>J:!<QQQZQ:WQD>>*21&5Q(K$]"RGD],5ZZ/ 'AD7RWG]F?OEOEU 'SY
M,?:%38K[=V.%&,8QWQFG:MX#\-ZY>7UUJFG>=-J%NEM=,)Y$$L:-O4$*P&01
MUZ]LXJ^M_3\$OUO\F*-]+]'?[V[_ (6^9B_#_4;V]\7>-H;R\N+B*VU"%($E
ME9EB4P(2%!/RC))P.]=W7-GP!H']K76I0IJ-K=7DBRW#6FK7<"RLH"@LB2A3
MP .E=)TI=%Z)?<A0BXJS\_S"BBB@L**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV]?,>-Q\LA5<8W8/8#(..E4[WQ?H]I8R3B[1BLLD"JR2 -*D9D(.%) V*6W
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MU&Y$"GM73T45;+2L@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1M/.V=/DV[MN?QQFLWP9HNG>#_#MAHZ?8[:[N0T\D42K%YTQ^:0H@[#.,#H
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M+N_O:)Y(Z6Z?HK+\#G/$/AF^U/6;/5M%U@:5?6]O+:F1[43@Q2%2=JE@ X*
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M&\P;2R +MXW!??%*34=_ZL->]:W7]3NJ*X1OBIIS:+::G:6<D\-SH]SJ@ <
MIY&T-$>/O9;&>V*V])\61:WJRV>FVS2I';I+>7&\;+9W4,L7^T^#DCL,9Z@5
M5G>W]=5^:9/,K)]_^!_FCH**P/&GBN+P;X=?5);2:^;S%CCMH/OR$GG'T )_
M"L_4?',PU&"Q\-:*^MSR6*:A(%N4A"P.2%*[OO,<'@?B1FINOZ]+_D4]/Z\[
M?F=?15;3[T:AI=O>BWGMO/B63R;B,QR1Y&=K*>01W%<KH?C/7=<6"[B\)F+2
MIG8&];4H_E16*EBF,]CQ3>CLQ7NKG9T5P=M\3A(MI=W.AW%OI.I+*=-O6F0_
M:"B,X#(.4W*A*YS[XKI=/\01ZAX,M_$*P,D<UB+P0ELD INVY_2DW:+D^F_X
M_P"0UK)16[->BN;E\:6EOX M?%,UM+Y=U;PR16J$%W>7:$C!X&2S 9Z5F1?$
M22'54TK6M#FT_43=6\+Q?:%E01S;@DH<#D;D*D8!!JFFI<KWO;Y]B>9<O-TW
M^1V]%<=XJ^(47AW7],T:TTZ34KW5$;[,(YEC0N& "LQX&?F.?]G&"36QHFNS
MW^GW,VLZ7-HLUG(4G2Y8&/ 4-O23A73!^]VP0<8J4[KFZ?Y:%;.QLT4R&:*Y
M@CGMY$EBD4.DD;!E=3R"".HI],-PHHHH **** "BBB@ HHHH **** "BBB@
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MRM;2QT"2\URSN[6WL;U9I;> V\<,R2(RE!&2 /-&?F;D<U[913ZI]O\ -O\
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M^"\[SRJR7;_@+]/Q9Q_BGPWJ7B;Q7I*I=7&G:9I\4MP;NW\EG:X8;%4+(KC
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M9HHJF[NX)65@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^RENKC>@'HR$NON%KVGX9'/PH\-'UTR'_P! %+[#EVM^/-_E;UN6])\O3O\
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MTVJ0^]  ,DL,=?ESWKD?^$V^)W_1(_\ RY;;_P")KTFB@#S;_A-OB=_T2/\
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M;MI@CVOVY+78FUB7WN"#@A1CK\V>U;=% 'FW_";?$[_HD?\ Y<MM_P#$T?\
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M?LJ0^8\:@J25_O$XQ2YMWY-_=;_-#ZI=_P#@_P"3.F\*:IKNKZ5)/XG\.?\
M"/7:S%$M?MR76]-JD/O0 #)+#'7Y<]ZY'_A-OB=_T2/_ ,N6V_\ B:L> O$>
MH:MJQANO$MIJF;;S;FQGLC9W=G+D8 C(RT?W@2>00.3FJ?C+Q=>:=X^GTIO&
M%AX:M(=+CNXOM<,3_:)#(ZE1O()X4<+S3D^6U^OZ7_R%%\R;73];?YCG\9?$
MN7;YGP?5]IW+N\26IP?7[M=)X3U?Q)K<ER_BWP<OAU[?9]E8ZC%>&;=NWXV
M;,87KUW>U<MIGBGQ9XO:"UL;F'0;JVT:'4+K?:>;YLLI<(FUS\J8C)/\7S 9
M&*Y.R^+VKZQ]ON8?$-K8W\<,+V.@BQ$S7LAA5F0$?/@N6 /H<]JJVK7;_.WZ
M G=7_KH_U]#L_P#A-OB=_P!$C_\ +EMO_B:/^$V^)W_1(_\ RY;;_P")I^N3
M>+T\5Z':6WB3[!%K7FDVYT^*3[)LB#[<GEN<C)JZEQXCC^*D&D2^(/,T_P#L
M_P"VO#]BC!8A@A7=U&3\V?PI+5I=[_@K_H+F5K^GXZ&KX1UOQ/K/VS_A*_"/
M_"-^5L^S_P#$SBN_/SNW?< V[<+UZ[O:L/4_%WQ$M]4N[:P^%OV^SCF>.&Y/
MB"WC\^,,0K["N5W#!P>1G%9=WXT\11Z3<^+XKZ!=(@U<V']EFV!+0B?R#)YF
M=V_=\V.F.,=ZK^#/B7K6N67AF#4]D6HW.HF&^'E@":!K>66)U] =H''=2*(^
M\KKR_'_AQM\M_*_X7_R-'_A,OB6(O*'P?7R\;=G_  DEKC'IC;6YX2U_Q?J>
MI/:^)/ @\.64<!:.Y&K0W09P5 CV( 1P6.>GRX[U/XTUJ_L'T;2]&FCMKW6;
M[[*MS)'Y@@4(TCL%/!.$P >,GVQ7 7'Q,\1>'_'UOH.K2Q7]I874D>I74< 1
MG@9(3'*0/NE3+\V.,#-$?>ERK^OZN#T7]>?^1V/B'Q3X[T[7KBUT'X=?VSI\
M>WRK[^W(+?S<J"?W;#*X8E>>N,]ZRI/&/Q*F4"7X/JX!# -XDM3@CH?NU)I/
MC/6+R_\ #T4TT;)?ZUJ-G-B,?-%"9?+ ]"-B\]ZT/%?B[4/!FN&6]ADOM,U"
M#R[".*,;TO!TA)'429X)Z%32;M;^O/\ X;ST"^K7;_.W]>0OA[Q3X[U'7K>U
MU[X=?V-I\F[S;[^W(+CRL*2/W:C+98!>.F<]J[:L_0H]3CT.U&O3QSZB8PUP
MT2!4#GDJH'8=/PK0JFK.P)W5PHHHI#"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \5^)?AB^M/''AXV7C7Q9:1>(=5^SW%O;ZJR1P)MSB)0
M/EZ=\TW6O$%Q\.OBGH^E3ZEXDUC3DT&0%"[W<TLIE.)'5< D=-V.!@5Z/XI\
M(?\ "2ZUX=O_ +=]F_L2^^V>7Y._SOE(VYW#;UZ\_2F7?@S[5\2K?Q9]OV>3
MICV'V7R<YW-NW[]WZ8_&L[-1MYO[N6R_'_,'K)M]E]_-=_@>46MYK&M?LKMK
MLOB37+?4K%KBY2ZM[YTEE*R.H21N6*X/3(Z#TKI-=L/%&F?!'2E\-ZCKVJW$
MCP7%_.MP9=0:!QND6)\9R,X'<"KQ^$M_#\(T\#:?XH6WC:27[3=G3@_G1NS,
M4"&3Y>2.0W;WK2N?A_J]UX'TW29?%<RZMI4RRVFIP6@B4;.%1X0Q#+MX()YQ
MFM)ZRFUM>/X;_III>PM>9?\ ;WX[?KZ7,WX0ZK:7TVL06/BC6M3CB:,_V;K\
M3"\L21SN=CEE;MQ@8KTVN-\'>"+[0]<U'Q!XBUD:OK6HQQPRRQ6X@BCC3HJJ
M"?S-=E5/9?U_7];BCU/'?CIK*Z7K/A&*_P#$FK>'M)N9YQ?7.EW$D4FT(N/N
M D\^QZUP^H^*=<7X9SRQ>)?$#Z&/$<%OI^LF22*\N+0JV_Y@ S8/3(Y/;M7N
MGB+P=_;_ (L\-ZW]N^S_ -A32R^3Y.[S]Z[<;MPVXQZ&CQQX._X3/3]-MOMW
MV+[#J,-]N\GS-_EDG9C<,9SUYQZ5G%66O?\ #F3O]R_,J6KTZ)_?:7^:_#L>
M7>%/%VLZ5X+\;:YI>IZOK/AZQM@^C7VN9::24*0_) +*&QU':K-I%KGA/5?
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MJAU&$I=6@X_<RDDEV'][C.:[NN6\#^#7\)P:C-?:DVIZGJMT;J]NO*$2L^,
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M<.PZ[?PJ;4_!,M_+XFDAU4VS:_!# 2L&3 J*5;!W#)(8^F/>NLHI<JY5'HM
MZW^?ZG#WGPH\//<H=)M+72;:2QGL+V"SM5C^UQR* "Q7'S*5!!(/4^M0WO@'
M7M:T>73==\5+)"EN+:W6VLS&K#<A\R93(?,?"8&-H&2<<UWU%/\ K\_\V+E7
M]?+_ "1C6^@>1XRNM>^T[OM%C%9^1Y>-NQW;=NSSG?C&.W6L^_\  &CZYXEO
M=6\26EGJXFMX[>V@N[19!:JNXL5+9^9BV<@#H!74T4FDU9_U<?\ P/PM;\D>
M5GX))<>!]4\/ZAK[W$MW-%+;7HM=KVWEQK$H(WG?\B[2<C()K4NOAOJ-QJ&M
M+'XD6#2=<$2WMK'8?OF5(EC*K,9,*&"G^#//XUZ!13WW_K;_ "0=O(R=;T&/
M5?!][H$$@M(KFS>T1PF[RE*;0<9&<>F17+ZU\,7OHV_LG61ISW%A':7N;3S4
MN6B*F.4KO7##:1U.0<=A7?44/5W_ *Z_YBLK)=%_P/\ )'-6^A>(I]+U.Q\0
M^(+._2\MVAB:WTPV_DE@06.96W=>G'3K4.H^#);CPGHVFV6H+#?Z(T$MI=O!
MN0R1+M^9-P.U@2" V>>M=712_P"!^&WYA9?G^._Y'!:;\,PFNQZQK5_#?74W
MVIK^-;79%<&=(TPH+$JJK$!@[B?45+8?#<0-8PZCJIU&QL;6[LHH)H/F-O.4
MVHS[CG8$VYQR,=,<]Q1196MY6^6O^;^\:T=_F<YX$\)#P1X3AT-;Y[\0RRR"
M>1-K,'<M@\G)&<9SSUXJUI_A_P"P>*-9UC[3YG]J+ OD^7CRO+4KUSSG/H,5
MLT4Y>\[L5D<;:> 6L]%T"QCU0%]&OY+U93;<2EA*-NW=QCS>N3]WWX9H/@C6
M=-L==M=2\2K.NL223^;8636DMO*X +JWFOTP,#]:[6BE;?S_ .!_DAVO;R_X
M/^;.0TGPIK0\36>L>)M9M=0DTZWDM[3[+9&!G#[=SRDNVX_*.!@=36DOA>+_
M (3N;Q)+*DADL8[1(&A!\LH[-O#9[[L8QVZUNT4^WE^M_P#-BLK-=_TM_D<I
MKGA35+CQ!+K'AO5K?3KF\M%L[P7-J9PT:EBKIAUVNNYL9R#GD5CVGPAL+'1=
M2T^TU"2/[0]O-8W B_>64L,2HL@.[YB2N3TSDBO0Z*25EI_6M_S'N[_UV_(P
MKOP[-?:WH&IW5\IFTD2^8%@P+AGCV$CYOD]<<^E4&\*ZTWQ&7Q*->M1:K;_9
M?L/]G'=Y6X,1YOF_>W#KMZ<8[UUE%/[7-_6HN56M_6AP4OPZNY'ETS^UH1X;
MEOSJ+67V4^?YAD\S9YN_'E[_ )L;<]LTRR^%-M9:GX1U!-28W/AR$P2,(,"\
M38RKD;OE*EV(/S=2.]>@441]U:?UI;\M!O6]^OZF%XI\.RZ[#8SV%VEEJ.FW
M(NK2>2(R('VE2K*"I*E6(."#7/V7PR5M<DUC7;^.^N[R*YCU!$MBD<WG)&@5
M06)556(  Y)SG-=[12LM?/\ 71AU3['F]A\*[_1M!T&RT7Q(D=UHMY<W,5U=
M6!F\P3;QAE\U>0'ZYY(Z5T%SX7U35=+TV'7=:@N;JQU**^,\%CY*R*AR$V>8
MV/\ >R?I7444]W=][_=_PQ/*FFN]_P ;_P";"BBB@H**** "BBB@ HHJGJUT
MUGILLL?#\*I]": )9KZUMVVSSQHW]TMS^51?VO8?\_4?YUCZ7H<=[:BYNY')
MD)("GWZDU=_X1JQ]9O\ OH?X4 6_[7L/^?J/\Z/[7L/^?J/\ZJ?\(U8^LW_?
M0_PH_P"$:L?6;_OH?X4 6_[7L/\ GZC_ #H_M>P_Y^H_SJI_PC5CZS?]]#_"
MC_A&K'UF_P"^A_A0!;_M>P_Y^H_SH_M>P_Y^H_SJI_PC5CZS?]]#_"C_ (1J
MQ]9O^^A_A0!;_M>P_P"?J/\ .C^U[#_GZC_.JG_"-6/K-_WT/\*/^$:L?6;_
M +Z'^% %O^U[#_GZC_.C^U[#_GZC_.JG_"-6/K-_WT/\*/\ A&K'UF_[Z'^%
M %O^U[#_ )^H_P Z/[7L/^?J/\ZJ?\(U8^LW_?0_PH_X1JQ]9O\ OH?X4 6_
M[7L/^?J/\Z/[7L/^?J/\ZJ?\(U8^LW_?0_PH_P"$:L?6;_OH?X4 6_[7L/\
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M^H_SH_M>P_Y^H_SJI_PC5CZS?]]#_"C_ (1JQ]9O^^A_A0!;_M>P_P"?J/\
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MUF_[Z'^% %O^U[#_ )^H_P Z/[7L/^?J/\ZJ?\(U8^LW_?0_PH_X1JQ]9O\
MOH?X4 6_[7L/^?J/\Z/[7L/^?J/\ZJ?\(U8^LW_?0_PH_P"$:L?6;_OH?X4
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M/\*/^$:L?6;_ +Z'^% %O^U[#_GZC_.C^U[#_GZC_.JG_"-6/K-_WT/\*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!ST/\ R.3_ (_^@UT-<]#_ ,CD_P"/_H-=#0 4444 %%%% !65XB_Y!#?[
MZUJUE>(O^00W^^M $^B_\@:W^A_F:O51T7_D#6_T/\S5Z@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!\D^ _^3R;K_L-:K_Z!<5];5\D^ _^3R;K_L-:K_Z!
M<5];4 %%%% '/0_\CD_X_P#H-=#7/0_\CD_X_P#H-=#0 4444 %%%% !65XB
M_P"00W^^M:M97B+_ )!#?[ZT 3Z+_P @:W^A_F:O51T7_D#6_P!#_,U>H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y)\!_\ )Y-U_P!A
MK5?_ $"XKZVKY)\!_P#)Y-U_V&M5_P#0+BOK:@ HHHH YZ'_ )')_P ?_0:Z
M&N>A_P"1R?\ '_T&NAH **** "BBB@ K*\1?\@AO]]:U:RO$7_((;_?6@"?1
M?^0-;_0_S-7JHZ+_ ,@:W^A_F:O4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD0Z9JKZ3>:B\-W>32Z=-<6OG_O\  $GRB.$,,'(4X&]L%CU]-HJ5%*_]=O\
M)"Y5IY?\'_-G"G2M6TVZ\+:C;Z"C_8+6XMY]/TZ6-1;^;L*[3(R@JNS!P<^@
M-;%WI=Y+\2-,U5(<V4&EW5O)+N'RR/)"5&,Y.0C<XQQ7145?6_K^*:_5A;2W
MI^&IY6?"6O2V%OI8TCR&TU;]C?B>+;?F9)%55 ;<"Q=6;>% *]372^'/#]YI
M?B>.YDM%@M5T&TL\JRX$L;N67 .> PYZ<]:Z^BIBN5W_ *Z_YARK^O5/]#FO
M%VGWMQ<Z+J-A8G4O[+O#/)9*Z*\@,;H"A<A=RE@1N([\YK$LO"^K0Z;X?#VJ
MHT.ORZC-;K(I%I#()B%SG!QYBC"YY)QQS7H%%-:._P#73_(;U^ZWX-?JPKC=
M$M?$.AZE-I-MI<;V$NI37;:E),I00RNTA0(&W^8&;;TVXYSVKLJ*.MP>JM_7
M5?J<?>:)JC/XS>VM()6U*!%LUN&!CF80;2&&>!GCG%<C!X2\17*ZS/?Z5J<H
MGBL#;K->6D5R&@D<L8_)_=*RY4J&^4X&3UQZ]14J-OP_ 35U;^M?^&/,)?#>
MOR>$K W&G7S7UMJ,UQ&UE+:07T:NK 2,/^/>20[CO!."#GDUW'A2TO;'PGIU
MKJD4$-W%"%DC@1$13Z )\H.,9V\9SCBM>BJVN+EUO_7<X^_AUAOBSI=[#HEQ
M+ID&GSVTM\)X0BM(\; ["^\@>60<+W'O1I<.L)\5=:O+C1+B'3;FRM[>&^:>
M$J[1-(3\H<N,^:,94=#GM7844T[)+M?\6W^HVKW\[?A_PQ@^-["[U3P/JUEI
ML!N+N:V98H0RJ7;L,L0!^)%8]AI6L:E)X@UC4M,.G7%_IZ6-K8O.DCA460[G
M925!+2$8#'@#FNVHJ)14DT^JL-:-/^NYQR>'+J2;P4;JR21=)@87.\JWDO\
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M (&'XVY]!7744WK_ %YW_,48J.W:WX6_(Q/!UIJ%CX4L[?68HHKM=Y=(TC3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<]#_ ,CD_P"/_H-=#7/0_P#(Y/\ C_Z#70T %%%% !1110 5E>(O^00W^^M:
MM97B+_D$-_OK0!/HO_(&M_H?YFKU4=%_Y UO]#_,U>H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R_$^KOH'A/5
M=7BB69[&TEN%C8X#%5)P3^%:E9'BW2I]<\&ZQI5F8UN+VRE@B,A(4,R$#) /
M&345+\CY=RZ=N=<VQRFA?$P1^%QJ_C672[03RHEK%I,SW;R%DW;2BJ6# =1C
M@=:V9OB5X2A;2U;6(V;5U#602)V\X%PG&%XPQ (.".<]#7.W'PXN=#L_#=_X
M*T_2(-4T?)N+5@88;MGB$;L65<[N,@D<\T>#?AOJ7ASQ)I&I7D]K,+>RO%N?
M+)^6>><28C!'W0,C/!]JUT=2W2_Y+]>_X'.G-07?_@_IV_$]+HHHJ34AN[J*
MQLI[JY8)#!&TCL>R@9)_2N&\"_%"#Q)X5U36/$%NNB?V:^^9)6.%@9 \<A_W
ME/YUM^/]$U+Q)X*O=%T>:*"6^VP2RR,5V0EAYA& ?FVY ^M>;Z[\);C0-/UV
M2V\1W$VD7>DJMS<:M*99(98'#Q$".,9C !4CJ!TSTJ+M<S>UO^"W^@/6R7?_
M ('_  ?D=[;?%+PE>:;>7MMJ,SQV0C^T1_8IO,0R9V#9LW$G'0"H)OB3I)N]
M.O;;5K(:)-975U.9()_M \G;NV@+A=N2&5L-TP.M>;:#:>)O'LGB75]'N;)A
M<SV"NUG//;6]XD2-YD23!0X^\N6 '(Q6A%\'O$::*;1I]/\ ,^RZK"/])E<
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M&\;#G:R. RG!!P0.M:5,+W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN-U;
MXDV>GZU=:9IN@Z[KT]F0MTVDVBRI Y&0C,SJ-V.<#.*GT#Q_::WK*Z3=:/K&
MAWTL32P0ZM:B(SJOWBA5F!QD9&<T+78'IN=71110 4444 ( %&%  '84M8GB
M?Q78^%+.":]BNKJ:ZE$%K9V<7F37$F,[47([ G)( KG'^*\=K&T^I^"_%VG6
M<8W37=SIZ>7"O=FVR$X'? -*Z8'?44R":.YMXYX'$D4JAT=>C*1D$4^GL)--
M704444#"BBN&N/BG:?;+B'1_#/B37(;>5H'O--LD>$R*<,H9G7.#QD#%*^M@
M.YHKG/#/C6S\2WES8_V?J6DZC;(LLEEJ=N(I?+;@.,$@KD$9!Z]:Z.F*X444
M4#.>A_Y')_Q_]!KH:YZ'_D<G_'_T&NAH **** "BBB@ K*\1?\@AO]]:U:RO
M$7_((;_?6@"?1?\ D#6_T/\ ,U>JCHO_ "!K?Z'^9J]0 5QOQ8TVSO\ X8ZW
M+>VT<[V=E-/ 9!GRY!&0&'N,G![5V5% T[,\A\>1ZKJFO7-[H]E;72>&+"&?
M?)<M')'+O6=A&HC8.Q2)1@E>'Z\UZQ9W4=]8P7<!W13QK(A'<$9'\ZFHH6BM
M\_OW(4;6?R^[;]?O([C_ (]9?]P_RKP'PAKSKHL%Q'K,6JM9>&I8@=+A$<ND
M\Q_*[$N&8\?,<8V$[>M?05%*VK??_)K]2GJK?UT?Z'B5GK5]/H^IV]CK4PA&
MJZ7'#-::O-?;4FE5)-EQ( S@C/;:#G'2N@\7V&D:'K/AFWUC7=1L]/#7A-W-
MJ<JR+E%PAGW;P,],MSP,G->FT4-75O/]$OT_$E1MO_6K_P SP?Q+XIU2V\/V
MS7.IWEOJ4&CK<VYN-1DM#*V]]KK"B_Z0Y55+J^%4$'')KOM#LYM8\;:]/<ZM
MJ82PN[8VT$5XZPJ&MXV8% <,K$]""!U&"2:[JBJ6FOK^=PY?RM_7]=3R3PUX
M@GN?B;:QQ:E-(MS<7D5S;S:I),Z[<E%>WVB.W(V_*%^9EY.>:['XES1V_P /
M]0FG=8XHVA=W8X"@2H237545%GRJ/8=M7?J>37'B*W_X2Y?$]CJ!M_#D^J6T
M,]\',=O,%MI@69N 4W-$N3QN4>E4=,N[WQ!#OEUO5?(6SU:ZB,%]+$6*7A$1
M)4@D*N  >,<$8XKV>BAQTLO/\5;\'JOZ86O;Y?@V_P ;V/*I];$MY;2>(==U
M*PG;3+*;2XK.9HS=RL"9-L8(6=\X!1MP .<#.:JR^([AOBI:Q6VHSJQUAK2X
MMI=3D9Q%Y3X!M OEQH6"E9"=S9KU^BJ>LN;U_%_TB5%J'+?I:_R:_P"">7^"
MYKV+6/#,LNJ:C='5K&]>Z2ZO))48QR)L*JQ(4@,1E0,]\UZA111T2_K<L***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]: )]%_Y UO]#_,U>JCHO_(&M_H?YFKU !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=_7K][: 3V*YM'?O^D?\R4[V?3_]K_Y$]GJK9ZE:W\EU':2^8UI,8)QM(V.
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MNG65V/MER\["60S!R"Y. =B_*, =@*<=8I_UU_R+D[?UZ?YG;4444#"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^@UT-<]#_P CD_X_^@UT- !1110 4444 %97B+_D$-_OK6K65XB_Y!#?[ZT
M3Z+_ ,@:W^A_F:O51T7_ ) UO]#_ #-7J "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDMT97D"A8LJ#U&<'&*Z?PC=R^&? ]@NJPWCB>_,$"?8S 84EF(CS$TC&-!D
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MS)=S;6 ))[MT8@G)ZUT'Q)@DN='L(?[-^WV[7J_: UG+>1QKL;#/;QD-*N[
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MBB@ JC>Z-8ZAJ%E>WD+2S6+%[?,C!48C&XJ#M8^A(..V*O44 %%%% !1110
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MCHO_ "!K?Z'^9J]0 445B>)_%-KX7M;:2XM+R^FNYO)M[6QB#RR-M+' )
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M=+<QRQ,2NY7 '((P00*ZJGYBOK8****!G/0_\CD_X_\ H-=#7/0_\CD_X_\
MH-=#0 4444 %%%% !65XB_Y!#?[ZUJUE>(O^00W^^M $^B_\@:W^A_F:O51T
M7_D#6_T/\S5Z@ KF/'E]-:Z&L']E:I?V5XQ@NY-)9OM-NA4X=50;FR0 =N"
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M[5TK5;&:SB>6:"5(6<;4#@?)(RDL"<#/\)SBNGT37;3Q!:S7%@)/)BE\K>X
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M8B2/'7YA\F>W!Q[UTM%)I._GI_7W >:I\'K=V0W5]9QJM];79@T_31;0XB#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .>A_P"1R?\ '_T&NAKGH?\ D<G_ !_]!KH:
M "BBB@ HHHH *RO$7_((;_?6M6LKQ%_R"&_WUH GT7_D#6_T/\S5ZJ.B_P#(
M&M_H?YFKU !5#7-:LO#NA7FKZI+Y5I9Q&65@,G [ =R>@%7ZX+XJ^'?$/B+2
M+2+04T^XMK9WN+NTO'D7[050^6 $1MV&.[!QDA:SJ-J+:*BDWJ=AHVJP:YH=
MEJMHLB07L"3QK* &"L 0" 2,\^IJ[7,_#FWU*T^&^@V^M6ZVUY#91H\*A@4
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MQNK.WNIA'+>RF&W4@GS'",Y''3Y58\^E<[\.C+>^&6UZ[A,-SKL[7[(PY1&
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M42,J&+;W7^^.F:Y_Q#XB76O#EO<V6C:\!I^IV<LL4ND7"2LBR DHA3<X '.
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ME;:]_P!"IZ-6[+\VOT_KIUE%<#I?A"S,_B/5+K2F_M$7]TUG,Z,'V-&!A/\
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MZI;7EG-INIW/D27;7:*EK^Z>0[V&5R-N",C!/6MN?Q'H=KI]O?76LZ?#9W1
MM[B2Z18YB>@5B<-GVJFFB;K3[S2HK/O/$&C:=.L.H:O8VLK;=L<]RB,=V=N
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '/0_\ (Y/^/_H-=#7/0_\ (Y/^/_H-=#0 4444 %%%% !65XB_
MY!#?[ZUJUE>(O^00W^^M $^B_P#(&M_H?YFKU4=%_P"0-;_0_P S5Z@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YZ'_D<G
M_'_T&NAKGH?^1R?\?_0:Z&@ HHHH **** "LKQ%_R"&_WUK5K*\1?\@AO]]:
M )]%_P"0-;_0_P S5ZJ.B_\ (&M_H?YFKU !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!ST/_(Y/^/\ Z#70UST/_(Y/^/\
MZ#70T %%%% !2.VR-FQG:,X%+12=[: <FOC*[U"UTLZ!HOVVYO[);YHY;M85
MAB) P6PV6R>@&.#DBK5SJD>M>#X-0AC>)9R"8I,;HV!(93C(R""./2L+5/#W
M@1/$(,VO-I=_EA]DMM=>USO.6 C60;0QP2%QDX/6MR>!+;P;;01V TY(PBK:
MAPWE =!D9!^M-.ZO_77_ ('_  !._-_7]=S5T7_D#6_T/\S5ZJ.B_P#(&M_H
M?YFKU PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/0_\
M(Y/^/_H-=#7/0_\ (Y/^/_H-=#0 4444 %!.!D]**#C!ST[YI/8#GIM<\&RW
M0N)]4T)[A/NRO<0EU_$G-+>R-+X3A=[Z+4"VT_:H5"I+SU !(Q^-<U8:S\/;
M.-X(-,_ULCRVJ2:8[M>!F))MP5)D3)_AX (Z BNFOW23PI"\5E)8(=NVVD14
M:,9Z%5) ^E-;"?Q6-'1?^0-;_0_S-7JHZ+_R!K?Z'^9J]0,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .>A_Y')_Q_\ 0:Z&
MN>A_Y')_Q_\ 0:Z&@ HHHH *1U#QLAZ,"#BEHI-)JS X*#X5K:M9&U\9^)HO
ML$#6]KMDM?W,9VY49@Z?(O7TKH-3M7L?#$5M)=W%Z\153<7)4R2>[;0!GZ 5
MNUE>(O\ D$-_OK578=;D^B_\@:W^A_F:O51T7_D#6_T/\S5ZD 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <]#_R.3_C_P"@
MUT-<]#_R.3_C_P"@UT- !1110 444$9!'3Z4 %97B+_D$-_OK6%:> 9TB<7W
MBOQ!-)YC%6BU!T&PD[01SR!@$C@^@JW=7$"Z1=:7!-<SOIDL<,LMRV]W)0.#
MN[\,.: ZFSHO_(&M_H?YFKU4=%_Y UO]#_,U>H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .>A_Y')_Q_\ 0:Z&N>A_Y')_
MQ_\ 0:Z&@ HHHH *"<#)X HIDN/)?<"1M.0.]3)VBV-;G*_\+)T%F"PIJ4\D
MF3;QPZ?*S7*#K+$ OSH.[#CD>HR/#;S:;?ZU8W:W-MJ\T-S$57&U1$J?C]W/
M;'2LK2KZ..P\,?\ "-:')J5['H^Z W5ZL7D6S>6"K,%(9R54<+_">1GG1T[R
M#\.;)K7S0C'<1, '5R[%P<9'#9'''%7:S?W?C_P/O)OK;^NAT>B_\@:W^A_F
M:O51T7_D#6_T/\S5ZD,***R=?\3Z5X9CMWUB6=/M4ACA6"TEN&=@"Q&V-6/0
M$YQ1>P&M16$GC/0Y&TSRKF=TU0[;29+.8Q.W(VM($VHW!^5B#QTK=H%=!111
M0,**** "BJUYJ-K826L=U(4:[F$$(",VYRI;' XX4\G XJS0 4444 %%%% !
M114:W$+SR0I*C2Q &2,,"R ],CJ,X/Y4 245F:3X@T_6YKN&P:X\VRD$<\=Q
M:2P,A(R.)%4D$<@C(-:= !1110 4444 %%%% !1110 4444 %%%5[&_MM2MC
M<64GFQ"1X]^T@$JQ5L9'(R#R.#VH L457N-0M;2ZM;>XE$<MVY2 $'YV"EB,
M],X!./8U8H **** "BBB@ HHJO<7]M:7-K;SR;9;N0QPH%)+$*6/0<  'D\?
MF* +%%%5[&_MM3M?M%C*)8M[(3@C#*Q5@0>0001^% %BBJM[J5KI[6PO)?+-
MU.MO#\I.Z1LD#@<=#R>*M4 %%%% !1110 4452CUBPFN+^".?,FG$"Z78P\O
M*!QVY^4YXS2;2W#<NT5GZ7KNG:UYG]FW'G>6D<C?NV7"R+O0_,!U4Y]N]:%,
M2::N@HHHH&%%5[^_MM,L9;R]D,<$0!=@A;'..@!/>K% !1156/4K6;5;C38Y
M";JWB265-C *KE@IW8P<E&X!R,<]10!:HHHH **** "BBB@ HJO]OL_L!OOM
M<'V14+FX\P>6%'4[NF/>K ((!!R#T(H **** "BBB@ HHHH **** "BBFRRQ
MP0O+,ZQQHI9W<X"@=23V% #J*1'61%>-@RL,JRG((]:6@ HHHH ***J1:I9S
M:O<:7%-NO+:*.:6+:?E1RP4YQ@Y*-T/:@"W15>_O[;3+&6\O9#'!$ 78(6QS
MCH 3WJQ0 456EU&U@U*VL)9"+FZ1WB38QW*F-QSC QN'4\YXJS0 45'!<P74
M9DMIHYD#,A:-@P#*<,,CN""".Q%24 %%1RW$,!C$\L<9E?9&'8#>WH,]3P>*
MDH **** "BBB@ HHHH **B%U SS(DT;/!CS55@2F1D9';CFH]-U&UU?2[?4-
M.E\ZUNHQ+#)M*[E(R#@@$?C0!9HHHH **SM8U_3]"2 Z@\VZXD\N&*WMI+B2
M1L9.$C5F. "2<8%3R:E:Q:C;6,DC+<W4;R0IY;?,J;=V3C QN'!QUHW M456
MN-1M;6^M+.>7;<7A80)M)W[5W-R!@8'K5F@ HJ"]O(-.L+B]O',=O;QM+*X4
MMM51DG R3P.@J2*5)X4EB.4D4,IQC(/(H ?1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/0_\
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MS T5O)IL\UL\-^S)*H>$,98#& '!;"D.W&[UK5ZU+]^;\M?R$VK6?11_S_\
M;OZN8WAWX>WVD>)[>YN&BEL[*YN+B"8ZG=R.YEW8'V=CY,9 <@LN<^@S7?7,
M9FM)HEP&=&49Z9(KD]$\<W6I7]DE_H\=E9ZA=7%I:3+>>8[R0E\[DV *"L;$
M$,>F"!UKL:R<5*'+TL5%I2;1Q"^$=8L_!_A&TLFL9M2\/&%FCEE=(9RL#1,
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MK@R!0%D&#E2,=/FP<TF^9?C^+U^^_P#PQI?EU_K^M2"/P%KT-BS0&W2:XO\
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M7XZX/%9OE=*_2U_O][7[_GT-5\?G?\O=_0@^%^E7UCX*GO))UN;V]8FVFG!
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M^M,\1MKFP@MD4$[PR/*Q)&,8PXQSZU)XLTF?7?">HZ7:-&DUU"8T:4D*"?7
M)_2M&]NXK"QGN[@D16\;2N0.BJ,G^5<MIWC#5;^46LNB6]I>W=@;_3HY+\LL
MT8*@B1A'F-AO7( <<]34MJUNW_!?Z,J6]WU_X"_R(-6\'ZG/XBFUJPDM&GAN
M;:YM89Y&5)#'%)&ZN0IV@B0X(#8(Z4LG@_4Y_"LUI/-:#4+O5XM2G",WE1[9
MTD**=N3A4QD@9/IFN6L]3\3V7P)U+Q$@5M3NK-[DW$NLSS;5VL3(BO&5C8'I
M&@"\#YA70:I)JGAWP'8;[5]INH!=NGB"XEFCW3H%*2R1%I 2?F4[!C(%7&+C
M+SNOONO\E_P-2;+1>OX7_P W]_H/\9^$M>U236QH#:<T>N:<EE/]ME>,P%-^
M&7:C;@0Y&#C!&>>E5&^'=^?%TEV7BEL)M0BU!G?4[M3&R!?D^S*1"YR@(<D8
M[J<5T.L>*+ZUUR;3-$T;^U9K.V2ZNP;D0LJ.S!5C&T[W.QN"5''WN:R+CXIZ
M?;^,CHC"R"I>1V+[]11;KS7 P5M\99 6 +;@<YX(&:4?B5M_^"OUL$U&SYOZ
MT_R-K1/#UUINAZM93O;F2^O;NXC.TN@65V9=P(&>",CI[UG^!?"^K>'9[S[>
M\$%G)'&D-C;7TUS$CC.Z1?- ,8;(_=KE1CJ:N:!XGU37=1G5=#CAT^WN[BSD
MNC>AGWQ,5W"/8,J<#G.03T(&:Z:A::KJE]W0J6K:?=_??7\?\NYQWQ&\(W_B
M_2HK;39K:)TBN4)N&91F2!XUZ*>[#/M6/'X%\1:>'DTZ32Y99TU""19YI%6-
M+B;S$<$(=S <%3@>C<<^DT5+BFK/^KJWY!_G?[CSF3P)KB:KI5Q8S6=L]M#:
M12WT%W-%*%B $D9B5=DZL 0"^TKGVKI8=+U6R\;WFH6T=G-IVHQQ"=I)W2:%
MHU8#:@0JX.1U9<<]:Z&BKO?[V_O(4$E9?U8IZQ9OJ.B7ME%Y.^X@>)?/C\R/
M)4CYE_B'J*YKP?X8U;1;/4H+Z2*&"X14MK&*_FNXX" 0S*\JAE#$CY!D+C@F
MNQHJ'%--/KH7V\CR[4X)? NC^#WNKW38KW3=-DT]VO9GBM7S''NQ)L)#9C!5
M2!N&1P:/#G@S5;OP' '\F":[\*_V<(YMRLDK;F!88.%^8>I]J]1HJI>\VY=7
M_G?_ -*81]VUNEOP::_(S+6#5;6XTZW4V9T^*T*7).[S3*-H39VVXWYSS]W'
M>M,^U%%-ML48J*LCD_"^D>(+.'78]=BTV/[?=27$!L[F27!=<$-NC7&,#IGJ
M:U?"6DSZ#X-T?2;QXWGL;**WD:(DJ65 "02 <9'H*UZ*2T5EY+[KI?F%E>_K
M^.YR/C7P[K.NW-DVES0FWCBECF@DO9K7+/MVONB!9PN#F,D*V>3Q6QX4TJ?0
M_!^DZ5>-&\]E9Q02-$25+*H!() ../2M:BA:)I=?^#_F_P"DAO5IG)1Z!KUI
MKEY'92Z?_9-]?B^EFD+&XC^50T:IM*G)7A]P(!Z'&:R[#P1K45K9:==RV L]
M'LKBUL98I',EP9$V*T@*@)A>H!;)YXZ5Z#14."<>3I:WX67W+_/<-G?Y_C?\
MS@O&MC=:=\*M/L(C"UW;3Z="I)/EEUGB'IG;D>G2D3PEXAAU<^)8_P"S&UE[
MQIGL6N)!;B-H5AVB7R]VX! V[R^<D8[UWU%:-MW;ZN_Y?Y$J*45%;(XS1/!E
MYI>I:%=2W$$OV&.^:ZVEAF6YD63" C[H(8<D<8K/\6^"-?U_7IIH+BV:S::V
MFA\V^GB\D1.K,A@1=DA;:2'8DC. .]>AT4NJ?;_AQVTL<YI^D:IIOC/5;R)+
M.73=4>.:21IV6:%TB$>T)L*L#M!SN&.>#5*^\'7=\GBM#<PQ?VS-#+:MRVPQ
MQ1J-XP.-R= 3Q7844K:6\K?U]PSA)/"&MZI?RZKJIT^WO9KNQ=K>WF>2)8K>
M0OG<R*2[;V_A ' SWKH_#^DSZ4^JFX>-OMFH274?EDG"L% !R!S\IK8HIK3;
M^KV_R1/*KW_KK_FSB_$WA76-0U#5FTF2Q-MKE@EC=M=.RO;!=XWH I#\2'Y2
M5Y .>U;&C:%+I>OZG>,\;074-M%%@DN/*0J=W&._8FMRBE:PVDW?^OZT0444
M4QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!ST/_ ".3_C_Z#70UST/_ ".3_C_Z#70T
M %%%% !2-NV-LY;'&?6EI&W;&V<MCC/K2ELP1Y*KZ-<"&?Q?J?B:'Q&BYE@A
MAN (Y.I6)(T*.H/"D;LCJ3FNS6749O EG)K2.EZRJ91(H5^IQN X#8QD#@'-
M<E!J%@88V\4ZYXLM=?V9GM;=+E563J5BCC0QNH(P"-V1C).:ZU9=1F\"6<FM
M(Z7K*IE$BA7ZG&X#@-C&0. <TUM_EM\B7\9M:+_R!K?Z'^9J]5'1?^0-;_0_
MS-7J"@KEO%WA^]UW5_#[V5Q=6:6=U+++=VKQB2$&%U! <$-DD#&T]>E=312:
MN)ZJQQMW\,M*N;46\.H:G9QM9O97(@E3-U&S%VWED)!+,Q)4KG//'%;FG>';
M73-7GU*"6=YI[2"T8.PV[(=^T@ #D^8<]NG K6HIK3;^OZN%E_7R_P E]QC)
MX:BA\176K6]_>0_; /M-HAC,,S!-@<Y0N"%QT8#@9!K.'P\T8V-E9RR7<L-E
MI<FEH&D +1.4)8D '>#&N",8YXKJJ*%IM_6Z_)L9S \#V\MF8=1UC5=1D-S;
MW/GW,L>X&!PZ* J!0N1SA<G)R<\UHZ[H UM(2FI7VG30EMLUFR9*L,,K+(K(
MP(]5X[8K6HH>JL_Z_JPDDMCD_P#A7.C#2;S3HI+N*WN]*CTIPLBY6%-^""5/
MS?O#DG(Z<5M/H5L_B&TU@O+]HM+22TC7(V%'9&)(QG.8UQSW/%:5%.[O?^M?
M^'867]?+_)'$^#/!,FF+#>ZO<7CW$%S=2V]E++&T-N997^==HSDHW0L0,G &
M371Z'I]WIT-XM]=R71GO9IXS)*9#'&S95 2!@ =!T'3G&3IT4EH%E;YW_K[S
MEO&N@7VO7/A];":XMA::EY\US;.BR0*(9%##>"#\S*,8/7IC-6X_"&GQ:+::
M:LEP8[:\6],I<&2:82>86<XP=S9)P!UXQ6]10M/OO_7W#DE+?M;\_P#-G/:K
MX/M]4U9[]-3U*P,\:17<5G*J)=(A)4-E2PZD90J2#@FJR^ +%=;CU :EJ6R*
M_;4([/S(_)29@0S?<WG(8\%CC/&*ZJBDDEJ#5]_ZZ?D<I'\/-,-U-)?WE_J,
M3VTUI%;W<B,L$4I!=58*'.<#[[,1VQ6EH7AW^Q))I9-6U+4Y9$2,/?2JWEHN
M<*JHJKW.206/<FMFBFM-@>IEZYHG]M0P!-1O=.F@<O'/9N@89!4@JZLC @GA
ME/YU7A\):?!HFF:7$\ZP:9/'<1'<-S.A+?-QW)). /;%;E%*R_7[A-)[GFNN
M>$M7U'QH?LUM?6^GRZI;7\LL=U";23R@A+.A_>B3Y-N%^0\$\BNIM_!FG6TM
MA(DUT38ZC<:C%EUYDF$@8'Y?NCS6P!@\#D]^AHIQ]V/*OZV_R0-7=_ZZ_P";
M"L"W\':?;6-I:1S7)CM-2DU)"S+DRO([D'Y?NYD/'7&.:WZ*!O569GZ/HUOH
MEO<0VKRNMQ=2W3F0@D/(Y9@, <9/%.N])@O=6T_4)7D$M@9#$JD;6WKM.[CT
M],5>HH!Z[G,3^!;*?7FU+^T=1C1KV._:R21/(,Z *'Y3=R% (W8[X!YK9L](
M@LM6U#4(GD,NH-&958C:NQ=HV\>GKFKU%)))67]?U9"LKW_K^M64=*TB#2%N
MUMGD875U)=/YA!P[G) P!Q46N:%!KMO LEQ<6D]K,)[:ZMBHD@< C<NX,IX8
M@@@@@]*TZ*+*R7;]!]_/]=SE)/A_9&"%;;5=5M;A$DCFNX9D,MTDC;W63<A'
M+<Y4*5_A(K4TOPSI^CZI+>V DC,EG!9"'(V)'#OV8&,Y_>'.2>@K7HIK3;^O
MZN_O8K+^OZ\E]QP^B>!G.K7]]K5Q>&)M6GO+?3S+&;<D\++@#=G!/REL9YVY
MYJU#\.=,CLY[66^U&X@:QET^V2:1#]B@D&&2(A >PY?<?E SBNNHI))145VM
M^%OR_JP]I<W6]_QO^9D:MX<M]6T.#37N;FV%L\4D%Q 4\R-XR"K?,I4].A4C
MVK.3P)9QZ--8+J>I>9+?#4!>M)&9HYQ@[AE-O5>A4CDC&, =113ZW_KI_DON
M1/*K)?UU_P W]YS>I>#4U)H)O[;U:UNTMOLL]W;21))=19SA_P!V0#G)R@4C
M)P170PQ+! D29V1J%7<23@#'4]:?11Y#MK<YO3O!%AIVJ1W:7E]-#;O(]I93
M2*8;1I,[RF%#<[F'S,P ) Q6KH6CV_A_0K/2;-Y'@M(A%&TI!8@>I  S^%7Z
M*%HK#.:\:Z'>:]:Z5!8R3PF'4HIY)[=T5X44-\XW9!()'&#GT-5G^'5@5MFA
MU35+>ZB$XEO(Y(_-N1,09=^4(&2J\H%(Q@8'%==14\JLUW_R2^[0'J[_ -=?
M\S!T+PC8>'YX);.:YD:#3H=-02LI!BB+%2<*/F^8Y/3IQ4LWAN)_% UVWO[R
MUG>%(;B&$QF.Y1"Q0/N0L,%V^Z5Z\YK9HJVVW=BLK6_K3_ACF/\ A -':SLK
M2=KB:"SM+BS5)'7$D<^-^[ '/RC&,?C0G@>W;2[VRO\ 6-6U 7D:0F6YF0M&
MB'*JH5 H]V(+'N373T4@:NK,R]<T,:U# $U&]TZ:W??'/9N@89!4@JZLC @G
MAE/YU0M/!&EV4,$4$ER%AT^73URZ\I(P9F/'WLC/ISTKHZ*EQ3W_ *TM^0_Z
M_4R8_#EI$^C,LDQ.CQF.WRP^8&/9\W'/'ICFN<\)^!Y;.[DO]:GO"\>J7EW:
MV+RQM!&9)'VRC:-V2C="Q R> :[FBKO[W-U%RI1Y5M_P&OU*.M:3!KNBW6F7
M;R)#=1F-VB(# >V01^E9.J>";+4[R:\%[>VEW)-!.D\#1YA>)652H=&4\.<A
M@1]*Z2BILF%D<4?A;H[Q0I)?:E(8I99M[RH6=I)HYF).S^_$/P)]L3_\*YL(
MH(8K'5=5L0MO]EG:VF16N8M[,%<E"1@NV&3:PR>:ZZBGV788BJ$0*O11@<YK
MD[+P3;:!(U[;W&IZJ;4SSVFGSS1;$EE+%]GRKR=Q4;F( /;DUUM%)JXK(Y?X
M>^&/^$5\*+:20^1///)<RQ;P_E%V^6/<.NQ J<<?+Q6CK_AZ'7TLR]Y=6-Q8
MW'VBWN+4IOC?:RGAU93E6(Y!Z\8-:]%-Z@E9?UUW.,7X9Z=%8P6]MJVK6YC6
MXC>:.:/?-'.^^1')0\;N00 P]:TIO!]NTVD36FHWUC<:3;_98IH#&6EA.S<C
MAT88/EKR #QP170T4+1W7];_ .;^]]PLOZ_KR7W(P/\ A#M/\R%S+<DPZH^J
M*"RX,K*RE3\OW<.>.OO56S\ :=9N0+V_FMXX);>TMI9$\NR20881X4'IP"Y;
M X&!74T5/*K<O3;\+?D/K?\ K>_YLJ6NG16FC0Z;&SF&&W6W5F(W%0NW)XQG
M'M7/3_#^W:PT"TLM;U2Q708A%:M#]G<L0@0.XDB=2P4$ @#&X^M=915MMMO^
MNO\ FQ))*R.<U+P:FI/!,=;U6UO$MOLL]W:O%')=19SA_P!WM'.3E I&3@BJ
MUY\/=/N]06X34=2MH/M,%W)9Q2H8IIH=NQVW(6SA%!PP!QGKS7644EH[K^M;
M_GKZZ@TGO_73\M/0CG@CN;>2"= \4J%'4]&!&"*P]#\'VNAW7V@7U]?R1V_V
M6W-Y(C?9H<@^6FU1D<#EMS' R:Z"BE9?U_7F_O?<;UW,#_A#[#_A V\)>=<_
M8&M#:&3<OF[",9SMQGGT_"KVL:);:WH_]G7;RI#YD4FZ(@-F-U=>H(ZJ,\=*
MT:*J[;N!S^N>#K37+Y[IKZ^L7G@%M="SD51=0@DA'W*2!\S<J5;YCS31X,M8
M]::^M]2U*W@DG6YET^*91;R2J  Y^7?_  C*A@IQR#7144EIM_7]/7UU$TGO
M_7];>FAGZ/HUOHEO<0VKRNMQ=2W3F0@D/(Y9@, <9/%2:;IW]G1SI]LN[OSK
MB2?==2[S'O.=B\<(.@'85<HH'O\ G_7WA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% '/0_\CD_X_\ H-=#7/0_\CD_X_\ H-=#0 4444 %(P)1@IPV
M.#Z&EI&&Y&4$C(QD=J4MF"/%S>>%M+N(M-\7>'I;_P 3JNV6Y-[ SW$AZLDC
M3*R G& 0NW(  Q7H"6]_:^ [.'5WWWB*HD)D\PCDX!?^(@8&[OC-8^GZ+KFB
M:5'HZ>$-$U18TV&_DO!&+@]WE4Q,P9CRV-V23S6R-+ET7P+::=<2K-+;A59D
M!"CDG"@\[1G ]@*:V_I?AT_K8E_'?U_K^OQ-K1?^0-;_ $/\S5ZJ.B_\@:W^
MA_F:O4%!61XLU6?0?!>MZO9I&]QI^GSW42R@E&9(V8!@"#C(YP16O7-_$?\
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M?_H8?#__ ((9_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\
M@AG_ /DRNDHH YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*Z
M2B@#F_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,KI** .;^P^-
M_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DRNDHH YO[#XW_ .AA\/\
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M -##X?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\
M_!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)
ME'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\
M]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X?_\
M!#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E
M=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V
M'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##
MX?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/
M_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'
MQO\ ]##X?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X
M?_\ !#/_ /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_
M /)E=)10!S?V'QO_ -##X?\ _!#/_P#)E'V'QO\ ]##X?_\ !#/_ /)E=)10
M!S?V'QO_ -##X?\ _!#/_P#)E9NEW/C?4M1UFU_MOP_%_9=ZMIN_L2<^;FWA
MFW8^U\?Z[;CG[N>^!VU<WX7_ .1B\9_]AJ/_ --]G0 ?8?&__0P^'_\ P0S_
M /R91]A\;_\ 0P^'_P#P0S__ "97244 <W]A\;_]##X?_P#!#/\ _)E'V'QO
M_P!##X?_ /!#/_\ )E=)10!S?V'QO_T,/A__ ,$,_P#\F4?8?&__ $,/A_\
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M]=)7-_$?_DEGBO\ [ MY_P"B'H Z2BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
MOXC_ /)+/%?_ &!;S_T0]=)7-_$?_DEGBO\ [ MY_P"B'KI* "BBB@ HHHH
M**** "N;L?\ DJ>N_P#8%TW_ -'WU=)7-V/_ "5/7?\ L"Z;_P"C[Z@#I***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_"_
M_(Q>,_\ L-1_^F^SKI*YOPO_ ,C%XS_[#4?_ *;[.NDH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N;\+_ /(Q>,_^PU'_ .F^SKI*YOPO_P C%XS_ .PU'_Z;[.@#
MI**** "BBB@ HHHH *YOQY_R+MK_ -AK2O\ TX6]=)7-^//^1=M?^PUI7_IP
MMZ .DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .>A_Y')_Q_P#0:Z&N>A_Y')_Q_P#0:Z&@ HHHH **** "LKQ%_P @AO\
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M:/\ A%_VAO\ H>_#_P#WX3_Y%H ]MHKQ+_A%_P!H;_H>_#__ 'X3_P"1:/\
MA%_VAO\ H>_#_P#WX3_Y%H ]MHKQ+_A%_P!H;_H>_#__ 'X3_P"1:/\ A%_V
MAO\ H>_#_P#WX3_Y%H ]MHKQ+_A%_P!H;_H>_#__ 'X3_P"1:/\ A%_VAO\
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M,_\ L-1_^F^SKI*\D\3^$?BW_P )KK-_X"\3Z/IFDZC-'.(+E \F]8(HF)S
M^,^4. <8]\UF_P#"+_M#?]#WX?\ ^_"?_(M 'MM%>)?\(O\ M#?]#WX?_P"_
M"?\ R+1_PB_[0W_0]^'_ /OPG_R+0![;17B7_"+_ +0W_0]^'_\ OPG_ ,BT
M?\(O^T-_T/?A_P#[\)_\BT >VT5XE_PB_P"T-_T/?A__ +\)_P#(M'_"+_M#
M?]#WX?\ ^_"?_(M 'MM%>)?\(O\ M#?]#WX?_P"_"?\ R+1_PB_[0W_0]^'_
M /OPG_R+0![;17B7_"+_ +0W_0]^'_\ OPG_ ,BT?\(O^T-_T/?A_P#[\)_\
MBT >VT5XE_PB_P"T-_T/?A__ +\)_P#(M'_"+_M#?]#WX?\ ^_"?_(M 'MM%
M>)?\(O\ M#?]#WX?_P"_"?\ R+1_PB_[0W_0]^'_ /OPG_R+0![;17B7_"+_
M +0W_0]^'_\ OPG_ ,BT?\(O^T-_T/?A_P#[\)_\BT >VT5XE_PB_P"T-_T/
M?A__ +\)_P#(M'_"+_M#?]#WX?\ ^_"?_(M 'MM%>)?\(O\ M#?]#WX?_P"_
M"?\ R+1_PB_[0W_0]^'_ /OPG_R+0![;17B7_"+_ +0W_0]^'_\ OPG_ ,BT
M?\(O^T-_T/?A_P#[\)_\BT >VT5XE_PB_P"T-_T/?A__ +\)_P#(M'_"+_M#
M?]#WX?\ ^_"?_(M 'MM%>)?\(O\ M#?]#WX?_P"_"?\ R+1_PB_[0W_0]^'_
M /OPG_R+0![;17B7_"+_ +0W_0]^'_\ OPG_ ,BT?\(O^T-_T/?A_P#[\)_\
MBT >VT5XE_PB_P"T-_T/?A__ +\)_P#(M'_"+_M#?]#WX?\ ^_"?_(M 'MM%
M>)?\(O\ M#?]#WX?_P"_"?\ R+1_PB_[0W_0]^'_ /OPG_R+0![;7-^%_P#D
M8O&?_8:C_P#3?9UYM_PB_P"T-_T/?A__ +\)_P#(M5K7P/\ 'RRN;V>V\;>'
MTEOIA/<-Y2G>XC2,'FVX^2-!@8'&>I- 'NU%>)?\(O\ M#?]#WX?_P"_"?\
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M210V]L9CY,8:!')"=,YSS[FNGT;3H=%TM+-+RXNRK,[SW<V^21F)8DGIU/0
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M>RQ"54)*K(JN!( 2<!@>IK32]UYDVERVO_6G_!.?/CG41HDMYY%KYB>)/[(
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MB:ZO))_(C)!\N/>QV+D#A<=!Z"K?B328/$7AV\TN681>>G[N48)C<'<CCW#
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MLW^^.O/7FI]'TEK36]6U:^EA>ZOY%1!&V1'!&"(UR0.>68^[$<XS41V5]_\
MAOUU_P MAM.[MMI^OZ:&Y13?,3^^OYT>8G]]?SIE#J*;YB?WU_.CS$_OK^=
M#J*;YB?WU_.CS$_OK^= #J*;YB?WU_.CS$_OK^= #J*;YB?WU_.CS$_OK^=
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MFNDH **** "BBB@ H(#*0PR#P0>]%% &+/X9MY)2T,K1 _PXR!]*B_X19/\
MGZ;_ +X_^O6_10!@?\(LG_/TW_?'_P!>C_A%D_Y^F_[X_P#KUOT4 8'_  BR
M?\_3?]\?_7H_X19/^?IO^^/_ *];]% &!_PBR?\ /TW_ 'Q_]>C_ (19/^?I
MO^^/_KUOT4 8'_"+)_S]-_WQ_P#7H_X19/\ GZ;_ +X_^O6_10!@?\(LG_/T
MW_?'_P!>C_A%D_Y^F_[X_P#KUOT4 8'_  BR?\_3?]\?_7H_X19/^?IO^^/_
M *];]% &!_PBR?\ /TW_ 'Q_]>C_ (19/^?IO^^/_KUOT4 8'_"+)_S]-_WQ
M_P#7H_X19/\ GZ;_ +X_^O6_10!@?\(LG_/TW_?'_P!>C_A%D_Y^F_[X_P#K
MUOT4 8'_  BR?\_3?]\?_7H_X19/^?IO^^/_ *];]% &!_PBR?\ /TW_ 'Q_
M]>C_ (19/^?IO^^/_KUOT4 8'_"+)_S]-_WQ_P#7H_X19/\ GZ;_ +X_^O6_
M10!@?\(LG_/TW_?'_P!>C_A%D_Y^F_[X_P#KUOT4 8'_  BR?\_3?]\?_7H_
MX19/^?IO^^/_ *];]% &!_PBR?\ /TW_ 'Q_]>C_ (19/^?IO^^/_KUOT4 8
M'_"+)_S]-_WQ_P#7H_X19/\ GZ;_ +X_^O6_10!@?\(LG_/TW_?'_P!>C_A%
MD_Y^F_[X_P#KUOT4 8'_  BR?\_3?]\?_7H_X19/^?IO^^/_ *];]% &!_PB
MR?\ /TW_ 'Q_]>C_ (19/^?IO^^/_KUOT4 8'_"+)_S]-_WQ_P#7H_X19/\
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MR?\ /TW_ 'Q_]>C_ (19/^?IO^^/_KUOT4 8'_"+)_S]-_WQ_P#7H_X19/\
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MR?\ /TW_ 'Q_]>C_ (19/^?IO^^/_KUOT4 8'_"+)_S]-_WQ_P#7H_X19/\
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@4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>halo-20240313_g12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g12.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,R-@  DI(  @    ,R-@  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M<[G]58$<\8HM_7SM^81][;^KJY[[5*?6=,M;5+FYU&TAMY)1"DLDZJC2$X"
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M Z*N"ORJ$).2"!78>$=5O=:\+VE[JMG-9W;;DECFMW@)*L5W^6_S*& W 'D
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MVX\%Z=XCUFYM='MKZ".4_:[E52,N,A=[;0?TI+1:=+?K;]1N[W,S_A6&C?\
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MB0Z)=ZD%CM].2Z6Y,/ \R0NORY<JO3WS7=>)_#UIXL\,WNAZC)-%;7L?ER/
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M #!9R!]^Z*,J5!)ZE@W!.,5T5W\/M$U#6-:U#41/='6[..RNX)' C,:9P5P
MP;GKGZ8KJ**72W]=AWUO_7?\SA_#WPIT?0->M]6?5=<U>:S#+8QZK?F>.R##
M!$2X&...<\ 5N^+O"ECXST!M(U26XBMVFCF+6[*KY1PPY8$8R.>*VZ*=WIY$
MV1R7BOX<Z3XLU"#4I+S4])U2WB,*:CI-V;>?RR<E"V""/J.YJ-?A?X>A\,V>
MAVHNK>VM;^/43(LH:6>=&W;I'8'=D]?TQ78T4EIM_77\QO4*X-_A%HC0^)+=
M-2UB.T\1LSW5HMTIAB=F#,\:E3M8D<DYXXKO**!W,"[\':?>ZOX>U&6:Y$WA
M\.+559=K[X_+._Y>>!VQS7/WOP9\-7VNS7[W&JQ6ES<?:KK2(KTK8W,V<[WB
MQR<@'J!QTKOZ*=W>XNEC.UW1H=?\.WNCSSSVT%[ T#R6S!9%5A@[200...E5
MH?"FF0^"%\*!'?3%LOL.&(W&/;MR3C&<<YQUK:HI;IKN-.S370X_2?AMI6D7
MGARZBO=0GD\.VLMI:&>1#OCD&#OP@R0  ,8Z<YIFJ?"_1=7TOQ'87-U?K%XB
MNH[J[,<B!D=-N F4.!\@ZY[UV=%.[O?^M[_GJ)>[M_70P[OPI8WOB?1]=EEN
M!=:/%+% BLNQA(H5MPQDG"C&"*Y&^^!7AF_CU.!]0UR*RU&8SFQBO\6\$I;<
M72,J1N)[MNQVQ7I5%+K?^NX+0XS6_A?HNN>)(=;DO=6LKI;<6UPMA>M EY$.
MB2[>2/H1[TFF_"W1-*MO#]O;7-^8O#UU+=62M(AYDSE6^3E1N.,8/J37:44+
M05OZ_ Q?%_A:R\:>%[K0=4EN(K6ZV;WMF57&U@PP6!'51VJB_P /]%?Q;=>(
M\3#4+K3?[.<AEVB/^\!C[^,#.<8 XKJ**.EOZVM^15W_ %_7D<)<?"/09_#&
MC:/%>:K:2Z(A2QU.TNA%=Q!OO#>JXYZ'Y:MQ?"[PU'X*F\,207$]I/+]HFN)
M9R;B6?(/G&3KOR!S^F*["BAZW\Q+2UNAR7ACX<:3X9^W2_;-3U>]OXO(N+[5
MKLSSM$,XC#8&%&>PK-LO@]HMCHFGZ2NJZU/9Z;JD>IVB7%TLGDLGW8ERG$?)
MX'/O7?T4TVG?^M-0_K[]#GK'P7IVGZGXBOH9KII?$)4W0=U*IM38-GR\<>N>
M:X#X@?#758O#/A>Q\%6<M^- )19$U#['J"J0!^ZGXC7/.[*GCI@U[!12_P"!
M^&P+3\?QW/+OAGX#U;3(_%%]KEO+H<VOE$2WAU#[3<6RK&5WF?G=(2Q;=SSS
M7HVE6']E:3:V'VNZO?L\2Q_:+R3S)I<#[SMQECW-6Z*;=_P_ 21EZOX?M=9O
M])N[J29)-*NOM4 C8 ,^QDPV0<C#GICG%.N="MKKQ)8ZW(\HN;&":"-%(V%9
M"I8D8SGY!CD=ZTJ*0SGF\%:6\>IH[W).HWRZ@SB0*T$RJBJT9 &,; ><]\Y!
MQ4^D^&H]-U!]1NM0O=5U!XO)^UWICW)'G.Q5C1$49Y.%R<#).!6U11M_7R_(
M-_Z^9G_V+;MXD&MR/*]RMK]EC1B-D2EMS%1C.6(7.2?NCISFEKWA&P\07)GN
MI;B"1[&>PD,#*/,AE W Y4]" 1Z'U!Q6[11:ZM_6O_#C3:=T8DOA6QEM]"A:
M6X"Z%*DML0RY<K$T8W\<C#'ICFJH\"Z8/!^I^'//N_L>I2SRS/O7S%,SEVVG
M;@ $\9!_&NEHIW;=Q+1)=OZ_4YV[\'6]QJT]_;:EJ%@UW"L-Y%:R($NE4$+N
MW(64@$C<A4^_ JK;_#VRL++2(M(U34M.GTFU-G#=P-$TDD)()1P\;(W*@YV@
MCL1DUUE%+^OZ^]@<M8_#_2M/9FAN;YV;51JS-+,'+3[-AR2,[3UQZ]"!Q6KX
MC\/VOB?0IM*OY)HX)F1F:!@&!1PXP2".JCM6I11_7]?<'6_]?UJ97B+P[9^)
MM*^PWS2Q%)$FAN(&"RP2*<JZ$@@$'V([$8JI>>$H[C4);VRU;4M,GN51;QK-
MH@+H*, L'1@K8XW)M;&.>!CH** .#O\ P/+_ ,)EX>;1FNM,TW2],N;=+JTE
M3?$[-%M!5PV_(#D[E89&3SBMK_A"=,.E?9'ENGN#="].H&4"X-P!CS=P&,XX
MQC;M^7&.*Z*BG=V_KO?\P_K\+'+S^ [&]TO5;;4[^_O[G5K0V=S?SM&)O*YP
MJA4$:@;B>$Y/)S5[5?"]MJMIIL7VNZM)M+E66UN;<H9$8(4/WU93E6(.5[\8
M.*VJ*+@9^FQ:A'>:BU_.\D#W -HCA,QQ[%!'R@<;MQYR??L&IH=LGBB77@\O
MVJ6T6T*9&S8KEP<8SG+'O^%:5%+^OT#R.;@\!:'!XEUC6DAD,FM6XM[VW9@8
M7'.6VXR"<\\X/IGFELO!=K;7=G+=:EJ.HPZ>P:QMKR1&CM2%*@@J@9R 2 9&
M<CM71T4+38'J<O%X"L(F55OK[[/'J@U2&VW1[(9MS,P!V;BK,Y)!)/H0.*6^
M\!Z??3W8-Y?0Z?J$OG7VF1.GV>Z<XR6RA=<X&0C*#W!R<]/11M_7I_DON#=W
M_K^M6<W>>";6XN+HVFIZCIMM?$M>6=G(BQ7!*A222A9"0 "8V3/UK>@L[>VL
M8[.WA2.VBC$21*/E5 ,!<>F*FHHZ6#K<X^7X::3=:>-*OKW4;K1(_P#4:2\R
MK!!C[NTJHD(7J SL!Q@<#'4V5J+&P@M5EFF$,8023ON=\#&6/<^]3T4 9?AW
MP_:^&=&73+"2:2%9990TS MF1V<] !C+'''2B3P_:R>+(?$+23?:X;-[-4##
MRRC.KDD8SG*COCVK4HHZW_KL!S-WX&LKJ2\C34-1MM/OW:2]TV"5!#<,WWB2
M5+IGN$=0><]3F>Y\%Z/>ZA<W5_$UTL]C]@2WEV^5! ?O+&H QNXR<D_*.F*W
MZ*.E@OK<X?Q#X/?5]-T3PVT5[=VEE-%-)JMS-'N")D&,X(9F=3M/R[2K')SP
M>XZ=***=V%D<Y_PAJ02R#2-:U32;261I9;*T:+RG9CEB"\;.F223L9>23P>:
MDD\':>K:,VGS7&G-H^5MS;E&+1L 'C;S%;(; R>&[Y%;]%(#C+WX9Z??:1?:
M/)J^KQZ/>,[_ -G131K'"S-O)1O+WXW$G:S%>>F.*U+CP?I]SJMY>32SM%J%
MHMI>V9V&&X500I;*[@0&(^5@/4' K?HHZ6#K<YZQ\(0VVH6UU>ZKJ.J_8B39
M17KQE;4D%<KL12QVDC<Y8XSSR<L'@;31X7M]!\^[^RV]XMZC[UWEUG\X G;C
M&[CIG'?/-=)13N[W Q;KPIIM]K&H7]ZLDYU&Q6PN('(\MHE+GIC.3O/.?2H+
M+P?#;WUO<WVJZEJGV//V**]>,K:Y4KE=B*6.TD;G+'&>>3GH:*0;G,Q>!-,B
M\%6GAA9[LV5I+'*DA=?,)242C)VXQN&.G3\ZT+;P_#9^);S6;:[N4:^11<6H
MV>5(Z@*LGW=X8*,<-CVSS6M13N!A:AX6BO->&L6>IW^EWC0K!.]F8L7$:L2J
MN)$;H6;E<-R>:HV/P[TC3H=,BMY[XIIFHRZE#YDP<M+('#!B1EE_>'OGIDFN
MKHI+38'K_7R_(P]2\+QWFJ/J-CJE_I-U,BQW$EBT?[]%SM#"1'&1D_,H#>]:
M&E:5::+I<&GZ=&8[>$84%BQ))R22>22222>22:N44=+ %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P ?VO\ MKS_ /9V;/*_X%G/MCO0!TE%>;?\7O\ ^J?_ /D[1_Q>_P#ZI_\
M^3M 'I-%8GBO_A*O[*C_ .$'_L?^T/.'F?VQYOE>5M;./+YW;MOMC/M7(_\
M%[_^J?\ _D[0!Z317FW_ !>__JG_ /Y.UUU__P )5_PAJ?V7_8__  DWDQ;O
MM'F_8O-ROFXV_/MQOV]_NY[T ;=%>;?\7O\ ^J?_ /D[1_Q>_P#ZI_\ ^3M
M'I-%8EA_PE7_  AK_P!J?V/_ ,)-Y,NW[/YOV+S<MY6=WS[<;-W?[V.U<C_Q
M>_\ ZI__ .3M 'I-%>;?\7O_ .J?_P#D[77>%/\ A*O[*D_X3C^Q_P"T/./E
M_P!C^;Y7E;5QGS.=V[=[8Q[T ;=%>;?\7O\ ^J?_ /D[1_Q>_P#ZI_\ ^3M
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M9]J -NBO-O\ B]__ %3_ /\ )VC_ (O?_P!4_P#_ "=H ])HK-_XGG_"*_\
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M?]C_ &CS?-W+C/F<;=N[WSCWH ZVBN)\0_\ "T_[>N/^$4_X0_\ LGY?L_\
M:7VKS_NC=NV?+][=C';'>LS_ (O?_P!4_P#_ "=H ])HKB?#W_"T_P"WK?\
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M'F^;N7&?,XV[=WOG'O0!UM%<3XA_X6G_ &]<?\(I_P (?_9/R_9_[2^U>?\
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M]H\W[%YN5\W&WY]N-^WO]W/>@#;HKS;_ (O?_P!4_P#_ "=H_P"+W_\ 5/\
M_P G: /2:*Q+#_A*O^$-?^U/['_X2;R9=OV?S?L7FY;RL[OGVXV;N_WL=JY'
M_B]__5/_ /R=H ])HKS;_B]__5/_ /R=KKO"G_"5?V5)_P )Q_8_]H><?+_L
M?S?*\K:N,^9SNW;O;&/>@#;HKS;_ (O?_P!4_P#_ "=H_P"+W_\ 5/\ _P G
M: /2:*YOPC_PF_\ IG_">?\ "/\ \'V3^Q?/_P!K?O\ -_X#C'OGM6'J7_"X
M?[5N_P"R/^$'_L_SG^R_:OM?F^5N.S?MXW;<9QQG.* /0**\V_XO?_U3_P#\
MG:W/"G_"Q?[5D_X3C_A%_P"S_)/E_P!C_:/-\W<N,^9QMV[O?./>@#K:*XGQ
M#_PM/^WKC_A%/^$/_LGY?L_]I?:O/^Z-V[9\OWMV,=L=ZS/^+W_]4_\ _)V@
M#TFBN)\/?\+3_MZW_P"$K_X0_P#LGYOM']F_:O/^Z=NW?\OWMN<]L]ZL^*_^
M%B_VK'_P@_\ PB_]G^2/,_MC[1YOF[FSCR^-NW;[YS[4 =;17FW_ !>__JG_
M /Y.U9TW_A</]JVG]K_\(/\ V?YR?:OLOVOS?*W#?LW<;MN<9XSC- 'H%%<E
MXK_X6+_:L?\ P@__  B_]G^2/,_MC[1YOF[FSCR^-NW;[YS[5A_\7O\ ^J?_
M /D[0!Z317G^F_\ "X?[5M/[7_X0?^S_ #D^U?9?M?F^5N&_9NXW;<XSQG&:
MW/%W_";_ .A_\('_ ,(__']K_MKS_P#9V;/*_P"!9S[8[T =)17FW_%[_P#J
MG_\ Y.T?\7O_ .J?_P#D[0!Z316)XK_X2K^RH_\ A!_['_M#SAYG]L>;Y7E;
M6SCR^=V[;[8S[5R/_%[_ /JG_P#Y.T >DT5YM_Q>_P#ZI_\ ^3M>@:;]N_LJ
MT_M?[/\ VAY*?:OLN[RO-VC?LW<[=V<9YQC- %FBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MICX>_P#/;4?_  #/^-'_  TQ\/?^>VH_^ 9_QH ]<HKR/_AICX>_\]M1_P#
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M?\-,?#W_ )[:C_X!G_&@#URBO(_^&F/A[_SVU'_P#/\ C1_PTQ\/?^>VH_\
M@&?\: /7**\C_P"&F/A[_P ]M1_\ S_C1_PTQ\/?^>VH_P#@&?\ &@#URBO(
M_P#AICX>_P#/;4?_  #/^-'_  TQ\/?^>VH_^ 9_QH ]<HKR/_AICX>_\]M1
M_P# ,_XT?\-,?#W_ )[:C_X!G_&@#URBO(_^&F/A[_SVU'_P#/\ C1_PTQ\/
M?^>VH_\ @&?\: /7**\C_P"&F/A[_P ]M1_\ S_C1_PTQ\/?^>VH_P#@&?\
M&@#URBO(_P#AICX>_P#/;4?_  #/^-'_  TQ\/?^>VH_^ 9_QH ]<HKR/_AI
MCX>_\]M1_P# ,_XT?\-,?#W_ )[:C_X!G_&@#URBO(_^&F/A[_SVU'_P#/\
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MNC_A1/PU_P"A6@_\")O_ (NO0:* //O^%$_#7_H5H/\ P(F_^+H_X43\-?\
MH5H/_ B;_P"+KT&B@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_ *%:#_P(F_\
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M3\-?^A6@_P# B;_XNC_A1/PU_P"A6@_\")O_ (NO0:* //O^%$_#7_H5H/\
MP(F_^+H_X43\-?\ H5H/_ B;_P"+KT&B@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$
M_#7_ *%:#_P(F_\ BZ]!HH \^_X43\-?^A6@_P# B;_XNC_A1/PU_P"A6@_\
M")O_ (NO0:* //O^%$_#7_H5H/\ P(F_^+H_X43\-?\ H5H/_ B;_P"+KT&B
M@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_ *%:#_P(F_\ BZ]!HH \^_X43\-?
M^A6@_P# B;_XNC_A1/PU_P"A6@_\")O_ (NO0:* //O^%$_#7_H5H/\ P(F_
M^+H_X43\-?\ H5H/_ B;_P"+KT&B@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_
M *%:#_P(F_\ BZ]!HH \^_X43\-?^A6@_P# B;_XNC_A1/PU_P"A6@_\")O_
M (NO0:* //O^%$_#7_H5H/\ P(F_^+H_X43\-?\ H5H/_ B;_P"+KT&B@#S[
M_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_ *%:#_P(F_\ BZ]!HH \^_X43\-?^A6@
M_P# B;_XNC_A1/PU_P"A6@_\")O_ (NO0:* //O^%$_#7_H5H/\ P(F_^+H_
MX43\-?\ H5H/_ B;_P"+KT&B@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_ *%:
M#_P(F_\ BZ]!HH \^_X43\-?^A6@_P# B;_XNC_A1/PU_P"A6@_\")O_ (NO
M0:* //O^%$_#7_H5H/\ P(F_^+H_X43\-?\ H5H/_ B;_P"+KT&B@#S[_A1/
MPU_Z%:#_ ,")O_BZ/^%$_#7_ *%:#_P(F_\ BZ]!HH \^_X43\-?^A6@_P#
MB;_XNC_A1/PU_P"A6@_\")O_ (NO0:* //O^%$_#7_H5H/\ P(F_^+H_X43\
M-?\ H5H/_ B;_P"+KT&B@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_ *%:#_P(
MF_\ BZ]!HH \^_X43\-?^A6@_P# B;_XNC_A1/PU_P"A6@_\")O_ (NO0:*
M//O^%$_#7_H5H/\ P(F_^+H_X43\-?\ H5H/_ B;_P"+KT&B@#S[_A1/PU_Z
M%:#_ ,")O_BZ/^%$_#7_ *%:#_P(F_\ BZ]!HH \^_X43\-?^A6@_P# B;_X
MNC_A1/PU_P"A6@_\")O_ (NO0:* //O^%$_#7_H5H/\ P(F_^+H_X43\-?\
MH5H/_ B;_P"+KT&B@#S[_A1/PU_Z%:#_ ,")O_BZ/^%$_#7_ *%:#_P(F_\
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M0,0/SKQC]J__ )$/1?\ L)_^TGKUKP/_ ,D]\._]@NV_]%+0!NT444 %%%%
M!1110!\P_LY?\EH\5_\ 7O/_ .E"U]/5\P_LY?\ ):/%?_7O/_Z4+7T]0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM<>N7EM#/I1@B6&))S@")@OF;DR"=S,#AN!QB[9W'B#6/B5=6.A^*M1DT;3
MXU&2:VM63SV'R01$0@Y0$,Q);L#R3736G@7P[8ZE'>VM@R20NTD,1N)6A@=N
MK1PEO+C8Y/*J#R?4U'H_P_T#0)TDTA=3M@LK3>4-8NVB9V.6+1F4HV2<G(.:
MK2_W_I]]M1:V_KS_ . <?H'B3QGJ&I:GINI7*0'PK;2IJ%U''&?[1G92T+!=
MOR*$PY Q\QQTKAM'^+WC#4-/\*6#7X_M/^T83K,WV>(>9;3/%Y0QMP-RS=5
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MB:24S1(&"JQ9CD_,WS=3GDFC2_"&B:///-8VCB6XMH[65YKB28M%&"$3+L<
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M8,B"1W+JH(!"@@>U*X_0Z:BCI12 **** "BBB@ HHHH **** "BBB@ HHHH
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M2.Y=\,1([+L*8X(V]<U4N?B4L&HZKIZ:4TMY:ZK#I5G&+@ 74LD8D!)*_NU
M)S][@<9/%167PYO?#VO07_A+6;2SBATJ'2Q!?Z>]SE(V9M^Y9H^26]*=-\-#
M->:G?_VOLU"ZU2'5;69+7Y;::.(1X*ECO4@'(R#AL9R,U>E_+_[;_P"1(U_K
M_#_\D6M1\::OH@TN+6O#L<%QJ&K1Z<IBU 20D.K,)%;8&(&W!5D4YZ9')K:?
MXYU^Y\1ZYI5WX>TV :'"DMW+%J\DFX/&SJ$!MUS]W!R5QGO5F_\ !>JZTVES
M:YXB2XGT_5HM158; 11 (K#RD7>6&=V2S._/0 <5;@\'>3XB\3ZI]NW?V_!#
M#Y7D_P"H\N-DSG=\V=V>@Z5+ORNV^MON5OQN6K7\M/S=_P +',:5\7FU+PM=
MZVMOX>D%MICZ@;"S\0>?=KM7=L>/R!LZX)R<'L:Z'1/&-[=:]9Z1KVDPZ?<:
MA9&]LWM;QKF.1%V[E8M'&58;U.,$<]:S[;P)KZ^ 7\(7?B+39=..F-IZ21:1
M(DRC9L5RQN&4XZD;1GVK2T7P?>6VN66K:]JL-_<Z=9M96:6MF;:.-&V[F8-)
M(68[%&<@8[5;Y>9VV_X?_@$:\J[_ /#?\$Q/%OQ7'ACQ)J>EFUTG&GV<=T3?
MZQ]EEN=^[Y(8_*;>PV],CJ*FUGXJ+H5T;6_T69+B[LXKC1X1+EM0D<A3#]WY
M'5F7/WN#N[8JWK'@C5;SQ'K.I:7K=E:PZS916=Q!=:8UP55 XRK"9!D^8>JD
M<"K$G@* ?\(A':WC1P^&'S&LD>]IU$)B +9&T\YS@].E3&W7^M_^ 4]]/ZV_
MX)H>(]9U;1?"LNK6NF6EU-:P-/=6\U\T2JJH68(XB;<<C R%SZBN;'Q/DL=+
M\,ZCXET_3]+M/$$@"3'5-R6T9A\P,[/$@SGY=O3GJ>E=GKFF_P!L^']0TSS?
M)^VVTEOYNW=LWJ5SC(SC/3-<\O@/;!X-C_M'/_"+XY\C_CYQ 8O[WR=<_P 7
MI[T+=W\OUO\ H#V7S_2WZG.3?&JW:-9;&UTLV\FLSZ7%>W>L"&U98X_,$QE$
M; !N@ !YQSS7;:7X@:_\)R:RW]FSA(Y)!_9E_P#:H'"9X$NQ<GC!^7@^M<N?
MAC>VVJ#4M+UZWBNDURYU>/[3I[2H/.B\LQE5E4G R=V1]*[&.QU*XT&XLM9O
M;6>YGC>,SVEHT* ,,#Y&D<Y&?[W/M4ROR:;V7WV7ZCTY_*_X7?Z6.%\,?&.#
M7+BS%W;:7'#<Z?)?R'3]7^UR6:HH8K.GE)Y9P<=3R"*UK#X@7<G]B7>K:$+'
M2M>E6*PN%N_-E5G4M&)H]@";@.-K/@]<53TWX87 M]#L_$6KVFHV.AVCVMM%
M;:<UN\@>+RB9',K[AM)X 49Y[5<L_A_>(NC6FI:\+S3-!D673X!:>7(712L9
MFD#D2;0>BJF>^:T?+S:;?I=W^=K6_$C6WG^MM/E??\!UG\2;2\^*5SX.6QD5
M88V$>H&3Y)9U57>$+CJJN#G)[\503XFZ@L8O[G0+5-(.M-H_G1ZD6N-_G&(/
MY1A"D;L' ?('KBHK3X/065KI]Q#K5U_;EIJ9U*2^9I6AED9R9!]F,NQ=RL5R
M.<=S4MO\(K*QNXM4T^[@M]<BU:;4%U$6*EGCE<LT$@W9==K$ Y!!P1CI4QMI
M?Y_>O^"OEU*EL[?+[G_P'\Q\'Q+O?*?4;[088=$35WTIKJ*_:29'$WE*[1&)
M0%+8Z.2,]#71>)?$KZ)=:;I]C9"_U3596BM;=YO*3Y5+.[OABJ@#LI.2.*YZ
MV^&MZ(9--O\ 789]%DU9]5-M%8&.9G,WFJC2F5@5#8Z("<=171>)/#3:W=:;
MJ%E>"QU/2I7EM;AH?-3YU*LKID%E(/0,IX'-+3E7]=%^MP^T^VOZV_0Y76OB
MRVAV4R7VDVT&J6NIP:==0W&H>7;1><I9)O/\LYCP.I0$8.1QSU>E>(7O_"<N
MLO\ V9.$21U.EZA]K@D"9Z2[%YR"#\O'O7/3_#)KV>._OM9\W5'UBVU2ZN%M
M=L<GD+M2%(]YV+CN68]<YKM[^U^VZ=<VN_9Y\31[L9V[@1G'XTI7Y';?_@+]
M;C5N9=O^"_TL<%8_$^]_LW2[[6M ALX-9L)+O3VMK\S[F2(R^5)F)-A*@X(W
M#@TVT^)NK:JL;:/X=LG']AP:S-]KU5H=BR;OW:X@8,1LZG:.>U/L?AC>?V5I
M>GZUKT-Y#HUC)::>+:P,&UGB,7F29E?>0I. -HY/MBLOP3T>YMDAUJ>+4/)T
M2WTJ"4V@62!XBQ\]&+':3N' ].IJY<MWR_+_ ,F_X']7$ME?^M5^E_ZL+<_&
M"$76DQVUOI%G%J>DIJ:3:YK(L5 9MOEC$3[F[_2MH>--2O=2DT[0-'M-3N[2
MTANKTKJ6R%1*"52&3RSYA(4D$A%QC)&:A3P7XAMM=LM9L_$>GF_@TI=-G:YT
MEG28!]_F!4G3:3QQDBK$OA'6(M:GUC2=>MK+4-0MHH-18Z<9(Y#'G;)$AES&
MP#$?,7'3(-)V_/\ -V_"W]7%K^7Z7_4A\0>,O$&CZUHMC;^'+&4:U+Y-N;G5
M6B>*01F1A(J0.HQ@C*LV:6Z\<ZG]IU9=(T"*_AT,!=2?[=Y;>9L#M' OEGS"
M%/\ $8P3@?32U7PH^JZIX;O9M2<R:'<-.S20J6NB8FC.=NT*?FSP,=L"J%_X
M'OC?:P^@ZXNFVNNG=?Q/9^<X;8$+POO78Q4?Q!QGG%+O\_TM\M_/8:M=7\O^
M#^GD4I?B/>7NH/'X8T>SO[6/1XM7-Q>:BUJ6CDW84*(7YPG<@<U0O?C-;I<:
M)!I^EQ/+JVG1ZA&E_J"69978*(HV8%'DZG:64<=>:M7_ ,&O#VI7,OVM(Y+9
M=(ATRS1X0TMGY18K*DA.=WS#L.G.<XH\2_#/4/%>AVNEZSKMC=1):K!,T^C(
MS*XX,T#!PT4A'')=?11TJGRWT[_AK_P/ZO87GV_'3_@_U:_H2,6C5BI4D9*G
M''MQ2U7L+--.TVVLH6=H[:)8E9SEB%  )/<\58I.U]!*]M0HHHI#"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \(_:O
M_P"1#T7_ +"?_M)Z]:\#_P#)/?#O_8+MO_12UY+^U?\ \B'HO_83_P#:3UZU
MX'_Y)[X=_P"P7;?^BEH W:*** "BBB@ HHHH ^8?V<O^2T>*_P#KWG_]*%KZ
M>KYA_9R_Y+1XK_Z]Y_\ TH6OIZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M[_U\OZ_X-ST6BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /"/VK_ /D0]%_["?\ [2>O6O __)/?#O\
MV"[;_P!%+7DO[5__ "(>B_\ 83_]I/7K7@?_ ))[X=_[!=M_Z*6@#=HHHH *
M*** "BBB@#YA_9R_Y+1XK_Z]Y_\ TH6OIZOF']G+_DM'BO\ Z]Y__2A:^GJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK&&&981(=C,<,$A4;1D$$'<3G.:] HTLOZZDZ\S_ *Z(****0PHHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@J!2P^4J<@=15S1_B)J^JZY!Y6FS2:?/?R69ACTB[W0HKL@F-UCR6&5R5&,
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M^FX_6BW]?=_F&AVM%>7Z#K&LZ)-=SK]ADTJY\4W%FT!B?S\R3$>8)-VT8/\
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M7_K^OZ:!Z?U_7]7['J-%>+";Q%=>)+8-J5K/<IXQN8;5IK>0I"!9R=5\S+*
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MD4KHT<K,6+HX(96RQP5(QG P*U;R_M-.M_/U"ZAM8=RIYD\@1=S'"C)XR20
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MAA<ZG/%-I\WDJ1%;@?OQTP=NP\GO,HKKK*QM--LX[33K6&TMHAMCA@C"(@]
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M]N+3&O6@)@5#G+'!.]6Z'I^N:ZZ/3;&%K=H;*WC-JACMRL2CR5.,JO'R@X'
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M,D;O&]Y"BJ'*L1@A25##&&Q@9!X'09'C*9CJ7ABP;_CWO=759QV8)%)*H/\
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M[_V"[;_T4M>2_M7_ /(AZ+_V$_\ VD]>M>!_^2>^'?\ L%VW_HI: -VBBB@
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MMEW?+(UO'L8[P@!;D# P".I%+'JEG-K%QI<<V;VWACGEBVGY4<L%.<8.2C<
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M,O!L-Y?^.-$U/6Y+XWYT.<YEGDC\Q!<!8V>+(7)0@D%>O.,@8UOB):VS>*_
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MV1GC^U-&91#N&\H" 6QUQD@9K@?B/J]I!J,6G3WE_;7#64DMLB:LVGPRR9P
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MYDN%M-2U2"'S+I[DI%]C+*/-D =Q\V06['J1@UZMX.;;X T-N3C38#\HR?\
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M;^9YV<?9F5<XV_Q;NF>,=ZZ"_P!3L-*MQ/JE[;V4).T27$JQJ3@G&6([ GZ
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M.UQFA10#D9'(HI %%%% !1110 4444 >$?M7_P#(AZ+_ -A/_P!I/7K7@?\
MY)[X=_[!=M_Z*6O)?VK_ /D0]%_["?\ [2>O6O __)/?#O\ V"[;_P!%+0!N
MT444 %%%% !1110!\P_LY?\ ):/%?_7O/_Z4+7T]7S#^SE_R6CQ7_P!>\_\
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M9VO;N86ZNKA$DG=U *G'W6%<9)I]_K&O^.-*T[1O,-[J]N#JGF1JMML@@;+
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M8K&U'XG:1!I4VJZ;<2W=O%IT]Y';'3;A&NPFS#QR%0-@W@$[6'S9R K50MO
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M.O7&<UGW?CCP]8ZQ/I=U?,EU;LBW %M*R0;P"IDD"[4!R,%B!GC.16'\.-.
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M;R)!$\BYW1K*5V,XP<H&+#!XXK/\2^-5T'Q'9:*EG++->6=S<K-Y,C(AB4$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >$?M7_P#(AZ+_ -A/_P!I/7K7@?\ Y)[X=_[!=M_Z
M*6O)?VK_ /D0]%_["?\ [2>O6O __)/?#O\ V"[;_P!%+0!NT444 %%%% !1
M110!\P_LY?\ ):/%?_7O/_Z4+7T]7S#^SE_R6CQ7_P!>\_\ Z4+7T]0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+41^6,$K\NT+U)!).=+2? 6DZ/>V5U;/<O+:P7$),KJ?/,[J\KO\HRQ9<\8
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MN#:6GF1^5 )U*NJ_)N(Y)&2<'VXJ:P^'>BV-I<6K&YNK>YTJ'298YW&&AB#
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MMOZT7ZW^1;\0^+K;P]J5C8/87U]=7\<TD,=HL9R(E#-DNZ@<'CFL^3XE:/\
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M>.=CKNYW9R:T?$GA?3_%5I:V^J>:%M;J.ZC,3;3N0]"<'Y2"01W!--VMIW_
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ME!GCUZ5GP_#_ $J"[M[A+B\+V^KRZNH+K@S2*RLI^7[F&.!U]ZO3F?;7]/\
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M!V+8JZGC#5-0CU*XT?18IK"U:Y@CNI;S:?.AR#OCV9"%EP&4L?50.:3=E?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUZUX'_Y)[X=_[!=M_P"BEH W:*** "BBB@ HHHH ^8?V<O\ DM'BO_KWG_\
M2A:^GJ^8?V<O^2T>*_\ KWG_ /2A:^GJ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUW_7]?U86NGFOQ_K^F:L^I6-JMP;F\MX1;())S)*J^4ASAFR?E'!Y/H:I?\
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M>"]%@N(WBEBL($>.12K(PC ((/0CTK7IR2C)I&<&Y1384445)04444 %%%%
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M** "BBB@ HHHH **** "BBB@ HHHH **** /"/VK_P#D0]%_["?_ +2>O6O
M_P#R3WP[_P!@NV_]%+7DO[5__(AZ+_V$_P#VD]>M>!_^2>^'?^P7;?\ HI:
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M** "BBB@ HHHH **** "BBB@ HHHH **** /"/VK_P#D0]%_["?_ +2>O6O
M_P#R3WP[_P!@NV_]%+7DO[5__(AZ+_V$_P#VD]>M>!_^2>^'?^P7;?\ HI:
M-VBBB@ HHHH **** /F']G+_ )+1XK_Z]Y__ $H6OIZOF']G+_DM'BO_ *]Y
M_P#TH6OIZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!X1^U?_R(>B_]A/\ ]I/7K7@?_DGOAW_L%VW_ **6O)?VK_\
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M** "BBB@ HHHH **** "BBB@ HHHH **** /"/VK_P#D0]%_["?_ +2>O6O
M_P#R3WP[_P!@NV_]%+7DO[5__(AZ+_V$_P#VD]>M>!_^2>^'?^P7;?\ HI:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /"/VK_\ D0]%_P"PG_[2>O6O _\ R3WP[_V"[;_T4M>2
M_M7_ /(AZ+_V$_\ VD]>M>!_^2>^'?\ L%VW_HI: -VBBB@ HHHH **H7^NZ
M3I=U;6VIZG9V<]TVVWBGG5&E/HH)Y_"K7VJ'[9]E\U?/\OS/+SSMSC/TS0!\
MS?LY?\EH\5_]>\__ *4+7T]7S#^SE_R6CQ7_ ->\_P#Z4+7T]0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /"/VK_ /D0]%_["?\ [2>O6O __)/?#O\
MV"[;_P!%+7DO[5__ "(>B_\ 83_]I/7K7@?_ ))[X=_[!=M_Z*6@#=HHHH *
M*** .2U_4[73M2UIIM/@FE_LJ)@)G(6Z3?("K#D;5W DX) ?GM4VCR7@\6S0
MZR+.6]6Q5HY[+>J+&7/R%&)P<@?-GYL=!BJOBW4-(N'U2PUS2+/44TVRBO(4
MN=I\QY#(NT9'R_<'(_O5+X2LH_#]]-H@T72],9H5NE;2U*I(,[2&! .1P ><
M@]L8IK?7^MPE_E^G]?\ #'AO[.7_ "6CQ7_U[S_^E"U]/5\P_LY?\EH\5_\
M7O/_ .E"U]/4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK_7]6"7^7Z?U]_8\%_9R_P"2T>*_^O>?_P!*%KZ>KYA_9R_Y+1XK_P"O>?\
M]*%KZ>I %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"/VK_ /D0]%_["?\
M[2>O6O __)/?#O\ V"[;_P!%+7DO[5__ "(>B_\ 83_]I/7K7@?_ ))[X=_[
M!=M_Z*6@#=HHHH **** ,+4-(U-=<;5M"N[6*::!(+B*[@:175"Q4J58%3EV
M]0?2G:3I.HQZM-JFMWEM/<O"((X[2!HHXTSN.=S,68GOP .@ZD[=% /4^8?V
M<O\ DM'BO_KWG_\ 2A:^GJ^8?V<O^2T>*_\ KWG_ /2A:^GJ "BBB@ HHHH
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MO/\ ^E"U]/4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(]K966B)'MA*89'>%L1XXX?OT'->W66CZ9I@N!ING6EH+J0RSB"!8_.<]6;
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M\+'9L^4M(=H4_7..:XD:[X7A_90N- N+FT77(V=9-/;'VE9Q/DN4^]PO\73
MQ[5]++I.G)JSZHEA:KJ+Q^4]X(5$S)_=+XR1QTSBJD_A3P]<W%W/<Z#IDTUZ
MNVZDDLXV:<>CDCYAP.OI4V]SE\OU;_4J_O<WG^B7Z%?P-_R3WP__ -@VW_\
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MLCPQ7,,MXD8)+0!\MP.PX)]A7<VOAG0;&XMI[+1-.MIK-#';20VD:- IZJA
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MDD*H YI(-)TZVU*XU&VT^UBOKH!9[J.%5EE Z!G RV/>K<KU.?R86]QQ[O\
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MXN[#3;2UN;K:)YH(%1Y=HPNY@,M@=,]*;U3]&OO=R8^[;Y?@?/GABTM]=O/
MGVCXL6E]/:R136&D6NAQ^;"54;HG:)MR#:""7P.,U[<OBG0O$%EX@M-/O!<-
MI8DM[]#$Z")MIRN6 !Z'D9%:-CX>T72[Z>\TW2+"SNK@YFGM[9(WE_WF !/X
MUE>)?"YG\)Z[9>$[73M.U+5XF22X,0B#L_#.Y126;!;!.>:51N46EUO]["FE
M&2^7W(YG]GL3CX*:/Y^<%YC'DG[GFMC^M>F5F^'=$M_#?AK3]&L_]38VZ0J3
MU;:,9_$\UI5=1IS;1,+J.H4445!04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 >$?M7_\B'HO_83_ /:3UZUX'_Y)[X=_[!=M_P"BEKR7]J__ )$/
M1?\ L)_^TGKUKP/_ ,D]\._]@NV_]%+0!NT444 %%%% !1110!\P_LY?\EH\
M5_\ 7O/_ .E"U]/5\P_LY?\ ):/%?_7O/_Z4+7T]0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M [?_ (6OX!_Z&_2/_ I:/^%K^ ?^AOTC_P "EKB/^&7? ?\ S\:S_P"!2?\
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M [?_ (6OX!_Z&_2/_ I:/^%K^ ?^AOTC_P "EKB/^&7? ?\ S\:S_P"!2?\
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M [?_ (6OX!_Z&_2/_ I:/^%K^ ?^AOTC_P "EKB/^&7? ?\ S\:S_P"!2?\
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M [?_ (6OX!_Z&_2/_ I:/^%K^ ?^AOTC_P "EKB/^&7? ?\ S\:S_P"!2?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>halo-20240313_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X2$*17AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,34Z,#,Z
M,3D@,#@Z,#8Z,#(   *D(  "    (0  $%KJ'  '   'W@  "'P     '.H
M   (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         #E&1#(V1C8V140X0C0V
M-40Y.$(X-35#,#!!-#<S,4(Q       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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MH:";5;U?)V1CY8$/!+8Z<4 =7X?TF/0M LM,C.Y;>()N]3W/YUI4 %% !10
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M)I=[!#); )*DRDY7G.,>H)':NW'3F@!:* "D//6@!$547:BA5'0 8%.H **
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M@2&",855'Z_6O.48^-?BJ'7Y]*T-< ]5>7_]?_H- 'J(HH ** "B@ HH **
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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MHHH **** "BBB@ HHHH **** "BBB@ HHIC]!\K-ST4[?ZB@!]%>8>*OC/\
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M9O=75TR [3J.J2P_,EBJG^I_X<?"[X9_!_PY#X3^%7@#P1\-?"MIM2#P_P"
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(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>halo-20240313_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,P,   DI(  @    ,P,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M!]W45QGPU^)>D_$CP^+NP98+^$ 7EB6RT#'N.F5/9OPZ@UV= !1110 4444
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M7$Y/F%6SL4CC:'.&."3M&>V* '_M ?$,>&K&'X;>$5%E;0VJ1WK1.<K$4PL
MYS@H06SU!'J:\(\(^'9_%GB_3-"M6V27UPL6\C[B]6;\%!/X4[6[F?5VN=;U
MB>:34;Z=9$)"LLRD,9&+ Y!#; %QT)&1MY]D^"%G8>!/A[K?Q/U\!64/9Z:D
MD7^L)*@E3U;<^$R/NA).Q- &Q^T!X^M_"OA^V^&WA0QQ(+5([W8V6@A &R+Z
ML,$]\8_O5S&C0S?!KX-S:_.GE^*/%L/E:?L/SV=I@$R[A]TG<AQG.6C[@@97
MP<\$S_%?XEW>L>)0]QI]M(;R_<CBXE9LK%[ G)./X5(XR#4/Q:\1W'Q0^,$.
MCZ#LDM8)ETO35!PC,6VL^?0MW_N@4 =)^SE\.O\ A(O$K^,]4MVM['3)A]AB
M1<1S38/KDD1_*<]V(R3AJ^JZQ?"'A>R\&>$[#0=,R8+./;O88:1B<LY]R236
MQ)(D,3RS.L<:*69V. H'4D]A0 ZJ&LZWIOA[3'U#6KR*SM4(!DE/4GHH'4D]
M@,DUX[\1OVD-)T..6Q\$FWU>_4E#=.2;=""!\N.9#SG.0O'#'I7SM<7OB_XJ
M^*0LTMYK>IRY,4 R0@R,A%^[&HZGH* /;?&/[4L/[VU\%:>P'SH+^\3)X'#)
M%G&"<8+'CNAZ'R&SA\:?%/4[JYFFDNU2'_B8:G?'%O:1*=^YG(Q$H"YPO)"G
M@\U[1\._V8[*Q$6H>/YA>7*MN73K=_W*XZ;VZM]!@?6F_M#>,K'PCX2M?A_X
M6CAM#=Q@W26^ (;<<*F!W<@<]=JG.=U 'S;8:9/JNM0Z;IBO<S7$PBAV1LQ?
M)Z[0">G. ":^Q]*^"7AGP]8Z#+=7<\\?AXO<MYJKY<LA(=Y2I!*G*1]#TC Y
MR<\;^S3\-&TVQ;QIK5MMN;M-FFAFY6$CYI,=BW0=\9[&LS]I/XI%Y1X)\/7H
M,8!.K/%SELC;!N]L$L/=1GAA0!QWQP^,4WCR_&BZ,?)T"TDWJRMDWCX&';T
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M0$@]E51_$10!QEKHL/CKXD6?AC0;IUT]7CL;-PG#I&/WDQ3.5W!993UP6P<
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M@<YQNP,;3@#=QR0,<BNY_90LM:CAUR[E6=-%F"+%O)\MYP3N*CU"X!(]AVX
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M-)T_6]/DL-8L;>^M),;X+F(2(V.0<'N#SGM0!\R> OVG]1TN(6?CJTDU6!5
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M]Q^!8C\*ZR@#COA[\,/#_P -K":'1$EFN+ALS7ER0TKCLN0  H] />NQHHH
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MMDCK_JS7<? WP&? WPYMDOK<PZMJ)^U7H;[R$_<C.0"-J8R.S%N: /1Z***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7SE^U;K<;_P#".>'%N%C+N]Y.&8X0?<1B
M!DD<R\X)X..]?1M?(?[4MS'/\6;6./.ZWTF&.3([F25OY,* /?\ X)Z"/#WP
M?T& J1+=6_VR4D]3*=X^F%*C'M7>U!96B6&GV]I"6:.WB6)2QY(48&??BIZ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OG?]H/X2>(_%'BRT\0^%-/^WK):K;W44<BJZNK':^&89!# <=-I
M)]:^B** *^GF[.F6IU((MYY*?:!&<J),#=@\9&<U8HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>halo-20240313_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,U,   DI(  @    ,U,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.16RDGLRTT]@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110 5K>'O^/JY_Z]7_ *5DUK>'O^/JY_Z]7_I7JY/_ ,C"EZG+C/\
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M]>K_ -*R:UO#W_'U<_\ 7J_]*]7)_P#D84O4Y<9_N\_0\THHHK[8_.@HHHH
M**** "BBB@ HHHH **** );:XEM+F.XMW,<L;!E8=C7LOAS7HM?TI;A,+,GR
MS1_W6_P/:O%:VO"NNMH6M),Q/V>7Y)U_V?7ZCK^==N$Q'L9V>S-Z-3DEKL>S
M44BLKH&0AE89!!R"*6OHCT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/%\F(K:+U9F/X8_QKR,ZK.CE]6:[6^_3]3JP<.>O%?UH<O1117XX?6!1110
M4444 %%%% !1110 4444 %%%% !6MX>_X^KG_KU?^E9-:WA[_CZN?^O5_P"E
M>KD__(PI>IRXS_=Y^AYI1117VQ^=!1110 4444 %%%% !1110 4444 %%%%
M!6IX;O?[/\26-QG"B4*W^ZWRG]#672@E6!4X(.0:J,G&2DN@T[.Y[_145K,+
MFSAG'26-7'XC-2U]:M3V HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KDO%KDZE"G98L_F3_A76UQOBDYUC'I&H_G7S'%$K9<UW:/1
MRU7K_(QJ***_+#Z4**** "BBB@ HHHH **** "BBB@ HHHH *UO#W_'U<_\
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M1WIQ3D[+<3:2NPBBDGF6*%2[L<!1WJ;6-8A\+6S6=BRRZM(N)91R+<'L/?\
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M/A:V:SL6675I%Q+*.1;@]A[_ /ZSV%&L:Q#X6MFL[%EEU:1<2RCD6X/8>_\
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M>=;_ #QM\LL+?=D7T/\ C6;14RBI+EEL.,G%W1T^N:';7-C_ &YX>^>R;F:
M?>MV[\>G\OI7,UHZ'KESH5]YUO\ /&WRRPM]V1?0_P"-=C8^#M,UJ_@U:Q<K
MIDH+O;$$,K@_='^SG_ZWM\/F642I3YZ/PO\  ]&FU6^'?^M2IX$\+-=3IJVH
M1_Z/&<P(P_UC?WOH/YUZ32(BQHJ(H55& H& !Z4M:T*,:,.5'J4X*$;(****
MW- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\SSW4Q]-X4?H/ZUM67A?1;#!M].AW#HT@WG\VS6M16,J]6>\F:QH4H[1  *
M , = ****Q-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>halo-20240313_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M0V%R;65N($=A;'9A;@  !9 #  (    4   "II $  (    4   "NI*1  (
M   #.30  )*2  (    #.30  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M_1]5K=OR#ZU1[_F?2]%?-'_#0GC?_GV\/_\ @%/_ /'Z/^&A/&__ #[>'_\
MP"G_ /C]'U6MV_(/K5'O^9]+T5\T?\-">-_^?;P__P" 4_\ \?H_X:$\;_\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O3_V>_\
MDJ=Q_P!@6X_]'V]>85Z?^SW_ ,E3N/\ L"W'_H^WKGQ7\%_UU.K"_P 9?UT/
MI>BBBO%/;"BBB@#S>'X?^&/%?C/Q??:_IGVNYCU6*%7^T2IA!86I PK =6/Y
MU?\ ^%,> ?\ H _^3D__ ,76KX7_ .1B\9_]AJ/_ --]G725:J32LFS-TX-W
M<4<-_P *8\ _] '_ ,G)_P#XNC_A3'@'_H _^3D__P 77<T4_:U/YG]XO8T_
MY5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>UJ?S/[P]C3_E
M7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_O#V-/^5?
M<<-_PICP#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%UW-%'M:G\S^\/8T_Y5]Q
MPW_"F/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>UJ?S/[P]C3_E7W'#
M?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_O#V-/^5?<<-_
MPICP#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%UW-%'M:G\S^\/8T_Y5]QPW_"
MF/ /_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>UJ?S/[P]C3_E7W'#?\*8
M\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_O#V-/^5?<<-_PICP
M#_T ?_)R?_XNC_A3'@'_ * /_DY/_P#%UW-%'M:G\S^\/8T_Y5]QPW_"F/ /
M_0!_\G)__BZ/^%,> ?\ H _^3D__ ,77<T4>UJ?S/[P]C3_E7W'#?\*8\ _]
M '_R<G_^+H_X4QX!_P"@#_Y.3_\ Q==S11[6I_,_O#V-/^5?<<-_PICP#_T
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M * /_DY/_P#%UW-%'M:G\S^\/8T_Y5]QPW_"F/ /_0!_\G)__BZ/^%,> ?\
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M ,77<T4>UJ?S/[P]C3_E7W'#?\*8\ _] '_R<G_^+H_X4QX!_P"@#_Y.3_\
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MV>W[['&-QZ>M>@US=]_R5/0O^P+J7_H^QI.I-JS;*5.$7=)'24445!84444
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M %%0VEY;7]JES8W$5S ^=DL+AU;!P<$<'D$5-0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5S=]_R5/0O^P+J7_H^QKI*YN^_P"2IZ%_V!=2_P#1]C0!TE%%% !1110!
MS?A?_D8O&?\ V&H__3?9UTE<WX7_ .1B\9_]AJ/_ --]G724 %%%% !1110
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MCW+?[TJC^AKQRBNN.589;IOYG#+.L8]FE\CWGQ;\3;?PI>6=O-ILES]JMEN
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M&M&_[!<?_H35YU7M7Q'\ Z]XBU#3I]*@BE6WLD@D#2A3N!)[_6O/KWX:^+K
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MX6 )C4G/L>U;-(0",$9![&E4ASP<1T:GLIJ9RVEQSO>J;8[6 .6(R />O?/
M)\=ZQX5B_LOQ)IT$-HQMQ%-9;V7 !'.>1@BO*TC2,8C55'HHQ7K/P1O<2:M8
M,>HCF0?F&_FM>5C</R85O=K4]O+\7[7&);)JWZG0_P!C_$K_ *&G2?\ P7?_
M %Z/['^)7_0TZ3_X+O\ Z]=U17S7M'V7W(^L]FN[^]G"_P!C_$K_ *&G2?\
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MKX(MM:FTX7]P7MK73;G3I80F#,LRQJ6#9^7 C]#U]JZBBE96M_77_-A=WO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:N%G5<7.6SOMYI]_+K?[SPO1Q9:?XHTZUTJ WURFH\V5W8M!>VHR<LTL9PX
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MO>$E\03WLEU>%?-LOLMJ!'G[,2VYGY/S$E4].$QWS0!KZ7J-IJFGQW6G2M+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>halo-20240313_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M0V%R;65N($=A;'9A;@  !9 #  (    4   "II $  (    4   "NI*1  (
M   #.#0  )*2  (    #.#0  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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MC_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\
M@T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A
M8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/
M_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ
M@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\
MA8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\
M/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_X
MJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^
MAR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2
M#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHK
MF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/
M^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#
M2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C
M^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__
M .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ
M.DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%
MC^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P_
M_P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ
M/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'
M+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/
M_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;
M_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z
M'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(
M/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X
M(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\
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M$=0H89/Y4P.P/PKTU=270W\:6"^(R /[/^SOY>\C[GG9QN]L9]JQ$^'.N?\
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M\#1>([FX\L7-X;:VM_+R90JY9]V> #QC')K;U+X:S:=\.X?$W]HK).8XIY[
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M .%,>/O^@#_Y.0?_ !='_"F/'W_0!_\ )R#_ .+KZLHH^N5.R#ZE3[L^4_\
MA3'C[_H _P#DY!_\71_PICQ]_P! '_R<@_\ BZ^K**/KE3L@^I4^[/E/_A3'
MC[_H _\ DY!_\71_PICQ]_T ?_)R#_XNOJRBCZY4[(/J5/NSY3_X4QX^_P"@
M#_Y.0?\ Q='_  ICQ]_T ?\ R<@_^+KZLHH^N5.R#ZE3[L^4_P#A3'C[_H _
M^3D'_P 71_PICQ]_T ?_ "<@_P#BZ^K**/KE3L@^I4^[/E/_ (4QX^_Z /\
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M_P#)R#_XNOJRBCZY4[(/J5/NSY3_ .%,>/O^@#_Y.0?_ !='_"F/'W_0!_\
M)R#_ .+KZ?UK4?['T#4-3\KSOL5K)<>7NV[]BEL9P<9QUQ7*Z%X[U;4-9TJS
MUKPNVE0ZO$\EG<+?I.'VIOY50"HV]SWP,>A]<J=D'U*GW9X5_P *8\??] '_
M ,G(/_BZ/^%,>/O^@#_Y.0?_ !=?3<7B'19TNGAU>PD6S&;EDN4(@'/W^?EZ
M'KZ4HU_1SI9U(:M8FP#;3="Y3R@<XQOSC.>.M'URIV0?4J?=GS'_ ,*8\??]
M '_R<@_^+H_X4QX^_P"@#_Y.0?\ Q=?5%O<P7EM'<6DT<\$B[DEB<,KCU!'!
M%24?7*G9!]2I]V?*?_"F/'W_ $ ?_)R#_P"+H_X4QX^_Z /_ ).0?_%U]644
M?7*G9!]2I]V?*?\ PICQ]_T ?_)R#_XNC_A3'C[_ * /_DY!_P#%U]644?7*
MG9!]2I]V?*?_  ICQ]_T ?\ R<@_^+H_X4QX^_Z /_DY!_\ %U]644?7*G9!
M]2I]V?*?_"F/'W_0!_\ )R#_ .+H_P"%,>/O^@#_ .3D'_Q=?5E%'URIV0?4
MJ?=GRG_PICQ]_P! '_R<@_\ BZ/^%,>/O^@#_P"3D'_Q=?5E%'URIV0?4J?=
MGRG_ ,*8\??] '_R<@_^+H_X4QX^_P"@#_Y.0?\ Q=?5E%'URIV0?4J?=GRG
M_P *8\??] '_ ,G(/_BZ/^%,>/O^@#_Y.0?_ !=?5E%'URIV0?4J?=GRQ:?"
M+XB6-Y#=VFBF.>"19(W%Y;Y5E.0?O^HKM-6L?BSJVGWMN?".CV<^H1B*[O;0
MP)<3IT*LYE.01[?3%>YT5$L5*7Q)%QPL8_#)GRG_ ,*8\??] '_R<@_^+H_X
M4QX^_P"@#_Y.0?\ Q=?5E%7]<J=D1]2I]V?*?_"F/'W_ $ ?_)R#_P"+H_X4
MQX^_Z /_ ).0?_%U]644?7*G9!]2I]V?+=A\(_'UAJ%O=_\ ",P7/D2+)Y-Q
M<P/')@YVLOF<@]Q6EXH\ _$WQ9J4=WJ'AZW@6&%8(+>UN8$BA1>BJOF' _&O
MI*BD\7-N[2*6#@DTF]?Z['RG_P *8\??] '_ ,G(/_BZ/^%,>/O^@#_Y.0?_
M !=?5E%/ZY4[(GZE3[L^4_\ A3'C[_H _P#DY!_\71_PICQ]_P! '_R<@_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "N;^''_ "2SPI_V!;/_ -$)725S?PX_Y)9X4_[ MG_Z(2@#I***
M* "N;\>?\B[:_P#8:TK_ -.%O725S?CS_D7;7_L-:5_Z<+>@#I**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M(?'-E<MXJO;K2O#OB.SUXJJ6FIZ.^Z"[4A0OG'H@!7!7T')QBL[4M,UR;XEV
MES=Z#<K)#JEK-/=6VG-,DR+L!D-P6)&/^>:*% '/(KV^L=_%&FIXNB\.*[2:
MA) T[*F"L2C'#<Y!.<@8Z>G&0#Q;4M"UH^&=.M&\.7CNR7JQS+IK7,D;M.<(
M49@L2LI!\W:6_N]#75^'O!J:W<:V-9TAXWFT:PM[6XN[8JT3FV*R;"PX8$ '
M'(KI+7XEZ?=0WEQ_8^M16=JCL+R6T AF*N$V(^[!8L<#.!UR1BK9UO1?%MA;
M:7/:7$\6K).LMNV%:%8FVOYA5LJ ^%!4G)(QQS0!R7P[U>:#2;GQ+K-K/-/J
M%W:Z4IMU#[1&JQ!SR,*9"V3ZGZ5ZI5"QT/3--TRTT^SLHDM;,AK>,C=Y9&?F
M!.3GD\]>35^@ HHHH **** "BBB@ HHHH **** "BL_6]=TWPYI4FI:U<BUM
M(R TA5FP2< 84$GGT%<K_P +H\ _]![_ ,DY_P#XBKC"<E=(B52$7:3L=U17
M"_\ "Z/ /_0>_P#).?\ ^(KD+7X\V>F>(9[&^?\ MC2=^;?4K:)HY54]GC8#
M<1T)&.G0U:H5'T,Y8BDOM'M-%<CXIU>RUWX0>(-1TN;S[6;2+HH^TKG]TW8@
M$4SX1_\ )(/#'_8.B_E6.MVGTM^-_P#(WTLFNM_PM_F=C17@WQM^'/A6+4]"
MU=-+Q?:SXAMX+^7[1+^^1\[AC=A<X'*@&M#P[X6T;P=^TE!I7ARS^QV2^&GD
M$7FO)\S3\G+DG]:(^]OY_@KCEIMY?B['M-%?._QH\ZT^-^F:[;%]^@Z/!J+*
MG\2)>;7'TV.WY51^U_\ "0?M):?XFCD\VSEU&[TVU_NLEO:C<1Z@M(W.:2=T
MGZ_AI^+_ %"2LVOZVO\ D?2U%>$^'?'>I>#_ (&^&_$VEZ'8+H,=W,FJV=MY
MK20Q-<.H>)I)#SNZAB<EAC:.GIOP[UW6_$_A&'7-?M;:S^WNTUG;P*P9+8G]
MWO)8Y8CG(P.1Q5M:M=A/0ZFBBBI **** "BBB@ HHHH **** "BBB@ HHHH
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M]&BNZKA?B_\ \B*O_7_;?^C17=5I+^&OG^AE'^(_E^H4445F:G-:M_R%)O\
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MK%@=HW9  P0">O%===^.=,M;V\M5ANKB6UE@@'DJI$\LPRD:$L,MCDYP .]
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<W\./\ DEGA3_L"V?\
MZ(2NDKF_AQ_R2SPI_P!@6S_]$)0!TE%%% !7-^//^1=M?^PUI7_IPMZZ2N;\
M>?\ (NVO_8:TK_TX6] '24444 %%%% !1110 4444 %%%-DD2&)I)6"(BEF9
MC@ #J: ,'QEXI@\*:"]V^'N9,I;1$_??U^@ZG_Z]?.=W=SWUY+=7DK33S,7=
MV/+$UM^-O$S^*?$DUVK-]EC_ '=LA[(.^/4]3_\ 6KGJ^QR_"+#T[OXGO_D?
M!YGC7BJMH_"MO\PHHHKT3R@HHHH **T=$T'4?$.H+9Z5;M-)U8]%0>K'L*]H
M\+?"W2=#5+C4PNI7HYS(O[M#_LJ>OU/Z5QXG&TL,O>U?8]#"9?6Q;]Q67=GD
MNA>"-?\ $*K)I]BP@;_EO,=B?@3U_#-=[IGP3B 5M9U9F/\ %':IC'_ FS_*
MO5@   !@#H!17S];-:\W[GNH^FH9+AJ:]_WG_70XZT^%?A2VQOL9+@CO-.Y_
M0$"MJP\*Z)I<-Q%8:=#"EU'Y<P7/SKZ')]S6O17GSQ%6HK3DW\STX86A3UA!
M+Y(Y.;X8>#YU(;18USW261<?DU8.H?!#0+@,;"\O;-ST!99%'X$ _K7I5%<[
MA%]")X/#SW@ON/G[6O@WXCTU7DL##J<2\XA.V3'^Z?Z$UP=Q;S6D[P74,D,J
M'#1R*593[@]*^O:R=>\,:1XEM3!J]FDW&$E Q(G^ZW4?3I64J*Z'EU\F@U>B
M[/LSY4HKO/&OPMU'PQ')?6#F_P!-7EG"_O(A_M =O<?CBN#KG::=F?/5J-2C
M+DJ*S"BBBD8A117=>%OAI<:E:#5O$L_]D:0HW;Y/EEE'^R#T!]3UXP#FFHN3
MLC:C1J5Y<M-79TGP7\4W[7#^'[B*:XM%4R0RJI86YZE6/93SCW^M>QUXOJ7C
M*VT[3SH_@FU&FV X:=1B64],YZCZGGZ5Z%X$\2?\)#H"^>^;VVQ'/D\MZ/\
MC_,&NV,7&-F?:X2C.C15.<KM&!H?P^U73+G3))[BS86D%]')L=CDSN63&5[
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M  WIBV6F0A$'+N>6D;^\Q[FM.BBOD92E)\TG=GW$8QA%1BK)!1114E!1110
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M_P ?;_&C^R;+_GC_ ./M_C3^L0["^KS74YJBNE_LFR_YX_\ C[?XT?V39?\
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M"UO3M2>$ RK9W<<Q0'H2%)Q^-,#3HHHH **** "BBB@ HHHH **** "BBB@
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M+^3,^<>N[GZU[1157UOYI_<[D)6CR^5OS_S/'M6L[9=,^,DRV\8DD0!FV#+
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M;_<;AOR!S^%<N,I>UH2@CLP-94,3";VO^>A]+44 @@$'(/0BBOAS]%"BBB@
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M*:'L<+&^[U^__@!1117G'JA1110 4444 %%%% !1110 4444 %%%% !1110
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M,3N7C9N< 9Q@=*]%FBCN('AF4/'(I5U/0@C!%<0_P[U!;%M)L_%=Y;Z&2?\
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M*['BY-2TW_56.+ZI&\==O3O<XVZT/[7XD%IIFEQ6.G::/MA*VXBCNKL@B/H
M&"]21WP.U1^"?[8_M ?;?[2\G[ GVO[?YG_'WO.[9O\ X<?W/EZ5VU%1]8?)
MRM?U_7Y+L:?5US\R?]:?Y?B^YSMK;3S_ !$U"^E@D2"VL8K:&1T(60LQ=MIZ
M'&%!Q7-_$#39;OQ/9S:MHM_K.B1VCJD.GJ2Z3D_>8*0<8Q[5Z-12A7<)J26R
ML.=!3@XM[N_]>6AY:FF:K:>$/#,GB#P[_;4=E)()K789)X8SPF$!"N0,9# ]
MNAR:V_ F@;-)U<ZEI/V73]1O&FM]-ND#>7'VW(>A/IVP*[>BM)XN4XN-K7_S
MO^?4RIX.$)1=[V7EVM^738\ZFTW4I;&\UNUL[FRS-%:6UK;Q-'-!8)(-^Q
MRLW)P.< 8KI_"/V[^RKC[?\ :?+^V2_9/M>[S?(S\F[?\V>OWN<8K>HK.==S
MCRM?U_7YON:0PZA/F3_K7_/\%V"BBBN<Z0HHHH **** "BBB@ HHHH ****
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M0ZM)#F]AA:&.7>WRHQ!(QG'4#G&:;=:+I][<3SW=L)9+BU-G*68D-"224QG
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M)/Z4!N,HK>L? _B74646^C70#=&F3RE_-L5UNF?!;4Y\-JVH6]HO=(5,K?T
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M_P B[:_]AK2O_3A;UTE<WX\_Y%VU_P"PUI7_ *<+>@#I**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *<VD:;<MNN-/M96]9(%8_J*
MK-X7T!_OZ'IK?6TC_P *U:*M5)K9F;IP>\49\>@:-#_J=)L8_P#=MD']*NQ0
MQ0+M@B2-?1% 'Z4^BDY2>[*C",=D%%%%24%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<W\./^26>%/\ L"V?_HA*Z2N;^''_
M "2SPI_V!;/_ -$)0!TE%%% !7-^//\ D7;7_L-:5_Z<+>NDK-U_18_$&D-8
M2W5Q:?OH9TGMMGF1O%*DJ$;U9?O(O!!&* -*BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
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M_?C3_P#Y%H_X1?5_^A[\0?\ ?C3_ /Y%H Z2BN;_ .$7U?\ Z'OQ!_WXT_\
M^1:/^$7U?_H>_$'_ 'XT_P#^1: .DKF_AQ_R2SPI_P!@6S_]$)1_PB^K_P#0
M]^(/^_&G_P#R+6MHFE0:#H&GZ19M(]OI]K':Q-*07944*"Q  S@<X H O444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>halo-20240313_g7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1[&17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C R.C(P(#(P.C,S.C$X   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,Q,0  DI(  @    ,Q,0  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP,CHR," R,#HS,CHT,0 R,#$Y.C R.C(P(#(P.C,R.C0Q      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #1H         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ )P$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
M   ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!
M!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25
MEI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/D
MY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'
M" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!
M"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)
M2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*C
MI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S
M]/7V]_CY^O_:  P# 0 "$0,1 #\ R/B%\3M=U#Q)>6>FW\]C86LK0HMNY1I"
MIP68CGDCI7'_ /"8^)O^A@U/_P "G_QKV:5""@M#AE4DV'_"8^)O^A@U/_P*
M?_&C_A,?$W_0P:G_ .!3_P"-:>RAV)YY$UKX[\56=PD\7B#4"RG(#SLZGZ@Y
M!KZ;\!>)7\6>$;/594"3MF.95Z;U."1]>OXUQ8RE&,5)&]";;LRI\2?%LW@_
MPG)>VBJUY*XAA+#(4G^(CO@"OFV?QQXIN)FED\0:EN8Y.VX91^ !P*>$HQ<>
M9BK3:E9$?_"8^)O^A@U/_P "G_QH_P"$Q\3?]#!J?_@4_P#C79[*'8QYY!_P
MF/B;_H8-3_\  I_\:[SX8?$K7(O$UKI6J7TU]97C^6//;<T;'H0QYQ[5E6H0
M<'9%0J-2/HJOG[XK_$?6D\2W&B:3>2V5M:$+(T+;7D?&3\W4 9Z"N#"TU.>O
M0Z:TG&.AYU_PF/B;_H8-3_\  I_\:/\ A,?$W_0P:G_X%/\ XUZGLH=CDYY!
M_P )CXF_Z&#4_P#P*?\ QI\7C;Q3#(LB>(-2#*<C-RQ'Y$TO8P[!SR/HOX6^
M,;GQAX8::^"_;K63R9G48$G&0V.Q/>M[Q;KH\,^%=0U@H'-M'E%/0L2%4?F1
M7DSII5>3S.V,O<YCY<O_ !_XKU&[>XEUV^1G.=D,QC1?8 <"JW_"8^)O^A@U
M/_P*?_&O65&"5K'$ZD@_X3'Q-_T,&I_^!3_XT?\ "8^)O^A@U/\ \"G_ ,:?
MLH=@YY'1>#_BCX@T36[=K[4KF]T]W"SQ7#E\*3R5)Y!'6OJ2O.QE-0DFNITT
M).2LSD?B1XIG\)>$)[^U"FZ=Q#"6&0K-W_  U\S3^+O$=U,TTVN:@SL<D_:&
M'Z9K;!THN',R*\W>R(O^$FU[_H,W_P#X$/\ XT?\)-KW_09O_P#P(?\ QKL]
MG'L8<S#_ (2;7O\ H,W_ /X$/_C79?#KXCZYIGB:SL[V^GO-/NY5ADCG<N4W
M' 92>1@]N]9U:,90:L5";4D<3K__ ",>J?\ 7W+_ .AFLZM8_"B'N%%4(*^E
MO@K<0P?#JW$LJH7NY57<>IR*Y,;_  S>A\1G_'2XANO!-C+!(LD9O -RG/\
M":^>:>#_ (0J_P 845U&(5T'@;_D>=%_Z^T_G4S^%E1W/KA-1LY)!&ES&S,Y
M0 -U8=17RC\2O^2C:Y_U\?T%>=@?C?H=.(^%'+!6;. 3CK@4E>F<H8)S@=.M
M% CWSX"W$-KX;U>6>18T%R@W,<?PUU/Q9N(9_A?K@BD5S&85;:>A\Y.*\BI_
MO'S.V/\ "/EJEVMG&#GTQ7KG$&#Z&DP<9QQ2N,5?OK]:^VWN(8CMDFC0XZ,P
M%>?C]X_,Z</U/,OCJZ2> 8&1E93>IRIR/NM7SA6V#_A&=?XPHKK,0K4\-_\
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M^,4?\/C],_Z)=>?^#I/_ (Q7YC44?V-@OY?Q8?7J_<_3G_A\?IG_ $2Z\_\
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MKZF&282*LTW\SQWCZTGH['Z<_P##X_3/^B77G_@Z3_XQ1_P^/TS_ *)=>?\
M@Z3_ .,5^8U%7_8V"_E_%D_7J_<_3G_A\?IG_1+KS_P=)_\ &*/^'Q^F?]$N
MO/\ P=)_\8K\QJ*/[&P7\OXL/KU?N?IS_P /C],_Z)=>?^#I/_C%'_#X_3/^
MB77G_@Z3_P",5^8U%']C8+^7\6'UZOW/TY_X?'Z9_P!$NO/_  =)_P#&*/\
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M ,/?OB;_ -"=X4_[]W/_ ,>H_P"'OWQ-_P"A.\*?]^[G_P"/5\'44?V7@_\
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M?OMT1![LQ5?QK\ OBG\2-8^+7C[6O%>NW+W6H:E<-,Q9B?+7/RHN>BJ,  <
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M* "@444]] .D^'/C[6/AAXVTGQ/H=W+9ZEI\ZS1R1-@G!Y4]B",@@\'/-?T
M?!_XE:?\8/AKX=\8Z9Q9ZM:B?9S^[<?*Z>^UPPSWQ7\[8ZBOUO\ ^"2GC6XU
MSX*^(/#]PYD&B:D&BW,3M29,A1Z &,\>YKY?/<.IT%7ZI_@SULOJN-3D[GW3
M1117PA]$%%%)0 50U_6K/PWH>H:MJ,PM]/L;>2YN)6Z)&BEF;\ #5\FOFO\
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M*[\O_P![I^IRXK^#(_'NBBBOU0^1"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHI/8:W/Z&?@'_P D+^'?_8NZ=_Z31UWP[UP7
MP#_Y(7\._P#L7=._])HZ[T=Z_(:G\27J?9T_@0M%%%9F@4C=*6D;I0!^)O\
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M%O\ U]:C_P"@V]?F+7LY/_N4/G^;.''?QY?(****]LX0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH T/#O_(P:9_U]1?^ABOZ1,X%
M?S=^'?\ D8-,_P"OJ+_T,5_2)VKXOB#>E\_T/<RW[?R_4\+\;?M+1023V7A2
MR^WW$;-&^H7ZM';QL"0=L?#R$$$8^0<<,:[;X,?$63XA>$O/OFC&L6<K6UZD
M0VJ6'S)(!Z.A5O3.X?PUX?\ '/P;_P (?X\DO((]NF:YNNTP/E2Y&//3VW96
M3GJ6D]*Y[P-\0KSX8:Y=:K:VCZA#=6KVL]K'_'( S0,3[/E2>RR.?X:^8Y8O
MW4O0]2[7O?>>M?%#X\ZKX8\?'2]"@L[VRTZ-5OUN=P\V9P'\M'!^0JA4[L,/
MG((^6NZ^&WQ@TCXD226D$-UI^K01>=/8W*9PA(&Y9!E67/'!SZ@5\E*S[99K
MJ?S[B5VGN+E\?O)')9WXXY))]*^F/V<_!;>'_![:U=1[-1UTK<E6'S1VX'[E
M/R)<]\R$=J3Y>5^0U>Z\SUMONFOYN/$/_(?U3_KZD_\ 0C7]([?=-?S<>(?^
M0_JG_7U)_P"A&OJ>'MZOR_4\K,_L_/\ 0SZ***^S/#"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBBD 5^G7_!' X\/_ !2_Z^=._P#0
M;BOS%K].O^"-_P#R+_Q2_P"OG3__ $&XKQLY_P!RG\OS._!?QX_UT/M_XD?%
M[2?ANL-O<Q7=]JES&98+*V3[R@A2S2'"* 2.^>>%:N#^&OQ\U;Q+\0(M+UV"
MRL;#4D9+*.WW%H9E^8(\A/S;EW#.U>54 ?-71?M#^"SXD\&_VM:Q[]3T/==H
M%'S20X GC'U4;@.[1J.]?,99V2.6UG:">-EFMYX\9C=2&1U[9# $5^>+EM8^
MC=[M]CZW^,OQ"D^'O@^2YL]CZQ>2"TL4D&X>8W)<CN$4,V.Y &1FN#\%_M,P
MLT5IXNL?L+N0BZE8*TENY)P-T?+QYXZ;QU^85Y/XZ^(EY\4-9L]2N[5[*&SM
M%MXK1N@E8*T\B]\,X"*3U6-3WK<^!_@W_A,?'\$\R[M-T39>3=P\Y/[A/P*M
M(?0HGK3Y4O=9-W+WCZQ5B3Z9KXP_X*R?\FPV'_8Q6G_HFXK[07K7Q?\ \%9/
M^38;#_L8K3_T3<5TY?\ [W3]43BOX,KGX]T445^IGR(4444 %%%*N2V!UI-I
M:L!*,<9K[:^)5GX'_89\.^%?#'_"N_#GQ"^*6KZ7'JNM:CXNMS>V-DKL0L$-
MOD#@K(-_RGY03G< OBGQD^*WP[^+WA;19]$^%T'@KXB_:/*OG\.2"'2;F+ "
M^7:X)5RQ(P,8QRSY&W@IXJ56S4'ROK_P.QTRI*%US:GB%%?3R_\ !/'XF_8T
MA;5/"*^+FL_MZ^"&UI!K;18SD0[=O3_;Q[YK'^$/[#?Q$^-/@<^*M&N-%L=-
MBO;FQNEU2>:&6T>"+?(TBK"WRYPHP2=S<@ $BWC<.ES<Z[$^PJ7LD?/-%?36
MA_L"^,]6^'_AGQM=^,O ?ASP[X@MUGMKS7M9>S5"P!2)]T.-[9.%7=]TY/3/
MG?Q*_9C^('PK^)VF> ]3TA;W6]6:,:4^FR>=!J D;:AA?C/.0=VTCJ0!@TXX
MNA-N,9J_^0W1J1W1Y30>M?2?BK]@?XB>&?#^MWUMJ_A+Q'JVA6_VG5_#6A:P
M+G5=/CV[BTL.P=!V5B3_  @UGZ7^Q'X]U?X*)\5([_08O"9TBXUAGDN9A,D<
M+E?**^409'PQ4 D<<LO *6-P[7-SKL3[&I?8^?**^D?#'[!?C_7_  ?H.O:A
MK?@_PC+X@0/H^C^)-:^R7VH@@%!#'L()8,,*6!Y&0,U[%^S+^Q;<?#G]KS3_
M  K\1[OP3KJ6>DG4GT>ZD-RNH),DZ((89H0)7C:,N_'R@ @GME4S##TXR<97
M<2XX>I)K0^#**^C?^&/?%'CSXO\ Q!T?PYJOA5?#WARX>>^\2_VB(]%L8WW2
M+&9@GWE&5954[2C XQFN*^-7[-/BSX'Z;H^KZE<Z/XA\,ZQD6'B+PW>_;=/G
M< Y02[1AL D9 R <9VG'1'%4924$_>?_  Y$J4XW;1Y/111748A1110 4444
M@/Z&?@'_ ,D+^'>.O_".Z=_Z31UG?$KXZ:9X!OI-*AM;C5M<6,2&U4>5%&K?
M=:25A@ X/"!CQT[C1^ H!^!7P[![^'-.'_DK'7$?M,^#?-L;+Q=:IF:Q*VM]
MMZM;NWRO]4D/X+(Y[5^2-7J23\S[+:"L7?@O\9]3\:>(M1T?Q +2"[>/[78B
MT1E78ORR1G<225RC9ZG<W "UJ_'+XIW?P_L=,M-':W.MW\I=!<H9$C@CP9&*
MAESDE$'(^^2#\M?-&GZI=Z!JEAJ^G<W^GS+<0J#@28R&C/H&4LA]G-:'B_Q?
M-X_\5:AX@ECE@CFVPVEO*,/#;IG8I'9B69R/5R.U.T?CM\A7?PGNWP]_:(LO
M$=]9Z3KEC)I.K73B&&6#,UM.YZ!2/F0GT<8']XU[#FOFO]F_P;_;/B>Z\2W"
M@VFE9M;0'^*Y9?G<?[D;!1_UT;TKZ6XQQ64[7T+A=H_$[_@IE_R>%XM_Z];#
M_P!)(Z^6J^I?^"F7_)X7BW_KUL/_ $DCKY:K]2P/^ZTO\*_(^3Q'\6?J%%%%
M=QSA1110 4?RKM?@CI]KJWQF\!V5];0WEE<:]80SV]Q&'CEC:X0,C*>&4@D$
M'KFOJ#XN?L;ZU\:/VHOC)I?PWMO#?A_3O"KV<ITV4_88=LMLK!85CB,8Y1R=
MQ49/)KBJ8J%*?)4TTO?[O\S>-)SC>/I^!\58]*.*]L^-/[)?B_X)^&?#_B6X
MU/P]XN\-ZW.;6SU?PGJ!OK=IANQ'N*(23L?!4$94@D8Q7K_PI_8!\9:!\2OA
M[-XNU'P3%<S:C9W]UX(U+5HVU2>R$Z&;-LR;)%$8<LNXY (QGBIECJ$8>TYM
M_P!"HX>HWRV/C2BOT)\:?"[2H/B=^UI9:%\-O!5[I>B:1!+"U]FT;1U-D7,E
ME'';NN\L&;@Q?,!\Y!-?*/CO]F;Q;X$_X5TWG:=K\'CZWBGT.XTAY624R,@$
M3B2-"L@,B94 XW?6HHXZG5LGH]/RN%2A*']>9Y)17VKX'_9LU3X4Z/\ M >%
MM8T'X?\ CO6-!\-1W=UJ<U[<&31B\4[@VVZU.Z8*H;&8OX,R'Y@/)?AK^QCX
MT^(GPZ@\<W>N>%? WAB\F\BPOO%^J?85OF!*XB 5NZL/F*YQQGDU4<=1;E)N
MRT]'H#H2Z(\$HK[X_:9_91?4KS]FWX<^'-&\.^&?&6L:%/!J5W'$D,5Q=0P0
M,[S30(QD/RR8?YB2V>,YKYE\+_LR^*/%\WQ2BL[_ $>)OAS#<3ZL9YI0)EA:
M17%OB([B3$V-^W.1G'94\;2J04KV_P"'LOO"5"<'RV/(:*]\^&G[&/C/XB?#
MV#QQ>:[X5\"^&;N;R+&]\8:K]B6^?)&(L*W=2!NQG'&1S7K7PA_8WUGX*_M4
M?![1_B1;>&_$.G^)_MDPTV,F^AVQ6S$K,LD00G<ZD;=PRI(/0FJF-H0YE&2;
M7Z;BCAYMJZW/BFBN^^/VF6FC?'/XA6&GVL-C8VOB"_A@M;:,1Q11K<.%1%
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M'3=[I;KK?_(CZNK<W-IK_D?!=%?I;_PS'X&^)GQ>\ ?&S3]#TK1_@S<^'/\
MA(]=L8K:)+*WN+5 &MC$GR8+;=RX(;RILY).?SZ^*7BRR\<_$3Q!KNF:19:#
MIE]>R26FFZ=:I;06\&<1HL:8484#) Y.2>:ZL-C%B7RQ5K+7U[&52BZ:NW_P
MQR]%%%>@<P4444 :'AW_ )&#3/\ KZB_]#%?TBU_-UX=_P"1@TS_ *^HO_0Q
M7](G;GI7Q?$.]+Y_H>YEOVOE^IQ?Q>\"GQ]X'O-/A"G4H<75BS< 3H#M&>P8
M%D)[*YKY#MYUNH5E*LNX?,KC#*>ZD=B/3L17V9\0O&4/@'P?J6M2J)7@3$$)
M./-F8[8T_%B![#)[5\:1^=\\MS*9[J61IYYB,&65V+R-CIRQ8\=,U\JO@/7^
MV=!X \'MX_\ &FGZ+(I:QYNM0;'_ "[H1E#_ -=&*I]"Q[5]G+A1@#&.U?(?
MP?\ &'_"#?$"RGE?;INI;=-O">%4ECY,F?\ 9<E?I(Q[5]>+S@TI?#'M^HX_
M$R1ONFOYN/$/_(?U3_KZD_\ 0C7]([?=-?S<>(?^0_JG_7U)_P"A&OK.'MZO
MR_4\?,_L_/\ 0SZ***^S/#"BBB@ H]:** /H/]E;]F?PI^TIJ3Z%=?$P^$O%
MLDLOV71?[ EO?/@2,.TWGB1$7^,;2<_+QZ5YI\9/!?A7P#XT?1_"/C7_ (3O
M3XX@)M2_LJ;31'.&97A\J4DG;M4[P2#NQVKW+_@F./\ C+GPYV_T&^_])VKK
MOV'=!LO^$S^./B^TT&V\3>-_"NE7%[X<TFZB\X-<;Y3O6/JS K&!MY_>$+@F
MO#J5ZE"M4DW>*2LO5V_0[H4XU(126K?Y'Q/D<<X'8G@?Y_SVI>N-OTY]?\_Y
MZU^D_P &_CM\1_CI^RG^T9?>/;6.]:ST6:WM-:73X[5Y"89M]J?+50XC^4CN
MOF').13/VK/B9;6_A7X)?"B73[*ST;QIHV@/K^ML66X-K'*@2-6R JJ?,8E@
M1\QQCFI683=3V;@KWUL[]$ROJ\>7GYC\VN&&5[].?K_G\*7ALGMZ\5^I7C'X
MR_$7P%^VOX1^#7A[PC86?PO@N[&&RT&/2(S#/;821[U9"A(:)R[AD("F+YLL
M&)T/!?@[PSJ'[:7[27BW5C;C7?"]E9W&DR76G/J0LR]HIDNEM8\/*R>7'\J?
M-\Y (+"I6:-)SG#2UUKW:*^J:I)];'Y2]_3W[?6O7_V@/V>_^%%:7\/KLZ\=
M:_X2W0HM:V?8_(^R;P#Y6?,??C=][Y<XZ5]9?&[XO>!O%G[/UYJVJ_%2/XC?
M$31]4AO/"WBM? =UI#PW$4B.UJ9/*,+_ "@G:V.Q(8@$<S_P4<^*?B?Q'X"^
M">EZEJGVBQU;P[;Z[>Q?9XE\V^,84RY501Q(_P JD+STHI8ZKB*E-*-KMI_<
M*5"--2<G?8XO1?V X-7TXZ9+\6O#NB?$2VT6/Q!J/AO5K:6&VL+-U#;Y;W)3
M*JRE@%.W/]T[CQ7Q<_93T[X,?"BT\6:M\3?#^N:GJET;?2=,\,I)>6]\JD>;
M,MT^S]V@."RHR[\+G)./2?@K\>/&WQD\)ZEX;\1MH6A^!]&T:.V\7?$"'3PF
MM2:/&<)8FY+8=YB!$B["Q))Y.[/9^*/@OX/_ &C)/![ZEJWB#0O&/BCPY/?>
M#M+TVSC;0-%TNU5S!9S,<NSE4+.Z' >0DKRH;+ZQ7HUOW\M+]%_7_#%.G3G'
MW%J?G_2T=J*^D6R['FNX4444Q!1112 *_3K_ ((W_P#(O_%+_KYT_P#]!N*_
M,6OTZ_X(W_\ (O\ Q2_Z^=/_ /0;BO&SG_<I_+\SOP7\>/\ 70_1M@/QKXS^
M(O@W_A7_ (VO](BC\O39,W>G<8 @<_ZL?]<VW)CLOED]:^S#QWKY$^,GC#_A
M-OB%=O"V[3M)#Z?:XY#,&'GR?BZJOIB($=:_.H6LT]CZ26ZL<1<W"VUO)*^[
M:JYPHR3[ =S[=Z^NO@WX';P'X(M+2Y15U2Z8W=^0<_OG RN>X10L8]D%?(\J
MR%5:"4V]Q&RR0S*,F*16#(X]U8 _A7V3\-?&D?C[P?IVLHHBGE0I<P+TAG0[
M94^@8'&>H(/>C[%UOU&_CL]NAT]?%W_!67_DV*P_[&*T_P#1-Q7VEZ5\6_\
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M^(?B)JOAV\T)M-!T^&[BFCU&YDASYK0%2I2-\X\D]0.M>;_\,Y_$+^[X9_\
M!I<?_(M=W^T-X_\ $?@[5_#%GH.I_P!EI>P7LT[B".4L8VMP@^<''^M?I7E?
M_"Y/B#_T-LG_ ( 6O_QNO$3?*N:QV6]YVO\ >;/_  SE\0O[OAG_ ,&EQ_\
M(M'_  SC\0O[OAK_ ,&EQ_\ (M8W_"Y/B%_T-LG_ ( 6O_QNC_A<?Q"/'_"6
M2'_MPMO_ (W2YEUM]P6EV?WG;_#[X#^,O#_C[0-8U0Z&ECI\\DTOV.^FEE;,
M$D8"JT"@\N/XAQGZ5]%]J^8?AI\6/&FI?$CPYINI^(&U"POKB2*:%[2"/(%O
M*XP50'J@[]J^GJFI>Z+I=>Y^3/\ P5\_Y+GX0_[%U?\ TIGKX0K[O_X*^?\
M)<_"'_8NK_Z4SU\(5^DY7_N=/T/EL5_&D%%%%>J<H5I^&-&_X2/Q+I.D^=]G
M^W7<-KYVS?Y>]PN[;D9QG.,C.*S*Z7X8_P#)2?"?_86M/_1R5G4;C%M%15Y)
M,]]_:"_9.^''P N-9T6_^-ZWWC:P@CFB\/MX3N8A/O"LJFX662-<JV[N>V*\
MD^.WPN\/_"7Q58:5X=\?:5\0[*XTZ*\EU/25"QPR,6#0MAW^9=H/4'YQE5/%
M?6'_  4>\>?#FT^,GBOP_>_"W[?XWDL;41>,?^$AN8O*+1(4/V,#RVVK\N">
M>M?3]G(L7_!0#2)"F]5^%N[:PZXNN1_GUKYJEC*].E"I-MW3>MM=NQZDJ,)3
M<5W/QI/R_@,G_/\ GVI=N.._.!]*^_M6^)VK?M(?L$?%?7/&UKIMS?>%]=ME
MT1K2PBMQI\32VZ^5$%'"JKNG]X@X).*Z']H'XJ>-_P!F.\^%GP^^$'ANQ7P'
MJ>D6LP5-)CNU\27$A*R12.RG<64(2%(?]YG."H';_:$](<EG=JU]-$GO\S!X
M==]#Y!_99_9Y_P"&F/B)>^%O[?\ ^$<%MI<VI?:_L?VK>(VC79M\Q,9\S.[/
M&.G-<C\)/AS_ ,+2^*WAOP4-0_LPZUJ,>GB^\CSA%N;;OV;EW8]-P^M?J[,S
MM_P4@N&>/R9&^&19HQ_"WVKD9]NE?FI^R./^,K/AMQ_S,-M_Z'4T\94K0J2V
MM%->6Y4Z,8-1\['J'C[]A71M)\/_ !"N/!'Q8L_&FO> E:77]$N-%ETV2%$#
M%S'(\C+(1L/ XX^]G /R4>&-?9O[7W[6GBO3_'WQ6^'&@Z'X7\*Z7?:I+9ZG
MJNAZ6;?4=5B1B,7,V\[]P8@L "<D="P/8^*/B+XG_97_ &2_@QJ'P@L+73X_
M%5L]YX@\3)IT=U)-=?(5MW9U91R\J@,,XBPN,',4L3B:5*,JJNYO2]NU]1SI
M4YR?)TW/@$X'&,=@.G\_RZTG'J,9X/\ .OU%_: ^.&I_"/XC_LJ^-]?TQ?#A
MFTB:+7=*@3RH[>&=;59H_+[!-VX(>AC ZBL;XE?#6Q_83\%_&CQSI\\4>K^-
MKPZ)X/\ LK!FL[2=?.D<-U7;EAZ9MXSW%:1S)M1O#66WWZ_YDO#:NSVW/S4R
M&7)XXZ_YXH8Y_#KCM7W_ .)OB)XG_98_9W^!4WP:T^TB3Q=9B]UO6$T^*\EU
M*](0FS=BIQ@O(NT88;<*1@U[#X3\$^'O!O[?%[#H6G6NA:EX@^'<E]J&BV@
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M*!U!_&BB@#Z<\%?M^>-/!/@CPCX:C\&>!-7B\*1;-(U'5](FN+NT?_GK&YG
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M.I/ _@>=[.7R]7OV^Q6..JR,#F3_ ( H9_JJCO7R1^YTO3U"J?(AC 5$^8D
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M<ASRD6"JG(+G@\*>:=U+WMNXM5[NY]-J<].E?%W_  5D_P"38K#_ +&*U_\
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M-M5R!G;LW8.0I!!JC\,/V!IO%_PWU?Q=XJ\>6G@&#0=8O-)UJ'4K1'6R:W4
MD2&=%=FE*H%X'.0QX!^B_$7[='A?Q5?/XGTW]HGQ!X(TV:UWMX'C\$6UY=P3
MA<;4O'@:,J6P?G)SS\ZY&WYN\<_M':1X^_8\UGPUJ_B)[_XB:IXV?6KFV:Q:
M SP%,&5C'&(%)8#**>O..]<-.MCYKEDVE==-N_0WE"@MNQ[[^UYX,/BCX4_
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M_P"*<T[_ -)HZYG]I/QH='\*P^';63;>:X6CE*]4M%QYQ_X%E8_H['^&NF^
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M99QDDJ .6 K[)- 44IZ4IR4K6'"+CN?DO_P5\_Y+GX0_[%U?_2F>OA"ON_\
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M_0]S+/M_(_.+_@L=_P @#X6_]?6H_P#H-O7YBU^G7_!8[_D ?"W_ *^M1_\
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M^DD=?+5?JN!_W6E_A7Y'Q^(_BS]0HHHKN.<**** #)HHHH */;M110 4444
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MMQ\,5349.TUT/E\5AW2DVEH<-11Q17MG %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 *%[]J^Q?^"9_P"SW/\ %#XS0>+M0@D'A_PLRW0D
MQ\LUUG]W'G/8_,1@@A2.XKS+]F/]D#QG^TGXBACLK>32/#,3_P"G:Y<QXCC7
M@D(/XW(Z*#[\#)'[5?"/X4>'O@KX%TWPEX9LUM=-LTY)P9)I"/FED;^)V(Z_
M0#   ^:S;,84:;H4W>3_  /5P>&E*2G+8[)0./I3J*6O@3Z,**** "D-+24
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M'2_^BHWG_@E7_P"/T?\ #G'2_P#HJ-Y_X)5_^/T44?VKC?\ GY^0?4Z/8/\
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MY!]3H]@_X<XZ7_T5&\_\$J__ !^C_ASCI?\ T5&\_P#!*O\ \?HHH_M7&_\
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M_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATU\%?^?_ ,6?^#&'_P",4?\
M#IKX*_\ /_XL_P#!C#_\8HHH_M/&?\_&'U6A_(@_X=-?!7_G_P#%G_@QA_\
MC%'_  Z:^"O_ #_^+/\ P8P__&***/[3QG_/QA]5H?R(/^'37P5_Y_\ Q9_X
M,8?_ (Q1_P .FO@K_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATW\%O^?_
M ,5_^#&'_P",5+:_\$H?@K;R;S<>)YQ_<FU"(C](1112_M+%_P#/QA]5H?R(
M]S^%W[+'PM^#TD4_ACP=I]K>QD,M],GGSA@,;E=\E#_NXKU@*.F.***Y95)U
47S3=V="A&FK15AV!Z4445!1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>halo-20240313_g8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g8.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,Q,   DI(  @    ,Q,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***KZA&DVF744
MLP@1X75I2<! 5.6_#K2>PF[*Y4L_$&GW^KW&G6LRO- JDL'4J^>RX.3C'/'%
M65U73WN_LJ7ULUQG'DB92^?]W.:X;1(1X<US2K#4]-L96D+K::C:-\[9!!+C
MJ1AL<_AFJ>JVB:3K6DWC6VF_V8+W=;R:>V99!NRI=FSNZ<XX]Q7)[>2C=KKK
MY'G?6JBAS26M]=]-O\]ST675=/@NA;37UM'.3@1/,H8_AG-+<ZE8V4BQWE[;
MV[O]U9954M] 37$>)]+T_6-5_L?0[.-M0>?S[R\ SY(YSEO4YZ5"UG97>H>+
MVU8)-/;0A8&G/S(H0X8>^0O/^/+=:2;5BI8JHI.*2]>FS;_(]&!R,CI56+5-
M/GNC;07UM).,YB292PQ[ YK#\/7 N/!-E9/>)'>SV3")7D ?&" P'7 XY]JX
MM;"]TVX\/6S:7;6UTEXI6[BG5VN06ZD+SM'J:<Z[232W*J8IQ49):/\ X&GX
M]3U ZIIZW@M#?6PN2<"$S+OSZ;<YJU7E_BFQ2PE@OOLVFMI?VW>);)R;A^Y#
M,V<]^!Q]*]0K2G4<VTUL:T:TJDI1DK6"BBBMCI"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJO+?VT
M-]!9R28N+@,T2;2=P7KST'7O2;2W$VEN6****8PHHHH **** "BBB@ HHHH
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M'\0^((]#MD58I;B\N0RVL$<9<NX'<#MDC/>MBN3\:OI'F60U:XN["9-SVU[
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M,2*V+>TMK1=MK;Q0+Z1H%'Z5-16\81C\*L=,:<(?"D@HHHJC0**** "BBB@
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M% '&?V=XO/\ R^8_[:C_  H_LOQ:>M]C_MM_]:NSHH XS^Q_%AZZCC_MN?\
M"C^Q/%1ZZGC_ +>&_P *[.B@#C/[ \4G_F+8_P"WE_\ "C_A'?$YZZQ_Y-2?
MX5V=% '&?\(UXD/76/\ R9D_PH_X1?Q >NL?^1Y/\*[.B@#C/^$4UP]=7_\
M(KT?\(CK)ZZM_P"1'KLZ* .,_P"$/U4]=6_\>>C_ (0S43UU7_T+_&NSHH X
MS_A";X]=5_1O\:/^$&NCUU3_ ,</^-=G10!QG_"!S'KJG_D(_P#Q58VI>&-2
ML;HQQP2W49^[+%&3GZ@9Q7IE% &-X5TV?2]%\JZ&V220R%,_=R ,?I^M;-%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH P=8U>]%^=.TBW:2XC42R-N487N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
M" RD, 01@@]Z6B@"E8Z3::<\KVT2AY9"Y;:,KG^$8' ]J<=)TXR;S86I?.=W
MDKG/KTJW10!5ETNPFD:2:QMI';EF>%23^.*<^G64KJ\EG;NR@!6:)20!Z<58
MHH C,$+3K.T2&51M60J-P'IFF)96L=P9X[:%9CUD6,!C^/6IZ* (!8V@N/M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JITVT;5EU-H
M<WB0F!9"QX0G)&,XZCKC-<]XX\<#P8MD3IYO/M9DZ3>7MV[?]DYSN_2N2_X7
MBO\ T+Y_\#/_ +"NVE@\34ASTXZ/S7^9Y]?'X2E/V=66J\G_ )'K%%>3_P#"
M\5_Z%\_^!G_V%'_"\5_Z%\_^!G_V%7_9N+_D_%?YF?\ :V"_G_!_Y'K%%>3_
M /"\5_Z%\_\ @9_]A1_PO%?^A?/_ (&?_84?V;B_Y/Q7^8?VM@OY_P '_D>L
M45Y/_P +Q7_H7S_X&?\ V%'_  O%?^A?/_@9_P#84?V;B_Y/Q7^8?VM@OY_P
M?^1ZQ17#^#/B0/%^M2:>-+-IY<#3>9]HWYPRC&-H_O?I7<5R5:,Z,N2HK,[J
M->G7ASTW=!11161L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4V16:)UC?8Y4A6QG:?7%.HH \U'AS
MQ)XD\0PQ^(?L,<6CW,;F^AMF26[XW85B,$#H<8 /K4\?ACQI#XHN=;\W0;RY
M?*P-=M,?(3)PJ!0 ./KWYY.?0Z*[7C)[)*UK;??]YYZP%/=MWO>]_N^X\_U3
MPQXNO?%JZP)=%NH[<8M(+MI=D/3Y@JC[V>Y)_08V+S2O%.IL8;K4[.VM)].:
M&>.U0Y6X((W*2,[>1W'T[UU%%0\3-VT6GD:+"03>KUU>IYQI/@#6X-1T5M0E
MTB&VTA]R264;":8>CD@#G^IZTDWPWU)_"3V4=U:QZE'J3WEO,KN%56 !4G;D
M'C/0]!7I%%7]>K7O_77_ #,UEU#EY=?O]/\ )'&Z?X)FTW7_  _=6TD'V72[
M)X)02=[NP;+ 8Q@EB>HKLJ**YZE655IR_KJ=5*C"BFH=?\K?H%%%%9&P4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5&A"BG&&W_ 2_0:5@HHHK<84444 %%%% !1110 4444 %%%% !1110 4444
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MI4_@BEZ)(Q?^$3TO^Y+_ -_#1_PB>E_W)?\ OX:VJ*Y_JF&_Y]Q^Y&ED8O\
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MEI7_ #SD_P"_AH_X1+2O^><G_?PUMT5Q?4\-_P ^X_<C:R,3_A$M*_YYR?\
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M_+?_ !5<M_PBWB#_ * 6I?\ @')_A1_PBWB#_H!:E_X!R?X4?5L%V0?7,?\
MS2.I_P"%R>)?^>5A_P!^6_\ BJ/^%R>)?^>5A_WY;_XJN6_X1;Q!_P! +4O_
M  #D_P */^$6\0?] +4O_ .3_"CZM@NR#ZYC_P":1U/_  N3Q+_SRL/^_+?_
M !57-(^*OB#5-;L;"X2S6*ZN(X7:.-E8*S!20=W!P>M<5_PBWB#_ * 6I?\
M@')_A6EX;\-ZY!XJTF6;1M0CCCO86=WM7 4!P22<<"HJ8;!\CLEL73Q>/<TG
M)[GOO]D)_P _=[_X$M_C1_9"?\_=[_X$M_C5^BOC/8T_Y5]Q]R4/[(3_ )^[
MW_P);_&C^R$_Y^[W_P "6_QJ_11[&G_*ON H?V0G_/W>_P#@2W^-']D)_P _
M=[_X$M_C5^BCV-/^5?<!0_LA/^?N]_\  EO\:/[(3_G[O?\ P);_ !J_11[&
MG_*ON B\E_\ GXD_)?\ "CRG_P"?B3\E_P *EHK4 '3UHHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%9FB:=/817<EX8_M%Y=-<2+$253("A02 3@*.<#Z5IT""BBB@ HHHH ****
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M6Z8-;PMP2$\O!<]SN] ,#JW2]#U**YTH:BUKY.D0M%"T+LS3$J$#," %^4=
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\4:Y_PC?ANZU;[/\
M:?L^S]UOV;MSJO7!Q][/2M:LGQ1H?_"2>&[K2?M'V;[1L_>[-^W:ZMTR,_=Q
MUK2ER>TCS[75_0RK<_LI>S^*SMZ]#SO_ (7E_P!2]_Y._P#VNC_A>7_4O?\
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MVD5Q->"0@S3F)5" $\A&)Z^E8<.DNGCJTMRZF&&SBN[A .LR!HD.?0@D_P#
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MKY>W"G 5<[CW..U :&CXEU[_ (1[3HKH6K76^81E%?:0,$DC@Y("GCO5>_\
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M::")=1M#)<*&A03KF4'H5&>1P>GI1;:QIE[=-;6>HVEQ.H):**=688ZY .:
M+E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)(Y<D(Q8D@H6(!  /(Y/(KT"B@+A1110(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>halo-20240313_g9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20240313_g9.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,S,0  DI(  @    ,S,0  ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *CN9OL]K+-M+^6A?:.IP,XJ2H[@S"UE-J%:<(?+#_=+8XS[9I/83V.,\
M,:OK6LZPNI&2TEL[A?+DM([@[K8#.&*'C)..>_M4^I>,;J'Q3;Z?I\$,EI]K
MCM)YI 2=['D+@@<#Z\UDV&GWVM>)HKRUTJ#1Y+"X:.\N()@1(X RH4<=_P!>
M33[GP/K=HNG0V&J_:8HKP3%OLR(8&SDRG+9<^WM7GJ57D]V[UW_X<\>,Z_L_
M<3>N_?Y.S_KL7]0\6:P+C5)M*L[1['2I/+F,Q;>Y!PVW!QQ[U/J_B+7;?2O[
M7T^SLETX0139N')=PX!X (QC=CFLZZT+Q#:_VU865E%=V^JR^9]J,RIY98Y;
M*GD_A^M&K:/KSW%C8?V6=1T?3X8U6-+I(A<.J 9;/. <\8JG*K9[_P#!U_ J
M4Z]I7YONZW?EM;L=EIMZ^I:+;7JQ^5)/") C] 2/Y?TKE[[7/%6F:E86=TFC
M2R7LNQ4@$I8#NQR1@5MVUUKCWVGH^E0VMD\3?:1YH=H6&=J@@@$<+T!Z]L54
MT_2KZX\:7NLZI!Y4<*>18J7#?+W;@\9YZ_WJVES224;W.JISS45%N]]]O-O^
MNI0LO&=Y)XTETJ\A@2S^T26\4J*V[<O0'DCGZ#K2W'C*['C:+2;6&!K+[0+=
MY6!+%\?-@YQQG'2JEWX4U.:+6YHH ETVH+=V+;U^;!/?/'![X[4^T\*ZC;#P
M\YAWS0W4ES?MYB_*S[??G@8XSTK&];;7>_XVM^IR\V)VUWO\KVM^OH=U1117
M>>N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB761IVB2W-VND17D):>\-MYN&_A&WMD '\?:IE7C%M-,SGBHP;4D]/3O;O\
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M#INAP>7IMLL9(PTAY=_JW7\.E:-%%=22BK([HQC%6BK(****904444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'*>._$]QX=L+=+ *+FZ+!9&&0@7&3CUY%<98^._%-\/[/M62YNISB-Q"-XXY
MQC ]\D5Z+XE\-6OB6P6"X=HI(VW12J,E3WX[CV]JS?#'@2U\.WIO)+EKNYVE
M48Q[ @/7 R>>V<UPU:=>57W7:)Y5>CBIXCW96AZ_?\S)TKX<S7=Q]M\57;SR
ML<M"KDD_[S_T'YUW5I96UA;+;V4$<$2]$C7 J>BNFG2A3^%'=1P].BO<6O?J
M%%%%:FX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^C>,[#2[GS(IK: VI,; RJF0['(X.6!YQUJW9ZG<^%-&U#0+=7:36+6WGTX
M?Q3*JN!^9Q[K7JLGA?1YO[2\RSW?VKM^V?O7_>[>G?CKVQ2R>&-'ENM/N9+)
M6FTU EJY=OW8'0=><>^:V>.I.]TVG9_-)6_%?=]QSK+:T;<LDFKK2^S;O^#T
M\_O.1^&&G+I&K>)=/0[A;30Q;A_$0K G\3S7H=4K+1['3KR\NK.#RY[YQ)<-
MO8[V&<'!.!U/3%7:\[$5?;5'/O;\CU<+1="DJ?:_YMA1116!TA1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %5;;3;2SO;N[MXBL]XRM.Y=CO*C ZGC XXKS?QG\3M8\.>++O2[*UL9
M(8 FUI4<L=R*QSA@.IK"_P"%U>(/^?'3?^_<G_Q=>G3R[$S@I1V:[GD5<UPD
M)N,]XOMUV/;Z*\0_X75X@_Y\=-_[]R?_ !='_"ZO$'_/CIO_ '[D_P#BZ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% 'SU\4O\ DH^I?2+_ -%)7(UUWQ2_Y*/J7TB_]%)7(U]SA?\
M=X>B_(_.<;_O-3_$_P PHHHKH.4**** "BBB@#UCX'??UOZ0?^U*];KR3X'?
M?UOZ0?\ M2O6Z^.S+_>Y?+\D?>91_N4/G^;"BBBO//4"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY-?[[?6OK*ODU_OM]:
M^@R7_EY\OU/E^(/^7?S_ $$HHHKZ$^7"BBB@ HHHH *^A?A;_P DXTWZR_\
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MI4MY!.ENL9AD56., 8(RIZ]>/<5'X&\<WT]KJ(\4W0E>"U%]#)Y:INBQ\PX
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M  3Y[_6#_IW^/_ /K*BODW>W]X_G1O;^\?SH_L7_ *>?A_P0_P!8/^G?X_\
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MH **** "BBB@ HHHH @O+R&QM7GN'"JH)QD9;V&>IH2]MWLTNC*B0LH.YF
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M /BJ/^%;^+?^@-)_W]C_ /BJW^M4/YU]Z.;ZGB?^?<ON9R]%=1_PK?Q;_P!
M:3_O['_\51_PK?Q;_P! :3_O['_\51]:H?SK[T'U/$_\^Y?<SEZ*ZC_A6_BW
M_H#2?]_8_P#XJC_A6_BW_H#2?]_8_P#XJCZU0_G7WH/J>)_Y]R^YFM\,-9GT
M?^U#;QQOYOE [P>,;_0^]=__ ,)K?_\ /O;_ )-_C7&>%/!?B'31=_;=,DB\
MS9M^93G&[/0^XKH?^$?U7_GRD_2ORW/Z^->95'A[N&EK*Z^%=?4^PRV%2GA8
MQDFGK^;-+_A-;_\ Y][?\F_QH_X36_\ ^?>W_)O\:S?^$?U7_GRD_2C_ (1_
M5?\ GRD_2O#]MFG:7W/_ "/0]\TO^$UO_P#GWM_R;_&C_A-;_P#Y][?\F_QK
M-_X1_5?^?*3]*/\ A']5_P"?*3]*/;9IVE]S_P @]\TO^$UO_P#GWM_R;_&C
M_A-;_P#Y][?\F_QK-_X1_5?^?*3]*/\ A']5_P"?*3]*/;9IVE]S_P @]\W]
M'\47>H:M#:S0PJDF<E0<\*3Z^U=37$:%I-_9ZU;SW-K(D2;MS8SC*D=J[+[0
MGI)_WZ;_  KZ'+)8B5%O$7O?KII9&D;VU):*B^T)Z2?]^F_PH^T)Z2?]^F_P
MKU"B6BH);V""%Y9V:..-2SNZ,%4#DDDC@5E_\)IX:_Z#MA_X$+_C51A*6RN1
M*<8_$[&W16)_PFGAK_H.V'_@0O\ C1_PFGAK_H.V'_@0O^-5[*I_*_N)]M3_
M )E]YMT5B?\ ":>&O^@[8?\ @0O^-'_":>&O^@[8?^!"_P"-'LJG\K^X/;4_
MYE]YMT5B?\)IX:_Z#MA_X$+_ (T?\)IX:_Z#MA_X$+_C1[*I_*_N#VU/^9?>
M;=%8G_":>&O^@[8?^!"_XU;35UFC66VM+F>%QNCEB"E74]&!W<@UG-.FKR3^
MYE1J0E\+N)JVC0:LB>;A71AA\9.W/(ZCK4CZ/I[V2VC6J>2IR%&1@^N>M)_:
M;_\ 0.O?^^%_^*H_M-_^@=>_]\+_ /%5R.%!R<G#5[Z/_(JR :+IXL3:"V40
M%MQ7)Y/KG.:9<Z!IEW.9KBVWR, "=[#H,#@'T%/_ +3?_H'7O_?"_P#Q5']I
MO_T#KW_OA?\ XJAT\.U9PT_P_P# "R'P:79VTD4D,.UH4*1G<3A2<XZ^]-71
M[!+6:V2W BF;=(H8_,?KFD_M-_\ H'7O_?"__%4?VF__ $#KW_OA?_BJ?+1M
M;D_\E^78-"ZB+'&J(,*H  ]!2U1_M-_^@=>_]\+_ /%5-#>"127M[B$YQM>/
M)/OQFMXS3T7Y,98HJ+[0GI)_WZ;_  IZ2!P=H8?[RD?SJP'4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;"SE*HMT6:***\4]\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA6 Q0%S)U'S[+Q18RB34(8IKP))/+<;H) T9"Q+$K''./F*KR"<DD9ZFLU=
MTY;X7?DR&02F95:>1HUD.<N(RVT'D\@=ZTJ "BBB@04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP_!UW<77VS[3<2S;=FWS'+8^]ZUG6OB1)/&GF)JD;P7-S)8+:>>&\O:HV2;
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140507324212864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Halozyme Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140507322416480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Pay-Versus-Performance Table</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Millions) ($) (5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue (Millions) ($) (6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,820,858</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,608,264)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,568,762</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,639</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208.46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281.6</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817,187</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415,581</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154,512</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.65</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">660.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,992,078</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,398,657</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,581</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402.7</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,518,876</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,374,731</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812,287</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,356,681</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.89</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268.0</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Helen I Torley was our CEO for each of the four years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span>See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2023, 2022 and 2021. The 2020 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar year 2021. The average compensation for the Non-PEO NEOs for 2023 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in calendar year 2023, 2022 and 2021, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 11,820,858<span></span>
</td>
<td class="nump">$ 9,696,978<span></span>
</td>
<td class="nump">$ 7,453,294<span></span>
</td>
<td class="nump">$ 6,518,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="num">$ (3,608,264)<span></span>
</td>
<td class="nump">22,817,187<span></span>
</td>
<td class="nump">5,992,078<span></span>
</td>
<td class="nump">24,374,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2023.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:83.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,820,858</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,088,804)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,803,183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,608,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 3,568,762<span></span>
</td>
<td class="nump">2,415,581<span></span>
</td>
<td class="nump">2,398,657<span></span>
</td>
<td class="nump">1,812,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 160,639<span></span>
</td>
<td class="nump">3,154,512<span></span>
</td>
<td class="nump">591,581<span></span>
</td>
<td class="nump">4,356,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2023 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:82.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2023 ($)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,568,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,806,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160,639</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img alt="CAP vs TSR.jpg" src="halo-20240313_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our net income for each of those years.</span><div style="text-align:center"><img alt="CAP vs Net Income.jpg" src="halo-20240313_g9.jpg" style="height:369px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2023 executive compensation program because it is used in </span><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">determining each of our NEO&#8217;s annual 2023 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our revenue for each of those years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img alt="CAP vs Revenue.jpg" src="halo-20240313_g10.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img alt="CAP vs TSR.jpg" src="halo-20240313_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2023 with Halozyme performance.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA (as used in our 2023 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Price (including relative TSR, as used in our PSUs awarded in 2021, 2022 and 2023 and as described in the Compensation Discussion and Analysis above)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 208.46<span></span>
</td>
<td class="nump">320.93<span></span>
</td>
<td class="nump">226.79<span></span>
</td>
<td class="nump">240.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">118.87<span></span>
</td>
<td class="nump">113.65<span></span>
</td>
<td class="nump">126.45<span></span>
</td>
<td class="nump">126.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 281,600,000<span></span>
</td>
<td class="nump">$ 202,100,000<span></span>
</td>
<td class="nump">$ 402,700,000<span></span>
</td>
<td class="nump">$ 129,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">829,300,000<span></span>
</td>
<td class="nump">660,100,000<span></span>
</td>
<td class="nump">443,300,000<span></span>
</td>
<td class="nump">268,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure:: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure:: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">relative TSR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=4', window );">Measure:: 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">stock price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 10,000,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">6,462,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(8,088,804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,803,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">2,700,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,755,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,806,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(657,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>20</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="halo-20240313.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="halo-20240313.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="halo-20240313.htm">halo-20240313.htm</File>
    <File>halo-20240313.xsd</File>
    <File>halo-20240313_def.xml</File>
    <File>halo-20240313_lab.xml</File>
    <File>halo-20240313_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>halo-20240313_g1.jpg</File>
    <File>halo-20240313_g10.jpg</File>
    <File>halo-20240313_g11.jpg</File>
    <File>halo-20240313_g12.jpg</File>
    <File>halo-20240313_g2.jpg</File>
    <File>halo-20240313_g3.jpg</File>
    <File>halo-20240313_g4.jpg</File>
    <File>halo-20240313_g5.jpg</File>
    <File>halo-20240313_g6.jpg</File>
    <File>halo-20240313_g7.jpg</File>
    <File>halo-20240313_g8.jpg</File>
    <File>halo-20240313_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="61">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "halo-20240313.htm": {
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20240313",
   "dts": {
    "inline": {
     "local": [
      "halo-20240313.htm"
     ]
    },
    "schema": {
     "local": [
      "halo-20240313.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "halo-20240313_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20240313_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20240313_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 6,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 20,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 255,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 61,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240313.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240313.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240313.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20240313.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r99",
      "r115",
      "r143"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r92"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240313",
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240313",
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240313",
     "localname": "EquityAwardsOptionsAndStockOutstandingUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Outstanding, Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockReportedValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240313",
     "localname": "EquityAwardsOptionsAndStockReportedValueMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Reported Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240313",
     "localname": "EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockVestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20240313",
     "localname": "EquityAwardsOptionsAndStockVestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Vested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r103"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r174"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r135",
      "r144"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r98",
      "r114",
      "r142"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r94",
      "r110",
      "r138"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r95",
      "r111",
      "r139"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r102",
      "r118",
      "r146"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97",
      "r113",
      "r141"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001159036-24-000024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-24-000024-xbrl.zip
M4$L#!!0    ( ," ;UA5DEQ8BU,! ,9>#@ 1    :&%L;RTR,#(T,#,Q,RYH
M=&WL?>EW&DFR[_?[5]3QO#=CGX,P:+,E=_L=+&%;T]9R);E[YGZY)ZE*(-M%
M%5.+9/JO?Q&1:Q4% ED6A<2\=]L":LDE,M9?1/SR_[Z/0N^&)ZF(HU__T6ZV
M_N'QR(\#$0U^_4?GZNCDY!__[_U__3+,X#*X-$H/Q?=L*^7^KR^&638^?/WZ
M]O:V"9^;@_CFM8A"$?%_?;C\\CI+6)3VXV3$,GCTZ^U6>V^K]79KI_U"/><[
M7/JM\)3;G6:<#%ZW#PX.7M.OYM)>$HK"I?@-7;S=:NW :].,13Y_88=8??6\
M\6VWMEK;6^UM\])45(T.7MA^_:_3+U?^D(_85OG5W _,7?1:O33P [YD1U\X
M9&%<>#Y^\==DQ)M^/,(K=UL[[1T[HUG3;^\XL]*7!UQ4CP)^*(Q"I/'N=OO-
MO+655^@;IC:M>#7^W&,I=W<N*(U%7;S_6OZH+\W3K0%C8W-MGZ4]NE;]X(Y[
M-MD@H=)%AR$#$G[!HZVO5R_>_S+D+'C_RXAGS,-;M_A_<G'SZXNC.,IXE&U=
M3\8P9E]^^O5%QK]GK^E1K]__UW_]UR^9R$+^'G=H2^_,+Z_EE[^\EH_NQ<'D
M_2^!N/'2;!+R7U\$(AV';'(8Q1&' 8COAW@A3^2?(@AX1'_"[V?YB"?"E^__
MGEWR_J\O_"TX*1$;X9.X..Q&\+K)$8PN8>%)%/#OO_')"T\ M?6WME^\;P%9
MMO<.6CO[O[PN/'2)=QS'/EP497(QY*-W7KP_[G[TVKN=^S^W P\-\,$?0S;0
M#]Y]\;[/PI1//?9U<7D2WN<)L"2>5NPJDMMA2B<17NP1TSC,8/B_ODC%:!PB
M'=)WPP3'5=C YO<T@.VE]]F7J'>F<9[0)V(]AVIR-'2<G/Z>TZ[H3R+ SWW!
M$X_&Q"MYY-');\7M*M_\7G]5?/H8EB<.]"?@.DEVS#+^'H_%5JL-_U_?9W\S
MPPSLI>UM8,+V%?(7_5F_Y'5AWOHY>23D&N2P=/K+$6=IGO#WBE$<?KTZUK?K
MG_1GO+]Z2;?KMJ3;BR_I]H\L:7$9=NJV#.W%EZ']<,NP6[=E:"V^#*V'6X:]
MG[T,:C9\@,Q9?@S@9=_'H?!%=LI'/7A%(.!74@]?@ YSV G^O(Z/XM&X\UVD
M+T@F'G9!F&:3SBU+@O1\C/I4VHF"JRSVOUWR<9QD//B=A3F73_SE=>6+%GQ_
M]SOW\TS<\"-8UD&<3.0X\*<+'M_QAM>E&=>5T1;I8/\)T,%YGJ&BC';%U^B&
MIT 2&VJX%S6\>0+4\ F,+Z" D^@"YIW\F[,DW5#%#U'%VR= %;]O".#^!'#P
M! B@@BUL:.(':*+=>@)$<3UDV4<F0AY<PR[Q#"D"M(BC&)0)NG!#'/<CCI_N
MQK@/<<S9B+,X@KTXNW,[5FW&K"DY_'07S!,BA^6MF34EBI_ND'K2QL:B)+JF
MQ/'3W71/Q>9XXG102S]E327'?4V<-26-I^"Z7+4!\L2YQXK\F1@E#JKWXE2&
M+>4._%+ZIAG$(R:B]S#Y&;^8#7)>L;:[LR*_XH_NSO;SV)T5.?U^='=VGL7N
M;*_(^_:CN[/[Y';G=1'3\]K!8KT.Q(V$;>&FB;?[!_UVL+N_%_3[N]M]SO;>
M\+=[;]N]_;W=O5; _A>=9O8>!?4:B6AKR,5@F!WN'C3WQMF[6Q%DP\-VJ_5_
M7]"5[W])QPP6L)<@XDC^;1XS^\>I-^%\ME@H!M&A#PO,$WA\QGHAUQ?TX@3F
MM>7'8<C&*3_4?[S3<#0)%MRBF]Z-6#* L??B+(M'ASCP&YYDPF>A>@F]3_YL
MY]1LR7EEL'Y9H-^L?F["3Z^GOS]XVSQH5?_4:K;I^]?TO$3_J!9T9YR]H'M@
M)K@TO[[8>5&:K!I^>YQY:1R*P/M;B_[W3OV>Q>/#[:D?QRQ _\UARX,;S?M?
MT\)4[;%<*GP67/^N:B-P>/IR&&V<'.IW]8$2M_IL),+)X3^NX4RFWAF_]2[A
M6$7_:*0L2K=2H-V^O# 5?_'#-HQ8?KR5"_$&GD-;IQ:FO8V;\/7LY+I[[%U=
M=ZZ[5]X4:<VCFU4,]ZI[]/7RY/H$QMHY._:Z_SKZW#G[U/6.SD]/3ZZN3L[/
M5CF'UD)S^(.E0R"<+(X:WG'SJ.EMM_9V#V:/VZ&<_4>AG-W%MN+H<_?XZY<N
M8CMK-/C%Z.CB\OQ?_Y94?]H]N_8NOEY>?>W ']?G'M#8-1)2>_<E>U7_(W'^
MT;O^W/6<DV%.1>?HVH.?VP<[NPOMT%MXH6)K6R'OPQO:S>T]O6TB0M7A<$M]
M^=-/SV[E=#^B(>WU)EXVY-XE'X@4D?B9F=^"8_H#YHCS3']L--^7?.V#+L73
MVU/F78#R-O%BV-P$=AB&4HMMCF>N='%IWTZMZUNSJ#.4M^4?]-B[<S3D_C?:
M!S8>)_$X$: S>[WX^^$B]+<W17]R)H^K=1[L-W=V]Y95.G>;>^W=N3KGHD_:
M;N[M5M^Q[)-V=YO;;Q[P4?/GIW3J60JTUH&WQ]^]DE:+>SVU+_%X<1K^\:/;
M*A[=+"A.8_]1IO%01Y$F<Y'P4("UR)*)=Y'$WR?>50:'$>WFF=.<WJVBQ?)$
M=_=@_7;W*([ZTCW#PH;W,4Z\KRGWXC[QWJ-X-!(INF*\\RB<>"]9ZHUY,A)9
M)F7G90[\M+W+MO9?\E<OMU^]*BS-^F_U]Z=TD(]Y7T0"XS6;<_SDN+2SN9U
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M4='A'\9A@.8R#.RB^5D/+1Y&J?<Y'G\3\&_IU73MAV:G*=V 5G1(#[',Z=#
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M4=6Q[]3NJ>:@5/%?EF;YRE'ZO9<E]TKI4FT4 (G_)R_:!OHE:<:  U!1401
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MD,UES2"I[AR6(">U.$]@?&MZN!=&1=3N>#MGE40 ]@B4L[G4BM]<#;) !K*
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M5%$.'05H%"Y0<3.9+ZI[8LKVE4YY=C0]J<S_*9M087X)1RPV$""]G))!KW3
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MGNL<OA3IMT6ZZJR1!,*B7-;EU$5E@\IO>:6Y(G$ 3R&0D#PZG()H**'@>.E
M2_><B-BP0UNNU;OF;-1P0C;VKCG6@:P:)K\7TPVD2LB2E&H PB?;F\M.".$'
M3L1GQ/[$!Q FH<_\$H1!H:.47XSZNNF5,.R)3#^J@QCK8X17$@^EYQ*G@(,7
MJ?- ^A>\)#61K89S0+2ZE:")0K+&\FWRO&"#F 1MG!1N\GFA@:P,^XC$/916
MDS;\;**7BJ8S=Z6H/Y>,C<&=Y$7NP6==@%DJ)5E*_L2^!NQ0MXL"@VQ4%)&S
M<[9"/0H,*Y(;E<K:= I\HV:G7&>RLXR-$A:]W4WO([6Q8=B7H^&"K P A; D
M7AF9DG -@XDT/YT""AI=K#)HIN$L1-TZDD>@'?=Z=91D*#&27<F&5(":RD_#
MCL$MV,.=?T=^C+/%$6YEC+H!4G#$65&)'9O6D,FM8-T3KA5XB^8H0_F/"B9N
M>JKO#]&'3OJ 40_07U\BCR>A?5-!0MGTJ-SSLH+7!&P"L]H*F*27<D5C6_-4
M[@>=24E82@XZ.X..(MODQE$M<$@AZ RAIEON/#S##K*RZXWI.Y$Y89]1' FX
M1I]QQZNO(812S9$L;NL6SVX!.48*0 #TJ#PF<HKT#F?V-GR@-)CR<FAXF.0A
M,"/-9%2O/C?^0,C% G]J.&RWX3*&_\_>MS8UCB1K_Q7%G.D-B# >;'.=CG,B
MW$#/L-L-O$#W[)XO)V2I;&M:ECRZ )Y?_^:EJE22)6.#P<9H(W:W ;M4RLK*
MRLI\\DD&NBG/7XI6X?3H\H].!N4SM+(V+-U@RK $C:RW"/Y@)$]8V J+27MA
M;J=DK77]#WU'Y^7TV NDV%%A^::RAUG?)W9JF9X_:_*E#T)R] LGC;%X2E?T
M@:LLJ3YP:3G9"FF_01.4YX\.+S9F  >2I[HP\9.\['Q><Z?R[.:W@N-_;2[
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MD]Z>('2:T7YG-!(NPG"P1%S5N/<]7P*$[> I64L<0WI0CWU;\V/H@'S&RDH
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MG]8+\1\-^1J%P<C8"<?L18Q]F+<Z<;U(]5A ;XJ4-BY?3331(Y$\R113#Z?
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M__,B(\94VYXUL3VKT*L3>VPFO^2AY-N!/)F6?\>KS<<*3A<P'[UTTK.='UD
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M)6ZSA,P?0ZG(#M!3I#$HUS4%F(*G;$9YW(Q2AU@D\7-,)E89PV+CWV1Q:!&
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MMXJ_C8C8\!J4!IXD.I0Q3'7'EDI'%- Q6C]Y/^*@^SBD&R$,HZY-,"5TW>A
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M/I \1C,W>F87JS*]6)=@:.4B2?*FU"$+TZ"P![$7TS%_N?\MIA)Y!Q\DX4K
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M.PCIUN.*K6TW$=Z3 9D\DH@=/VA*:C"J*NDM*^&H^AB-YBCT_? )9YXP%YN
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M>I"_O-W$O G%]=5=UAT"36VV.C?VHCAG7B V]RCM:)<.%T\OP>(&]#$KC3#
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MV\ L8W0*0P^'PB/YZ@4!/;!B0+N^&R="$KE#UOKDF35751SX$=C]=;P,]U_
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MJ%A8@Q.\H#5$Y]X"38NU2"DIV>/7$E+9&R&5<D).271)'SP?4O;TA4HJ84C
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M)3\&A*0J'M5R1E&QYI!4BIU6:4@6N[3"B)["RYS#YX^S!)@G3$*P>$#.8&G
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M[>W=29%[(Y"*"=[SPU;;]X 301D?]/RKRT/4\7=W-C:V/R!T\^6\[QT(4A7
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M9<4+Y(\>U[TDYV#_24"O<5[!N\LPU\O?E>X>D_H'M[/Q"U!+ P04    " #
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M45#4C:4U_Q; A1?V\<.G-$FX?.E,F^*X:;\_TYS:5J ?#B%XT<(_@<X,^"X
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MA(K4[50(;EL1KV0YM,K81XK7*R1=77G"#7>>P=&JN_N59'#T%5!+ P04
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MX0%]5]NL-'-I?D0TZ5M^*Y\%(''R?[T#KCK&X3XY?NC49]U/MIS_X][SVP>
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M"_ ^ZQT4_!M['SPA^TRT_F>G_QIG[H[Q#G*WQ7IY7[(^8O:O ?_A^#\/.X3
M"F-.AU_V-M/]5^=_=_2OGHZ^?B'>A]TON0=X>N\ST]'4,S+4-]#YUYC__OS?
M#M,V^ZW$;_G[8=I_/TSG]S!];0-M@[\?IO.O81:XR]C@T"!O<RSFLG= L/N?
MR[;O?P#]VV[_FD)L0$B0>W#(WPS\Z]1?G0\'^?GXA@1X!P?_3?=_=_)OK$GK
M']X(M_[R7=B1%?\?D#60-9 UD#60-9 UD#60-9 UD#60-9 UD#60-9 UD#60
M-9 UD#60-9 UD#60-9 UD#60-9 UD#60-9 UD#60-9 UD#60-9 UD#60-9 U
MD#60-9 UD#60-9 UD#60-9!_R;_^+X]W@)>I:I@JRNS/MVWP_?>R[J_]NG\*
M/_]Z_M\"M^#&^M^R[L_76PC\;O[YMHV_QJY;S[_NW[K\I^3?WK91Q/>6GT]I
M[6T;_Q]XVP:7J_8\#OCGMAMA7H>;L#D:OOYJ4C9P:O>V(=<S+C\#+K[[TGS"
MZJ1!R*NDM/67^N_X1@4;!/G/YS!S>,"-?+8HYTGH@%VE@NS["JB0(7CTT=..
MQ<@-JZ:HZM6]T-?B3YVN7C4?5;7[+()^8)3LMV\ZB#IS7?G%HX;AD<IGU7+R
M$]U('? 6:&R,8&^/F]%W\F#834](.)N\QY1E6$+WF/EGF\"Q%_:?8Q/1J[^.
M6Y+_(%] ]0L/M<R@J:^72+=61VN<7Z;?(V[!F;O>NL1&4X=55XO+BS=3[S+3
MI55B%VYO%@4B+QDCLC443426Z@E%7INM@9"I@\(6TL^O;=JM8VJA 4B<\E*X
M>:J5[\]#:O\56Y,$8&]]KUU9KPBPM]@Q'A'1*CB&9$M0F+&=/, '[$VJD2'?
M(F6WE_L-1QY#Q@Q*=FI0&C*LDU>-7I25)V6JQ'5UC=>JL@L?T99;&,_TWML&
MJ]NI%#;I#08W:JVN3*T6P#/?#Z'.=(/>/&#35!]^0P12 '_J74?QKXT?SO4/
M]$P:7]+A 4-GEO)0S"7T-S2[],3^X[-/!; #HI_M+BV10CD99B90+A,+?1KB
M 7%FTF5E=\;37_B3)E+;:$BQB6#;A,-UYQFCC=M1BW78/>@5'S<)2Q[P<&1H
MH<FE/3]@*8*#LGY;_.%SA];<\[?OWI?&M'PH3_8K?^@1PTUO%5S=.EZ6G?HI
M:R)]D*ASOG?R:H@A,TV[Y*S3A=O>"3Q@2^=SD:!M=]X2"!/K+Y0O4*UN!92+
MT;N_#(I]3&LB5F>*MBUN5%DP:75NKI/U".,!_6;%(^@BJQE_NB[3M;6YF&%3
MV\5,OU5;:)9 ==4#?:%2M+=H,6:OU?>@T_6_&D:K<A2\<@\B'3 G+8=O"/+O
MW_"!)(T_2$=5S^RQ#:XWTZ:W1.G%GMC9B;<M<!Y/]P _[YV]EU1'3B/UH;C"
M.QG]-*_2=,/*"'5TE)G8W8?/._ ?EEKD!NLJ[S?HU[Q;.3N41"V^TR V-G.8
MO*O<=3A)#C?G^*$;'TPC;\&5.G].^?ZQR\0J;\#?^446M\Q: P ]N?O@!7O"
MK1Y$?(C F \34O)<K;X'0BZ'.\L=_+3:YKOZ;+#LVVX.ANQMYDQ-JY"H&@7C
MQ\HKML:X;8QDNQQ)]JTWYD@=W<+02M)ER)2ERPZ#>$ XTRZ*(L(^0QM/1A>>
MG[Q20G:G+^5%I4C6Y0:/]CVK]_-J L!S%>(P=#:WVDVS++&N?=BVY%Z8[LK1
MBEWTYG?41E?*TDKPI9+ZJ5^.?5P1Z,$0,K;,>0J-8'M30>GQF:J+;MN[\T/[
M5<UN^*K<]9%D?V.CX*OM(+0J[(A6)\6BMU0@<1N,',">$"@ [_+&8D;GQ>5^
M?AYP?N1N1'?[G]!J[$-0V*M:&CJ&!Y2X%5.QXL[U):(.U631V:(#M!X><#8@
MQ64!G]4N_11!F7=]:S[=XL8O!A$G3MT8N^.ED*-XH6(OQ$=%]?-39[.WQW -
M<>W4^KHDP;TZ%ICA)V;")$'\H7;\JY849H+!?I7"<NMC5LD[HX^6MZ>$=E7\
MD(U5V3<,?6H52/\O\&OU9 FO5;JI+T)=;'YD:[W4L^L^)S8Z]!>H-YOMQ-O1
MK:H00OYFQE \+1)162%&7\IA1A?34&*3C/'5LQGB)8:V>C<WHQM/D(WN\B7[
M\O^XS%K>]K4>J:D-M9G6[-GLG6@X>:9G-^H)J((NB6'+Y;_T,S0F1J$\YOBJ
M:0<RSKTL1$D15/J:L$^;;E@]R<9%JL1-'K_Q<C=V)&8]8;[-'MVB6@="N\DS
M5,;L["\P%BQJJ=T]$U!QKLAN$Q2'CAF4LN<!)DW1&4Q_!QZ R7J*6)PW9-YZ
M<);6>WO2XEO@:@<U/NIKB*E0':6-W!!Q JIFN!SO<'1JKU#!S5>?*\UHB7$H
M9%S)$E@4!UOL#(RN=L^@V5O;N<(Y+"MN,U>GM5R598%KK"'*$S9,.M^1N4+2
MBL>^Z"(H07L&_38U@9ZY#1FY1-5 E'=Y,M:P0:Q^)VGU&\"=@>?.E$ZJM>.'
M,JAC"7H?])-$<23K-,O.O +'74<OB'(+3N2J@%/*]XXF[U:V6K]%%%2A%,/(
M"&84Q$\3=7"@^T2'4N+(PB,?DUUE:PB2;[D=W47]X(KGYMR<>E9'LD)%B!@G
M38X[Q3D#NBF(,&*BV2 51.#:*_N*$S]3L9*^)8-*=.[G'-NQGLFNL+NU@?Z!
M(D_:CKY(N+ZHW_F07:.N]"+KI9 (RAG@ GKH*% 2;Y&+1$#!U+ :#4_T.7QI
M6Q%1\.+VTAMVN*SX)=(@#X!4#=GB"S5F@@RS*-9!PH\^3 4Q=US\9>Z0773;
MP[G1]H+#I2EO+C[D? ^JK7G;;\'ZFCT_:"YKJ81L52LJ=EPXU39H2!".?3 U
MK\K=!+(B$+W]54WT".J5+%G\!49%BK(=>+$?_<7XTJ"7Y<I1'I#6<.6[AA5=
MZD[,"W^U#> ,BP<('*+S@.G5LK0J[(TVO\'=4$/A='I!SH[M%?+0E<U@-U_-
M<F9JUG+@TGVZ4MI*,*,^B>W*D*V5(=UAAY*F%-08;J7!S 0[Y\X"PD!8B.#!
MIY>5^)-4N4[=AN'AX6"HZ<#TLJ%CF$Y#6&AHL"'1Y+TMM^S<RU>58JISEC2<
M:#J0D$2G!Z_$39I(#H';V!8,@Z2AEO4X\#3#,"YTBOC.3\;L 6;GZ&CCDDKU
MXA(/.#/2[4+W'Z(D<DUQ+ L(0^\_\K&+?:; EE74/](SD<H#YMM6)^$\A-EN
M[8U<-2"_!7OJF1*0)VLGSD M9 J'MV!HG2N^7>[*X#]9<@@,H7SRVSL=&(6]
MH'(^UHJB*&U2?0,PV\!) H<2*R3H1<X^">2+Z$*HOF;P=-A9'B Z7:!-U9"Q
M)5]9I:*&YT_B[WHD-98(.&$^2EWDU-&7HXO0&_V<"=>I3[8?:]4SU>G%Z''4
M+=_%V[9/>\)W)5E^4$EQ4?+'^]W*<I)&"C?;#W.&&DK#+O=NN+;W#SDOG\G=
M?H*'%K.?KO^RB'R@J=WJ2?]WO.O_>M.[D/OSIX4?5J/F^[MZ"8SRMB$1D5;!
M)AY0+#BC3\]E'H&,:.0$LE2Y^;9X*DK8!9_*I'-RG!BBBZR*AI<3]#&=GRVJ
MWP! [7NR7J"52A1[#AQZAJ*?HB2BZ">U8K=.<O>59U21-Q6Y6EH3Y-@[?I"\
MN=7T#D^S,YW#8.,,(\D,TU'N1=RCYLGIC"AE;W/@;I)\P^TG%\&L)(8MF__3
MFBY(U7P=2B5&E[D^3N \H44\O+!O4D$IC7NU,51U"P]H.>"D]$7<QO#1<BE;
MO)0KI![.R#I"GYOA8WGT7^3*0*&O\YS)-RHV'USP(^QB%!<$RW>10H12Z[[!
M" X2J D'"\.,,6?NW'> &\B59DM 9$:&4\I!R(9>7<\#Q)<^*"V\:&.+4N7-
M:QW?6O$ TPN)?;M-/GR>ZN:J$:K@C(2L!#>3XRMV$YJ14B9;J2XXPH\PFBFZ
MTO''^%5G'M ^VIKTK41AGD9N)U+M*I-N$=>;:.5 ZE3#:R9:].4J9R^7O8O(
M31-B?MO$(EN]YH?M,@]+7+#BC-P4#^[ZE.]YI#TT5W8 =:IMNEC6]G"7BWJC
M2X]29M<OHRS?3"-/$^.CTN^%QIX-QP$\0'G;YCS[ZR*;-[U=N84T<U06E-Y
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MT^Z>K-RU?\0=<ER K4WP0,%+E"<QZN5/Q/1+SK-+W$$P?H:_ND*9A>*:L]S
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MJIX3@4!71MT3_Y)JJF,UR]]5T(H^N0)^Y'9\B-.53'_8>?2V4O(E/9^&>1Z
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MBUWWPW79T6<Z#?X[>$!!:\-!))JM#7VDMPS;13]CI%61Y7!@O8+L1U!K9E6
M!_2)YCW^)?O*;@XSR@->.EC)1;655S-C.04$04*C<I4P(ZNF+R;&+C'QJ<G^
MO2;ZD31D"4R<.4DSX2R]4^$XXULY.F#+1>YEP@ZV*><I.)1,*4+$E'L/M6PY
MC\NBDN*\FVZMQ/DC-K,/M0]E<-3-NV90G5:1(D%>8MS<9O%J'J"A%+^\[ B=
M86F"E8>Y4GAYJ'"X1:!QF+(Y07SX'/UT,)3E1!^MCU'IX-9OSO?1;B=AV+WN
M']N&2^_;_/)PD3:IT#DJ")M%]0#9';NZ.U,9;@:2P'E])'T9V^/"C?.)Y0'T
MG_X4=KPKDFV<PH25?B[( QY9U:'9I:1J+6BW716EUY.*K6D1(K2@WH]5'?)F
M[!F<'9RK*ZL@#J/$<8TGM\NDS181-SOW#5+.FS,?X<<#LCG=3UB-3K0I30!U
MN0A>D3T^TZ%O_(R9GU]"U76.JZJWV@:QXA>9%!']B4MZB!([IHM=L0T3/;#2
MQIU$.:^V#^74:T53B@RO37-WLO=TV\6:J$:\^NFG'JAQIP\S8FCP/CS82C_O
MWFU/_,HIH(?3\0-U6'T8W4OA;F11$3'$=\3;/, G2<JYYT\>3Y!*'J818S6&
M$\,]NW8E-;]E[?W &;EZI,(NA;CB+Y*<M/22;(@:NL<#)/7GKJ.+4+5:/<NT
M T\T0;&+:?<FKF)JR..K8)P>TEC^L)HE.#K[31KQ!%X<L!#SV9=_]?1+74RC
MX4!.]U@:6X+,A&<T.I*3:N(3_ *M3TS@*B.@LYD(WYWS6I=&.[(R6(=7=5#A
MTD7OHN>=LN5WL0SS@:N&E2W]:<Q@B <PD">A<_2,VCYRO(E#MK/;Q;!?_557
MGU3<%OA\O[5:HYMY\VTL_OV"Q>AC[D)SO&0V'<MLA?@8PS2K.((X7I_AEIT/
M#5?V><^^*_!+,]O>H8>[-+,XQ7(UF+3X^"%N_TAM;8=RU,_N*C3=4JMWC"L)
MQV3YX.'$S^XC4,:P*0_H733\$+_=@(!LWY4J!4X1^V8K.@TY^M&RTNKTJ.K,
MO5!E%K>5!TB7(^B6$5_Q&$:+6Y?91K F;T7F1=?5^KB]<[OBVK K5Q;(A=0X
M/W#TOH/-062[5KT6M&?[= I=_7P%O21K6-Z3MOWVXJ<43)XON&G1B7VD[Q*Q
M7J3O?J'+!/</>8_$D49DRB,@#WD313]+[%F@M<1JX T-R+266V6IST(T]#Z:
MJ8\;E&U."U?YC**Y8T*#_6"RB0VR.!\S/0?'P+N<](IMD(L=D388A:Q+B@W;
MQ@THSO5/,SSK)MGNE<'!%#QY6:L2*/5\XM? 2N%6H;OAY^;K;X*5!\&A-.*&
M2UP$]&EX^_0RE0PY#JI#P<_/X\AN]#HB&!I!;9'TNQ*XTA<;+>UUM]_5W%_B
M??4(=]).]9LV8:'Y#O^RT\_#;V5?INM'-2Z8+&C-EH0NJ"_8T,;8DD0F"K(K
M<,,%P2Y#I$7GYK0P,>9<R0O7-W_,[K/^A9FO>Q8<C/$/A/D79F>ZV54F3%9O
MD8OJ9XQ8-FPY",X#ZU>AB(B@],1W-/4$_M,,?-K\QIWTQ]K5^@5IH7I@16+]
MB3B-P^?(8_DOMJ52%K^A^UMNP+Y]3*M7EIH4C=EK@AYJ@<Z;:41@H<=08;WA
M=DOACSHF+>\GM!N9+K[L[P^C=Z9Q,ZP/R@M^04-[$-,Y#!Y04V(FTH8WIZ%B
M!M6[-+L:#[9R5?W.5BA@KOAYB9EC_4.QP8%^O[[CR7MV>R>>*Z>.1D^@LQZP
M)V"KLN8!0^F4300IMFIG!8H-M)%,9/#2H5C51+R80FYHKF]8ZO:TD[T9,Z@9
M'6N-HK>->KN<REM4JKR4O\'<.WQU-ZSP9VB%ADB",UQ:=#%J^Z2C##F>*S_5
M#0JS+?+<;,8&IU"]/\X-^BWKVL#.N).U^9F/1"'8Z/<L]<0BW^J.O:_78_6^
MWZV6(W@ECG'.$(+8,,6[\89;#PHN'6C:;"<SA10OSMV8KCZ#HEY)0L922\"5
M,<ZSO26K^!@X6S6@,XGTTW9]RS1$#1BWA5"#!KP[O!/'3A?2YVJD]38>[<1C
M\MQL$0^H7[W-:_/,0E 7D?-M:(/=8*A$!;8=76C(%EL8LJO^S&_;66%Z+ND.
M*!:P(W'NU-LT^[*V"N3X*3QYO*3DG;5<6J;C*ME@;CDH:<4=>0SHIH^QM^4P
M3;OUI?+T;;6&45$:3^BKY-OXK>ZF-\$YT.>BHP."M8S.!D4(^_"Z4"<U RN-
M5V<T7Q].$OU9FJJUJ/Y.NRCE\^>.(^$E\TDKHWJ!#>UQ*ZKU2#H\33U9=:LJ
MJT:0;@YT>*1>\3U#\(9^[MSFJ72O!'@./<TNW6W@SG0X6,%UU@JI1BL.)5QA
M E8J5Z @V&6K*5O=H$(J^HX^8E<7;9C#;\,H?JP;WNTFSQ#( S\F_I)Z^=T0
M9'9IP4'U(+)KI^0OHE#%+LAS6+4:)8 _1?>N/H_SA\ODBL\O];(NT<,;65-^
MY(D\\=ON]Z\D2ZNWC:\#PI0>BX@1OU7 U?>->&Y]NM5,+4L=MSP464OS,U,J
MVP(EP55BK*;D"UO$^?:,YK?))[BG<YJ*,U[/8W?5M\2Q<M\ QJ7?#IS<>.J-
MSNFQQR%/$31^[D;8E 4 J!(VJ4@&,0[ER0/Z7:B&244M,5B:4?%G31MAM251
ME\IE1V19ZMP)SEAOJ.BNN89H]*(1&*H2;(U,]TK6Y]["P";] 44_GI&OH>_)
M.M[3]X4>GN072%^NU;YX5P[,96DQL4_()>NZQ^MKD3>(&ROTQAOANXV#R]KR
MC0QURT2TL:EJO<*V=K9==K4JFYDH^_#%)LY[(U)&40NTBSR-?#;8/WD%^3[L
MBUX'QFMA)L '<LT:$ Y'C3VO5U$E7@6@@GJNL"Z5G&@<2T^:5F?IX4,X>29.
M"YR[4Y=]<^FE5+>,_N^=)N9PW:'@]B&S5S=]U:ZZKWXFF-Y(3:L#^ZR8GZ#;
M0TYDJAAD58"+LH4$Z:1#+-5JM$!]3E])OD8G]_,5E8XE]3EU.Z?R5@S&8ZOK
MS6ASE5-6JZ*P'@A?@F1[7@A*% *M6T,2C!%*C;8_IG>T[YW.0LXWJWGR;26>
M4)^'[Q!D'&%KPNOGSVTU+&D3Z#3Q]'S)-FKWT%E!!'(*WYSK=1.HSTZY* ZO
M@@S  XQ$G9EC]AWZPOVOCR^']=U<3G/X&G0A^2RJG-1&@E3LIHM59\ZQ@M@*
M]-!9(G-. &=XE@?<>L9 &/  O^)XVU;O: 9F5I ]7U;!;7YKUG>=]#V5U6;$
MY0&H!! +TC&.TZ]YP"8>P QGC,T<(O6N7)VKQP1SQ2@;;$P4&S!/(8(?YE?Z
MMDG1P>?=-^Q_^IWMX./HJ=CW]=>*:VZ32M5N7I?PV1^NW3:YPV:DA1(FGN,0
MS?@FZ8V,3;Y>[QF4I.E=".1U'(JAWKZB.'EDZZ_&M@ZP_3PG8T8+4EN>,7I%
M^(XNS/Q(@DZ-*D)1P\(];.FAVR-PC=V;MOU>T\Y.>A+W">;9A]1]8-BO_ \F
M,EP=S=G94.F .6Q  ;;8]K"?9L%LP86%L51K<K>U'F6AZYIT<&#8J\;@R(BP
MP @P4B_-X>=Y&V;\;3BUA:3 F<+4?_4://\&W(9AZEBU/Z5/N;;L<E(=4GR&
M4#GT:M:#!QQMPYM*$!D,Z4E4D4K"A8GO!LR;D0OH:.0[U>FF-X0.(K)\)WWN
MZT?TQG,G3,P9L@[7\>1ISJZVHX1.Q$-49T,8ZY/3.SA@:-XASW\CEV)4K=H7
MY0\<;ROZY!(AJGNL,+&J^5N;-A:#$=&.]4S<_^7+T6Y^_O;K!V7CW@A*3T'%
MFJ[!5<,FZZZ>Q%WF:VG\(CE"D3+;AT,,8:^'ML2BQ?0;31'5Z9*YKK#L7]B)
M)TP.#NZ=30T_VB]GG_#=%L"[PBMQ$NK-82MS4LK#7LB^2JNA2&JH0('4 =/'
M >4R=XZ7W7_\>#JN<2;&5"1?(M)+$OH(>_]]3DH =Q_>IQ :H,UH'H+=8G..
M//.!?HTH$]P*Q:$&G:P4C-:U/@QX:9H=UVML1+I<!!DR*-Q-_8R*;MI<DL82
M\1;Z/6Q]+U)LZ/;EF+(G ]?OX:'%AR(7=L]JCL1&OF%Q3KN=C%^F^,Q/K6Z!
MO.G=E6C!<LFG>%,H\GGU4\BN^HIZSH1SZ'-\7!3VX;QUYV@JVN#<SON/5)+/
M225;J_!WW!<X<T;JS'F^"70FBGZ&O+(/G41<5N<!D][4;QR$O& ;V00UE(N>
M_X.,1,TZ\H".QNK[?"MPB;8^CP.3W@O8/G/8SF,2S73Q^CS@9F.M,[I.P[S*
MP)C$WI6I1*?T+D)%R,UN%MB17K?^VGN:S\)8[5M2ECM78>:Q.8=SG0>,WP!_
MG62DP:L[-8:&=G2STY-J$*S]&,]_/""I!7X_;JF&?>H/<%61N'+?Q)L'-%YE
M'X"*Z3'4N2])T!Y*)3&:O*G<&+][Z#-R.*Q:.$,4R8+-SGG^17F'GFQC%C.W
MU_O1@DK;X_ ''#_'^166"_CM@AG,1GN](3L>D(4W/*C0"Z_Q3YC0RA.G1X=P
M%Q[H1?23M^ ^G2S5(?R:I;6P%)K;T"Q/R5_/>,#U!RQ)UDZV42M7@MM$7L\6
M?=KOTM\[@=H<\BFWOG04BYW#>,(!AL3"A(:&:G&*28UVD*9A5:1-#5+$#,%&
MMV-&TKNIE-M+"!'<'9?J[]M6%Z\$.[O"KG3\^<>V(^BE[E-Q%7!I?N,JF]!:
M@>(V4D2+;62_]M<J"+;F<>4A9G7SNMGVDVT:[H6LTY_9G[[2XF:5$U,>KM;N
M!")_6$B<%)S_!&NC2]]P>P@+QX1J5X<CUQ73:&=^/X7VO])JJ70+BRHEZ3WR
M0BUU^/Y^:.YZ(9D<20X 5W1)?2[<KX.P];[0<5RXQ0IA![=R?S^Y,L=KO,9Y
MS%).T[NK21(X+/5$4F[_=]684]RFKHK>5S;;]B>C2B9E;MH?VY^JYG'7RW$Q
M@A7, QJ>$-HH3,NE%LZ.Y&LH+?)0S/+8<4B9=>1BOEC*M().8<6\H*A62E:3
M81I: X:1+=?&,*R811"1$5,7!%["$:NXXATF]IZ!E_$K=>](%Q5L?Z^ J\GK
M8BGRS'Q%'CQ+TOWF$?2(8<Z#JHWYL^QP=VQ0#M<YK\^KPF>LK,(,[G %2D7W
M##/9C.XOV-NZ3Y0HM6F.1"'+9Z\(-,2,$/;9)_I2=T:B1P>>M <F O8XN,AZ
M^3Q.C7\( >U.JW:5I:&GW1F9IH>%?3I,1+/J&:K5I?-699$Z"U8IS:E'(T6Z
M\D'_Q?+D"CA1W%#$?5L^Q\D@*$*'9\^-V0FP73ZD'-?A :\+2SJ*^G??V<>*
M?"G; ,[,?H[@;NIES!V%K%F[<6E?&G"""6:P"]6*4:>$LFNJ[1;<TUP^WP=;
M=F RSC-8 \<4BAM^5T\5LJYX?<X]378@S5XAE;C5Q.<5;K9OS#[=U$PH)/Z
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MFPI$*I+===Y,R8>YC]@[0>"Q)$UH^;HHIRUS!Z(SS&W\'V5M-J(^E>73:8N
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M,@C>WK$E?U&I\WYJN2J!0W,YVA-HZ.%_H)5>1MIEX<L_OE)S0'TWO:S84DR
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ME^ANJJL_0O =SA%=;K$8K%K=W>K-H(%^%O/_,A>=(P2YQ7LY_C27X8!?5*V
M*%2>AI2T0\];;<SX<W5EP_O+AI>X%Q/<YTK-<H4HX#/#PQ_'=IPKO8L\[.2A
M>55NHOI@PO2XMFQ)>G][/G?25:1&EY[JGFA-^%4O+9@[Q6]_36><T"7"S=43
M/B2,?"O#;2>\WPX_)I\L5CAW3CT9WMEMEL[5,MO13B\U@=R()X,W3@K"NNR(
M=-;ZZQ.7(X>[(*?6:E0&@2G/-(4UW%0S'ZAA(&X@K"QA[;0T-3T#?*)$I5U]
MF9_2E+T?-S*2]RB94B"9A1T.M.FG!1!L6O+K)M'<ZQA(%R(XD[[0. I8!N5<
MX'F*U-DA;D2R#Y=M[]B0V^35\! ]6<*'%UM*1F@<*.T2E<"2>M7@"5'"R*YS
MOV)([URV#<:FQ'YFKE$F><?W7=#7"<%$U]T[?+W(2V,$^XAYSF;-?+?;9N<F
MB4&OAV=U%/3<-*L]"KPCS-R6S(6+%,.QGG97E:ZA"):'2AW*4B-M4F#9T(B[
M#E,LZY%WPZ4H<NX.=6B3!NXWUXSER+=_J7S]JF <TQZ,]ST[M+Z'=Y2M)^;M
MJS)2M,-A"_N7^YG?)"N-( ,'(%%7VPLY5@33;ZG6J=.H&7@1M3M:9;:<?\AI
MC[&X.3#F*OZ0%:X$SC-E&U]H$ET+R5%:C!777JE WEMWO1NGU:3$*CMU^/A-
M=@9\C7G_6L/1TOP=RQES3RX2%' K(J]WZ5/Y4X,;[O[B@2''J=E[G]E2@Z5*
M14 AY4_KB[2\F" Q:XN\1Q8^>@:#7T^7VVIB!\6A]5';ARPFT1^!J)YJVV;#
MA2N)BZFR!H8:Q57(NFBY5._"RZI'5)N>,1&UX=TD7K57MLR7ZBL5G9*8!!X=
MB\MG1TR?4$"O@W;1(F--J'[INIJ#D[8TMP;RL88!\?$31\ZEQGK)T"SERS1D
M0B(*(*[8H\B/R;:SG4[.!<?ZP;>JH/NMP691U1OJ69'A(\$,!Z*"A>\J"S7'
MV2+]9(&"[:U^C^D1HN]&>0<O%48@R6N@*8-;)TKG9]5"H9"-V-ZHJ[T4\ +!
M@6\>"K@G:6=$6VCFBAZ.'.D&B?*)"9)5^(BH2-:@*RWSZP].7Q)M;N&IM,,,
MI HVTJ,LU2"XE::VW4HH/=@CS_B2 &^CL"22-MXU)-?>W=T&YP)IRJY'_JRJ
M][O E>:3W1@6< ;;#HEZ'U/E>'9V:30ZNO:0*,L _PHA[=W49YZX#V.L':[9
M*+\W9@JRF>IK?" W"_A[GE$?Z 5ZM(5TN=V=.?AF/A51WDCE3$Y6%IB,T7.T
M@Y0O]WZ<9E0Z*&&R<IV9W&YK! 6TBT7=.2\'$TU_4I\HM[V/ X^XPJ.CKJ:F
M]E0]42+NS3_WA2D+K6J53Q (M>]K?NQ;HP'V0E=.*HC.WT]O"E?CB_<VU$;>
M5R,<8PLW?8$1J<1<]N02-V0%"FTU'4O/&@N_@>VO-^)?+_)""CE#Z#7)5:;3
M=-_I2XNO!6-F8JI'ZH%[RN[>P\JVL6,+V[QF N^\]VP])$NKCCR2]26^5+#@
M=\ZP1K(!ZY&OP\VF9X9O< -FG'3S\DH/SAF4*@^N^;GX +&RFCMJ71^7=A/U
M">7-3GO8((0*I>Y>G:--%L)NM^7=R::&,^=D* <U]Y^+@!"6#B52I@-0*+)4
MS&73J7N@24=/(BEI$W%3SZD[R5,@K@\1+%#[0D2NP>.M80AR,R:1]H2L>NE]
M383*X.RV_A,NNDBWU*]31NI&HKJT[T_VM&AYJI##S0V'S>*%Z2_$REJVL6NL
M<SXPBU"[]BZI6M[%.2VIF.Z$D$0:/+HUX% 33^RO-+>1_DT@3Z5L*@S9NK?5
MP%_R;C4V8+.LH"(6X:,81>K> ;Y)<9M3ZCMCL5Z\?+71,B#?OOF<_8._@=B<
MJ$/$)A5M,NDJZ-M4-PH(A.K,/OWR8ZZ41VNZ<X5FY?9P)5;1('_,GG[RZSR.
M5^K8?#U9 =\6H3FB@XHMC304GE VQ0;STA0#3\2-PNS0#?&'H>Q"9UW:4IDQ
M'D4ZLIW%%V_JED5SEW-*[JN$JRUO6RCKVNQU[=R9IY_@XIJN?#G5ENITJ2Y_
M'EAA&:[Q<(2/B*JVILM7$[-A)22WI@5!*&]<*//]Z5Z_ZB@;55B_E<"\FP/)
M#<2&+@O":@A<[4NW!3XX<K7.L9TSCXK*=KH8GYS')ZCR:*PM8RSWW0\110&M
M[S-7%*9?)K7C'@UGEDYF[F^ ,X*EO9;VB+1,?)J&#.$\]^Q@!5N:Y :DM^?[
M1VN*3(W/GE4$H #O<DBZ[7=O\/Y)QHUJJR!0MT1@F[3?I?I)641>K$UU;="L
M#WTX]V%.TFW.*7V_OO",0^5C#?B0)!)V@*Q& ;2N]P>%=NEO'YS$97[Q^P&Z
M;5G@VE"VH+2?9.%P;@]F.TYAN:R"4%E+Y5!"[CPWD"3DZE_PC;AV<P8FK#A#
M=KU@GQH)'=9R-Y,9V[<1Z'<V'$D6YH$_5[14UNZ)$+&.6 C*45H(!7AXQ)1E
M2(N&_U5^XS_U)Z#O"U=*4Q*Y1Z?61ZX1TT[I#5OA1Z&QH0!+=O1'-:9W@,O]
M-V2A/^ .2Q['#8M5PZMO/_>URL.L=M8PY)0SQ*_4;8,/I#0Y<Q5=F1NC7W4S
MLA4K%=H&'& VZ+/%FWW^WLGA<WW\U 9^29LNX]$$EYL4)&/]8)X:]2QZ-+//
M(52I"OYPLFURT-K8-E.L.^IJ;35GBQ>":;?,7?'0H#,L*5N2S.L]I_&\DX!]
MP5GNJYPCP4"OI0HT(H2RJGF0%"2MD-N]6[K+(/R"^KB!2<&@F"'ENXG,2.Q>
M=)Q*ZFPCTG[54I/T3'SH'CCK$X)EM8(S.ZG0ZYDNDH+EL@DI*SG?K>,S+3#
M9_%^/U\#_Y)@M01BYWZDA0*B?=-L;C?R!-N!]N01[,.< M/L.-.F%CCU*"!?
M.1"I]CK*6-V &KF#M7FR!G\:M?)A=7X_X#Q'8TU[TI7!Y1&[?-0Y$?[E9$)2
MQ^Q]:JK^U-3\8VSZS$].ES [&<' 7*@E,D\.2UH<ZK96%&.ZH$>DU/N]IM^^
M,T=LS_"\5M$*('WP J !=A1D["AZQ!A=>F[[UZCYA[(4LZ!9*O"OD!5OER*]
M;]^G'F'/FT*;HKM=7)8O,E1B(C,NI.#*.3J;CN[:5#8,VE7Q<CR1XEW!XJ_P
MQ\P4+[:]W ;T#IZE#+3$ZJZ7W.SHC1',C4Z6^-&%\49T*;-S0].X_7*VUL_-
MRM#+[.8 HC?9_A:?;%' X?UK<LS##KVP2.^YD9K4X2-+I^)#"^&"@MD*C:-[
ME0>^!1996TGD8S+>D_P<0C!,GA+V.W+2?G[M<,O!@ I]O;+O408!ZHTZ<LY5
M.@;<=R(?W/2K=X5;JNVWEK@M)!_K'.1-Z[Q5M;7N>AN,*VHSZS1SLIJ, JY'
M5A0J<0Z6^5@1;)G8T D]_?0JLBS-\YBVI?A.:<HL"M!O2X[5?+O4- ;?@XW"
M&A0Z?1DG!6\Z=A 7Y5U^#8>AR8?I;40239UQAA6D6RP/43:9E+_!ETM^]VUI
MJU>6'>=+@C1:\4GU](6;^IQRSQ(/]?BN'P\_MK,@QDV*6OIAA@+*?2P'8,'-
MTAYF!;HSEF2QEJ?$S>]6GD3$+ZV(8 V[%H LBVKV(.=6"4K3Q<\YQ9$I!F57
MR<*MS# . 1_+.9TNKP&A54:=O$#9$T?/<M[IDY+]\ZI=HFOS\NX+4"_YJ3$J
M8/:>B&H-@?,0S")?]YQ;M7D$*NWD8CD5F>- 7:YA'_*0^(W(D--4N9Z[Z-I!
ME66V>;>?2X:.=UI-\775\%<G@SX#3'?[9@WJUBKZ'[YT8)TUJ&VUV=JLX7!G
M4!D7E+R_ [7H.KNE+R'NS[9/ZOZ#<!DFK]E*,5(NH*#SK3Q#6)B\2O=>>%S@
M*Q["!VNA4^6-3Y_>4' :[BQBDU>RSPYE?V2?'?.>+;8+$(OU5#>%A3CK<" *
M7D)5Q JC^7T?I3Q_*EYE*M*K)7XW7H/)Y8#[0=U0[!FY'#)9)@J!3QHEW"UZ
M'\+];&1*5A+_LSPZGCQ 0M]6"N2<1FH9VQ]<&;@69(_HVR$:EA"J2(GC^:JB
M]<<88*V;H/U0=Y@JVN(C*Y<_; 8MM!V34A1==D((=!BV(@TZ"Y@/*]>%A2<3
MK5*;"E_15GTFOT#G7)'-XA;14Z%/YZ)+I'YFA#!)F_U\S&GH374M^4UTL-F4
M_TDQ?=$4TTN+Z_J>0,$% 9YHY9TI5L^/:SU*YK\X'QM8MQZ?1)@X>_)02<(#
M2#*"+0K./,<X7C]R#(X_-J3JC^IZI>%BE6WA*G)U/]WJ!JBKD@6<J=TB5UW&
M'0IQ)#(,2>I5F7MW!&%8O%]RMB+DD)'))Q?5OYKE+32Q]TVHNMQ.\CG^%X@0
M?0M]J%0)[H$00M-'-O5\.JE$A/Q<^97-T^["&0Y$>LQ3%# O 9J$-H-_</++
MJ%LE*#Y<B+KLRZ8P.'NY!M+>9/G)C/7&%1D".CMT1R*SZ3DL24G8(M\08"C(
MD#9,_JL#V'\4S3G.YL:/^WF( 3]Z9VEH4K'_)^)S3,5G>?WDS,,A?0^YE#Y4
MRW@C"BR3)N]FZVL-,$\)^S^7/Q)=]W'2&SJ=CT*G&$=C$5F21-'$)]$P&@F3
MUZWDA^-'%J^5"UMQ(9Q*3XK/A$]=K5+["^E^P0,L$]+!O*2HA'RHW1L;7$P5
M!#[?#%<+LPL4NJHSV(Q[JL0H0V$P'J?MI5UU;GB6ZF/4W(IGX%4YK.>^U5F;
M?+.PM&P#KWKM  M49C3[ZTY"VB\["2B ;0QZ[K8P;4T.C5U IRK,QQ2D4*OL
MC9^0R+1!0R+F)R0XWR7NT*WT*+GF;!1UH( .KT4]A0C0HPLEV=L2]7!9')#9
M>4@Q"BB-__YAXXC1'6T:OI;'H2R7S9G=PA>X$\S<BR_MQAX-P!9JR[S;H>E.
M'IL.K:H7E:0%5OM-LL'75KU* F9L\=JRAK;TRD@FR6(W''/\.LL\[+:*0JQ^
M[!%]7_HRFF4D_H4@\Y+,2I_B7IUBX@&C F+\1<YQ$4O9TO5>4^-B@06B0$;T
M\B@;_NOW=O^ZJ#&,;Z],Y(\9)[G,W"ZMDJN!%\\2.D1U"G+.. Z82K@>>C@V
M6Q>B@%DC$7"ZAT:0P!6$T#U5L>[@?I*/:4D?/X=GO-O])Q64;8%-S@P%DORA
MFSFR@@SWYTI,$<['(@<4(2II=[0EIY%U)Y*VH8<^=IV3$4L18D,=8WJ*I;T.
MIV%7O6EM\<FX:Y+\VU+IW:^]92;O'1!<AH=YW9'.>U([68LT)Q+("TZFTUU^
M<PT#!6S!9"2(:N)5$J/Z;<,43N"1VLEA!92B<B]W6B_UMFS3O8\ERT,'QZ']
MDL*=8UOWU3(F69J[S=_SQ(UA._1]@EOU-W,Z47D_&W.A&G@ZY=7R=$K>[+M8
M5<_VDR?ND@\#*;9TC^U'BVXH6?F:*7KK6CR_I7VD4]ZWX?2MB(;LR7?&%Y\[
M"4K1T:OBSCY7#CIRMA81%KBN..\H[-QZUK5?)>N&=7$+3*SA35W'#U?X.%$A
M?V=S<FQVAWGW'D<QF G^KCPEV2M8N"5;KVY>Z=-*07)Q*'Z2^O;$J;9578HD
M_7^ZP7.80]'[I(0VUY""7483S4JR._ZA%U]6)>27!I@[W29/W8@9D^X\"Q,P
M?,<C.VLBHCH6E50TH#,A8;: ('G@POE4I'6$(I'N=EH5;40@;L"6CA=>V?WL
MDV^=6P*JL8[:=N4]*Z3!7DM@(HLI'^C.7-$=G5FN=4JUM/K=!T#F:(WS@'J_
MUD>%6;X%6\Z9:!I'41IIW&A?*%?:$NWK]+ (;<<D#I/4$\X1S;M)D=["N9:<
MQH66,=V.!01^-+69CEE^Y^-UM-S#92Y6/GP^TF2[Z_<"A7@)0;OP3S9K6TK?
M)J 7!C-*DRRSY2[YJ3F6H7TP">4<=Z<^Y%0+68_WA;&QJ+6Q!(M4-K28VB0V
M3IM?1J1!I*!X!JV^6/]_\GM$OY?KY64YS=4ID_;/5&5'ZG%QL5^A +%E >[@
M/N,2GSKUUL;6*\;EC1$%QU$.WA\VC+>DK-<*J/'6\PYH@[&'""X',TDJ*S7D
M&A]\D7LA+7'7#,XD!4(!6;NI*, O!@5$.'>H+9!3%+QV?!E)FQN?/P%+#K#;
M'_PR:+%2!8-NJ:>?]2_K8\_Y[#>?[&F+P?R<;]H./C']&#2Q;+_C8$5@P2K:
M=U&;T;*Y]^=V0?OQYQ!D0*,=\IH<4M VGZE/02>;E(,^+#+1U!U.E=-;.F,)
M,B/@XDR<**-\.?U6Y7J'<52C9%'8CP@\[EO35F2GRCK]MJDJ%$:/PT29/5ZT
MN9L%9'24H;VRZ@(*N"3<:#NG!)V/H( ;2L$H8%T\'P7\,($L*0^\.]K6X"+O
M]SJ>^9RT,!@A'"0;PICT>D8W-2'.\R)TK9QPQIAVHK"5XF.47N6$$5]NK5";
M29"@X4=F25G^#!\+%/#[@0M _M#=F&.7Y![L8(:$IW)"IV"ALD1&HWJ<XX3B
M6://#+ERB0TWMM\G28=HST.V;B>!L6JQ,44]'!+E)_^(K\9-.B]?G'YZ<*VB
MS#P%$:I_845SFNSYYF+Z)5!,Q$Q'F)FNN @B_0X.LK;^4%-=.P%-Q0X/J>VE
M*>40JZ8-%64#@RI,(0LV["HP3JA.OTFLEXLIWL@'+3Z@W]3Q22_U@;J= "?#
MB_>*D#PMO:<D+!YE(]\PADTB$S8X%-D?)0O;;7 +H@ "#^X;^D<K%LR7N_!,
MN&BGKM5=4$ S5<$WBR0RL?RL \F6YH7A+(ZN)OX,4F'AAY"B,M -W77:F_L1
MT.;&V;*^E"7KV.F^U:+DX%DJIS< =68%97E$,V]6LP65>8H3O9E1ZI/]ABV_
M2+8GQS=I6;!Y+818;T4_9= QP:-VMC8N/-E29CM>(=3PT9N;2GET4YU817U$
MRZ[@Q/BSM[QS1;%[];;PZ:E0CZE""542K<TT@Z/QEV6"2[/)_$F!<1CT^U0'
M69U[L_#-V5S3JA%2\V]</J[+&F6ZYIZ*L[ IV^,FUC44D%$UG2.\*FOI4@55
MZ'2M'2[KB^KG?]=SF#PX.^NPH\/A;93$-@'Y='4J.J?#*CS 284"P$V^&07O
MW$,O[<C-&X-#;&^5"E7J?'^0^\KC;5!\5.\Q?<M4$<1HPZCK.^3U=T1,JD?=
M(7D_YU8=Q5"+7KFU++V@40ZI286=(OCS5L>"Z4.5M-F9,H@>Y"O:H2R)_V,.
M^6\+4;*$'@I@*(>B (,CR/KKRBWC[OE#L2V#$Q0@C RRHFT]3=I?6H\:8(>0
MZ9>BAS/\^=?L]73/O^V0>0X"NX*LUU3(5(B=LZ, >I\U!*0.&?;T6/N\U.WJ
M*T)IV''^[*FOGPR)!N7<W[VA,G1>T*/M]I9L BI2;D(NX^]QO2RB?M"Q\ZJC
M$>\P*A*\Z6QPEH^4UW,74R[3Y\D8@D=R^%@,=S[-%5:'CY2@ /R<SLRCK2+(
M?"X*6%Q' 8$C"T,7)^-M>Z.0 Y>%<8T1B*EA,_)H!5);Z0.;\8J"<T410H;*
M\U" ;QP*",M!DLL%@]=@*BB@#9T%=<."E>5.U:F&]HAV2@U<SFB7_LL>E!$)
M04=7G5=6Y+,^O?5HS[6^OP:_W#0XVP"?-PX/(YG74Y!0NWPMG7G&,QQ_@<HL
MY4#./@(EZ0T#L(;:_A#RJ5 "\CCSDK/D[O?7M"1Y3%ZYEZD+1]YJ3X??EKT>
MG?YZ>3^4I>*]U*?_SNV*B[@_0J/VS]#9LX 02KV#C]8=F&ZB05M&\&LL)++]
M$S:.*OZ(G=!>2//0. *7$P4X%ZRCE]PA?>'O=93ZR@>]B.=AR./Y/O:)K2]2
M(BB@: 0REWK!Y$EI=S4N!8F3^#J-^ +A'J"50Z/R6R;V;S";\.9' ;$1>9 6
M9F28Y8I5\;D9"F"B0F=SGDH(LHD@YG/B8TC,6  *\"A ,EUD/AZ1(=TO6/^[
MA_I_X_._9G"A@!B8-@JHN&@[YM<\J5S<NZ!QJ;A$ >CX^D@PRL!+X=SA6&XU
MH2V,6QT]#7.37^?CY=9N<$&\!]Y"M!UK:V3#TKU)T4U)'2';IE& 3)XGI[>Z
M.&+5MV!=U.XJ#_P@.Y0]?.^O/FMC!RD?R";E;9%YFDYTX*?6L@$QN E^::U/
M/DGB%I7 IM*#WH=.)>Q LQLZ4D/4>>:?I;2920K,&X,M<'U<9Z R0JS&&4R)
MY%H,#@UZA(^(7EB6:O<D2QYI21=.R3LW?+TAEGQ-#)ZU6I#0&B@JH[WGN$*J
M/J\VMKO'5 -MK4U9I;[XV,M7W1L0D(#+@!MI 5(;6QHGZU"X,FF&--F.L<0T
M[3<,2&GI3Q*Z3YUQHI>$"1UH'_P'\9#K!9V(<5^-01@K-"I8SI>0!3+HA;5;
M3E@W;=M[<8%\=L1O=\8*;Q/PH"%1-C#R_NU]OS]:8$)YR4(F/-Z&';$!/M91
MI\C\H32"E'M.A%C-/$]:]2%&8ZHC,R?PKPWAGR0@/O<FI)R>%;)M%04,#QA/
M]H:U+;M,MFTA[1 $DY(^.]P+O2.@%'4D1XNFL@SIA^A?7RK;F<>!+"LUHZ%T
MB@)&+/3]7)Q(TTN3B-,K>_B>4%: _V"ENR[&M@(-R&^1^[>PWE**?%[;WS(@
M2N[K@<IS)<T/([#0L'0*_F#P=&(.N:B97Q=+?+8P3ZDW<C#HU-=7T%DV-6-9
M9G@K^G-#/YJ)NE .&'Z?G4MFKAWA,FU](WTH4%+3,PL0.$REODH2RJ#[&+@M
MD?@$+V:-G0P[K55NJ=M[G!?*B=/:V*1G5V6YOK-JIB&Q86-[]&Q:19"C=ZJ:
MO"O1+K_?DR%-#O^M*9NP"5)0';GJ8SMX;:R,,67FF??Y["3?M(-?WSHDS_C9
M46U,20@G/,OV3'B0<'+VR]729 EQ9)KI54OI]O;)Z-4VH5YD+8WVE W+)I[F
MPV*%:R">7FO/T8V4-+&R:B7;*K:2>/H'&(,8VTIE3C"R,:Y*KM W859%DTN2
M_BZ&%WX7ZIE!USCM@GB1J<R'I&4$:EJ3X4Q5C;XEQ]-[=VU7)TB4]8ND?[7F
MV/-@!47\%Y."J:DWN0U&N<J=[+4?U)$--.&05D=+BWQ:BW08D"M5="F&/YBH
MX-P^[O^\(W">'\JIR\_69:PA_M)>A\-SGU\OH;>SC'"O6\6*G*SR<^P];FNU
MVIKN*A-F5R)JFQ[QR<B*'SM8^HT*Z1J*D1XQ#X,)/]N+8=6$(P6W2DU9ILYL
M)^&-!OT^1(2:=T=5GO;IG[95Z'C,,CMQ/SW @0YU?LNMNI(,7$YQKM+YWDM'
M('2-4F8KO,R^4G-C<@Y_W_=#?JY5<7\QG84Q"M!A_CKMMVO_,-SK"E;"'"SP
M[H1=YWS;6"'UB=00%BL=HS>\R2ERK<ZSP/B'W<V-QJQQZYK"[$;5!@.G6P7C
MK"*@-Z5%BQ:J+14E;6OY5Y96&KC:!6P)->IPJ+9=_GS(JNMH.E&/&Y*)6MJN
M8LC*U1.Y^="CM_;&Y6+>6*S5'O4YI,M-.F"+_(S[;MR9H8R:-'QK++,CA2/1
M,[#D6U"PROLAYWPYQ%)<^O=!.:GW19 %ZM'F <'N[( \S%IW5]H7=%@]'C\(
M&\KTQ5(G!T_KOLROG5-R-!:/;L*4UEPNN5M2G)5E/'#K_RHC60%10\;7V_84
MX;$M^LTY2U&7Z>2(C;98C0^)**#ET=H%_]>!MIF"0_C(,KH5GY#]7R& H:?1
M";Y@F=*X&H6LUY:K-U8$00Z5:RK.T,1AQ$;3".('EKN@$0&?I4 6#9*/%4DT
M6.U<'-S*/:KGNNV<"/(%:A,Y,)/7;FY:'7TY#Y3IUCZ#3** )-7CU]LNSAJ\
MI9NP1+?RZ,W;''Z?%)2)<)0<5QN%^: E%+4W0KT;KIHJ>Q=26(V,U1W?JE<>
M(T!KA?K+\>HXT+D<W!"&CPV-"C7F87VU/*T&N&/[\,V;^-I-F2\.H3<>]?)5
MOMO!]R^(Z1%79Z=12I;)3[5QGM49&L!/IA$D'=AH[-[9>T>J_4SK*TVV(MI/
M VN4.WI,=L%=CVZ3LUBG!Z6C^4"YWS_3*?[3G&"8OO1^6]<CN?V!K_=A@_/N
M0YG\ME*/:8-'F\#GSW$16$,() K8MCIJ[N?M&.UY^7;E=:894FY^953A!M&C
M@KJZT-%9PSJ]F')[/B7OLR(K-%]\^P,R+($"YO>0/5&_;V)0*Q^/[0L$31\8
MVE*8M60<(?MI1)>XF5<(%/#M9_KZ"9TU>Z YYCPB KQC37Z$)(('_%<505/?
MN-?@H M<@>=5H6LU0Z01<LJAL&U?@^3,U(%!GAL;49;K5E5!](GT$N/IPV-*
M/U\;=(C1T^TVLQ <Z+<.(K%@M":&/N@3H3XF_8HFIH/[P8AKN$BL?A30-=D;
MTK:L,H$"MGKL$&16*Y<G57!2B6<FJW/I4<3\7]D6F$D5F7W1:?+:"&B_NOD>
M"I#V0P%O#E'  3I;_GU+L,%CC0)$U*,F./CS(;C. =P/ZH4/98,7S-P?(0.P
M4 #&"IHWFZ-Y<_H"T24!$1PW"06$5*2OYUS1!KN=0Z(AMHN01' 4FG/]L6&T
M-O#%.T#'%*!S(FX40&P@/B)W*DFXMX\"Z)"S72B  P(ZDGKWIX;+$T=WJ:Y8
M;'= 7_V=[\B>,SC&1-M[5,27;%3@HH#/<=DH !8.O@0JA$%^!4'^\52PABW3
MY A=W17*W-)&2&?4I"#[^]<*-X7HS^+NF5@7XN'ZNDO>)-Y2D;:R2F6].=O'
M5KO]B3JR ;Q6IG%PHY;_<5(B^1U_(-0+TDP==XC,0%BFV5NZ]N<;S#X2[/PT
M6$%!E7N]$VO3$YEP<&(U$6%16#=F6M6X87/BLW<HF3@[,,"MBAS12E@PO^]W
M*D\IVGYY5E@.]3!NLQ+'9VY*$;QYGYKNV?'R63&9BKY6KT\A"C#[NN,B\AU7
M#G^(.;2HV*)4T&HMI6-U79=.:(_0/BK<*6!KZ_&!8,+UJ;/6\EG!.EEHU<89
MSFP$^]YMB-F<3J=D#@:C F-$V_LJ>UG>02DH%[2\/&8E,&#(#><=49WY1D9P
M0VG;=FI)6/VK)CG1L>;::/^74HL/A@H72WS\D6LR+?5-=?$SUY?J0B6#'=1,
M&9<JVM8TAXC#5E(T8#9"54T;L,?LU9419ST5X;; 8OJS-Z1UX;?]23#!>#Y>
M(].J:"K*^D8CWML!!:BBEZ)%^/#IB>?O\CS](!WD"5'F\A"_$ IPS.P_DHM!
MT[Y3YO;?'(2+ 0$*6,ZQ,-A#YVO94PW:FZV4**!/=K1M#FV@,E##$"0V K3L
M_ ,%S%F@ >%K-B(XH%1@Z9F^]KWB&:U:$[M/[N-'(L>X!3#2T1&##-B'NQNL
MPG9?$90E[U/R4XLM\9DJ,\:GFG8)/GMW4:Z+J\59%3U<X;2EOQ+3\7!@K[CW
MZ1-SU-&&]LN7"'7J00TW7[M=^,,>LKC\S4;OKB_6Z28^8PI)?,*+[L5["TV)
M(Z/8*4P-D:]=['NI=/SYPV$*,F8G>!)ID3M6L):VS[J%?0%R5C8J@^;)$JE>
M$)9(-^(A<)F5LHSS6!Z>?*$+32DZ)%GR9(>R '^60FX[PX\U7F&QCRU@6(Q7
M+T\RRQ!)5YR3"!-SBC<]O+&M)PD6(F/Q.2V-V\R5A)EE%P<ST&,E2\.O;^0I
M#69/I58S32NTYV89\:D/!,(:^=EL[A!9MLO;VG% J1040NS*R("1S^N/;+&]
M&R0R,(H6F\.4QP7B+,M]NXD%4, ]*BGEWHU+6!2!C9*+0=W07'7U\RE.VY!5
MX3WH]6U2X6Z!H?NNN:P-D6(32N=/MB,3[1),331N5^%0^5V^+ID_3V&I>5]N
MHQPP0Z8)G^B9H;[CD-*?NJVP$$ 3T3M%K<OP[ IO)6K<2SWAH$SQBK5@=WY_
M#-:6)>HJ]G*B+/.)V#O.91P.1RG;^EZ8P(ZP2O!+*/]T:>B'T,4'&)\OB;=T
ME[2_" 8-=Z#QT6?/Y83LX9-;\SLI4\)'.P"Q)62KP:5Z/*^:I?J+V+&7:$=3
M=X'Y%S+W7V_AR6I['U"[HX#R8#BKL!(*D%A"^^I@-,RRB%*\_Y0TPTX@;\GO
MEM=Y%4*L& TLZSUJ/:AJ=XT<TCLE?=@RX:Q449<WF9%8D%.7D_$C:C;_YWKB
MX$,IVG*U\ 1Y0<**8A3 W\]2H8IV< QH<Y%&LXA/=LC!J',58=#Q727X-73@
MV40!-1\SA\[!A_S(OAX4P+S8]O7P"_LX"EAX,@,9M@#O4Z& ZAPD240OXAK:
M/##:KL3 ?[F#:#O-[M"7'3[$D=VB],<:?[CY2N$&' 4$_/2ZOW;1O:\!]V-"
MQ]D@=(!6;[P[.2)U5]?\E-L.D1UG&]VZQV[WXII8YE.T!W][?PGIB]91ZTU?
MY;17#A1I/MKC.>YU.8T(I9(.Y:+G;PT%B^5X99S1D>;M#&1H!G+6GH.\E1IU
M<16%/!=<@9@L0>(.#%9=')^LLI1G_G8%'8.(T3H!HV7^6M1?)M(9^Y^V)/!K
M0]2Q_#]W AAH*B;:CHGU0W1[DA>L(L150K>&(I4X,I.PS>@BVR*<=0I00,;/
MQCM_1KC1%1'/>D\N0;5T%/#8BF1T/#$T#-W/T2#XZAQRGO(''%1H9D?]*;1>
M)JG69"J/VG%44D,L_!;FF].;XL.7J$\J./^TM"W-U:2R;TV*Q0W&+[;G<0V(
M11J56Y)<+C.T9#Q_CQ=G2$=,/9HGC$)^"*,#@G[=:2+Q!0K 1<J%(.(BD$K=
MD.25>(TB=,C_?36Y/[1@80C.W(<L@[Z+S"_#-2[^BR[D?NU!^K<.$HYA:$PL
MRX] MGI "$ C[8]WZ*VF9F^EV"99&1.6@))L\+K:ZO4?AD.>'E1;VXC%+Q86
M<'I"VBNW5T0D9._FYJD+->ZV?5W/8%F>7J5OG9QI"K+WD6L1JY3JKOB),/#5
M?MN"W#>T:5WB]:( 7W(X^YI/#0I8&V\[-$ ^N62_H')69_[]=98KLC:T8C51
MP![:#032SA7 +Y.0"NA @3/0R$Z\K8T"$#CH-*<-'TGB$V: 'G<IY&P!TA%E
MIXKT05=#@WO9?W66-.24$X+TKT0C(1 %X+68TN80<-3%]CJN5(%V7WF^PJM7
MBT]/NWM2M_Z-W+RP[O= R/D=0F9,H+_/*A1^=VD9[O2C)(I2SJ3-*G)H.V]H
MEL]VMFXCJND2]AHOE]6(0;2)"?)YX2O+8"W9RXV2.KL!D-2(/AJ=>+)+R !T
M!'PSCT@'[>?:@M<%,L]OHH#OL%$4\)?%]8XZ?2Y\ 29%FB4J_\U[1A!Y;Y&0
M=A00_:N=>)B2;D+^4.5/MT]I*OW"37_K01WVEBD61*HMCU\EMM?)V@YB<"M?
M^X-;:<CS!M6/"8J4HP!HK &W6]^RL:B*V*X4M#>J]T7)VY+G:2UKE$RM.^)4
M"X?-)NP/58)"RDO:BL"GK3EH4S\#GYVT]43M^,@A(;N0O2U(A T:X+_S N</
M;<%KN^"K'[#EMA=?O<#P&Y#D$W@5+QAZ D)CMP&]+F5( 8C5)O@(!3BA (@.
MW,KN/_$HA:\E,Y'8;5]%38S^<(,Y$C8.64.N(9%UYY/S\'O"H*,S$&+?_/>.
M#O27SM\[?N[Z7?411 6:O0TAAA (NX.RMM]&BU;L=<5>. *-6^^[4A_>GT+.
M[Z  GI68;T5?""Y5QMG,\'"30%A(3Q#R?M+O@'/UTEI!1J81<K$&0L#!<$6J
MW[NL8>P:#9Q"N,ZH0(O*:L=BSWZ_#?OC%<P$IN>$HAO=:FB+&/N 'DS@V7(F
M7,VEE.Q>22%_R"K%R^W5*+GLYB4D^7,TA*7(YV,A!R\A'1O#:%/KN#I40K)E
MCCN /W<C<MZB@,QWQY[L@^ %YW7(T8+/!3,*()6#<Z43(;VYVQC1E+_P,I+Y
M@@)BO@!>6Y2D#3V*.M<3 \'/#7Q_[K,KH\E]P2-T(_A[?>#S8JF<$*0L:$I$
MZ>(\2B[7E#!0)[KSVD=O_L5Z;XT"!8_\:3$YDOS[Q!]5HS%V,D3+RLY 1ST_
MU=#18(9[0Z3/TJ7#H8B4I2F?XY:<C6WTIR8&Z4#=-<S<PCIT)*! ^X %-'J%
M?U=^&ZLN$SNB;(=V6!F\/W6&)/E]^1/:P?OTP@^BD$C0?LYOI:P;:!O7A0RQ
M_-KB'PC #?/\>_%U@^]P"QTA>5+_ _Z-XC\7*=.#8'CD% P!440!'U)Z*MS'
MD7?,/?-+7""2JUE5,U]&&W-#:LA$1;XX%[?MYWF#T88QE82 1Z& =Q7%!2F&
M2]BI7JY2?.5*H0GR\DPEN^X1I#OS?ZJ(9AT5:,6L7?U\MA*#3AQ)(5/UMGN[
M_,CN[E,#CT4!C3I(1P(ZFT.S"TN#LT,PDA[-;5I!:%#L*""1<F@8*R-*@G:1
M/_Z^&]PS<2#+*BUHEK+ZRVY A&8&V3XT\VW-AO7Q14&BJ"E?G"AVP!MQC%[,
MVJW5 S4&]9H"FN23]V(J.<$1HKO^H2SEQJ7_JA=(_SYI$-_1/NJ:>EV4:Y'R
MNBQ?#Y$.+RGIA]P7HO,+],YX[GXZ8/$\-?60KTA-5=^'W.E#S?CVWJ[MS@[3
M$6-UW)<T&P9C8Y$^"@E/M<;#^6O?-D[OKIU*[J86KGM^G50BKM(ECUPV7HVF
MM>_$#K=G2PQ\[<P=DO*B>;1<X)Z$K9_V^BQ^+YNL5ONGE6!I&(T8S/JC0W,\
M.M>=-N@];$M>ZZ61TFR0<S-KS:C3][%9]D20=GFKC'.5U8A3B8-%J*ZZ@J3Q
M=\R>46=)5G<[3 5H:;J+=]]]K$T]);AM87GT\"S37)W6<B' &7=U#32:'WES
MPC_A#%*L,3]4Z7*P&;Z";UT!\Q*V2=F8J$C>(=&(TMIRTR9_"S7 RQ$W2'T;
MH(0-'Z!>8@!)Q_6ZD@[#V:KN6OO2?52?X71A?BM</L=_J:QZ;:-#U<ZF>3(%
M>4^!MG@\0I#F[-!SXYSVYP-.C(W_KAW__S91G:CY+)C.985?3=_-@Q%N PVZ
M3A?P;1FO049@1F\XCY1Q['N:OM_^);NF26:7L-O=R \<?#H"L;K5I0Y"&GA/
M<,65#%0<- 3F 8L4WXIK>9QS'PJ5K'EQIVTEVHFN<K#R7$C4#[LFXWQ/UP3L
MG>ECE;^M]'8B0,C;%\?!7G5!.M7NC!9RR=1OC=D<-C:)5)^!"(_C\BS)G'3G
M9^0+MZ]DEH]PT_T_OA*^'6XJ9[FYGK,EV)9\!II@@;!-]6"W$HP6'#!%UM'%
MSVH]9I"9$1(:?EA-8!*3J3RLU@)Z !UA'F>J\4B'XN<W)GU]]>"UZ#U[7)#N
M9!XI(52>2_V82X"U1_>+V"XZ=S:Q_D??D%0?OQ?I14GFE<R936'!&&G $4B=
MF5H<3OB$;JF^_.G([J[IF+5I8XNBU.GIXA.*P2W^3T7Q.$=MV"L-HCVX4)>4
MQ%2K$LV6]$N!:%&<!!.304(Y-NE-MI)S-Z7$6<-XO2=WI-DDDJH%WGWK4>O?
MU2<R8J%,>'70EZ5WT^!%8R1,L26%6T173**P]&&0R\7[0UQ<1C]8BZ(8YZ,7
MC6/'+4:;EY@I3C,\D0LYT95QEG:F=+%%X<N''J+E_@:$%DX6IY.*V"$X)1?1
M[]9B\-K 0BNOY/N8&=<84^3APODSW7>>)W$9$=QYY"&<''3UQ<!UD>B#2!87
M<^ ><]M^2^# M%WR(M4\"$)M"W?([($617?20)OM'X11*Q<^EJ' RWJ%H90E
M_;?29=V],'ICJ\;!W1U!T3>A/11<E!AQHC,OJ7FP$F>C,4_7)$G-]-?5A<^V
MO$3J=1+"OMR1=N-@?NT4%1,,V=AX,&BETM#DI6BG1I[$.[-15X33[/"LGVSB
M=BS!JX4Z<NLUYFC<IV.3"PYE6C>E#K<WB75[[[W3%4ZB:8QFY*00=XW)>-+W
M&J!]W\8=+-"PA_-U<O?0%/^UV_0]I48]-QM'24WB3WE)G:=W-E7F8YQHODY[
M]P0=FG?N4.@6?Z3V$<_4QEQAD3CW]N'@]' 0X-/TR&8%+3]:-5YY 6S,5Q0)
M#JN;#W-<*T/D(>-.6U.1WX5XTW:FFVQG4  A[X[VRY_[T=?_EK->/&'==>XO
MDUV3;6EJ(!/B[_,<&S21YL7(P2M840?QWGL &$O*Z(T9IPQUW?K6[>/&**RM
ME3QE$9YGHO&"QFV-DM =Q(T5.EJ]/Y?\2E-'SOYVG6W@[HK[M*N;*65HVO()
MR942D46M\I?$_;ZK;X\)AB0B.WC3Z*MYV40E,%EHOJ;S?1OR*.JU*)Q# 2:E
M"C<R%/)=^5FE#.6,GE#9WZ!8$VFG)(/SKC:[5<L)'&Y4#:42.[ _6<%\,] 0
M8I3GQ\!<('F]2+6C\:6G<R*F>)P%HZ_J@[-J/NS/(D!;_UBMR&*%YL9'B\_]
MUC "*FHE)\9OO?FG(G 6S FT9_I;K]'A>>;:RQ=\MMW-JZF+6DM\LL)+DQ.+
M'_G@\I;/5F*5<)W&7<6(E8%M5S<[-X>[R;/W>5D-6/7:B4:.PM?\,A(F++7U
M\BO,.2N6+.@)RS&_?';#BG;,I242U(.##1EO]](U0M@>,3I"EWM>,KY:5)Q^
MP_!1).NU8,(7Q062ALF]"FQUIP&R=3/SN37K\)#$9_R\  '6$6U#H2"5C38W
M[G2_ZU1\RELAQ48%JP]W/YT/7@!T#5@?B=*H"3WF,SM3=$]K77>P>DEC!NJ#
M/.AYTXQ%U;$SFC,\I&KBW.T4Z]6T)C<.*-_%>0F9/(N##L+KE_>_;X5BKER)
M/C[E>1H;DOADXNT'USUL,Y&=C/JBHMMD(A,,+]YEX:A1 )YXVMC_J!O[_XMX
M&'2A $JK.9H#P9;\*,BI.^V J<FAL7>E&V4_JR10+HPD"PX'KW.C@-B//SGE
MCC8LP!ET6S]OKM+P-&24]TY;.KVA-#.%.E:18#J:H[>AL]KCZ^B\OZCMO/%T
MW6C?/C='S,VJ#P0.^;2TJ1Y?-%'EQ=YV*)'ZQW9)(!W#!\$('!1PJ Y"TK>8
M(4E_/MU9OXT"XE0A!\Z0CHI]" (3?&AIA^2JO3S%0OKXXL,'(=O;_4@(9!F=
M@]/G)RS>?'ZT(-E:XN"6>I'9;Q41*A14?WCVBL"^8 QJ,R>#3OSF4CD'XL\T
M[CPQ\F-H;O!0_>IVG3J1,5(G[1:AI.5.?F"^EKFQ7%V-<D&@Z2%U$H61_$H(
M<ZRB; ;UZ.B4^=T;]R/-N^S6AAAS698!O9 71!+&:;39S6Q5X<5/E=45FT#R
MLGR!+#VV.TQ.M$<&DQQ[SU.1 9SS4UDA9H?IQM_9VIB$B1-X,Q>7C0NT=0QN
M;;99!._X?VY'Y$]9^[/,\'^<#<'@>!A)8G/1E#Y;\IJ;:*/2AA[736ORASS'
M$$,RB:'\:\8TK#<WNB7,&]U[."_UJ-J/ZBZ7,E,K&I8*H*^M/KS+N#>!TY5T
MIZS@F_$$N/JK/-5%*?X.49,KWPU]H;0?A^+<P<T*A99GZA%,14)U,<W).JPY
M9.?M#TSM$I^%']8ONY6(&026[524VW$KFZ;OY3:&65=\-$G/+<#3Q?1H9ZC\
MH1Z1$69:,&A23=PEVO5P]=&=Y>5%OFG<'R)9 J+3H#M;3E-:NI(M:;TO_!?*
M?H1H:9E$.&95&EVWIN7AC>DKL5ADC0RZ;S4-@4([/K777$QD&S75>E"%51M+
M?FH?DA[,VD>FU$X.R^'W)!9OX?Z?:LXKD V&;<-IPTM1K0ZU5V(4I49#[ XB
MU5+47K4I"976;&N5JIW0J!5*C1";B%DK]AY1L8H05;Q%K5(^_]%_]IU_!\_1
M<WY?]_4</"FJQ3J\_]J'NVX-*)QP9,IV;S>FHN@!)UY4YYW7 PU^ >FU=+Y7
M/[3<4+\\>(AEKQ;ZHI .Q!M7K+]4?!+T^+1_4]0O/+Q62.#IG]_%EOH5P7[Y
MJQ2*#E>IK'":*_8[7+XH]UP(ZZ:#7GQ)"Q.5>*.]WLG7ESBBM05S!^F=B_<S
MU7'0LP]'ML[X*,2[:0B,7<RL*6K9ZG*#A^;@'OCO9"Q,A#^CHW'!+.=7Z6-D
MGH'%\FH]+EM>;AEG^5R2:SPLMF@A\MS-Q("N)B];#S35__$N_II(C*&R#I16
M:H+:U+TN;<F9SMQA6A2^/N_<5B%8WZ,:^ >#FL352->;)%-N6_0!@H)\XOB<
MX\\]0@RI+0%+SGWN=IL3P73!OU8E/(DQ:R!B9NU)'@ERYH,F;UWXL?=F_SQ[
M@;94^9VVSIGFK42I>$3-,$P5CFCK_K+U<3Y1(:-4WY]F.KL94[!VI4=TN;)W
M6POQ#0N2T/7T#@P[QU2HSIP/"2]H"K=H]&E$2/9;E(+EO;C: R)J:0@@=%5N
M-*1>?K)#*8<Y]@-RD-I:[E#8<HTAK@6IK!:8]F +O+'8K;CK[UR+"WC6X3N:
M< O-&ERJ">+#,VHM*?=TZK\_!O$83)NN3T-31:_*N"86)@*4-F;CNH#BW.H[
M2?KOS]*<)]I.&_E3S4>MXN2P%Z0L')V_D:L:[RUQD5U0^RMI=*FFN38.;*Z8
M%S 1JEE_I.<%XF>VSM*7:AC9Y7ZE2>PW8:SVD[U89[T\<9O0L7_8SJ[*OLMZ
MX-L[;X!3AU 54PES%$VY;Z5CF&O;_C-=N!I7[3%CV/#Z[X.M&'^3"X(=+3[!
M5Y,.AMF6U6ZJ+T]TIJB=]93-JZ< -_6^A_8@L-A9PLB@$NJFH?@4LID2[,G[
MEPK:?]/59V39KMZ[80]T2T2O7/KT^D=M 5=W:>E@&[6-++TA,G7>2?**%1Z\
MNR]6:'5@I4N<ITUK#B$I7^YTQ#(\CLT)ZW+[[BT7/\XXTO^3!Y>+]T<>BARI
M6%IJ>V((H50X]P1?XC()&+C+IG]);5)[,7S%RGTOKM_,[Q=9XF0[S#JART52
M+X%E=?(1V]Z[N*B(!X-%K?]<JXQLOZPBU\.'(C\N^;&]QNG]]R,:>6L31(KJ
MUC4RJ6,"*H- 6]DR+NZ^HQY7[6QGYN? P_-];/"+[2(/T,V J7TK(:=-IK+1
MXE4!!*6AL*G#,J/9]+,\^!2 $&$PC)5-64&= EYS#"#T%C;DK2;KW;C@(":T
MD:OYLOUP/; F89S'_"4O;Q"](<2Z"XQ)S33=-.2%KCU$4H,ES]-EP/5>P((/
M9D\:56(D9YY9*R7#/0-L37T=F;P>T3-6:JOOTSP"-S#!Q7K)F6]BHU@O':U>
M/1C?.O!X&/U#7,^/5W0'(ZMQ_TK/I'>,;XL/*L,[X*?!F.(A EG#FX[5P6[3
M_;_I<]YY4JA!LL[R<0/^WRO2NQ;4W7&*I2B97+7^$;+A"8PMYS^IR36TL6P/
M\MS;O]DLWKG<P]TZY)7G;"F?"=5A'RCP,E2/9SJY$N=X$JRY?24X0O!7LH?@
MSN$I(#'I6*KD%/#.#G8*R-(\CCX%+,&.1?YH'I_M:&:G )[#^?\G$DC#P@\J
M>_#P3L+A\2F@&WYR?<3?[&GC>//DWE3CO*S+?#*;JV_@)7O34\#"C9%3 'WH
MC&)?#R:*;TD.Z5LP9HC)*O'^6D?%+N&7\*4$L4N\#ZM=3?,6ZVV:<<X2/>KZ
M#_LZ\$JQ?EU%('* &M']N>N<R+?B2@-IOKC^2M2,/"6B++JT(-2B9'$'X5F
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M_H'_0[L$&7^M^$_M_F-(W).0DK\G*7]/FEM<2EY*6EY:ZG\YAS\'P 'P!FP
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ML-]]*;9D?\G8[>'J=Q_GX)%/>-TM$Y 9,^TN(\K]&T7?N]2+C0.OID)DBV&
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M@3OE!EOEO\PR$<AX4>J^]S4]&S\IXUMVR" 1M.-#!:I<0V5HV2"CH\H9\=/
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M=L-^UE Q+^.-/[<']"8N*$?,N1EON7Q\^MRZ/+#)U[\W+<[F^\T[I]]-/O>
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MWB4."!2FY72.XJD ,"$<, 6.5L2MUR'(.Z5RDV(;W:.*\.+MA6F$GZ?"2+K
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M\PU_V\ZNKI=K?809_(?GM17L)EV]^WFJ8HXY__'/>;JM+S=%+(A#J]I7Z.^
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MP^E*4]'04G=T,!(8=?L05@@0EK=-0/(J@5&2V)N07/K2'OY^X8Q[ ,?89D6
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MBN51/1HRF]H3.KB5*IIQJ@73I<ST,U-M,#$7$WEA\)L'5CKHQBY#9GHP;?<
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M>460<?. :D(',G8/F V!:>Y57=%^UU82^?]*5OP_ <G_A=ZP9OV#H:=T551
MG]RU=RJSX ]"O1YF-27C=.YU=VM#-)LY,VT$JRBG<V"[XL KOEVRM=\MR13-
MVA-OJFO*0^>[BS<"DO<<+!J&Y)L#CS^<5TU=W"[<8M9CG\]4'=:/8_D\[3.4
MN*[(RBFWIS2 A8SK-C="C.9^.2I#*+S?TW\BD;5'E#<*W]H$/N9JTRS=:;@F
MUQFT+7)(4/R-<2 17CJP%' =4!?>,<\L]G%7F^%W!%<Y)N5 MR#(65&;F(\)
M\DTO=209(V+M"THNF5[-U$,K3 ?]*7/?4VXBQW6:ZVVBR12S>91PK!)-I-W-
MP'^6AP9&T-/?LWG,'%-&I3M[7S$AB?K'XH\,#;/?^=_)(8EDZL#L4-D^3DA-
MQ$<COP-Y7=/D!-BQ#U1STCJEKX4AJS;W[:-I,8-FWTTLS52";P7'D2&:"--U
M5_,\[]51D;_]C\XV%7K4LTCC2>3KK%UCANES$4J!H-9:?=$JG&T_N0+&'!#1
M=*-+WX=PAY&K@S1R67T9&/C3BBWUCJ[#4&/M/8"C4X](3B]%\\1B?8QJ]4\'
M+RS 4)21?9K=2(:U5?,#T8BE3L8QQW?BIEAG/'EACFHYEDNHWE'$P*48Y;03
M3*$&^M%A1"SIC\H?D)9\,C'^(E6&37NBQD0=BN50JP6*NDVMY\9,>BS,MPV)
MAXWA,[O@83^H]?S[FASZ4JC<]_S>MR0<(Z1!0VE*R[1R9]0&U+WN\:&';TS'
M4\P:KXJ"^[=%D_);4>N5%9=!G-$^P(%K3.A1;/]%Q[-9 =N9M#-^%%MS,_^Z
MFHRJWH/!#7V$)CU18?F"3Z]V[$IVY&D?^OFN7^%G=WK7/<K& 94L;C9E0S+>
MIQ,U69IO#2MC 3Y6%OQ;Y[:'R5>>@( KX?,PC<@;;\LPZ@'A99HB>P3V$:+9
M-]"S%(3P@(>U ,V$LEZ3#<2T*SSNLGH"JW)$5E7<R>-T F]_Y 4*3BX?_H^C
MWVP$>^^4SR_Z$>+AQ\=()"]8D?PS>U+J1]T'9.1/CZ,37*1AWJ;S1[B?[RH\
M2Q338BIFUJ/X>TWL82Y\Y3^Y^+YQZ79A%WAD<GN8?PO\K14567MRV_,W_W[]
MGW2R^_\3V%M#B%W\6_75[?64(;17D0]%DMIQ6VJ&J?N$#?-/_]D*6$P]/\G;
M"=0IR@@8F/(6NC@_M%Z<:8&U0%C%]HGDP/>#[XAAP>#:7Z$VXNGJU'B,U_B<
MMQ;^MMB$_BJR4M>A!L56FN Z)JS=V:=)..A U)>2@D_^VUIGE@K;\17&Y-?\
M]UA,FCCY]73OZZ2;P.&=@,[?:5%I8,3";3JH=O3LSK"O1KW 0;PQP=XPWB'M
MNWA#++UJW""9*1=O/;8TBH'FERHV1,,/$U\ZMTMIL&PY;=GNW0!Q68#]\5D,
MJ*$PM?0B>2]"+*4OO4RU?9XL\DY@,G*$[7%Y F JWT:1F#Q.G!O<]02B[%/N
MT$F[[6727[:@##.I.#$Q>6MI'*W-%^$6^DSC\Z>X!FC]UV[60AY^\,XEZN+O
M!G&*;W(0U.D67#@H[(V\,_7)MH!6BAE5/2-%E!KE"TLVZD77T+!:&9.Z*-B(
M*%]1=XDF!PE/PW2@%>OH!_#%]GW*7B6@T2?Q =(>[>-#NE@T=F/,3VRS]2"I
MH_58ETXXKECCMTV0=6."Y/IK29N8><5A+&:&L.KX/6,_'#A5E(QAL3WI@D5;
MBVFUK_+QYHZVV=K8JH, I3A@3=I]S'_67E##3[#[\&2.L\SOXM9PIUFE2PK1
MZNN==P]PM#^VYRW=[G3V2'B41_J;!F^H6F\E8LO+E]ZRP.9R9- D.7$MQ_9#
M:3D^V-.6/EGDBHL=8JAU0%ZFSMP;N&$WH_J"+9IQ^G*K-_<<.;V<>8ZQN;B1
MR0)2=XOPJ#5:UGQR*U6CEM%?D"?=:;PFV!,_?LOWA/857\-4WQNNH?>5.5\'
MF3\IH-(FA\S4<V$;7I@]T#%#O4/9/8#]'D!R(K/MD]=OD(Q?K%2B5J+N35RT
M,2]6[F]IQ]!6TTHN34](JC;^GL@A0*8]\A[0'\2<M=S'=!3WK*&6"<Q+/=27
M:K%46H4W8>4A$PH,13*%1VNKG[?&TW]E6X0'=N'32)*]$+Z-SW)!A4E*<I*W
MR$,\1BWTVJ#GBT!-9V^QNH] 7SV-#9Y:(?:7@W)%C15O+KQ15\Y7<:C"]N"J
MWRM.;>KN@E'\ E5G*0F8@3UMFTF=>0+C?)=AUO<_\<##6%?I1-DI  ,^C.",
MV*C4+D$G62H?ZL"C;-(7IV'LHT'S@H QRZ/BUE=@Z=]=BX-)5?K92/DPU*I:
M_C2'L&S:LC-DV%OO<^-'99X(.VE-Q*",-T5%WF6H!BS9O5"#-=T;GT<=)ZZ%
M3$2D\N=*:)QKB)2^@N20Q-1R*(_!C&=PU2WV^*T8LI/,7IY4;LB_%(11:VV*
MU! <6Q+5*CP4T.0']W*\U&W?X.JZ_4GV$.S3:#9[FDUFLN-%UB VSD-'(Y/T
M <S28<.VLB5,UNNEK'4],T+""$=<5L(4@=Z^ @:H+T=L5;2^9%^':ZFG'_B.
MOW])(_T]#=;!>H0JZN,]*7OE3C0;^^%IQ7J(UU?\S)2/'.+.['K60;9CDYGY
M#\'/[LQA^)R' IW)G;"SDF'U-4W2^HH%(P=^][)TA\V6*<I9%H^&&.J^KH?+
M0X_E?8SD]JL>5*FO 5'^^NK!)#Y?^#-.=HXJ9O*UU1K_&+]M5>?&V: JEF2E
MWN6=.*UP&C&M35A3C\]_TAPS991%%=,U!E/!^GXLR2HS:\K(]WS'SW3YXX)W
MH ?8NN'$C7]>PK>O :&X[^3R?/#M5'UY=LK6E7QO<5;)_,5MISH-1G960)07
MC"M_J4JG$K)Y"US:):%G^WJ;2L?6\EVW66%,2%:XWSV9D1UM=CTJ2G7R9]9$
MOW^I[0F\3[XN4H/E]>AW-CQ]W2\+&='O#1"M:U6/U0OO 0Y<V3KIJLX-)KG
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M[^BO(QG,\:F Z.J;G.'DWP-N/*JWKJL[@@+\&(2E^ YO6\W"$#T?ZSW N,%
M*[:Q8\H542BW7\ Y SSPMJR?UC^_\Y(YQ) 1!<G2::6\F^FLA;Z#.HMA$;5G
M8%G'"Q0 A+A<\@6(A31-0Q/\#IG>'/[<-G2SUP%5"Y39G8PR)9,_6.XS,\)*
MD*?716$XMA.6$/A*T^(-FTNL\>5;)S8)6NO,$2/+DY*2TC7"!XT69![^_+A@
M16]!GKO\?F><YZU/""C83TB%"3_A6\/SUSA+,EDI@B#W /?VCCT\01&09\O-
M3*<RQI:NR![S[.C\2R)((C;P/'\F/T+3WX,K08FWAH*G=8@M(^2=/Y:9RO_,
M82KUN>B#+[9U]4W-/I4'.,RY"R-LKD-<#UE%PN:H#_!P0B&ND<V%EXW*,V<<
MOWZU>&<[2#DW)HBFZJU&.PU3OL0'?.>D*8MT!3M##]B-^XVO[FX879EB;E\*
M5"ZHSXPU%@_Z%O=<<\XC[P$JD8(2PXGK6O< WR=N:D2MV'$:3WV@!F8"Z+I.
MROYB8+[XE$:).KDV@9K9[P0FX8]V$RAZWU*O8)IUVD.QD3OYU7M Z.$9G8-/
M,M<&*-K=E'IR(_F=NK03G*!#K1M[JGC9Y^QT&:")5.,#>SZG]GH]Z=P!P^:)
M3G[^8X*+^L65YL_%=SP&G;S!%K!Q#2+V\KHIU,(A)N66X1T+"04BZD?]0H7;
M]ML6HJGN#L2#%"+ZRQ,*%3*B5@NW7SH 1ZQ^^7?HS0I17:#Y928S%*H=^4*L
M:W;JQS,?F@&K)WSRHI%47K/8DD,RL9IHCM:_.??W7L\87("!>?L&L>[KOND2
M*%/44FAL)9$;;3:$3ZQ)AMWJG.H>@-:6LZ:$?YF-M?P<VHR$#Y(<HWZ/D130
M%@UWE@UUGEBD9GUSM]"P6$RX!PA.;!S<^B.3H?N,#$$#4Q(A():.-NM/%F\:
MR5@&2('#%H^+ ^KFMKQQ6TDH?<IT:W[5&&-F5INRSJF=Q$ /:_M^#R]$XMI8
MTS!8*0VZ3AM LI&'>-O7CLG)AAH.MA\(AFDJ"A^A2ZX0$M9]<YR;/,#$<9/
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MR#/6E6376S+\Y>6C#Q=^[Y&M;[B-@==[G8C_PO7W%JPG?O (8T'0[W7#5I,
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M^2]8FS;;'T3R!_Y=9_X[W\BES@KGZRR555GL?D:L&2=K*8;9>L?9-8U&(4U
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M6M\#7.X!/*DCR?PQO*TT$S[9RLT-T*+&3HCJV:LHD9^)XEB<V#1=@/6LAS;
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MR!IATS470BQ6V7Z[_K(YC5(ST)!;IT.=4H+/5^9<<:]&687N=3_:$WG<5\7
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M/"(6.%#9US%Y3!Q]4UX =K!\[3FWM3L4*9J6H?_:Z"832ITS_:G3<AYXZ)8
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M6MSVPK>ZZJ3K?<"BEE<7'U:&ZKZ]QECO+93IDCKLVPL&>U-YJ:E O[,V]C0
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M!O3/6S.T9QU;#53]6E5>06!=X?C:6ZG/_953 %1"KY6Q:GI"0&4IQJ_%8J<
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MZM6P0F"RYWES,S..!-G*4-'*%-V3?:QZ<R9 _7A9HT9;TB()>3N/8FA_"+Q
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M\8"P6IBOXD#>>'QV?97YR>(R7(>^P]+S']W'LR^,#NGECF617&B 9HHTI$?
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MHD (LY7WH=M?3E VU73#!CPV'MZ>\)AV/)M6PG]/:EZ50_U>=Z$KF\/'"1K
M3V+%6IM]URM@8Q?:QM:;"FJD 7B/QGGFTI?@X'^>I".9"7,?]WU=T=6V61QP
M.OOTRR8$$EPYR*.XJ^^V]\1V<D=PBR2X;+9O$\Z/+ZRMC^]YGW L*S!W;):L
M4QKPD@9H"B<_.(G"^['L[<=MY1S8M%$#<RBK!101$_5*Z*P6Y=)1,CEVC4,.
M?D)# 994]%<:(*N0!E#60/S26%[5&"B&MLK;K2D>;FNTQOUM\F^3?YO\V^3?
M)O\V^;?)OTW^;?)OD__=)K,=QQF=97(HAI+_LGF9M\U$^Z[I1X$N9QK@# !M
MPOSY?=CC[R'IPVB5+PWC%E6I_C&U2EWE?,O$LL@W1WSZWZ27P$D)YCTDP2S^
M7<L^O6V[=]SRD&5+WK?P)XI(C]P77'(D =@?:O\M_Z>X?:<!NA=H@#AJB#73
M?_KPSULN).%D]TXH'JQ9(/Y=N\7VK^E\. 1=8()L:WP;6_UO/<_A?Z\T),X7
MM,+<<) =SAVF\2S(8<9.G"*^0MEI2[4!/!ESV)8^CP#X3E\@&E&N%\30 #^E
ML#0 Y506#1 ]1 ,P%LU#]\^0H33 ,0D:8%Z.CH3X;[F3D-(2(!G L),T4A75
M&;,N=U"",;>X>.^&*-MER;L,W'POSAPH_*.2E'Y"%URA732 9EE8[7_0_RZU
M_YKX)\YI[*FFP0^8'%'[)SL"P+:B9!:JD?@:M<T"3@URL;5\0*?-_H!!C842
M:T0^"J7\=_1_T+__]N4_Q-SF(@WP7@O:A"CYIUI%IQY% PB!H)^I+^'&_)S4
M6^,T@!:EW^9_P3'!__/"DN#/0 -()'K0 ,]@IC3 K1HXK&0ABXX&Z%F8ADZ
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M> =KV[$[M9*1[ [?&1_ >P]H@+8/Z(9Z:!NTY298"F<P4%!DGO.*B3ZCN($
M-(5YYT[U<-F%WZJ-OJHCM%CG>O(A^;$7CLGR(8&Y ,>U;( F-D=ZZ&1R]=[5
M38Z_0*<0S=2VX=$,"^!MI@H.4XR7)AU3O-@F()FS]Y+Q-E(L-]/K=.@7I[<
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M6>SS8LQOM3'1M,P$L=I\HF>(];7J74T_:E&UF.0#G?) M$W3C<$U*UZUL9@
M"7[Z/U:M##]-?Q#NX4D\<AO"VT%&T(*DM8-*48L6RKS9W%&S/TW3'GU?X.S
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M0 )O-WTHOH_B3*!]?R;80LU[]M<S;^!\69XM73_"@=,J M0#XFJL;7-V+J;
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MTT8&/H3U05R$W[9F1'[L,W/:J"XA'FX3+9<ITI%V*NJ\%!/2;JVTY]<]FE%
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M'*OZ:UZ8SUCGGL\CP-A_9?9?3 ,;;WCQ+]$$/@)68:&<C:L*193N1=2(J'=
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MYN4#7!R?OBK[<L1,]F#;6?U!A:\>#)NX[R3VWB1)7WO+U'P\4(S&YGBJ9,?
M"F\" EGEAU10VK&.C)1 ^;NC*YEZHXI3D5J!NY,;KI-6C4(\(0^[C:ENG%*H
M3I'5/WE%"OU .]>M_NCMA$\&:LPWZZNTAK):R=Q(T; WNN<Y;BD8PM[3N?QJ
MT5ER<?BRTL3C+6-3-5?=E #:M?P:FT)ED4464&\ QL&IQ%WR_KX64=^:=X@C
M)2R6!>B7/Q$%SE1?C'K863;7(,>M#P+_GMGBD@P[M.6)$ W[@A",CMQ>1@>M
M_/\ S,&M=P(I MF*0.+G[C;J+:LUM+:U-D)_BEU^+74,H%NL?VLBR8"_;N1
MFL1N]-KJY'E$B>U3_007S 03L^>1:PGW!8PWZP0XO3)G%]JF$[13Z87C)>7=
M*YZ@TN$5$.WR,B5#8W="1WE^:O]Z;J%<GJ+%#$1+R*">?@0$W8*[._,7B*LZ
MUAL:.H0\R.*H]']*C HETIK#ZWW+$+';23>U62)H[N6:6[&>SD>?GH+#^0.J
MD@_FUHR0+@+>OX'%<$J_Q#" (>P4=Z][I!O4&[M+MD.;M'J7;HPS6CI/8"H0
MU-6:9'&6T==%(O.SFPG01]L\QK:?HDDWL+R%IZ5\V;GJ,E=29=Q%2KCC3;*9
M &\OX-[UL -ARZFITXE T##RS(J$!Q6WVGP*E3RJ=D$N!4:[1&-%!=[$Q_IM
M3Z4M]B%H!#.XSDP484UO)O8E?6<;J<W6LG]PC3C<=9\S>J4@IH07YF#JX>5\
M'+;E*5:3/)G,2C':DA"/_X+\V+.2ZO_--V!@E+DJ*HQD4RXWM'8O<BI 0!'(
M@;:%HUA1+)ZKRX/A<:?H69A=7-L2W8Q9&,7B@;FF)@6[8@: E56(4KGRXD&>
MQLH*DAVN<L'7QK>6*J9$D8(D>-!7"NBKZQ>X[2%578AJ97*9SI*JO#T9DX"O
MW:T6Y1=BG/AM+O\!#<:5[50^ZQD9C4-YF<M$Y^R8<S>GM(:/9L,SMHK %96)
MW)FHH#@RB6:8--L_+;4R^@:$XWDRG<5[P8 LNA0:"4ZM2W/WG!ZS!KND^9\I
MG1+]*G/Y?M3XK[QRR<I4J":=N1?W> 1@'F;2C,=YO?FS-6/6V)@.C#_$[;1Q
M8'$?^! +Z1+\B/E"]+RJ T3UJ>$ZHL N+3M$1L6IN )L$_I)2!GWMWFW%XE.
M*7;<%@\JX$RUT<:K<QAQ>M]:) (LN'L$= ,? ;V/@ 3Q%\V/ +SKD=Z^E"LM
MB/N5HQ@FLUR3++:8Q3QJ$>P-55P(E<UZ(<@P%3;B8DU2A0;:?/Y7G]KJI)KE
MVL:FPD:"G3M"',B_M^?BY"=^F+G)W;[NZ_.#KA6ME46M(86>Z(-;4EMG]>BI
MH9JZN_'<Q8.Q^80BS&T4A,7!U!ZM@3LVHN]5@J*3.D[<H="3W+-AE4RG9\BH
M#X&E7>T#N9*LG&$#EJCF54V+]6CQ*"/Q4AN4,7V76&6>&AIU\:0_E>T8OAL<
M<C2LDV^+#/",VX6T_LYM^'W/C%>;;VA+2=,>$3'*W."33,9>HK9$C\TSD3J,
M@3,OO$MR\8^_[WCB2.I*"_D4D_$ZMKS=2-:A$.^!]-5AQHZI"Z74HS8>@4@6
MW-:%EN'F$?E7JNZQD?GLC@IB6UE+Y,UDVBUE?Y_ O(U\Y0[8JNF.CX+P9?(>
MCTQD\,!QGU/WQ"=6B3/HQ8GSTRZ?$[G_AURYW8;W@QJLT9J?@W1/HQ5(2Z7S
M*[H6H!/S-592[W09%PZ77G]*#C=IAK_>3::HO@L^0]053G;#>V3Z\M',T ZH
MG:9:CWZ\5'8Y?@3HAL.PJE[;:<T3$Z1X2(3GQ_L%JPBU_B)KG^*_,/RRK "%
MI&TR630UA\^CF1!2RKTHV(CF]:I8)O!L%I,LU?WS.J9T%RH4!V0=+"[XJ,;(
M2@ZY,CZ*3JT"/R$;0[O>Y"M!/<&VY]FE\Z/LZCMD6&P,0UAO@X6$ 2X!3JJ[
M/$O7<_UPYJTXSM8<Q*"-%_$55[$7+TZ#Y"NB@?>'%-T#_AK1(6FMDQY@#U:[
M$\QVM_V.N];,I80RO3UO\:+BXEH?NZ9DG0A.O"F^H7V_LDV-*?Y6$)%\PS0[
M23)\BCF$>RRA <?9)^T,5UNE/67MN\?OO]-,)[O'ECNNPP6QB(,7^@?F^SKC
M"CQO5S:R]9SMLI.^/E4$7#-43J%\.TCYRAFAE%B;2[XE(P4&*#2J,%EF4E,.
M>!_L51S@.IHI-*@MZEH*$V'(6%A<V#G5_QBS]:SDS&JT98))&*V$?&B<K?YD
M(#R+_EBPMJ@Q4;M.V>9M((LJ]YE[YG>K7-Q ?#.-U[,"7&QITBPJ25><!G;)
MR5=IAAU,+F5\['CA@I%RQASQF"O>;I6L9P+'R+A*W>OW(\N]3XD Y,(%K]B:
M6EH2<*B'* T,Y01NEY*;[1E<EN?:CN59OUSZH\0<W%XXPX9VRW\;FL25?I>_
MR?1C"/&<4":V(U^D6&B4C6M/Z<E=/7B^9T /'L#=^SX@EV2D8%WS')E*^,@3
M?/5):8A1/4U$#+]#;>&6L4<#F<;G.F-B"!2N7MM7W@L4]98,,Z4XP0?JQ0*>
M6[W@54"+W%YXL$LZOM@J+91"4D;(MPE].3W(.EDWARID;L0Q$Q[ -P[5:J@#
M/SE%&SS,\S<V(BU>+VC GPJ(BT< JGOT8?CQO*^(BU->OT.Q)U@5VD3I&6IT
M!J)1/NA.(\1;D_3W3#PR[&+9@Y=VYT;1CKQM!+W8MSG=359FKJEW/ZNY @3\
M'%U]AIM#E_AV4%I],<UPL9/*;U%-[&YGLK/G$>!U-*,=8TOY>6QUCTW[^#X4
MF*+:D@Q;VE-,.P%]D=Q-JOP<V,P<GM(5$_EMJFZZIR5J^_N1O0 'X2E(?;H'
MLF,^K<\'I)GB7W@M_;!RX^V,0A,C0.,+N:^^JJPP!N]5=AQ"Q6$E>GLO#?=2
M;@V<?M7K%*@PU@5$,J%%%8M(NFY_,\#++3;,#H/!664RA;2LW2**Q%$1414%
MX(9E*\D@;7 )G-'FZL@!U2_/QUW.FCM^./B5E-F"^;HXG\;K&9%V,/ZUD#%]
MQ%92NR3=->G=Z"SZP<2?"D[.[T0&Y&8V8C_)7.--K&RC>56DV"8Z2&S.;*#O
M(K&+!-JK$_ XC9535&R8;J!L?8-V3>N\.2AU(L)5"6O/HYXWK]!\@?F]$Y=3
ML^)#O#_&TE%D! 6C8&P-KT3;%A^6YY7ZG#X%=>.YU5U7'N!63_Q7\Z5<2%,O
MIP^==^E_<#.)#Q2ZQXMQ W2_ &J'42-C16_G<*NO3=TJY4;OY($^0Y7W(KQY
MPR@6P#/:R4@SSV[&ID&2"<]0^:RM 9F*OY3)^:5CQ3I1@I[[&S\1==^V64SP
M$Q%U^L(+PMOD!4L08UB=<2'2DOHHQ3X[#UR]XB-+LJ'Z%SYXS_&\N3E$VE7
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MJS&%WG*59@^E^48Z7EG:\!Q/W[%6R*$Z7_2#'8N+8@3DZ#YE#WSMI %N,T"
MN\&%G:O15(HG$OFKD \GGRHY:]%AJ33GA'YI_!D*XR6FS[C+YFU><@%.G>U<
MD$2C7+7U@NDE57G0+Z-W;RO UGS$9\]BLD<')M+='YJ.= E]>1(T)JT:3U[7
MTA8Z@U8AT%@=5ID7'U9GR",$[^NBYNVE!DDX8GK!^XL2?*8>Q;JVCL8/+5A?
M&Q(#X4*GOV1]@[_6)5F.&[NKJ$TU^G3N566'/ )FSP+C]1X!>N#4?,D8#@8(
MQ+HA4V]MR_7_8N\MH^+ZFW313B! L!"<X [!@KLE01IW#1!<FL;=)4!P:"QX
M@A-H"-"-0T-P#]8DC7N -!K<;OYWYIWWG75'[H<Y<\Y9YWQXUOI]V++VKEV_
M>FJOJGHR#>N3'I'(I8K\H.H1>X,Q,*QQL+IHW!#TYIO5[*,<$R==1L[&78Z4
MWNY,MD7(RLKCE +!":HRD 5^KJDI5_SMRP&M&88DA\U<_2G(O@BQS'J]B.5F
MAA0?.T;$LRKUPSB1=L>WLS<5AV3,Y-:;#WB^>;V5W9R7 LB$Y'D4(SK^^NPJ
M-6YE:_?VA81D:8"W=8&6U?/FEQ:H$V/372R.OM;4X=?*X!]=LOQO[!-_K%4K
M'3&K!IK&E]?-,#6I<KI"2_V^X7UG[C^/WYYP[T&S$ 7H,A[RS)U5)_I75U_I
M.FE6\D!^_')GML>U7?+XF+?NP'(^0)96%L0 F^8^@(+WA;[K@"7 ,H_!,+^U
M/.Y(ZJUTD1VC)^IA)WD%3LQCPVE+RXFME\N'U\,6=&T6AVVWA!.OYD*;F"#Z
MTWR_K!^8B+8GZJDE"%#YU-TDX>P_TCXJN8HJ@_#^.@5ZC:@&3WCR0&M1O-0)
M3$6D;AZ]]@GK91*)\Y*A]4;=KFVA:<_*?EF+48YSB9I/>4M>\M0(F;W=:1*Y
M[B9^:1>M;QGQ[,4>Y 5NWJ'G##'GC*&ZTM4=HN9K>2"[X(>TWB66+*5#\ :7
M38J3SA^;.BPPQRS8].L(=U-*07ZL?SREO?6,7;GX>'@67]+MLRI4]=[^A!9#
MJ%\P+8\("RBKJ8)PI_L<I&MSJ)[(8C+*:_T<(=26-B)^O2CZ>WT.;HZN0=\B
M+0YU6-F@(2,';8B?AK##S+12)Y)=$[."^2UC3#O36'.QD?S1IWAD"8( C2[!
M-^"Y]T' U:T9L L\?=8%,HPA5&@O3YLX,\WM$ O7J[>,!UPZ<["<F&=(#)Y-
ML;9'<!KC ''W<;ZOK">L3S6#Z5?WJQQ7K]'TAD<$\-\4UJ,GGZ:ELCLGFU]D
M+PQ?C\N)=?V4>! 7#]I K/QL"\UO'\Y$A9J&6H2F2E=W,K?<(;^M(0<*RY=>
M4NOE</1^_;%.V,NAR3>*S6#KLYYVD!B\'FPUL*J_>%K:U3%K$UCQ>WX@UG B
MCN<7+Y7<?%B<AAQJP)7^!1FT\@)/?P:&=VUPA,\9^MEL0/ITX#MEGY##I]=,
M?$)D+TGMM\5' J9/Z6. M1>^OPH89O!S\GS23$R7=KZ".-:2Y+"F<=6CM:.&
MZQC628U_W"!8[P$$TU6_]'C&_N)5]X">VR5[TW*5DQV?-!5?( O'J'L"Y&-.
M@[%(@/1XH6L)ZONN#FMI'&F!N-[HW"L[+!L/8S?_W6 N$UA&7G["SJ("IPNI
MM@+P7\0Q]5V]]LSDH8D;YI;P?!?&R_?S#(/8D1.ZW6O0?^+;I.#?(&JPU9Y^
M-/DU>.JS*I?RV'&M@A805W)5;FCCQ+"B*"GS7X98[>G#T!)SP.FUNNFU8_ G
M3"87GH2\4Y:"LNK)?SVVS68OA'(JZ+4EV&!)R>'5<RE1XI?SIM0I'WX =<,S
MQ+$QF. 5'[%>X?L<*N'CU/4]>_=:.^PC/N"13!S'H[+W?ZN]>0Y-R@>55:\-
M\W&_T3@GONG=3VVQ'EJ7B8R#*]"Z_'LCJ1ZIZZHT(&$[W-X<07O^.*ROZHGD
M,8F&Y75P,/\L=(7RZ09>U5VSY9(H/?5DIF+U-_M^:N?+^J%0!U@UH_W%Y6]Z
MC/]_X=9:&"Y\<3IR^ZJ[4R#XD3#GZW.#J9VZQ6(54M[-!?DW80+B.[H.YCBS
M*T=DC4UK!Z2(][R_K""2+QHY'6DDCUKB*B4_A"=LE_JD:\&^TWWZYX? EEY;
MQI.-9:S/'-#-4IGYO7-S+?E]W5BJ\;E>M.)J>H0\C:&P;%B[9R5JS+(F2$54
M(GB8LH8Q\E4TMI<4$0W_?&J_6\!<L;;*( YW]>KT+YY?:$,;\J-J[=JBBB[Z
ME,J?196-B]\A0.,_QE*V- \(H?<K5LWQ:Z==[Y_\/60/\:XO!,;M#=M;C9+]
M")^'*-,VF$<I<('<Q&7Q+B2N@<@:8<13T!0(U8[<<^(E^&Q:XLY%CJJK%!L2
M9Q=&:BOP&_TQ']9_K>@E1U&+!87?[MS79\LQU;70\U=0LUP+&)7/>VIZ3F::
MC12)!.U9WI7?ZF<2G[E&"]<V-\ZBS=B_3H2<'6IZ!\4'59[Y,6>OX9>4CX]M
MUN$-:,"=KM?HWZ?UHD)R2_UD\/; .LSNMEZHUE[;6'VJ#^69/JF(3U)K[Z_G
M0RUF"Q>N'\.:[A!5M1U_";'0/3NJ?=\.K!ZLN]"@]'*H98<'*UWK&X?'9GMN
M7+X]-BP+/*WYNG2&W#5>A[=$._(4CN0SI_#''A(B,3YU8V/7D7JI!3MK*EA=
M%%ND]9R13X#LFK)\LSA!8/PT?X[QKM16-=IB7/_N;0R:F1R1)E9TM6JU"0&[
MEB]$MF[DA=7F$Q[JMZYJ;_>[5HX?L4PW2],6GMX:(8L:;(_88C!]7&4:RONS
M!L@3SI4?=?]6*\P]'-.>EK(NL]AKNI(Z%\EL.IM3=R5K6.3+=?M$%O^9AB;H
M^[JTQ+1)6Z@%L@C,\_\J=,HK8*[8_*YV#+)<_0Z+7]0"Y00U^K#$QQ:W)6:*
MW.V(=UGY <Y+4"J_JBQ>V<5ME%\D?JK)*MK-G,OT=&S-GTAEG3<K*JW=+WC5
M$6W([((SV"T-<@E]^M.G-;CC%-E0WF/O)=?4#-DA%X_]21;;8X^J+(MMG3X0
MJJB^GB!R0'GM$7ZJ^HX:GO<9D!YFIOTQ'Z891!.P@@R7LLM23>"H\>SI%)N$
MHVEK"6X38=]ZIQ;GJ7OMX%K*([^?OQ"$/ *] 9F8%6G,!63DX8&)Q\0SO;6)
M17S:; [+L3$/W1QVW!;:%-[NT;V8\EK&S[=:UIG:3K*5M1+8Y7]%-O.!A6EX
MP%5L;^Q-YQ%Y8JF4]BX*'I50'\5).S:E:,J.0<4L+J7%E:.GS^D-Y5W6BU$O
MU&F(NUOU?>5T4I$IOUNAH7R%J^P]QK:NGZ46J=N0I17NJ^J0A6.;$%"/D2)3
M%)Y5\5G"I:5DC^#%E+"DY(G+-1MYTV.^S*5$6!Z]M:Z%Q8\='QUS)U\W8U2O
M(,LY,<XD=AO- \4NHZ+ZK2/%<->R^5V2O1QG T-V9PH^7\HDW9_5&M2'4.&W
MPU3*# D13TP )EPO_+)>@E6OI;VA8DN7!88_HE#^N9>7/MOB*T=SD<J=[-_H
M @=)WDR;@,AX?"G;$N#-M*H)-\5[<:($B2K/2=L: \O@JN]S5I_:.$1&[+Y+
MH4QJ9J&AM];:->G,+3:MONK_!++$$YF%['K' KO%1H@$PS2_/1,A&$DWL!V(
M]>)25:ZI@4,EJ/V+3ZQR5$OT4@6P5H#=5&\%I)6@0+:.XKY@L#UOE56687PG
M"JM%[J3V,Z]'SXY<31/?I/'A1:1B\ZRI6J1A79:6V3R4>!._F-8C;#OI1D=I
MC8?<H,,('H\- JBOF):PS=,&C8=H#I#B3Q;5\4DIT*#4T1/1;-/>@?%,K[_<
M(JP^T:2,QFV: @X-CRM_!_O,ZT_]WHOQ@^[S52/18+6/S2\?L'BQ/.RRI^W#
M,_VGJ,MO9KX\=UI9J:  ]GR$KO85\1QPQ_S\3-S*;7CE-T,2SN>3/Y]58R5A
MMGNE<5^HV")!\7@5=^2L5EYAES:RAW?2>&^-@.K I7K:H Y4)<3G"6AY><A7
M5>-1O##MW [\M&ON>N;34+YXR7]9[T^A?$W"XB(FA1\A^,O1[$&I@MZTMYFD
M<0-%@,(M]+:.]36R@;M">5>4DZD>CJ!TO*,_(BPL=SJ9-YY?,AWCF^>M,6!1
M5$S O&QF;9\P7SS1A$9Z?BRJ6-C+4<\8@W9L5=J[2J_VP706F&#W@/V''LM1
M;]]<7(W<D5P$<95/E*I[$$E/Y%=RZS"R)/,PX_9M=''K971U3PBY3.U3U#OO
M.53_O)$O5G?WQY3H>)=F%#'G#ATF;\*H="_,.NHCOV.8K)G:00L'/D9.W,F8
M<*5;8E-='H:8BV_%GV(HQD'+=PTDX!!S1\/&<^3$N7UCAHWBE0"$P!9T)W)X
M#X@6II49>3.#KMZ:8>$DRO%2_\@E<K:@2+$Y7WA )#F)[)[:.B6;Z%GGX;XH
M.GG5T0IK:(E:4_7.W'FU2*&^S$1#DI1G!YLVGMJ<+51)UH$%*PHOG8$DLC."
M5>P9 M>B:KZV\DYJ+9FC=LZ2O4,]":#MUGQ"4Y@*Z"$IW%**6!CG+UZ^CW^H
M 0^/G. "*XIR#=.&W'G5 T?J3*@FVG'2>-HO_G73%/.LBW \#FR'O_YH/]72
M^7=/&FQ[S_C\3N)P*;?VN\-<3E^>H>]1-J-!<P*^>Y.XZ]K$R.TO&J]RY-=6
M^'ATW$#H4Q-ZLIY/I@O&ZIX;[4U/XV=(NA/;/)\L,3;1^6%@(,OA1X3QP<&L
M&9FUENZ^Q)F0)>IT?R*,")7(%,$^#"&'ZEO1WF<B#2RI/Z\Z$J_[[NK +CHZ
M>:F#.NZ#S(>5!Z?4/,^'#H151P*YC.YNS@6J'1 &5H#BM\?<D\9-,BS??J&M
M6MJ07A<,.;(BXK:M"H9JX<W$;HK&BL$#4 <E)G7B(;SJU&;\FG+&\)_R'[&U
M]; Z2FAM=C#TZ^ZF\=I_!'^20C>/^]C[\*.U%-9JGVC,/20(5$M'#6R-$Q\+
M;K*?YV)OTFV%"5=4Z.S_V,^9Y64"O5-(+2+$^TPL9R6QDN(6G*A0Z=3JDVCG
M<AI_;8IGRZ@VI\NM_/BG*/_#Q+ FA;=^,?T!LC$WDFR5O)^LKJ$E!>-L;:^O
M+?6XR07'?ZU_D78$M^L[^M8:.QH<_Y >19:MK3T-*@ANPM6C[#S!:+Y9>!"^
MI[C?/2ES#SB4'5TJJN!M*Q$I%<EK+4WM#)<:@BI\]:^K/<\63)$>DX8G\C.>
M6&C#C&Z280>"%72:-[_'0[:OS3B>,&V29?Q)[C5C^MJG\WW5CM^F#6=J-BHU
MBG9+&FU'AOG)I/^0,ET=A**WLRRFIJA+^3 3 RF-];R?>T9CS&AA=9 5NJ\1
M//MF0@TUZ7\0G%R?S:L=,EF0*Q#BTM$ _'-APL3;ST((=. 3]$-E\D)'3:$4
M@1"U[;!@#K+)8H6W#B%_.</[4_ K]<E325!NU6,U#\6T8O('>EE:CUGEP27W
M +^GJ%H0ZBQ_%4JX;8!TL6Z$-;X<'5_UI1L64#3ZC=%2LICQ VCVXYF0(4_@
M$89"T_1OL K>O/CO,8V-KCD$2)ZLD^D/J;7UP 4S,V.>KL&WC^AB0.7SRV8@
MB2 1W]=X@;&\J=8?"L*-\D2"/U=/BIH$;V60%7K_>:C^'9Y:;Q"U_X:M7APH
M7=%JH0*0!W$?@,I>@U3OOM\-W4TUW$W]V I.GK"0=#UOM/>1/E*V17'Q2ZE^
M&FPJDP9INI='N.(N,EZ+2%SFW10F<?%UAPC$][N9+?X(M:<6*^5\"I]YU%N"
MQ2SP48YYD K#T^89>9'+@.;?YC3_-P#COW16[QN^7DTLS76>5TI-1%M30JW&
MVX0?NR;(F=T>#S$>^HWSF\V2"<1!&C"^!DFOU-+Y@>0X6KE]SU$U&;SY/B9G
M0M="T?YF=M:%^<I9+'Q27K7RR5_/D>;<AT&91_Z-)C+9[B"IZQFP5>KS0PT-
M'[JP]0X?F/[RGY!E%GK)IOF\XQY04[B1S'@H^@Y.^V3 ER(@)L(%:0S':\&"
MW]:7L<8I^5C\=F?<Q:'W%1>O59OJC3C7/1%Z__M45)9E\*?ZS^^(#D9_[ NW
MA9O.#]#GG#S$9AG12.BYK_@]@,K$S/RG%5XP^;19>"D]:+K&)U+(2-:M#I>&
MML1E/?+;RAQKZ4\9ALDY543\ZY9,+E 5@DOEVMF5IX2XZ)W9_K4R?DD*Y8H(
MEGO<;]3S-[J(/SPUJ+MJ?N3JKE,I;<><=.YW,!-.39 D.91U*88P[^QX@B++
MD4DHJGWTRRBXW=YN_=@+&G585M3D2Q*/TPOQ@^"A=P<%<?OC+&K\>O"]SVKE
MBJK0GJ$6Q%E;41PG/*%0\5!FT5X3KRM$M+>TQ)0K4V";,6/2F]M^6P8Z&?CP
MC@EYI;]WH+M,0BO3/< JD9_)W]I5O#_$=1'R$'_5,_HR^6';\'-;,I;IO3OU
MD.HV].:=X]W[E;=3WF!5S<,@T58:9(Q"1S*:RUV(%[>TH3RGC;9>-#6\Q[>K
MQL,5\R)SB<O8&HY@U"C%,/VN:MNA$YCIQ8[&':I+ Z O8VCH% ()R'3.%Y<+
MUZH'M8$LK::';1;9O3]EGN9,]*:,5/XH[8/)T#=^.;&SR?)ZOV^F"2@0.8%A
MF%5>E].EPW33MI8GCGQO%2&F_B&/^;X=<P11U.[*4,<#TUZI/P=)2]PMHP4T
M2?#*\X@^BQ#+C5/%6V/BVT'-_$+-D6RSM34WXK[@+9.=R>Z'RUUI61% JAP1
M QM\T8>?DJ;[W0?IRA4TAI?GW!R%7??*+^F"@F1KS8+HY[QRXU]Z<WVO46C7
MP6'.5+]$V?);\;U(@\@/2 ?,W+$?]G^J7-PCGO_!W1]* +3$H)#/_E#W8VA=
MRG-ZJ>TS!Z0#49,84IS<>K =VB?[[1B4C'D1=:/$MCEC V]KK6M9QC^+Q60B
M2WC*Z.78]#!!+F%E?[>%Y>?.TC,D.LA14*%LB#SOG$)GF)<MPM3N!,/RD^S>
MN@^+*_;F7L*1>:H"@9GQY9V(Q:?G(@:_;V17QS%6MZ*J?UZ]&PFU='>TI<WS
M.>+YE7FBG%!RDZI*/_XM_)OJB<WO/=,0,=C,@5"@9;&I=&^=N1+S>TPV+_G"
M'#[)\\#N@:5UJH.X'8YROH"Y.WCSE,I=Z*;U0%KW$G/3-W0V;$QN>< W9(\5
MNEBE%B\5GBXQ]-Z,FEYL)<&-:U;(R 7\FQK'%4G:FK0DE V><W9:E6.4^RGX
M31_%8<(5:O*HYF#OHJU G3W\M&>=;<90W8)C-\0O:RQ94F:6>OO ?I]3;*]?
MNM(K]#&HB8ZQR?6IXW%WN9)M,,B#3E7;I<!1]SHC>?N[FX8-:\,,[FE<TMH2
M=9LCS_YJDA^K#D3A>;2AS@MY[(@GI?:4'-WR7HBU:EPNE/BIZ]WCGAM.."(8
M:UL?R6)<LV]#/O0\+R9ZP5^YZXK?,/2"5OV(&&B).$QO/".H&**KIP*GIAH?
MN?)?JJ:TT"HJ4]$J^&C)DT';W4Q?I_0\BU)>U_H<Y@4@!)3D()?6E&V:(SC-
ML4\8[>7Z1;JITPMB,!.2>I'0Q?*="URN3!Y?S2.U%2]-'"=^4"OM?JDE?1J)
MDR]Q[W@2CWIOW.3 7%IB5\;@WH1:@\EA9P4JJ<[:NH3[[ K>5]UXOJ8\R4W.
M$.FHXWO3AL?;Q\PS+C%7K*W:E'6Y?+4K4I-_56!8LG.5":TV1Z$<[7!X;M2E
MUW?+C,["/E9JM2RW;[NJMP&WX?:.!0^/6"2$QS)F)-XUF/PT# A2=W>W8RP
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M,5N<;PV7$"NBP:>7V9!=XN4;P6]\Q=>:*,5*!T90;/NYZ^^4=[$BB;M:C=2
M#''AGZ=]?O&]$OH;,G0(6#MWO=/37%_(^"KZ1_S[;!N.0I;(P$>$>J[]2C3.
MYG[3\M.GF5/[!RRJ)1"QC8=( V64FO,3!IWX-H:'RD/K4$.E;?;+URK#2_$G
MH>';AB$L+?> J'Q\GYR$G_< U)2)IBM;):,[1?H%UC>^K&?DN 8O?45 Q!.]
MACPK?+"?2TPS![Q/8K9R#3-J2[/1]EBRW EIFRTC*[RB#PH"YJIW[EXTS-[H
M5U[X\_"M0\;TJ KZO1.'" KSBW&Q:8A#7'Z4MA_>I9;=2 3C7AT;">6:\K&I
M9M.^JG:2.1+K]_M]\YQYO\=\N=CB,%@EY'<^ NIZ#P"LN)Z.-'OQV-[P5+VQ
M<*CD20%=GE*9#G,/H!G>6/X@Y1U-(1P;"VM>J[J(6+][.F_DZFTKXNE$ BWM
M#6%H2<)*M-8A6KJT,M;8 G]2FDBP6>MX<D?.%U4$RW2$4S$H,_G;F,:+%WF]
MUAI5$<"B><&<_,%KG$#3>[WVB8GS"1]K:DGJVNNFAAP['WW#MY_? []^D0J\
MHB%PJ47</#F>A@_%U?_5"/MG&VKI=1!THN-(ZSYKS:RK[&T*P#RG8$.B5QQ9
M@8SZ=ER1J>VW 30)<7L;<@@2V&"93RB[8N$@KX=Q^_?(0L\P1+Y)^]%$C+-S
M]?[VC*A\X)-"O!Y,R-U>PN \Z2_YU$SG!PNSTJH6AZ,%S[_$!5YFZ=:E8!*9
M#JX[CX35=..^<ZXAE./^:,\0-XWF\@U-%MT,#(H8GC!?CD)(AK#SK]R:^%RD
M>=K+5(D4'4LC3U4O'X=QW50)%T<P=G49O,3P9MA.JOW*VM^P5I$E:Z]N>FX>
M]H')?N &)^V4K=;(KTEAYM1WFKLF?S\M1-1T,):M!WZF/$RL7AX)R_.M9$[6
M."R+]Y0Z:36MAKR9D%H6%)0D9UGQ\' #T(7I*2T".Y$WNK>X3NBKY4/^3@84
MWD\A:OM,!P-UNT=\F-&B&$\F8QBNDT 3I[2N!K"&AH;F&93T<[Q;E<6: WCE
MKUB'4CQ<X6'F-J*V+^4'X(V\M^>HVEX\ZF"1X7N AH\?M6[2,)JM(=LNW@.B
ME*ZG3+^_0K;-')G3?B=UN.O8>(X 9ZRU.)(+)4W99_'G 5L9HN8<K_O2P0=Q
MZ; 01$FHNNX)M2/\)^+L8.<J>*$@'*M\C2=@?-D$Z<V1'23KZ+4VOFOJ[9@
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M+G;3WST!TY+W#MBOX29)&<*P,WE1=JTVPTO&8-AH*K[6E#'9.XC#QQ01G\G
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MPB=M2K$]-107^M/_,O@;;R(:Q:-VVQ<$\_;GI2:U/$NI)_"39S;3OB20413
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MA;63I8V0E1-$&&KA+"PJ)"(,*"A#G2VLP#;N')8V=B!'1=[=6B0O!\A:D==
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MG^^O10B(KU\G)2&E(2.CX6-A8.'[/]QPOP"JZU>;B*"$!)S %2H"0BH"7 O
MCL\+5PG^UOX9( FN$!)=O49\G824##^AXB9PA8"0\ H1X=6K1/A43N"/_SU
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M).A<?L]YLT2HL<2VFU'ZS(Y6Z#"#:A#!&"KP@C'((\5\F_X6. :TEG[]B[6
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MD!=:J5V^/<YJ8MM6%]6>. "]V=$%N^G0L:?]%6!W&%/>@_GC@/:"U%0N$NW
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M[L[3%4LX5%G,KVW3S+^?A':L'X$A\^@0CN>#[H01 :_P:#M"/\XD\UAONH$
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M9SBDP14C$\3I[A:O?GDE2Q;VFO-<($OL26(6R;%P.+9^3W2REZ"C$4$$;,Q
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M66LL4<GU#B!4#U_;5,]UAV1+G>[%)"N:STMI"8.EMW!2>S5+L)6][XI;#41
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M#=\)P]5>=>"\"&%+S M[YII[]RY[LB7$2\V>&F>49*TAYY%4AF@$@Y>6%\5
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MC^>/2Z3[(GL?CPIGAQA8Y3/S?.A*+W\8:M'YXQ[G/9<1KF%//!$@#6E%CW7
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M2+M>N\6N[K.64O;57S&YK;^H^5V)9,[,>\,1J6\;UBRN/[_IL?HQ"N1)^YF
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M[X<-922K^?B#KBD\;&;=61K[5<X8>#,20UN5%^?A7AU7_.+]O8>;>_'/K"X
M>@9<?IJM(U?>*UAG =7 #)\+B #K]7MT4'NQFR@)@.;-@'@G1_+@^X!#F>43
MD+30/I[NY9K;J!U,*6Q>>.7HR330S/QK,HN?CM7UI#/,3^T7WGOZ7 UJ-4PR
M5D"EAD)+>TO."%#56O5QN80+<VG;^Y",RT9/ZA"&=*\1QV%FF1L'Y X1^ZR@
M]QQ<C952XSUY/8'-7$ !C!A2_[Q>-,TGWCW3FD)F-N>;92UD00R(*'\-*9C3
M%Q25L(<HYK:CB,ABL.IE2F?^Z[PO'QT\O\*H2'#P_+V9I9]\!+H!W;/-&K*$
MOEA0A%J,OAR2&!UQDKR5M#H];:'&^SV3^P7CUJ!<YJ>T/;2H?DKY*VPD5+CR
M-#<F(5\CL-Z?V=[@4[)T";G I[N/?"XDQYP<Y3;]WD5.!'SP L)G23@>-?F(
M[07MR@0O:#,>&1][^C9_4AIS@G 7E^G?);OB4S<;F[K<)J+.J.#\#%L#!+&*
M))=VV+]PDFS_T'*UVBU'.T>>0SZMTE#<BE^,]HVBGJP]$/0[@,HP!#YF/6*V
M$2B2R]@A>J4ZVA[LY78D1 1,3T]+UEL=R\HG2<L>H;#C-W?U2N:F==HGI'T#
M&GW3EXML[<I0S+"<]U7U>*SFN-;=;WJ#7Q(Z_897X:75@EW%!I9//.;!&%6#
M'4PGS%I,*K-$F\$M'V%38W?'QJGG1IOOL:&8#[NNLC[V,PQH+UK0_,F2^: .
M]I(("%=<I)VLUVBZKO65C-]XK>[*_N U5]8AT.D6;^GP-L%342]BL5%QGLIA
M 50S4M7R?'Y?!_B OS)ZI$?VJ1W*38KP[%H;)$]^U)<3GXCXG5>3,HF JL(]
M^$;O@QL))I:@:'C?IEWQ&41M^+!?MN2P1 IA$"3.W>%U[N>W']>8+IZW34 T
M^<"" WOF(.]F&&MWMF+S6HK!>:SBGD[!P>WBD(]YS#^N>'?W_.C>,*S"*U_'
MY"+,LAN7H2S><9*?_.69ACL+))^6)>V@NI_;(<?RK]\)?'XS=(I^)K!Q]S-G
M!*Q1L6!=+B EM&'4 Y5^+)0W97GG@0SWG8?7TC'Q*N2OR65Y%Q+PL!/H9U$=
M'R*@A0C@&;<KO3+2=3QHJNHWSZ[P"]GCY.[&5_E=7I>L^R9OVX7XNZ;WF5DU
M>TJ#%XQ&[R@PLA-R^-.="CY9B7V>S*G18@7$;/K(D!?*L-F$9=>>_IK.;NQ4
M?L]":B%\GF=.3B1[GB8F?@,&1/@]^QHS^T$_:<M<*"3TJM'8KT:K^<L>='.[
M9RF2+[XUA:&:$0*31\*UF="$9><!)A&T.$P6H\L_GCF.7G[G<>9/ZITS0M1<
MT%31+4.2D.H3]06<PW'?W9472O8#X@-" XUWM_.Q8MNM0PCNGGG31M0#T 5#
M4W813VA]6041\*-#Q]<?+E92!$S%TWAF-R:H[8ID9?D+#S[1;!J> P.ORX><
M/ZJ81HB0M;Z?%S304SJ9'L0WTAE7*=-M!/(.*JB415+J2G%2YTX5##8F:(Z@
MNE&JVV0//L@*NHV0E\AEK"< E7_S2<W2@0:&I]G7*!BR4&Y%T$Y[Q[:]*^72
MD2DV9#6JC+M4^^AAOG^8S$G(N2_4%(;ZY)3MOK<#]$%C6Q)%^M=-DU_6')F\
MKX^)*Y<TCN%:<$CD@E/G\RYI;1A:E%?PTV3<SBA2\^G,7PAPGF%WV%>7HK-/
M$?GL5$#N1?FY=&AH,OGFQYLW[U-5SF;6^SGTS.,.X0G:M.8BN?PY5XU_%-&#
M[>GZQ&@;9"_%QWQQUO<WM/^B*^E6GMV8<0P:JU)4;4&>$0&_0C]+Y2B,'WU_
M..^=Z.1\E[GWVF)0!KUGANR&X1H10">Y4<)WR#A"V::4++D)VA5H#):7UCS.
MUI)XP_MS6OJFI>\YZ@>^)'Z#QM^9&S40 >FQ3[++&Z6E"CVR4/^#N;?ZBO.)
MNG6;0(*[NTN"$]P)03NXNTL#C3O!@SN$3G!W&H?&W=VET:#!G> Y^7WGXMR<
MO<>^W'_!N\8:J^:<3U6]H];MD^%B$[UL>6!:VUD^*R3F\1/=A'.7'"G= +Y+
M\8)\TO!4_Z+^N[OPO=SL1;^6O4'G?,'H[QJAUUGKV&,]O,!UWVCQJU81,M;Q
ML_; ;5+>4PVMFM OT5/ 6;"'0+CMK@\3GNSDY3NL-Q?M_-BMV=/>0X:+?!W8
MVO:!-7U%ND<02 +ZX+X/^43P6,0:H23'N_42P4DYQ2KMK"[HZ6.4 F_Z\3^;
M\LTB'/?>&<"_MQY3(5+]T3+O.%#I=*?G^-F$7LB-P$1DB_9!AUI5J-(OD/28
M6%\X2G]*L9W8"= \[[Y:.C#ZX=TU;2.XCM\M!!VSD,H@=BKP^''-"1AHLC@4
M*.-3%;=S&M@/@8M!,HAR0.7&1<=C8@L-&_)$LY$U=&Q516.((2M2F:%:'I0F
M_?K4D:(&4,E6<_Z<8KVUC=76$9;OY?+Z@FL$J]._5@Q@8UJC?= $S?P:495M
M]#CJSPW9O2B[K9VM(;,(W.+ZO)4 ZR%!TDG!J2^Q2^C;+](&"_/W-AHI0!^H
MA]_;YD3=X<4_+E_Z2VUCVTW+UHI^<@W1BS)D>%[#]EYME158'TRN_U]=(!^L
ML_/L?'\ATY3B1YA5V?HM:0H[><!2"Y84\LM(EJL$$!K:\*]I6-3!C2\6TA=+
MX>;S;[_#P;>5KYK.GX]YQ=5Y@^HA'YY"LM]4\0CQ9B6WD?Z+3!#0_]D@R:2U
MF^R@V_O]!0@\X4R "YCJBL#[JS5GZPA4-LQ[VU^"))IM?<4"H?^4(8X#W/7/
M**E29:0LW.XFQ#<.'#>%&5,<?2T1$Q:;37"\#S1F;I?#.B93/:P]!-FH)LE!
M>ZF?8TN-#I#D\-]L.I<=QJT(8DUE_*B^B5(2O*8*E7%>-&9?(AY"_++XJZ&F
M,7U;%_H+,ND!PK&Q*!IF)XA='DE Z:8JH=BX3(CDPV3LU]=Z30-_6&T_I9RH
M7$I1B']3R4TH*+$Q<A!4TK QP@.%QE=%7V3Y#8@S+=Q,V.O6+M#/Y67T3)L4
MU<G1D^BM_'%PH?MU+R&^D>']X'-\<)D3R<X[8?V(6SP&^O7]<Z<"39)EAQF:
MXO[']L@@[&ZZ+]D[4-#POT"WV$1LP'G\^2] XU^B$VJ_+(G24;I\5V;=:K+2
M\'1_ @7OP5*^AJ7CMJPI! ?3DJ#/(V8/> 12V>LCI8=G^6%"%YZ]/&L,UO3U
M)G\3.1^POR'V8J%W)'A>\]^869W<C(,^1!]?/_]WHW'KIIK<;A*\J5-W5?GO
MNR<:QL"2-3U4Z:&?>_+[#]^='E!$6FA"-:N?G;8C&\8HE=%%Y'F?F@M;@"5S
M9QRJ[]WVY)B_K^:/>UN\UU956=])>7R1>PF(*)S1;>UL6-P@49(=/5>.*L'U
MT5A7',3.#$*!\[QXJ\4-(=(+47AT)=P>@IUHXMR?,L; =DO*!N'UV?#W%AD@
MSCT1(J1W@B*1#F\$>4_.G8[=N]2,7*_=Q3BBKW__G]B+3@#5F!MU!%\9QW.!
M:_K 92"K"#JJRI?K!#L5)1/[5Y-]K2Z1@,!=S^\ZF;\[!2\)TL432H^Y#^/3
M-[(8)]H]D^2+-S['C/=!W#IT;7*-2A(RH I%WCD#K66S#NI&9.0O0*77>9#^
MI'8TRJLD'?I^R F0HG,/$(A:/*=4M7D1.)+RS]?^36V8C$_J9O^$OIC$Y^:0
MP7Z%JH\K4A3)B>QGLY_",I,%>IU=@K \$[9)@'\!%!NVCYT%9O9F(,HU^'"]
M@#;<88ET(-.UH1KC<SOTF>8-%V#DP5;QSVMKT6/"XVOGSEQI-7_.X"LK& M^
M1,D(?3/&ZZ53;[OD^GX%-F;5.#I>^A3%?@V&RTTLMK(#!XJ'?AUYAZ.<5C,F
MLWQM#-'F:DCFR7T8#:WYZ/$!"UF1/=>C=F[&6&?'WZ:?OB^ _N*NP*4D8[AA
M^9SH:G'Q<]RV#QJO]4?:#YN<F.TAV.N$93O#C93XW;Y\5:$>H.)VW]2PMI?T
MA8+(BB_16A9Z[^89KMKB=5BSW3YKP:]!_F>;0=451HW/'+YO"??@[VJAMLGK
M*AFHO&T)!"K6%P_*3$P*D=>(YW" 1%_#;B"Q7>.OKDC?SI:*Y:X[AZF2S2F&
M3X(W?@W\D0+@I#-='W7$!LO_H8GW<AL*U?^M$;4QV26G:_L;FX(979WTO8FN
M^(930CQZL(>9F^N9U :90)0F8J8%'L7EH6%XSDX._C'_C%C((1=N7IRZ;#HJ
MQ<>'^#8 'L8;_"IE;$&Q]P)67B].KU^J=!X"^/\"/LZQ5#->>D7S)> _2US2
M'XY8@"R<"AA^<*N0M]>EY5ZCR&&\>8LA]&$U@9I3OXVS7\E8S/AL4VG.JKEI
MCL.\T<^V(:9EM^4M3ANTWW2 E/Q>&UG$AS5)9_3<L=#(M8P][;!!!\%EVXEX
ME.\X[L-BKS?OJ?2):C<D68%_<QWR<UNMS=;S!1YD0,%UJ&DR= ))]W]Y)@O(
MXZN$Y5M'3]I:QXS"0 !<X'7O"1=:UAH5ZKN2DVL?D\?7+K7;NO/_:)-KX:O'
M-A1O?;_#B,J%/]BCHKNFY\.#$_6/)GXFZ?: :PBYVS*'4'V%]Y/!!7QSJ,)
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M,#,O1SD1$>.S0)SMG 5'/,8*/C;["KYTUYF*1RL)X@;OD0BL1OHXL#MLI;W
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M@8I1C0=%I'!^6'OQANS\"[;ON'S?'O =X4AA0MN=#3XG]I&%R>^HEN>Z [
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MF>OAG9[#CC7W7X ;@XT33+'+"00&[?M#-EB^+ETS7$USW'63QPMG(DPUBE3
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MU;JX\<[_7?F'']5\VC_'\O]A[JS?HOJ^>#\* DHITB4-DM(- E(B*0T#(CG
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M1L&38>+:SG5*P\ES>E"#W7?&-1TC5<L16B#[Y0_\LI LAQ<][I@61,^Q,:=
M=@X;18?0KTNRCERA)_,4Z[>?%2Q?'E -/7UB[]ZG1%&)O28%!6'EDV9+;M[7
M=1LH<]6P5"#]^ :S +32R\ITZ)7%=R[:&[J*(958>>NFS_<HZ\[&_4N\=)1
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M;9<I9]:;IAU,/TVUR!>-8N8NO!ZCAWO$U-[G1=7R<,XSA4J4.^&S58*,1@-
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MM:.RN8VP6AIA<6;UBO7L-,E7R9S%@+CGY%+?:6TWG"LT.9U+M-^3:'L\+7D
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MP4_JDP(T.U$*"ZN7$?9@LWJA/:>O\(E\/J9!^#M@2U)P$L$K<G,Z"[?!M=:
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M)ZK1XT]L9PV%DHN11H61\5UI8L:3X1H,V3WBVBL;,>4G?&*GHSZQQ(?W_@^
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M8_ 2BQ@!U'2]Y.Z/1(FI!)V/XS&I7M(A'HJN.86YJR.?6NDQ,17#3XMO.6B
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M:G.Q2%Y"*!O(W2R-+C/V1":((9E9J^8&@YE1TH7*DUW>32#< YV1%=!&VUY
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MG92C#0J6JJV& 0]P+T(>,C";D>1W$>NJ0Y/&DX=;+'^<*R4&6<&1-_),P]H
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M*NINY;XQGN(?1R-";AR/4$A4[%D92E)US\+K4\7K@]ZDI_&:BBVT^NNS9FG
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M8Z)Y8$2B>/R![=EB13;;Q=3+G+"W_V?K#7'&OUM@-!OW,/T(.'GQI_V"^!$
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MJC!,1D_Q/$\]WO5F-#%M[+X7P,IRA]U>K\VZ<@^[,?EWDW%@E<U)#6,))8<
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M7_NM_Y2S8@NZ2.MN;TI5:)K1QP^O0+OR.F$)\Q40KZ\AI35P&"\,$%P)> 4
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MG&:Y[T0L;O@?6&VX.$LE%P6FDFA-DPO"O=^-C"Z_[-?I.S&G.=5G!Y?J7D7
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M1=5R%-W6'P$#[L0S#S[+854KL%,[-V,Z'Q6'.Q?P2H>+)8[>PK).EV/2:S1
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M&O>X1(S3GKYNY9;3O$P4=0[LYQ&3UYH]2MI5[4_-_GN*1?U_TNPOQ?ZAUSC
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M?/W2V^L%D!!,0E^^]$_6!"*]'K\J%I[(?V[JZ"OBDD_@&\%LI^V@'5L$WOH
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M7@:P?^QK94+S,;#VHT%TUY12<ZS8,+0;<Y0O8-Q^'\>$MW)(BW(&I>V:R@L
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M,3-?9S,N:G!G[7IU7)1?M^\S#-T@W0H"TMT,)24B"!*2TMTUP-#2#0**E(2
ME$B)=#D@$M(-0XCT##E(77Z_]_V=]]QSSWUOG1M_W#WS_3SKV;-FKV?57GO/
M[)N9FQ6 ])&*N@H  H& E-L7<(/ ^*T,=; % $U-@ L  %P $R0-8-Q2I
M>A3M &#>TJ#;MU%.[A]7@ 4 ,,:V&0"<VS["VWO(+0"&[;]Q_?\& *HVWA9>
M-GXLSVV\;.PLO $ *P7\IT4I;BU7EH+Y+W1K6NJ?-%A   #2TOY!_\.ZH)P_
M1OS_UOU'$Q(0$I$2$)(2$F 1E)02D) 2%?IW^V[] -@ WH %X'5[];L-V^>W
MUS]HN]N^6Z_<QC[F/7MO;W<I?GY7+SX+:S=+&SXK-Q=^J(4[OR"? #\@(P=U
MM[!RLO%FL;2Q<W"5Y3AHZ>!@<;"6Y3 0U130=%>RL7=0"_"TT0UX\LPJP,E*
MTII##D*$+P.5@KJXN]Q& 0O4Q=G52PHJ>^_/T:5NZ3^Z^>]!9#RM;:5T'JK\
MG>/V3O:O9_'S\^/S$^9S\[3C%Y24E.07$.(7$N*]Y>#U\G?UMH#RNGJQ_GV
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M@XF>1_,O]:=J\_-^ZIX]#7DC&RH;8-#?3H#,;$+EK^KU3>XF(8>\3G,?H;I
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M53/*99U.N9GEK?T-$"1-?$4\"8GF'7DZ<U'ZLIT(RMI5^W6*3L0@RU[APK4
M\W"=7(&67OLH.87_T;F7-OH"Q:JM4[4JUJ0XWSAOK,PDR4$?OM\Y+'5*._#S
MX]>&M64Z<^>X"_.I:EH:?W>9<<8B^H\5>=B(/.FCVY(^/05A@:K*SXF&D&TU
M?A^J9S5Y +L!O@AYP$T,.((N'L+$ZG0W=M(6/P>5\.Z^7ZN1M &2I)E.CH(S
MD'=6(54-Z3TC#G?(";/2X51+PM\R%_?&:T:G/:AW\VM>1^>O,HI:<Q7OJM.
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MEM4H5Y+A!: ).!@,R=6?]=)L9C)C;F5)DJ9ZE.W2#B*M$G).,6MWAH=?BQK
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M/S(8&SF7O)M/Z/ +$8]GESR2JDXCX2\N0+-+Y./Q-:4W53&>P?Z='L4+3D:
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M>6Y]B3&:[H=Q,5)<": GMSM=KKR*2H<YJMS[UW6!6!F5+S(S_?#;A),"\DC
MV>=.JR-[!/ZKRI]_R-"-V)2(664>%6?9*V"^2"A,"6X-I@ E7BBA?_)3PQ0O
ML"(JLX/CJMP8XGICV=AH:;P2K+'Z=YHZ**>"!WS'(,VKQN^2N;CM65W]!X7)
M;BLJW:&I;J=45"+R3 OUI/#Q4\=TK+J7-=]1D8-J'J/D\N9/T[^J!.V</JE_
M@) -/AH -&"I_I\W&E5SFT^7\]&40.")04='_=@N>_M$M65#0YC&H,@PI79
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MVVR=PS<9KY?+M1D1A D)28+3;>[Y^.V $13'B&Z_IBQ12S=&:+[2(S*.5(7
M*\V8EK:_DR-BJBWI;R.]GX.\_IU_&N\PE1@4"IEX82X.+AU)N&[P_%?+E/\
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M4.ZMG[M;F:4ZN$UYCX(*5#P+'Q/-R%C;B5K^QZ;#_VF ;V;_$U!+ P04
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M@RD;!S\_/QL[)QLG)PNR!XNCNXV3@1N+C2/UGU_PW-@1ZF!NYV1N:T/YX][
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M<MVC_]3C/'\$7@\_QJR6-DNQXHZ7IK*:TA)QNGO',4&5;\][R8.YI#M[C'9
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MIA[NDEL$++>P<CW,!!D+DOXNDOP9:&->=VJ\2*$[M0A@<4OK*'2>8/^2-BN
MXR+_VBAY0PMTI*R2 W&G'GG[!6G^ NG?C2C_6ZQXZ3WD*0D__G#]\;I\4)4W
MB/+ *9S=.;#)!S-\0Y?54W*X,[?%2>TBL:>6H-H>SY04Z:N+J\.O_\Y/E1:"
M)%?44Q2WVU#$/>QE93OM>6 U6*DP]VAZY1KX%X69S!'0.R\6JQ$7YI+U 5;:
M#PXL7S>12_[*M#CM?V*\$1)F71;/*R+;4[I6D[,&H>_R'L[ZVP,"@B$:'Y=C
MPR2%RSXHZ*4_?$R8D;(1 R8\2;0]:)UE+JZ<CO#&/1VQ)N0,@BU'-X4DZ/0/
M;L21EW>''Z^^K?=\O&*&.5-I<^GARY;A"$K[K4<+JU,FM<<0@(V;YVJ)C8F?
M]X;+3EO6_KE:XTJU4E.#I?3\9?@S3A65D2N%KGX(X<&7OR<G:D[!HKX%FIK^
MR3S&2H>](AG<\2Y/HJ;#+0:MKSLS-+46*93IDV'^JF:I]>5,3!3?^I".H?]'
M'T818AP^-"].HMA^A5MDD104]%Z%<IXEZ66PO7E:-]@YM0PTJ5=B<4!/+"YL
M>(6+ /1 R7IO%^@[<365,VJUQ,>5XA((8I#)D0FU\>?XP[ 'H3E@EL]QA?JE
MU?%ET1E7Q4OJO%*0%.PD8-09FZ/?4;)\T"Q\O\)2X+Z&LSD1_C?^^W/'2+9W
M73JFD&]Y]U1S/']3PW@X75N:?DGKY9@G CCO-="^52.QN<]A HTVX:<Y']VX
M9&O<P(EFNU]W'5QY>6^1RVLVZ9!>"%SL:DZ>)(9<'UUM-,F:4O1% [B1/Z_N
M@=]R79Z@6(BD0Z=!JRSK][6C/\3KYQVU<^9GRS-VK\532!AS-WRR5\Q2@\[F
M?N5J&\+D&MYIS9GS;SNM[_'X3HC07]TLE*U3FE^)/Q;!C<_2EG2[:)BC]K^2
M6]3Y"/8ZBHG.'*+NYG;^<?) LO;W'O?'@%B8L>3 :F -L_MFD^]GWW,$T%/-
M>!AKJ)'BEDXBKICNJ98T,U$7M12][RSV13@-7M1]FH>VN9&OK KK/R\ZT(LX
M)+&V,0/;9BW].%EI32K^4_(7ID]/,@XB9-VT(W#-(EC:K+QGSE0<Q$ 7:_A:
MNH8,@WS=&JK^MG&DV]2PD[6 :D%#G&J*HFD6 8QX8H-"#1_>T@(E!C-_+@L.
M-"8+MO/$]44 &IM,_K^R]97OZU,= UC+PFA#OPL""/ RL8T_F'F-F:5Z9XNZ
MM+TE-DSCXU+DAB2$\/SI_M\E/$U-BFK'%#WW$00@:+W?><M[G*@/ 82:]"O1
MY[!J6/%UM$R3"_^>RW-I@G_S:8O?"2E>K)91@@+'9?4/VP^I:55T;(?)NI&[
M&,&_S 8C4;A51UHAH ?EHB.!_OA(Q&^E[MO(C("T1,$\<1@-5MH8CAKF[J1X
M1[QJK(<)/9(SA#]<.QO]-%KGE]$AE[C=*XI[2SR^"IG9OR<^^F>=4:@+TPUZ
M71BXWKU:HEYM<T8 &ZI'Z#?0\=Z[49X4"KK@$T\)9LL5S9US:8*,Q5+CD!LU
MPJR"-7&9FF^H^I$?A).&8_5"#.V.V(>-Q7)+Q4<&<QY$*(5U_3KOCW @,X?#
MY/^-Z/&W^+='DYKTM5*+\W0>503@(;8,;PQ;NL)0+%+;%7_3$ZYOLSU*%(/-
MB7M9*IOB4]>+ #0_VPV16T2O#8U$\?*K?\_/GQ_<-"BKT($_2U'V33H2(E ;
M2(>5",D@B47F/_-#,X;G!M_.%L7-S[RBTW)0;?*MA HB&?1%'#!%EQ#$@U9A
MV*FJ7, Z=+^]-NW\X6Y1?*^#<WC6%H,OOH![X>R2!S&S7G$,<_U]._@ODHS,
M[QI>=J1<_9+.RFJS/5(EEG-_\9WR^8\?KO)ZIR?$32."N<A*.3KH1CY7(:D$
M^<]4XHYM?+7N/QHZ_B6AQ(5'^,X@*.\49$G$E"EUJPZ.SEDEXN1;FGQ=6=FT
MHO$\1RXIO!$!H/5G#MN^]=U0S/(79!Y5RBS(%K\.)^G":KJ"^GI^%TGTD*&B
M:@UZEZ(BANKOAYG!8ODLQ*PIBB*#CUZL'<DNIOK^%1]XVO=PW[((BIHN]PA6
M]_FLZ_,KK6T+Y;4?65/M0.HMM;X?%R^K>X]2?!JM'A:2DRH=WKI==\G$Z"(T
M=/YR;-2&E(A1>&.8S"V$V6*]S/2U@L[#0$%2]Q0NF3L;\:P#V<LB,^3U=4P)
M11Z$U(J"_::!?%*XT3^.$DO^^XT<;&;&,F> U"Q.0WM>X89DD?ANKY]AZ;AK
M 4;<G$.Q\_/S\^3!#775(FS&?9ZT9\XZJ8:GXE]M<PGJAPEA70X123BS<PT]
M=6"^ >)HO@B%NP8J8@#%A_DV*:;5C=$H<UWQ&K$0L]8?.OXR]:_\F(:%?E?L
MZ?IM!_")'W,Y^>!:AM4V+NV3J\GD+-NF_<+/00.)&H.N+[ER9 D)T\-O#QT*
MB8M'FJ18[(7,ZY&HGN.UR!?YPNA70M-B[S\W>*-*@KE;**=ZZIZI"X=]G6@5
M'1=;$GEK^V6T0)H]>" 5OCS\1=)29FK_&U/Z4.W- O,SLSDB^_"%2GZ1DUZ]
M3E!/!VGS,JV8&+G*&ZRB9X2/0&XU"?>R^ 0DU:T)%#3O_HJ9JG22T\D/S5J_
M3B^]R+U,6_? 7C^<?1,3:7 DG5ZIN]?*6[G:YU,>*G6X=OEB)/%!E#"!/>5]
M?0)\R2]H=<X/'OH=L<A$2P_SJ$X[4IZ->;*=CJ:8"Y,,E,G?3BSF#"N5/."_
M]/0A+K X8#*YO2;CU2L5C<)BP24@T>=TA?^0M1'(%WN@NCR[[ILEU9\:=$!+
M1^?BH1 45(*,^^E_^%[Y'X7\U/BD[N/.&K<L/<F[[%<6%@R9(U^&3_@G&U#-
M>)\7EYL1G[QNO[HCOJ;!=<E18G45+U\5/M@%\5T.VJ8O6 PL($\W8!8BL;W7
MHS?OW8X U'*>S^X\%S\"H7EQ#KV=JBL3T6DZ5\OLU[SR:'!DRU'8=,^]Y&@0
M\;D>\R8,57\[[VEZ1:T,>-"(#,4=,C((6KL.66)"G/A.A1^LX1T(GB@]E)D7
M_RY28*WAI@<I_EHYF#(%YG[I?CD)*H! &8],:V/SS13#^@%4/^ +.7*ORW1/
M_W<VP?]R9+,9)"UT+Y1]YH'!@1?9Y.^-3%&J>CA1*/WL)(1PCJ0U!HDT^K>Y
M3SY7EVF]'AO4+-8@,'U_$]V!3]#IL1\_8>T>:"64]UAE>'I?-.\C;!^]0F.U
M7/FL?0;]>2#G)S^NRCT!GKA=.71=BT#:Z:X*/%ECHOY4*9IP>_H%=B+*$*]:
M:/6&DOA\QWQQT 3;70O[,QP<M@=:6=$I4IO8<'2FEWTY7]&(6U@:7EMM;>E7
M$A&%8]^\/'1WJS6OOW@!G(5)4A.C"=K[/R'K7LE;$&)A3M&16I2/41Z\[H\J
M#ZDKI6Y9(8Y26B&E-21\F?!I:6G%FK3E0-OBOBKX]68_5H93M 8+EF<T)\%K
M,O1)HMLDAB[+[4\#R,6V$^<ERE9804+/%HS*+@C+!@6-"PP77S4"LBJRJSBR
M_9&C+)%?XQPEC0RC5XBW%&G,%#X4? E[2N7^^@/\4>O"4W288T(?YF^>[/\'
M\C>T*6@&"D'03%'GS[L"C\([[0]8';A"7(36Z_.*IB8L[FFL1=_T9"G/FE@]
M8!7\E <C5,,>AY97\9$YK^2,NW%M^C!;VVY=G,@PU\M%AM>3AD[6V!QN*5E\
M%LYT#HZ_>K@99FL%2>]TI*:+5H:K$:M.GTPRM3WMADH.F5] K'U1*9=&:S6&
M:B&$R2\G]2J">]]NKMD_$-B<*@@QFEM\N:/T?2(]KN#E%%I6QQO&-ZTG6W@)
M=W;@=M[%%@6%?A/"B<" D7OAUEP0NE9>]:L[N81R'56YL%R[9PGWDMR[XA['
MNEIG6VB&I;(L5C4X/29U8<W.CA?O4I&^M^$_YE(0S*3N5B)P$:R.4?Q&%*=D
M-I"V;:RVM#C OD?[+MCNEDJ-+X$Y$;L,MRMK'HXTUTU]&(^1#6&4QE,[B2^,
M=^30XG(0 %8'S/>>K5EJN"8$XM;6E=8Q)NVT2I-4MP'&O;4>85YY"QMBF0WZ
M_"0&JEJ=4/)&\1MOT;8_L%]-+>CTZ7;6GFXX1=)HR50'&9/(^$>AVJ -5J[B
M%)TO$2$XCA'KC-X".O!A4[?\T";BKU.]YLP66)2$4]]NS,EBKU(G\8%ZU-U$
M%=^R<7W)GVA66_899EZ&*F.K==E7QX<A@"RIX>(!V[D][LJOE"6E[R6,W]RJ
MIB6Z([7E$)(+?T\ 4^-GZ?'HNW&E5M]0,<B<7E,7^2U T,8[?9$&Y<MJ#J%A
MZ=$TVX4E)%GNH#9<P':'9[N5F/=%N%2V0S6K=6 ,9_#R%'>=J^Q([>QF9[A(
M1RL"B(@AZ0'[?[?DE=HS K>6'%?(97U4%7\!VKV0MFIGIL3VT0[;O,/?9N'Z
MNI8%J;?1B89!X<'CT.3]3I/IFKH>GR.%TMV,?5!4Z*06:W+6M(P]SJ[4@COO
M3B.>?RF%0><-FBURK@@598*)S.W S)6YA.%8^ *YA?6= :9WFP_6>>+XEGQ!
M"M [ZWXG-,MM /0EC*];1JUY]#ZO9L#X6I[SC1CL;D]J;7>KW*>&>"Z)S?0]
M-W4;8XO,U ;-7K[H5^2'FJ?%+C4,/391A%'/W5>C(:]:Y_AN47?\,G]*.M<[
M>9.CK4 K70VRXF#]D4&,8=_G8%D0K31"(XZ4Z'Q)%=]\7R+OF+2-WB9X[KG4
M]HL0)RN\)';[#>6Y/>_W UM%(!K8T#1U-PY>"\T^\=,%,67M;&KT)7TCG*'K
M1WT].?-,H12CG1B+$HL'@1,\[\7<A).BY'1VET[BFHF.)4H8->--*B^\1J"D
M_NB"3V#@T'1H2B\!2H;]@A#CB-EB] ;5DU>29+)[V8ZOF->QLZ%]<))LNCV7
M4%MWH;RI%X-:[5015.71,H7VK\^4EQ)V,76];QM87-\=MC4,&^B>#VJAK @C
MEKE<KTCEBM;QM^>Q8^]M/UPH2VXZ8;+-8]+2G"&=EM!I#G>FH5"_27R[3KZD
MRFAK8[0<<.(YR.C^+$,<H=#Z!,83^G98'54$3U&%_/[$?B^DO'*H4'C0F4Q?
MDE6RX[!C:3%3CHY$,*[N"8$-*/Z6])LW"]XP5LX:XD5JH=</>E)X8M)[W6U-
M1D/Q[W,$$@( OB3=I\5BNK%A<O$F7]L&V.J6KNZE5[VNO1^F]H5*M\NMR;K[
M*Z.R83<?5X6F"GNU@N2_B3D0EHAY0/>*!&XJD8++51_?A(@X%^;N>.M)NX 9
M6X-"='A=A]+HWMG0ZO"0<S8*!$]NZ)5_S*C:'Z#_HKW<"*=SS$:S%4SB4"W;
MN:NIMZ;IO;CM-]L01?:"\[D?!T-$&REI4H*J3'UHH49%K"<ZV%-74P,44EPW
M>&:3S*"&N[S$HY0YI7^4'?EEWLK)+6G=!=;CR[F<5IM$JZ\J,TFHA>W*M_HR
MY&#LG(Z_(7>]85S&9+_I\X3[R$V3Z7":2JQFZ'NM6T-0NPUEZUHMDW,KWLI
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M    :&%L;RTR,#(T,#,Q,U]G-2YJ<&?LNW5<5%_W+WXH$4$1I%.ENSM&1$!
MNEN:H;MA% 44"0$)20'IDI8<D.[N[HXAAYJY\WF>Y_/TZ][[C=_W=__X'%C#
M/F?>:^^]UMY[Q=D;Y!1R"7BH("LO"Z"AH0&O43\ <AG]5,8;; 4 2DH *P
M=P%,-#$ '55Z  !H"J%@ !-51D/]ZJ:D_O87H ( ]*$=*@ ;]0P/=2\)_/9P
MY\^H/RX D#9U=;!T?"QG:N]IZ@@ 6)\Q_J1/(I3><CYC_K5<%Q/]IS*&"#\
MQ,3\K?PWW:(E_5;?'[K]V\7+S<LORLTCRB/\F$=8E$] E%OPWSY#C0)@"K@"
M#H EX @\!N10=_: )^H3-2*H68_YV,;=W5F4B\O1C=/4PLG,DM/<R8'+V]29
MBX>3FPL0!WD[FYK;6;H_-K.T!CM*,!W60YD>@RTDF'0$E+B5G*4M;< O?5TM
M-7R5-<U][<Q%+)A DO?OB7N+>CLX.UBZFS[V=K!W=!/UEGCZI]I%4>7?'G,]
ME11WM; 257\A^Q<$ZD[BZ5_ZXN7EQ>G%Q^GD:LW%(R(BPL7-R\7+RX%"<+CY
M.+J;>G,XNM']I8(7EF[FKF!G=["3X^/?[DW-G#S<)9YZ>( M1*U,K03,+"P$
M.,Q,^2PX>'@L3#E,+?AX."SX^"R$!'B$>:UXS)[^I7D+\[^V[NSA:O^GMBW,
MN2SM+5%3V-T-I0T>KJ=<_[UMHE3TUT;_K?I1,J(PHM*NEJ;NEB]0)/G;$'-P
M\W#P"&O^/L2<(GS"XES_A!/G^J>._O^@+4EQ"W-1\]_ZY.3ZY^8U+%W^:Z-M
M#Y;\!Z/R9S%13_]<0-6/FGPX.#CB7'_?]+_J@NLO<P]5^NM,17$^_A^X_E]N
MY&^KW=(1M<2]4&L9.8LR(-A86'>P,+'O8-VYBXU]]QX!+DK']XCQ'^(1D!%3
MD),1DY%2TC ]H:1FH"8E>\KYE(&9A8V=C>(Q%Q\7*R\3*QOK;Y6@8=^]>P_G
M'A$N+A$K%1D5ZW_X0C8#!'?1-#%P,-"> N@$:!@$:,@V@!;E$;#0_G3];AK1
MT#$PL>Y@W\6YAXL"5#T$T-$P,- Q,;"P,%$N'"T ]3V 28!%^(1'ZLXC-5/L
MIRY$O&^C,^[2/2]K(58?/J+G,W,-PKE'0DI&3L' R,3,PLHO("@D+"(J_4)&
M5NZEO(*&II:VCJZ>OKF%I96U#=C6S=W#T\O;Q_?=^^"0T \?PV)BO\3%)R1^
M3<K,^IZ=DYN77U!>45E57?.SMNY7:UM[1V=7=\_(Z-CXQ.34],SRRNK:^L;F
MUO8.[/CD].S\ GYY]9M<:  &VN_7OY6+ "47.B8F!B;V;W*AH7O]!B# Q'K"
M<X=02@W;U.714]ZW=XF>1V>4M>#0\:D?$9NY#M\CH>=?9H#])MJ?)/N_$RSH
M/R797P7[FUPS !X&&FKP, @ $' E&\;\#3WLJ/0#+86XUG+Z!]'JC]D&6_M@
M,QB[@YL#6]?LMTCIF/*\G37W+;94)!#R'@:]N?:&( $@%PFLGC4XGUF41+\O
M(\K<FSYM)#Z1N^%GBD "F[.M2 ".!4("M%D(BD<=2.!D?QD)W*"G(X&H\0#M
M&J>N]&*UP\MTQ6$3?DCK<^]%1$ #"OU& PG KD#+&>).2$!R@18)-+.@*KJE
MU2J>/<;_@^,/CC\X_N#X@^,/CC\X_N#XG^;8#R3RUX'11C2 !:-+I+*SZ\#'
M1FQZL]V4!WI/57' 9.:$-//!+_(T@S9BAO+,6 8,RWS3VF6(M!F798A4L;LA
MI$A@K=P[ 5$WBP2VZ04Z)BUA$(0BTT?(;C$4$2-MZ.#W!13\J*4-0B*%XNI
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MW*\H-V)_([64OL_B7O^B*M)I'_RD2_6.9\%%A]_X?:[.ZCJ2>@AGQ#+<=%B
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M1IS4CDD2VG@:,P[MY?P<=^ X^\FH:U;GW;#K,X2>T1.4K>SR=L!ODCA@62R
MMAE#>]QXA4-[535F8F:.&Z=<DMZ*K+O5TC=L*KD]?Q4797W =4:-H<$#T>PQ
M!O.&BT(Q[YXT6YFF+G*I*Z_X67V#0U<^F1!Z]W5F]U+5!83YJ/&;[,QW<]"5
MENB>'8:/1%4IR9Q!Y]+2 UL3REU<%9WZ"P,I4W-_N=R?_)4JK?!SMD)[++L<
M;_%7O_V]].MM&2,#T![H;4T=YJ?U^4Y3K/W.@LK1%/QF!A_'T-5\=R[<UN^S
MTXXQU,822H[B>ZYO[B>[+%*[+6;;V2(!XNSQ31A]S+:?; UUPTLH>' ZGB[]
MX&::/FVJGV4D.=G.:G+9Z03BO#W^_G7L/%?_+ISA(OEJ\SV[N"+,#N4".8S/
MJGPXS -$=YS8Z<OO:H6]).29S5 5QL[?;8:ORHWX2ZS(\T=0K*QL37^+W $G
M/AR-:GJ(1:;JO2F!+S"D M-!L"K9M9%0<%>/5]TEQ+4+J3W!2GI_KUWG]5PG
MM7<G5&33WW+%V]^@4"8_0L#>29_8H%/>BZ/MC7D?;J4#TRA3S:KFJCHGR[Y#
M *2T+2DFE[G>Z61697=H,R\S;$?XUY]>T/PGJ1%T[H<$8G)=D,!K@ZA;6B=C
M4^/T:PDDT*WQ$PG\X.A$1-64^.L<F9R-[?Q".1&($7[V5F883,6>.3,,./$.
MI(6;MP?RP0+.H3D!)1L2VLQ:B&%64ZS@?(Q[S1[FE^.HL$F#!@T)?,-'**L@
M@?:)TF!4D&,&2[\-0:V6T8!4]SC;[R/E]OVC[[Q<Y.XC@7OFS:!3%$-W-XJU
M#K3\RAL;\09T*8(*LDB-^HENBU4V(-Z-$:!U$Y=6R*_$(_Q; '+L"D%P1OUC
M0Y-N,C03N2>@!HD_L']@_\#^@?T#^P?V#^S_&+9P6Q)O2/P)3.45$GCOV;H'
ML1UVNCE<E&?<KYC>O]YSB>C,+?:][^:U>*QYRG6-OF-R)=D1FR]8-,NB\=YH
M1$Y>ADB3A$A-!G +)$4"T9\Z(.<444A Z=QC1$=H&7))UF"-!$SSD,#IHK41
M _ ;\O^6O ?#2P\-.M.>A.X;<_/,S#9/P+9X:1E)> A?9<&E'M-(4%1;P+]Z
M?/-VDX[?57;0%BDRC=]5$\)%KQ!$TVW%7_BY%F<LY^\6D:K1HK^WP#A6%8#1
M'OJ2(NQ%['/^T\1T#H6HK\F1N=^H[;!5X2S$;<[MYL6W:425D?-MYP0#ZY]C
MR*D_\*RE?&[TV1S"4*8-<X9&K ^MC]S4VQQD5U[KS Q_7Z2(Z7N-X:R,WS]Z
MACX9$DBO[QUE$-3RI";"Z4F,G548S/(SJZ!@SQM\EK#E-[U>Y"O?DI?39\4-
MDZJSBN6][*B0@(V!'L>7GN)WQSC=7.L6,71;D@T3I2$W=![?E!RCBI4\3"UQ
M6ZQM'W:@5QS<,>0AY"93]<SK4.:UP<C-#&,&,L."CA&CRC4G9[AY'*9SI'UI
MSS[%#EG 8I\]&I8A M1^(]498P.3F>S^B#8=;DE/1=Q0[9:6%BH:*6*!_]!8
M_%>)N'\1TJTQ!-W#S8=L75-LLR4W_1;/9D"F2-61P/ Y/]J(VI^[C-8/-T'(
M<I$C@2E;T*W0]*2\X>(_QZ)? +7?Y?O?$]IZ.@%7;C7,E[.^:+>.)&3BK8.3
M>^8OAI0#I@&VF,YU,K4K5SLY;7B44,CRJ+HB7=&L/":'8!&#HF9*+0;/D\'$
MJ<NP_%6)4"4( 5Q#?]P#QY'?A,1PF\=0>FW.0*)NKJ,U1Y6'\@%.-[5WB9L&
MG._^6'2$F-ZU0-U,*YKB)[(#^GD2Y]XGCW.4<7##3Z;> /15L,BL3#UX"*1L
MSNY!TY.?03P"0V&4-G$/;T::M 7(EZC058C-N#XFA60S?B5YN^PC@%/JOARX
MY:3-Q>#_*YQ7\P"(O+NVF4V1^ZMSS'_ZD5ZD2+IFNBJ-8UIL&V9>@6K'6B%!
MQ9.H5VEBXX</X/1P61LNQ#P#2I7NN64/.QVJUFC<%.Y>1@F+N<R=1(^\8=^B
M$8YJTX],=C"W/I[?3I]YU+UIO7?I$"1NOB'V[L&BEW !A,BII.A40E1,L7[7
MX^<87:3%*"6I&R-9W*?;HC<0_.9EN'3K57]-:(-2_M;$A:\2(MN]]57( ?$)
MQS(AB6K7YCT<KT%C$<I(OAGOBE9>[\B9_J(STE&N/4ZL]N*9-H:IJ<=!H4%W
M0;U;S\1G7XW?*#(F?]LA--EY-/-,WJ=&[.XX)\27LQH6?1<!"FC8J(=B[![9
M.O??;U\KMZT0F^]W>ASP@XV@FI_>X5?^L^>Q(4S"C*G62Y951ZY;]_,:>@4Z
MTP/$VO@\$A:?K@JKSHO!H@?UD^6/WHS<&/@5!]3TZ[5E,HL7YX $AA<Y?AY<
M?C9_^\9O"%O16 V6H#6R43]R RI<#(B97DDZMKK;YX5I\=Y42KS6R2F^4>:0
MP[PA<D0Q47M#BX.*X_&#)8\GOI]9[U;ZD7GDGWDOM9^U*>+%DII_,0Y#$\;8
MNF.#T?L-!OD@,"_4"K,1_07>=\GJY^B+L(^E%41'>RST7"%ZD,Q^*87"LO-3
M@U&!;J=D:E%[[J4D*47E5*6\>#?Q'#<Y+>=2UAB>LTBI=-612NA>Z??ZJM&;
MVN]\)$_!/-=S/HE&4\"2,S9UF2)^T.G=)S:9/V8B<E.YHT2ED\WD62X:=4\F
MTRK16FTEQ28FI6%:>SKY3@RI(<DN-H6$!+BO:F,IW\[A//:?;I?W6J7V!7V,
MGYBX"DW-ELQCIUE@0W^M\F5=?_F-I*?/5"W980OV]PEQW*5/7TD";'^-"31^
M_N1?PT$S1;?J<ADZCWE_,[I3X+4W_J\$_15XB(2H4%.,9JU!WJ8_'][#I3NS
M VC;[Q9%OMV#W@.M)6Z#SF>1@)R$)[&*_(A]I00GAYAB:%=5J*2AWW19/+N/
MF8JZ[?I?;(B6AXCQ_:?'NLGVT<U[16(/O[][1I)7RG)D'73@+[\T+Z3;!"O]
M9/ZS_E-?M.FXPC<1NC>:T:,3-:!E'20P!EL%W5 B@7/BPO<:%=%A*3-U42M>
MFMU&6<'S=& ]S<]AS]@#[GB7T"&((;<J-'Q(H 6*\EI*"<N9K;A="&%8SAA6
MI(!A>A<3OVOK)13M1.42\BAS2-PH$QYG8<0*TU\AU+;3N].=\7@I1+JK974D
M3V55A6ZEN/2=9$O]/H6Y+:W]25G- QVK_H;3 :] XO4ZTI8(.QT8?=U$5KXM
MA5998C?N(.AKX&H%'QZ6F=@939Q3>R#]L#_VM?3611/#V'K( .@^F>0HK_C
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M!X,@@J^F/ZX4= +B<ZNZGTI3RK,5V60Q)"[A=_S@:O!;#A"3#*RP7X/@8?9
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ME0<FU6M6I5^BF2"!R<KT*YR<FD=3FP@22#?'$&07Y8"M!"8F&8XJ$/*.[Y"
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MH0'+4::Q*:/8]BK^J^W.$;@FIF,H7^,+7D^0_/.EUR\/A#'7WMAUY\.Z?9"
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M924Q_VAAGE$S_"7PI_J7?9FX?]F[^9=L@4B@T6Q6:KA$@'*B3;7$)<WP7.U
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M2&D8JXUX2D"5I>ZS78XC-O%"QTH_XYQUN>EZK;:#L V7M*$?Q)D"2N"?VA2
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M/A=BK+>_K1=F<C Q@!A 1Q:/GAN 49YX/$H^,XSE[F]AX[^C?SY8)3"B(Q2
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MC,6*K?6-[&I/FIUK5>/XI :;WM1O3G7;/?T2JQ4)H".!H0C#$HP5R46XNN@
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MX/_-^2H:$*RZC3,CV^1M7[0X.V3^<=3MW<GXR<H;NP^T]\''JW'U,_CC9$A
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M<'2(CI%[PIEKBA3>C5'G;#>1>S/X!I-R*M0TN!I-H=4_*VY,T6X?DE<X$$^
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M-E.H;:0\+CO+:](4<XHZ1=3)4=Z!>R-%-M'M$G$K4K)5I*6=>I)KP%QUX\A
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M4!($RXF-^?4SK#<NRQFIH4;W"_:W%.],]M<9WVPY"< FMZ//2,UA$[,/9S^
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M6?-)9PQ%6U_"9%<6/;F7_?F>WIC8M9+ILGUS&A,LR2%,_ 0C(NSU7]D7W0]
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MH0%"&7A!XWHE2G1^47LW#WI/NBWEF)K)O!H-I'A"]_T5_GKW&!HX@\<CS]!
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M1=T[9!NW[3W30P,>KX)*B1&G4FIHP*!ZZY*^$;_X9 _%T7C.A/=EV9@+EGX
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M0A2-T:BE2;9:</S:A\?R6M>:&+X'SGR].7S?CW'KM4TR/3QA;8!!X%+V!;\
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M* =YW<20P18)HA05 I8KKX,?8&WU7/?R&H:KZK3+#:\TC/*2S<U)7NN-5N+
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MN\S>CK0SL_<1^D:QE\U"AP]Y*%*^6O))]9?/;N>FQPY9C0..7[[=3A2Q.%;
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MG+SLKT&HZ.GIF1B9N)B9N61/\IV4_1\WR@> ]0@@ C(HJI/ (58J:E8J2BL
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M$0Q,+^DV4"\;F:=1A(N-(LX%52%ZR5+B**T5SP>KH[C7:@XW.L^*3CSA\76
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MUV6I4QIJGO9W54PNZOQQ!WBF?NH/67Q]?25]Y20]/!VE9)25E:6D9:5D927
M.R2\_-V];?PDW+V$_AC@HH.7G:?S?6]G#W?!7^<VMAX^WNJG?'R<[57NVMQ5
ML+6W5Y"PM9&SEY"1L;>1L+&7DY&PEY.S5U2049*]*V-[ZF\"NMW_._Q_- 6(
M!]ZCHNWI8./MX6GFX7%/XR_MN:M)_?EE_QC'X2)X:/PJB26D925DI<W^5A*#
M YS_IQ?^?I^:U)\4_N,*:$.P]W>+@^87_'^@'8 <@!R '( <@!R '( <@!R
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M 'X3%V%474EX/_5-L#J<3C&IQ&F6X;Z;R,>/_.*K OW%'+PWQ#YU>:T[DAE
MS-/89LBV)(K\# L[8C$.,@X+[*YD,%B=5OQ1[&/T.RG V.(>1#R:+/]K^]'L
M^U\M^.35P,I4Z/ +L/0U1BS88@I\]O/ TA>L\CXV%2&&^F%[7*A%_N %5,P,
M\R(<)*5C71J3'XDSOSY"@_A(/>U!"G*![C&_#[8= NGG"57R!0@C8GG9&&2?
M;LL;)]YG(DF=$&AWIM+:;-<<.+V!CD>,UPB]NHMKBWJ/-^=#P (+25;%8Q\W
MBL_<E&(GG.TGY(W/?Y4/TKZ>Q+C<G),:+^_TL/(1O: ,X/54&95)U,QQ$6 ?
MJN;G-:]*ZC#K^VE?5?\NC3<OA:LT=[7)M*\O7GR+K0G#UG@2AYDJ7GGA.Y-
MKS?#6%H<>%O5)'HQ9?/%K5?<J<<8/AOB6^RX/LY';[ PD;$:O+CB5?[]2WX1
M'>:K^'-^1S\1M0]G^;'S7[GYQ/6IH]GM8B?:&V[?4GN^'![9'5$.N]Q97&UQ
M97M_E:Q;HJ9FE2 T1*;%8E^);S).^\8V<NQKDGN0$(5 "A"J08<;BE13SVU\
MEYX=FJ_+?KF<KUT]MX;]Q97CMQE2:;Q'Q$T@-' H(6I?, I]G*#XP5JL?W.2
MN=(O'&L<EH>72)FZ8+4J0N<%=)UD??J*P'LC83P[[85G@R&SY;?GI)LO1#CK
MZW;[9=8N^^U9+/H^0C,0I*:E5O9QHR;5[PA2OC-0#LN.4I> B+;E+^&7QSF(
M&4J=3QGH.?3%@&/T)C>_[SINC^&D6I"'X>:5=02'TH6T$8'RXL+Q[NS'KW01
M;C:^=:F7$Y_.B3!\.*^!_T#-(-_RXUCK]6T7*=3T+IOIT<4VO8:(QQ@;)(0P
M^:$>%H6HAHOG\-M.N)9#=(>J?:HQ Z?B?.6:N$V.=/@Z?!#,%#N,AM?7N*J^
M*!_+5S,T3A<[<?&C,)]*$E< ZU-=P0T8 DZ'YPQ%N&##--@(;'C8Y4;<9/3*
M"C>18R;L44EMF#;MD1OP%M84\1UAUOO7!PP\H;3!K 2O*5BS1QR,5<UNFE]J
MAB5:C:V< C0KNA:X,,X/7Q)-/.4\%QNK<B+E\IC<DP\C-X6.V#D:=)L/%)4U
M9KRME$^A69FNP%NM?[ H@L-)2*+VOC*AU!!' :(\Y$='1U=5U*\HR]?9^[6Z
M][PJLY9716L_I>)7WMR+:1VI"25+!7_(5L!O0AD:1:8F.2R7W[TS0N0ZBQV"
MKKFM?SE!.W,;59UR(\07,J.P@N'4.$KPG;58_395+M5V'OO2*=WW4?Z 0Y]Q
M=$8+W]NPF!#Z+J5[AV0Y^<\Z/*\6K[9'^?PH)]O=\'CX:6*;:-2)[B^.92#Q
MDY+)I^%04@%:V*]%:T"#BD"G\ZZB][6']Z=-TO%37TZ]%=./:[F7!.^*8"C@
MN&?WX+5%*T]Q"S(44<'2 CEN@!NZ, 3WF@E266\>,JWO6QW3NEB8_N,VOB;C
ME*UT'<W4F[%\P652WNXNOV)@8?TR8EUH:6EL;,25K-OD;;'H092#/$:?@5OC
MZ-J[H=I?JQ"ABAI\%.!)PNV*Z!'AMS6UU1=XAEN19QC=QFI/-I94)ADB--!B
M?F^[.J"L:IJO%],OI886P:P_G2[**+8JK#J!<V3-:W]N'$8M?-10[T?]F^&V
M*'B%^=NAH8J4*Y+I#0A<AQ3(3'.\?KUEPO/GG1()A*+UG[<HW ,LVO!'-]&(
MW)\.&-?O>YFPMK5#2(B?P(;1$['^W+:!&$7 \-$J]PK7":U \?3=HQ,^]6$.
M9[MJX9VS3,7UB<,)AJT6WY#'&AU8'L$A):XF+U.FKFK2*VW<M7LG3[SQ>$4V
MT*(]<7=2K4;VQ<_"Q.)L6VF'E.'&N/C,"KN.JT.=J$=;Y&]?_*B;5F<I (_S
MWKEHJXZ,<LT*"B"YH'.- @SIG$5J=50'9=8:/Y*)'UB'-%$ +D0S,_Y0IS_,
M/:/$K<^#?MHL5>,JF)(=/L$*8@,MAF)ZF,7@,JM[\5 VX;^XD]#S^TX"_-]V
M$O('HT6I%Z#?;FX[@CE/K$0CS <O3=!O>ZLO]<T;MD+O 2<<EUY5S!:^")OE
MU<-V=13Z%[<;T8)\04,^"-*LH0!.]II1O."9?LS;HKZ+7N$.?O 2/1'W =4F
MP9\=+CM2A#-*%""V#C?OL<F[1A)Q6<;8C!_N(K-!XS6DJKZX-1K,(A@6+3C1
M?%_=\S9";WD\6[NQ5WFHXG$-<N)8[9E&E92E:^4F!A-BXE(6'E]^ABGU/S&Q
MJMF%L,T]Z*&S]8/,$[<+E^,PAD$([.XRK( "'":KPG4)B_MBY-ZT"?7J^*VR
M3<OR587"OMEJ?_IPM^WBKNM'A78O_T3;?%)FQXY4SCA48\*"Z>&B:49O*WL;
MG?.=6%#+]RS=F<L\<RX/O#WT"BD3=4?W\X-X%W,;1=-OM>*3-U4WKZ)*.]*0
MSXDCT^$6&,-@S#RN</IM8  >5F(M0^C"<WZ O<,\"6;V"VP^?P+!.-50$=ZE
MF7 YMD7]W7'=]Y8,QWE$)*>?/BJ2RCC'E<5"2U!M48E8+=S7\ZLQ/S][&_<^
M):L]^?1@YM[32BFG(OW"Z@06<9$T2"=2L>>"X)L2RWR]GOM?AZQVG%"O7)*"
M[@6;[&SNK&ZA8*0<J".&8&P%:UFN1/&[DH^/,TBX.@X3$]YZ +N6&Y!@Q:"U
M-*5%F"7<':0:'B>"L4/I[TKQ)M#(25;Y(!->+*-?.9S.IT!-D?5R_&"1D6@S
M!1 5<;6K.!E)XP7%&6.C@T7PD$=H^L6 U)+M&/Z;+>_V5E=@CE'PT5DN4\GK
MFGR7*<#9IXV;>:DJKT\5RN>[OD..B5V+4Q 1"8J7ND1Z-#6P.5NDCW=MJ1=I
MU7<[ 3WFHL$[4%X8/M+<W7]^U\/3]&Q9X2/3&NBX:@('WFO;M _-!!>MPM\M
MQRNV[/TH?G6;-TCD*JY3S]\#_DHW0W9< SN>HW3N91>&,3,Y08\@CI]MG^16
M$RD!^:E;KE,P76^5TVKC;?PA?K4SU6<2N)MO9"0-^SY_?%RRN37)7[7R&R%_
M"A-* 9P^J0GLI9;/,#.V:XCBYG8FCG[='%4:O=#KW7#=BS;SL^?*]VN5]7QT
M3Y,:7]Y#5UC'>4QVZ6_"AH@RAEG*'6-62.1FU<,\=.*]!@'76K!>;OU]CU_E
MUQX_2)PP__2VF8SKYC+YR"0%.$4!VJ3V=OLHP"9O-+X2N2-&Q,AA:(E^%. V
M2^\[:CPJEGR*H$CFH !QJ,W(_/7-;W*^Q0\>"7J1RQ!#Y\>>KZ MU5U76CH"
M=MEF16*AT^<)80]Q[U95]5B*1V:??N;R7P^6?(5^'LDZB%$)*^L;WM-S+WO
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M),IH!DXGN+QB3'4R8]2W1SF7&=SK$9TV.[/H^%"79-X^N[J>Z!X\/+45,=!
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M'6TS)AU0N&DED]<F+]FT\M#379-3#[SDG@D2,Q$4NJ\1'>-P65U2=!*$R>N
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MK+QO>+CV"!B(AJL<-<"M8*&-MRJ--%KAM#OS&KCAP772P\BF"R']5P))?/=
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M.[E)>LO<^@6[)+;_\S+?+5EI5TMK2<V'"G^&P)[)_$J+EY<7KY<0K[.K#9^
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ME0F-YDC@Y&3PQSL4,]MA,=0<Q!_*&*P@LFL;QILM1;,;(XO1=V:YTQV]P/
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M[(U.R[FBN/HUM9HOC)SF]E'"XEO-0OH9<X^:*P99*U*5TE_K!Q322EORW6S
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MR/;*N%(UDA6WAC-W>V&"8ML. W!=1,K-#Y"+F7"1?[Z&LA>:!Y.)F?""6G^
M#>>RDBKRD46[-&79V+^*)(ODP8E>+JRV3";O>L_B%)Y%RS;%V(.)X;A7F+]E
MZE.?U9+R%U6Z*L@H+'2?M7NZZX+U<O+[8^-:O^O(9$7#0J9%Q;.#<!]$T$>'
M9^.FRU-]]PBBU+A'\,\T[<:A;;Y6FAK=,Z9#!5JT-710*>?XF9V(M>MX)EF3
MC%=<XJ%A^1Y^3F#(K7(.N!';=9\&M9*#NG6VQ]=^21JY!SF+V8-S^2I<!PA"
M,@XNJI 0470__$TV!NBLGFB6QP!Y1;<5!\^11:FC2+-%J8BA)+UX@VZB'X/W
M'NNSEMS;#*S>J>[;,L4?/.D]\GG!$6Q]L4H(@$:N@I6_E-#[U^1SG*5Y[(M(
M\"@X#Y;M\U9[E'@_5_7W4B6%$L73SKV\#"H!$6]PE:3G&VZ(7IOX\94U6.!S
MO]NFTJ[]J*>69N3U^)'C@@Z-O&PQ3VS.8U#P2]WS3S=Y#\G)B;X7\PG!HJZ$
M+R[9XAIR]\,6A$=;)E;W(#T#B/0W3C)"XR<EGT TZWWTE3/;SW"X+-RJ$.X?
MKC1PWT!?GZ% @\&'V(@?Q+R?N)YY=($!8C*1G'C6X1T8X&WM0PR0.8=\BP$6
M%)'L#1Q(- 98YL  Q,!$5CEL@6<0M':& 6Z"X-C4A<@I# . 8.=$&.#+2U';
M8F>XBKOZ.0J;CZBC*<%?C++  WOH!^#]#U=2_JT3F_QAXIV_._%2]1S=R^LR
M9$\FZ'P>VT">TFJNRPK,M? X66E>TG1,#PC%?2E%S,WFG:D .D1FAM?"M3I#
MC]\,H9F_I@##697!L)R,E"#8XF*&2//=XQ%',%T2TA;WA.JQ/<)NH\ P,Z<7
M+7Q0J)^15+.VP84!H@"#K \T-?FYWS@V6/(C0M65LD$*E#CLE-_7?04S/^8_
MP9&G_$-CY9>_N\Q5T,TVCV-P.LLRM+O;TN?L'75'' _?\N(ZORW>?^Z]*_<-
MS0/=]-R9&SY-W6S,W@\_[""6P[&"_5#9]!H]RLMCYN_\'0,H9_SK7A@\#ZWH
M&.SZ&-NJ2U@GO,F)%X]5,?'4CA]Z@B,V[=SHTK:OT\ QE _^$*NX0ZSB2M$B
MU?+ ,ZQ"6;':2T++@P^RT=<8*=#^L$-NK.@<->[1PO9#L=I;P0"Q9DA;+#[%
MGR;#APS' $M&VD\N\2%O27(@S\'+>AB 'K1P#6LQO1C@%@P^-DJ)$X$!+D=C
MK4;6[)P* W0D_1;W\\%[M'._P6WWQ\%1OQ\,^2W5E?* !?CO$/U'Q'\D6OC)
M);&_2W0?)4Z_F3>W:MU;$OZQ.+RS5[SD(Q1*5O/IHI<?-?)YW 3YL0,(P"$G
MZR4_Y(V[Q1 ALY+A>W^:'*8P?L0CAP]9+R6&YZ/8CL7P-EBP7F2WSYOHJ^(N
M&PU#JKJ_>T+([T^8=UK7P*QKAKZ=XD]@,;DY'^")]1 /X2>$M_WQ'"9/S4\T
M'LL"(=7(-UNT6-JVUC^0B2-!:I,1Y,4@5((8^NHEL_I"K(\R@+=')P;O,=@@
M6<95SD34D2\@6XK(FREQJ#XL3P^8QQHE.?$BL9RK&)C5%X&7%;$>*K!(=9'2
MB5:, 2MO8_$*H:_M492JFH%.CSC@&JBPQ>J-PC7T[ TD=V762_&!;1@-G\HV
M!IAR1E<S/SL(/ZX?0%49_AQ(O]O;/CS13=5J=\OJ/,% 4'&AS\TST<N+INA*
MCN"-E].<M%R*I;F^.Y0X'3Z!(J!.2 >7-(2>J6()3<#HZ?Z$D.[4C([YW!D"
MI]<X9:9EJM7' #41)NE8<+"-=Q,&Z%T%[11@I0>J0!KZSEF@I\ G17\B"4S-
MU! -VJG_>;-<6MMWTQM;*09CSW[AYP*OG0/][ ?V4M)/@ 7& XFM8O#R2.;"
MGY!_$5F4&\=.UIT,^@*!RR/O^6XQGS.I[Y?TAP-+H 7*<7(3,ZP5-#/OAVYQ
ME$"QQL/TJQ1!.C(>SDB?=6Q72$/&PPQ%@G3XA23X V>(B=ZQ,]8$KSIDCVMC
M8R Y?-Q&'G#)W'_US7<S\_PR!CC0B2KTMM L;Q#HQ*_5R&R\JQ&?64#7[FN%
M-?(%$]$ /OG#DN )MI@N+9 7"VE@)O3YX+_H74%'1&_1P-6DS"?!0ZMCUH]X
M\B*(NWR1LSG$VT7OFH=%'$T/BOE4ZU_?)N-%QM&^#ER7$;I'(Y*ZHSQ@4/9H
M-8S'B?>ZS*=Z:SJZ;AG)TT*1LY$=Z&IC#2Q\[++%-&4'78[S W5U>X@A%I'<
MD]K$T>*Q&P;XY3Y!;=2T%S\8!:6T??/BBS=I=(>$?C0]^53^^L$%Z?OE>3(%
M7\OO!$:EUV:@&>D,\9T6/%]-GP]7^=5$SIL''*3,##JICJ6Q.2RWG(<>)<HD
MGW+_& OH2"A2]; KX)[@.2;NZ@X^##\]&Q#>XF'6&BY>C![:I8K=?3PNH799
MO*>4:78$1]ULW/E9@\?0\K6VYSWQLI^GTB$S:]^):Q?I3E0X;S?7PL)G+Y^^
MC>@A'6(ZYT#H!,BUHJTJV8-V/O/QO1_LX]L]FI[G,PS\F&5?N?FDEW*LEOJT
M)XMV=Z+_$=[='PQI9Q^N],G:.0E/^9106%8H%&^M/RJBHBJ=E.W)=#QL0OJC
MU3S1=*NY?SLHE$GK^,@TB7YG@]G4U/,P')W[G9*2S9Z#$IS'U!HFWVG<;7!M
MEPR8X%D.;4'&"'5*/\$753B1EB1(V(&V*1[F+'A?>[4."O75M*U-B<Y?R)2P
M4:\1HKK^Z W@=(PW+#S%0X\!5(=X;U7'C9:4L/,NM%T>N19)ZJ:A;T<_$QPB
M\E9H(IOY1//.\\C,5 ZF=/$/EQU/BBZX9S1O] :UA/<S+NI$<@QTT$ *D84(
MZE*1G>,' =9T)B.)548!C=[]>!9Q=\8,J;.94GG3W4XI:Q)HA6/V!*FW.Z69
M[$X-J3^>]MX1(=JIT;^I[Y\@X21P9$.)DPNUOY+_ SWOW)#\]@5'$?-^,0[4
M7FG!KS&,]U5]\%'W]=#QH',_"\8^._#3Z3DY_)1VY)S#RYIN'EH6  -\]ATQ
M= HJV/!, EDU:TG'.VNP4D>6PNBF_6+7.7'[7_GR(I%;)(77(LDK0\,]=N:D
M W4J]2?58CV</QEO2KZ-20T;X>W"(29D:CJEJOS;R?#/4/^5ZU6<TCRQ8?!9
MSP5!YZ1^L:R63Z04KP0H ;#1AT?W/AFUK'@UL@-TG(.:Q-GF+6ID[*=]F]\V
MA/S(JM>K:V6GI!B>RW7SM9H8/I$BN<R[X\&M=_<69_:W-R,'PX4H7^U2%W/R
M:&CD]2E%XBFJ9Y$?Y5;JQ)>$<6"\I>97#@UD>E!9<D&1N&H!!\,'!5BA"WY9
MVS[S<F!HLO*,CT3,N^A/;H_QP^.5!+J=(N,;U73>48'X>#;@(Z:W,^BR&D0G
MH0V1?*EV*R^'8K_O;GIWUC8#'EU;M[@_DA8+7EZ7MXD"JS@L6-?:#R=.4MYA
MR7R\1$50DT]AEWA:>)':77S6#A"R.(JW(KF3A_A*[D*%#QQ]2%L<.SHKKD8M
MQ1]1C(-0]L!FYM<49=,;NHU?>SD2]7K!S6D6XIV&(R5<NPC56TKY0QZV3@3M
M2U(&YW*>BSYGVX3V.[9_KU##(]0?W9,_'ZZ*\(Q;%+G>-?7.W.\EN?$((KCA
ME/ZYEZ)ZG;7E;)?"('.EF$6\02"[Z*&9C^M&+=B>.\(AU:(WS88Y9$E]9!+I
M+<LME>I0E-J]U";LLC<53+C*V@**_7#%+UU_:N.:*32GDHZ5?*6S?RY).J-M
MMD@L-$%:YE+>V#=#SQ\Q(7MQDDM30UEB%>1$;]$#+4>D9M:'2$BJE$ C\\Q9
M\8?:(;CL#:KADE?!]SCT0DB[E$"W_8[7J@%W>NMR]IV3]O29>$/C>Q^3_3\O
M$4YK>?#8&\G<OUN\;;CK&=JC^/XJ03>C^O<QA6C>JO$1CLIA9]GN,N$7_8V6
M7EW,QA:R52DC;G/VU$=F&[40>\=7.M6/NZ+;8CKIEO(X\=08/4]/.VY I93$
MB%BDSHRYGK,L,9P@1M/)=0.>]:TY.%<&Q7Q K:)^[*41=VI],H*+\ 3VWFE(
MB.0L2,MBVHE. TNNNV^Q#5>M.UILT+]4+]P%4]RCMOT7[0'XE^TEN$R:PX]_
M[36YKR$G;D)TO%V^=*GC]9#$!RLUD27@MT]?R!1V*@U'IO8%%?JO><75#Y0J
MU\H#.DDJ92D*<0XW[!CKK;VUX^&+:0B/=R6E[.F-%2^I4MC9<#;:];->LO(_
M&"[>N4ZG[6A '/79U_I]HF[Y--U239"UC*7^9POX2>'ZA\L$41_J+NY5A_3W
M^P_<=4(B1H[_?KE,:IOM<UTQRF"IOX,[KGY^_C3_7Q6;VQU@5_74QMHSTJW<
MO*ZD?;!W4WS>7U8BB7NY=:"4V7#'H0NI4;@QZ00K,($[:XY4[?@-3+%#8DRE
M:@AOO%RV*%P;S_6<WU#(F8R#G8P<'9SD*Z>X>(ZO'<*6/5/&(55]UQ>6$H>?
MU#]*H+>#0L\4KSXEWGVF('@9N7F:N]@G]'A_6G*YE*VF\NVA+GMOE]$'(';
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MYX_ 9Q-(&!M6Q;Z$B;\JVY>F%7S.Z 3>:L4 Q^);TPYM+208H&O+#0.8DF.
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M1#RM^J^>?O<5^*#>.$A)E%YB:5B)3PC"XA+:P^UK>Y#QR.BV7'<54_OY]NQ
M#-Q9N;.6NI=<PNU7T'?>FEJ>_M SQ%@@?+)4$"&HG!'':(G%4$.^[CIY?Q6Z
M@=&>]?(:X/!$U0%1XKF#6?_SD+6\ID!VF BT_59D=I.,E]3FX(.R8KA=X?3T
M-$89)O8[-D1TC?-5X/T>%>[R/*N.[PU>6Z/8AB]65>&[BX!M8>+/%/ZD'->
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MAYTFM DZ[C()H-RB]ZGV21JI"7^#[!#I8([<JNB.;GIV [J]&\0\=^]N,UU
M7\ZBJV(;G&VD$XMYG[3I?2<@9?]&FTE<X^T/$X%@''1L[[8%Y3O&1J^"'1.U
MZEB93ZPR6)R2TXC9&S5F; D<9YSO[]3J=;Y'"I$IULMBPVVCLXLW];0<[?!2
M3M_KO>/5;5SWBY%KYH%6]?PA=1[X%0(M:>.6<4$!Y Q8U0X*YVP<F-)J7;GB
MS[*0.]CZT?*D[@H=8^C_S$@MKIOK0G4O^'[0XQAG\766K@SFY1H1S?V_^.==
M*T>0-)N<M2V3#S-K<<]SKP$4H-;+]&9A&1)#*,6"?+VCRM@2+],<&4/??E%?
M>4KM;5=:>-VI)$[>WOY/BL6-?OMJAV^8UDR>?;2EQ<<*J;.'Q!-D24_X7@-H
M.:LE1C&SI7U@!:@H= U'_3DS$5[]F]P.M"[F:S*6/P[6%JH4G''16SR-%_[!
M0"6Y/0BO]!(XX/?H!T.@69A]>22LK]/;/EZD4J+/ZZSGH5<7H,39W.$425?A
M7]D-](9+!F-(!2**X\GZ1=AP  (=DJ"%/ Z?FK\)\Y#1F0Z7HKSZ+"R9YL^^
MY\",)XMU[$ D)<@ 2KVW@RRWM2J I-!)O%WB@>9Q/5'0*RMYX5C[M-/FR89L
M$L@5:SIOX7B^'D>&&.^N -?'<F@<5='9FL6K:@( >VF D='R*?T1G& LE)ZJ
M)#V@06WEP\.G<S9_3"<U!&]O#FN+][$:>EQM@N+^V-&6_C<N5YY&FDZFBIU5
MAE_-[2JTA:F1H0NF, D09VZ.6MLMGIPO[>'%EP56E]_PE+5@_ZHK_Z;5H^=V
MN^LR4N<&/_Y=JTFA^?9-"ML6?*%?B?P"T(2;L0F13*<!6I5?FUMK0KY^]F!2
MXFQ'A!)NIRILZ-O%M6UN*B,K\BWFQ&JR<B&PY\&F/ 6&5M'U@+5 @?]9:Y0J
MZ "L:%L7]S;*IRKCECRU[JM9\]GYKC53S?A\UY?,2_DW:PW>/1_3"1EJ;4!,
M\N&.N&+9UL>XLEW@1',-.A!1>/LR+X<V(WA#E3B0XU\=K>+Y-S.;PY\][M3Q
M6[_#//(F>"(#2U@(.=/_J4,[0"96722J+1ROTI;TJ9"]%"#[;[L9.MG\W<1,
MK'FWV-I%>-G=#9LCU-/3PRW#0W!)JRL&?:Y16)K;6N/X.1:DR]=G,AZ) $JQ
M Z4>%K%/BLZ41R6:AN;.%;'.EFS9$'HPP;-X"%;_KQP?2Z]R]4D/L/U]Q?$/
M[1N=O1?=6LN1;KD@^-GD):UP>(:W"2WK#^6N+-@-[WA&M6Y87P-Z-UO_I+4C
M]^D_&QF0,2N21-7R3Z6'$KI;JLK%#OIRTO;S/928R*#NM^\MKCW]3Q,G]Q<^
M^6GE;Y/!BK??."!O*RGC/W-@82AR8JFR[O!122_E.8G3M X2;6H]K<TUMRS&
MIC&K,>CQH$+.U20X&5*:9S;PC@\\,!N9$<P4H E/ZXW1S2RQ3%[0K4\PMJV[
M&D%*D+_@N=?+!5KB+Z%Z KB?=2:V(6JD, ='YR 6<Z.8#,9[4A0OX-E(22ZK
MD: A?;\%=TMF\I#PM#U]!%15$PHWJJM 9JO>KP]?_6:8N)Q1)M4F^? @\E'2
MW(12@:)'7-%N@"0XW;^>Z7WRW:S4(=726W#TKL?VB@:+K/>W\5RPT#;_MHI9
M!1'R%SW%[83Z+_MN)/(47^)7+-#^^(OV@^U-AXITQ&&G<B+M3 9+DT^T9#=O
M74Y@?0\&^T8BO/OC%#T1O[/%V?=YMV'AOW'),BJG5C$O:'.7 D[2N"]#WUX#
MABVJOXWE?#*H'P=*#[I^9IQ7("W.(%H.2N:XF&@ +)_XUHFB[VF))<TU=PUV
M3AY@(?!\F]C@1@N!OP04KOVQ/E2.<AU+7GG#7"WV&#3.".(\DC\9;0@!&'%D
MMB%VK%TDAQR'>;X*T.@J_W.WY+\8DF=-,DM&J3-BV8D9,<>?Z8^!X47^BS'W
MU)W\+D:\?KBQ72C5RGX5(FALX $&COD]6R(,S9I?WI&.>?K.AG_W_?I)<?9^
MM%?V58C<F9C@'Z-_/ ^$R2O+L\JW/\ .I-1:&T86I/(2R?%:TK7)1=_5&^??
MJ_8-T\,OW7$$;^XZY_$6JD.H![K>%V04)QSN2CY68LZ:+CL/)X$CQIU/2$N.
MU?9.[G@B?>V$YP6^XRNT>+K1"VSQ'_0Z*8!4.DX&I0^==YN4[.B^%:F[/Q[-
M21>OU5KIY_[R2ZX_Z@S@\?N4)-+C^!6]%/3E$K]<5Y6Y ST='J$A&MV^BR-#
M<)&O*7.[175"9118?=\63F.UB@<75Y)5D(AEW""?CV]S$QP:"W5)JD+/#WGW
MKA.NU]Z<>&>7/[N#4$ !-@#Z\!5*)B9K5N_N@-SXNKV.H*,+BB,D"U)@"O,E
M"FI-P(6\\?#RZ\:R8KL46+"L92)M./,N&J*A.^T^077I2D);GA(IKY4E\!_U
ML*+I-)1)J63M\&I@4!WSRKI8\Y+@V=T_\'_MEWG1:YIFD4D7E]=FY30T(M^H
MWZ/P5F:?"/Q5L*@'.P<V_E,4FC38C*VM_5DZE"[JG<H@ -I O_K1:+QR+U22
MK<KR/N=I^ON#3#$_9:[W7!S19K&1QO&WZ5BI *!H';9F@G""166:5ZS_RPH"
MX/7,OP!02P,$%     @ P(!O6)Q_Q?HX5@  U&T  !0   !H86QO+3(P,C0P
M,S$S7V<Y+FIP9^Q\!U@46Y9P(2H" J(@.4@0).<,;2(+2,X@23(--#FUJ*0F
M"0@H43)(DIQ!<LXY2\XY-TWWW\Z\]V;FS>[L[,[,[O[?MP7GJUM5Y]YS3[KG
MG*K[-6H"]0.X(R<E*P5@8&  ']!_ &KA&ES2S?(U "@H "P  -P"KF.( M?0
MK3L @"$78 E<1[<QT/\Z"8D_SP M %P;VJ0$L-#W;J.O)=  4&[^$>O_#@"0
M-G,R@IBYTFJ;0<S,C9P X,8'S#](E @MN>P/UW]KUT9&_*&-R<L- )&1?VK_
M2;H8"3]'_#_I_NG@X>+A$^'B$>'AI>46$.'E%N'A^C?OH?4 F %.@!$ 09]=
MT6:KC3[_;)NC[Z&U@K;]ZW063D[V(IR<=A .(U.PL1F'"=B6T\W(GI.;@XL3
M$ .YV1N96)LYT1J;F5O:B3/MU30PT5J:BC-I\BMP*=@_,[.PE/%P-%/U4%0S
M\; V$39E DG@X8BYB;C9VMNBK8#6S=;&#B+B)D[WA]%%T.V?MSGI),0<35^+
MJ#R7^@4#?27^ZUQ<75TY7'DYP([FG-S"PL*<7#R</#SL: QVB+N=DY$;NQV$
M_I<!GIM!3!PM[9TLP7:T/Z^-C,'.3N)TSLZ6IB*OC5[S&YN:\K,;&_&:LG-S
MFQJQ&YGR<K.;\O*:"O)S"_&\YC:F^X6\J<EOU.V='6W^0-O4A-/,QLS6S,X)
M@I8&-R<=YS^7)EI$XG]3_&@>T3@BSQS-C)S,GJ-!XJ>:V;EXV'EXU7Y5,P<O
M-Y<8Y^_PQ#A_-]'_ 6E)B)F:B)C\G!/8\8_D5<T<_C%MVUA*_&YI^2.CZ/M_
M;* IH,T/&QM;C///B?^U-#A_L3YTZS=;1?>D_6\X_C<3^9._F]FAG=P5[<VH
M:> 9@'7CQLT;U[%NWKAY"POK%@XA+EK&.,0$=VX3DA*3DY$2DY)04#,]H*!B
MI"(AI>.@8V1^Q,K&2D[+R<O)PL/$PLKR<Q ,K%NW<+!QB'!QB5@H22E9_M,'
MZCM > LC"Y, $X,.N$:(@4F(@6H!:-!QX0;&'XY?%TB,:YC7;]S$NH6-@XM&
M*+L#7,/ Q+QV'?/&C>OH4([AC7X.7">\<?<!]Y.;]Y2-L.@<B'A\(U)NT3\M
M:B16&=QGX#5V?(N-<Y^$E(R<\2$3\R,6/GX!02%AD6?/):6D963E5-74-32U
MM'5,3,U>FUM86D&<G%U<W=P]WKWW\P\(#()%1GV,CHG]]#DN-2T](S,K.^=K
M<4EI67E%955U4W-+:UM[1V?7T/#(Z-CXQ.34PN+2\LKJVOK&YL'AT?')Z=GY
M!?PG7Q@ )L:OQ[_)%R&:KVO7KV->Q_K)%\8UUY\(A-=O/."^>?>),I:1PSTZ
M'M];1$\C4HH:L>EY5?:)C1T'<>XS\"TP'OQD[0^<_7V,O?TO<?8;8W_B:PJX
MC8F!5AXF(0 "X%(PYB_7_EF0,[M%_CJ9-@P%*)>60P9?)[Y,_AY7Y, 98<LV
M,;N28F-.]KW7O;\Y_WY[BXXMLJ)0MSW;0&^F^'ZE_L)C8)] L<'_!J9T&GL+
M)_C4+T8@P&Z/BVLZ7.^X5=(L1VM3IC_+0'?V*R7O$Y9*U75[Z^B#T@]ND.^V
MF9;<%P\WZKO!=XLZYF1MS),^TP3F)>-.H8 FBH.["MCQ5S0O2T,7A7]TY'8B
M9*!#;\H#( Z%ZZ>Q>&#G7*U&G@0^1[W4;_"W$$WC..%%[5<1IJ'^ZH.^UST)
M#>3Y]P*VZ^G/0\Z32-?\1MAD!LBP;?!)PO!%E[VM,\_5S;S-%[1]IB(EB<9O
MRKLMDSZP%UXK BW-^9:E3 _JY3? "AX<C*6D6G6#B6LU4(!%>32QKQEP+R$J
MB7> H-KZ.D)R=+S)1,N30IU$L&UN\K,>'2V-^X7P&GV($Q].SS&,E:19)"8E
M9T*6(^L4^Y:7M$0RQWF&'OYGX>LT.E-?)+7*Y+'W#/HHMBPYTOK.[YIQ5&Y%
M]TG*5)07NIT&07#UVE*2"&DYOIRQCN!+NA-$BX?#G%' 7>V5]"'G%UUOKL[U
MOCD@&G0VG+JW' Y4=1ONWBQ'=H>!N5P5BLJA+#A%\X,&K^;O.?.:PO,<UA<[
MS:;8XI:O\@H<$LQILNJY>Z47K1-5CA8EWD$RK\+/!O)BJ%WV!8J7+SZ=,679
MO*3,RAFY'SL6]_ZA-6ZV72I>:2T/EA[<U#5K^F+^=?".@6'R-_<D Y?==J%^
MH5YW)3_GK61\+\;J$9LTF&PD(EO;E[7CL<<=J,[UZ'Z=U$K)@X! MA-;(FMR
M[Q 7G19?.BW]D*)=6KR6!.@=,9PBA\503Y4#?F3L@JXHDX(0AMBXW[?^J\'2
M?<=;:P,#]T5%6,-&O#3SH#9:%CH*H=FCF>7:N_5#RZUV#I%5!HKBTF62)DOB
M+S@:3'(GIYN_6@H4.M;+FA"]X9!63=J:3]EYK)U81KP:OK1W;_K<<;B%A/QU
MXE4BVUL!==<CRN6WS0G,'?0)<<.E!SY56#"^69!!48G_O)K"/H6+\<'!=V-%
M[(T!UR]L?8NP([3,B(\VJS^*B%KL3V_TO$Q\^B-WAJOO^2O"I ":@ +6_/VV
MZB3Z_9/R](@+!=H'2WTNWX3H^6Y\SI<D>DF;"F,&_C<!+<^'9MK])WMZ[ 'O
M$=(+P;G9"%;HJRGOYKT[A@$]S\/2++:F]XEGE1_O.HC$OG-6NF-HL=2B&3/N
MXF*UXU2T&YKAPO #76%<)^L0H]$)4#L'WR@[3?1>N/6CJ*HL098IF2^$\K9#
MWYZ27=F<\F/]A+;0A=PZT7;RMA*^;_QUA[[D:51+6<HA+B?\PX.2UX3Z*<\%
M4$"+8$QL-7N/P+BR),/=TIXN<H'KKU[1['$AK&:0U"-Y",XL2P_*F.NZM-H+
M]<%>FI20)!X)FR1QZ^Q4WYE%)\Y;UCHWW^6R^^TDD"<>PP[<+;P"N=PQ:4\9
MG(X+*A3"#MEY9OF%5:Q;0[#30XRT:R*^(]5?PZZ="><3--_3LC*@BWK)I6";
MJZAO\E1VPM54X/'V;(FV!.D^\6IH[B9GMOXSB)F#U5B$C<FJNVF(W?577FF4
M]_1GB6Y,KHXU$#B'2I 4E1L2Z.GN,7+L;E?,,#,-Y& =/"SWDEP0E]O2&#P1
MQ_'DJQI6[3[<5<NS$7W%O-1 /(&63,0T=LS8 Z>NX??7I)[XL8?)G/;:WT&
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M^[ITU[P?*$_(4D, \6XK+"EZ<6FM6OPAK&G(RSS5FD(#M\S_-0J(X46$GKN
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M,D9>$M;3JA ;ASAT8(KS&@0LS=^?WDBBB!.7.*4I[0=-3&G-0R>#^@X;'9\
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MP(OS<$Q9%  U05>\?W4C=Q8^2K!FZ"$!V71+OCCCK$JH(QZ!-E4<@*\PTE%
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M?3@"5HR1NK'8,H5K=N?^C"93U%;"ZF?(%\M8R.<"]HJ.[]=<OZUS"6$-J**
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MA*PQE3D?JWM;Y>]!&Z$Q<\^O%/WRP:WPL_E^2$3I.=36B"D V>FV&<?;_8"
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M^/YYK,HT1!0;##YE;U&YJ'&W_84 'G_,R2M]238ZDD7MN0D].:]8Y/\:<*J
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M;RTR,#(T,#,Q,U]G,2YJ<&=02P$"% ,4    " # @&]8P,F(>\Y2  "(:@
M%0              @ %_J $ :&%L;RTR,#(T,#,Q,U]G,3 N:G!G4$L! A0#
M%     @ P(!O6!Y[Q-8K"P( A(H" !4              ( !@/L! &AA;&\M
M,C R-# S,3-?9S$Q+FIP9U!+ 0(4 Q0    ( ," ;UA9+S*H(HL! ",: @ 5
M              "  =X&! !H86QO+3(P,C0P,S$S7V<Q,BYJ<&=02P$"% ,4
M    " # @&]8F2B$>Z4T  !N>P  %               @ $SD@4 :&%L;RTR
M,#(T,#,Q,U]G,BYJ<&=02P$"% ,4    " # @&]8J1(S(6TV  !T/P  %
M            @ $*QP4 :&%L;RTR,#(T,#,Q,U]G,RYJ<&=02P$"% ,4
M" # @&]85CB>\](D  !L.0  %               @ &I_04 :&%L;RTR,#(T
M,#,Q,U]G-"YJ<&=02P$"% ,4    " # @&]8N/L4R!)E   -C@  %
M        @ &M(@8 :&%L;RTR,#(T,#,Q,U]G-2YJ<&=02P$"% ,4    " #
M@&]8PM=J/-)H  !)C@  %               @ 'QAP8 :&%L;RTR,#(T,#,Q
M,U]G-BYJ<&=02P$"% ,4    " # @&]8=;OBM\1S  !DS0  %
M    @ 'U\ 8 :&%L;RTR,#(T,#,Q,U]G-RYJ<&=02P$"% ,4    " # @&]8
MCY76-@]=  ! =0  %               @ 'K9 < :&%L;RTR,#(T,#,Q,U]G
M."YJ<&=02P$"% ,4    " # @&]8G'_%^CA6  #4;0  %
M@ $LP@< :&%L;RTR,#(T,#,Q,U]G.2YJ<&=02P$"% ,4    " # @&]8\;?S
M&(@#   L&@  %0              @ &6& @ :&%L;RTR,#(T,#,Q,U]L86(N
M>&UL4$L! A0#%     @ P(!O6#+\KS6\ @  *@\  !4              ( !
M41P( &AA;&\M,C R-# S,3-?<')E+GAM;%!+!08     $0 1 &($  ! 'P@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>halo-20240313_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:halo="http://www.halozyme.com/20240313"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="halo-20240313.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-2">0001159036</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-3">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Halozyme Therapeutics, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-5">&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.635%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.105%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023 Pay-Versus-Performance Table&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Value of Initial Fixed $100 Investment Based on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary of Compensation Table for PEO ($) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation Actually Paid to PEO ($) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Compensation Actually Paid to Non-PEO NEOs ($) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shareholder Return ($) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Peer Group Total Shareholder Return ($) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income (Millions) ($) (5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue (Millions) ($) (6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,820,858&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,608,264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,568,762&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,639&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208.46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,696,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,817,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;660.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,453,294&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,992,078&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,398,657&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;443.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,518,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,374,731&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,812,287&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,356,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;240.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-6" unitRef="usd">11820858</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-7" unitRef="usd">-3608264</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-8" unitRef="usd">3568762</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">160639</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-10" unitRef="usd">208.46</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-11" unitRef="usd">118.87</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-12" unitRef="usd">281600000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-5" id="f-13" unitRef="usd">829300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-14" unitRef="usd">9696978</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-15" unitRef="usd">22817187</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-16" unitRef="usd">2415581</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-17" unitRef="usd">3154512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-18" unitRef="usd">320.93</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-19" unitRef="usd">113.65</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-5" id="f-20" unitRef="usd">202100000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-2" decimals="-5" id="f-21" unitRef="usd">660100000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-22" unitRef="usd">7453294</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-23" unitRef="usd">5992078</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-24" unitRef="usd">2398657</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-25" unitRef="usd">591581</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-26" unitRef="usd">226.79</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-27" unitRef="usd">126.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-28" unitRef="usd">402700000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-3" decimals="-5" id="f-29" unitRef="usd">443300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-30" unitRef="usd">6518876</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-31" unitRef="usd">24374731</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-32" unitRef="usd">1812287</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-33" unitRef="usd">4356681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-34" unitRef="usd">240.89</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-35" unitRef="usd">126.42</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-36" unitRef="usd">129000000.0</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">268000000.0</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-42">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;Helen I Torley was our CEO for each of the four years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#x2019;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.&lt;/span&gt;See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2023, 2022 and 2021. The 2020 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar year 2021. The average compensation for the Non-PEO NEOs for 2023 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in calendar year 2023, 2022 and 2021, respectively.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-3" id="f-38">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-1" id="f-39">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-4" id="f-40">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-2" id="f-41">Helen I Torley</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-44">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2023 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,820,858&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,088,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,803,183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,608,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-43">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2023 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.808%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.171%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2023 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,568,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,806,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;160,639&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-45" unitRef="usd">11820858</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-5" decimals="0" id="f-46" unitRef="usd">10000018</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-47" unitRef="usd">6462883</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-48" unitRef="usd">-8088804</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-49" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-50" unitRef="usd">-3803183</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-51" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-52" unitRef="usd">-3608264</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-53" unitRef="usd">3568762</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-54" unitRef="usd">2700053</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-55" unitRef="usd">1755631</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-56" unitRef="usd">-1806488</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-57" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-58" unitRef="usd">-657214</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-59" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-60" unitRef="usd">160639</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-62">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;/span&gt;&lt;div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"&gt;&lt;img alt="CAP vs TSR.jpg" src="halo-20240313_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-61">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;/span&gt;&lt;div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"&gt;&lt;img alt="CAP vs TSR.jpg" src="halo-20240313_g8.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:708px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-63">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This column shows Halozyme&#x2019;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our net income for each of those years.&lt;/span&gt;&lt;div style="text-align:center"&gt;&lt;img alt="CAP vs Net Income.jpg" src="halo-20240313_g9.jpg" style="height:369px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-64">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt"&gt;This column shows Halozyme&#x2019;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2023 executive compensation program because it is used in &lt;/span&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;determining each of our NEO&#x2019;s annual 2023 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last four years against our revenue for each of those years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;img alt="CAP vs Revenue.jpg" src="halo-20240313_g10.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-65">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2023 with Halozyme performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenue (as used in our 2023 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Adjusted EBITDA (as used in our 2023 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Stock Price (including relative TSR, as used in our PSUs awarded in 2021, 2022 and 2023 and as described in the Compensation Discussion and Analysis above)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.&lt;/span&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c-17" id="f-66">Revenue</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-18" id="f-67">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-19" id="f-68">relative TSR</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-20" id="f-69">stock price</ecd:MeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
